TWI255266B - Benzodiazepine derivatives - Google Patents

Benzodiazepine derivatives Download PDF

Info

Publication number
TWI255266B
TWI255266B TW89120913A TW89120913A TWI255266B TW I255266 B TWI255266 B TW I255266B TW 89120913 A TW89120913 A TW 89120913A TW 89120913 A TW89120913 A TW 89120913A TW I255266 B TWI255266 B TW I255266B
Authority
TW
Taiwan
Prior art keywords
phenyl
mmol
butyl ester
general procedure
nitro
Prior art date
Application number
TW89120913A
Other languages
Chinese (zh)
Inventor
Geo Adam
Alexander Alanine
Erwin Goetschi
Vincent Mutel
Thomas Johannes Woltering
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority to TW89120913A priority Critical patent/TWI255266B/en
Application granted granted Critical
Publication of TWI255266B publication Critical patent/TWI255266B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The present invention relates to compounds of general formula, wherein X is a single bond or an ethynediyl group, wherein, in case X is single bond, R1 is halogen or phenyl which is optionally substituted with halogen, lower alkyl, halo-lower alkyl, lower alkoxy, halo-lower alkoxy, or cyano; in case X is an ethynediyl group, R1 is phenyl, optionally substituted with halogen, lower alkyl, halo-lower alkyl, lower cycloalkyl, lower alkoxy or halo-lower alkoxy; R2 is halogen; hydroxy; lower alkyl; lower halo-alkyl; lower alkoxy; hydroxymethyl; hydroxyethoxy; lower alkoxy-(ethoxy)n (n=1 to 4); lower alkoxymethyl; cyanomethoxy; morpholine-4-yl; thiomorpholine-4-yl; 1-oxothiomorpholine-4-yl; 1,1-dioxothiomorpholine-4-yl; 4-oxo-piperidine-1-yl; 4-alkoxy-piperidine-1-yl; 4-hydroxy-piperidine-1-yl; 4-hydroxyethoxy-piperidine-1-yl; 4-lower alkyl-piperazine-1-yl; alkoxycarbonyl; 2-dialkylamino-ethylsulfanyl-; N,N-bis lower alkylamino lower alkyl; carbamoylmethyl; alkylsulfonyl; lower alkoxycarbonyl-lower alkyl; alkylcarboxy-lower alkyl; carboxy-lower alkyl; alkoxycarbonylmethylsulfanyl; carboxymethylsulfanyl; 1,4-dioxa-8-aza-spiro[4.5]dec-8-yl; carboxy-lower alkoxy; cyano-lower alkyl; 2,3-dihydroxy-lower alkoxy; carbamoylmethoxy; 2-oxo-[1,3]-dioxolan-4-yl-lower alkoxy; (2-hydroxy-lower alkyl)-lower alkyl amino; hydroxycarbamoyl-lower alkoxy; 2,2-dimethyl-tetrahydro-[1,3]dioxolo[4,5c]-pyrrol-5-yl; lower alkoxy-carbamoyl-lower alkoxy; 3R-hydroxy-pyrrolidin-1-yl; 3,4-dihydroxy-pyrrolidin-1-yl; 2-oxo-oxazolidin-3-yl; lower alkyl-carbamoylmethoxy; or aminocarbamoyl-lower alkoxy; R3 is a 5 or 6 membered aryl or heteroaryl which are optionally substituted by halogen; cyano; nitro; azido; hydroxy; carboxy; morpholine-4-carbonyl; carbamoyl; thiocarbamoyl; N-hydroxycarbamoyl; trimethylsilyl-ethynyl; or lower alkyl; lower alkoxy; halo-lower alkyl; 4-lower alkyl-piperazine-l-carbonyl; lower alkylcarbamoyl which are optionally substituted by amino, lower alkylamino, acylamino, oxo, hydroxy; lower alkoxy, lower alkylthio, or carboxy which is optionally esterified or amidated; or an optionally substituted five-membered aromatic heterocycle, which may be optionally substituted by amino, lower alkylamino, acylamino, oxo, hydroxy; lower alkoxy, lower alkylthio, or carboxy which is optionally esterified or amidated, or lower alkyl which is optionally substituted by halogen, amino, lower alkylamino, acylamino, hydroxy, lower alkoxy, lower alkylthio, acyloxy, lower alkenoyl, lower alkylsulfinyl, lower alkylsulfonyl, cycloalkylsulfinyl, cycloalkylsulfonyl, hydroxyimino, alkoxyimino, carboxy which is optionally esterified or amidated, lower alkenyl, oxo, cyano, carbamoyloxy, sulfamoyl which is optionally substituted by lower alkyl, or amidino which is optionally substituted by lower alkyl, -C(NRR')=NR"" (where R, R' and R"" are hydrogen or lower alkyl) and their pharmaceutically acceptable addition salts. The compounds according to the present invention can be used for treating or preventing acute and/or chronic neurological disorders such as psychosis, schizophrenia, Alzheimer's disease, cognitive disorders and memory deficits.

Description

1255266 A7 B7 五、發明說明(1 ) 本發明係關於通式I化合物 r1、乂 -------------裝—— (請先閱讀背面之注意事項再^1^4頁) 其中 X爲單鍵或乙块二基,其中 若X爲單鍵,則 R1爲齒素或苯基,其係視情況被南素、低碳烷基、卣基低 碳烷基、低碳烷氧基、鹵基低碳烷氧基或氰基取代; 若X爲乙炔二基,則 R1爲苯基,視情況被_素、低碳烷基、卣基低碳烷基、低 碳環烷基、低碳烷氧基或卣基低碳烷氧基取代; .線 R2爲自素;羥基;低碳烷基;低碳_烷基;低碳烷氧基; 羥甲基;羥乙氧基;低碳烷氧基-(乙氧基)n (n = 1至4);低碳 經濟部智慧財產局員工消費合作社印製 烷氧基甲基;氰基甲氧基;嗎福啉斗基;硫代嗎福啉斗基 ·,1-嗣基硫代嗎福淋-4-基;1,1-二嗣基硫代嗎福琳-4*•基;4-酉同 基-六氫ρ比淀-1-基;4-燒氧基-六氫ρ比淀-1-基;4-輕基-六氫ρ比 淀-1-基;4-¾乙氧基-7Τ氮ρ比淀-1-基;4-低碳燒基-7Τ氯Ρ比啡_ 1-基;烷氧羰基;2-二烷胺基-乙硫基-;Ν,Ν-雙低碳烷基胺 基低碳烷基;胺甲醯基甲基;烷基磺醯基;低碳烷氧基羰 基-低碳:基;奴基叛基-低碳:fe基;叛基-低碳燒基;燒氧 羰基甲硫基;羧甲硫基;1,4-二氧-8·氮-螺[4.5]癸-8-基;幾基-低石反坑氧基;氣基-低碳:1¾基;2,j-一每基-低碳坑氧基;胺 -4 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266 A7 B7 經濟部智慧財產局員工消費合作社印製 五、發明說明(2 ) 甲醯基甲氧基;2-酮基-[1,3]-二氧伍圜_4_基-低碳烷氧基;(2-經基低碳燒基)-低碳院胺基;輕基胺甲醯基-低碳淀氧基; 2,2-二甲基-四氫-[1,3]二氧伍圜并[4,5cp比洛-5-基;低碳燒氧基 -胺甲醯基-低碳規氧基;3R-#i基-四氫p比洛小基;3,4-二輕基-四氫吡咯-1-基;2-酮基j号唑啶-3-基;低碳烷基-胺甲醯基甲 氧基;或胺基胺甲醯基-低碳烷氧基; R·5爲5或6員芳基或雜芳基,其係視情況被鹵素、氰基、硝 基、疊氮基、羥基、羧基、嗎福啉-4·羰基、胺甲醯基、胺 硫甲酿基、N-經基胺曱醯基、三甲基石夕虎基-乙块基取代; 或爲低碳烷基;低碳烷氧基;卣基-低碳烷基;4-低碳烷基-7T氫?比命-1-談基;低碳燒基胺甲酿基,其係視情況被胺基 、低碳烷胺基、醯基胺基、酮基、羥基、低碳烷氧基、低 碳烷硫基或羧基取代,該羧基係視情況被酯化或醯胺化; 或爲視情況經取代之五員芳族雜環,其可視情況被胺基、 低碳烷胺基、醯基胺基、酮基、羥基、低碳烷氧基、低碳 院硫基或視情況被酯化或酿胺化之複基或低碳燒基取代, 此低碳燒基係視情沉被卣素、胺基、低碳燒胺基、醯基胺 基、羥基、低碳烷氧基、低碳烷硫基、醯氧基、低碳烯醯 基、低碳燒基亞續si基、低碳燒基橫酿基、環燒基亞續酿 基、環燒基績sS基、亞胺基、燒氧基亞胺基、視情況被 酯化或醯胺化之羧基、低碳晞基、酮基、氰基、胺甲醯基 氧基、視情況被低破烷基取代之胺磺醯基或甲脒基取代, 此甲脒基係視情況被低碳烷基、-C(NRR’)=NRn (其中R、R,及 Rn係爲氫或低碳燒基)取代, -5- (請先閱讀背面之注意事項再 -裝 頁) ;線· 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266 A7 B7 經濟部智慧財產局員工消費合作社印製 五、發明說明(3 ) 及其藥學上可接受之加成鹽。 已令人驚訝地發現通式I化合物係爲代謝移變麩胺酸酯受 體拮抗劑。式I化合物之特徵爲有價値之治療性質。 在中樞神經系統(CNS)中,刺激之傳輸係藉由被神經元送 出之神經遞質與神經受體之交互作用進行。 L-麩胺酸爲在CNS中最常出現之神經遞質,於很大數目 之生理過程中扮演一項重要角色。依賴越胺酸g旨之刺激受 體,係被區分成兩個主族群。第一個主族群係構成配位體 控制之離子通道。代謝移變麩胺酸酯受體(mGluR)係構成第 二個主族群,且進一步歸屬於G-蛋白質偶合受體之組群。 目前,此等mGluR之八種不同成員係爲已知,且其中一部 份甚至具有亞型。以對於二次新陳代謝產物合成之不同影 嚮,及對低分子量化學化合物之不同親和力等結構參數爲 基礎,可將此八種受體細分成三個亞族群:mGluRl與 mGluR5歸屬於第I族群,mGluR2與mGluR3歸屬於第II族群, 及 mGluR4、mGluR6、mGluR7 及 mGluR8 歸屬於第 III 族群。 歸屬於第II族群之代謝移變麩胺酸酯受體之配位體,可 用於治療或預防急性及/或慢性神經病症,譬如精神病、 精神分裂症、阿耳滋海默氏疾病、認知病症及記憶不足。 關於此點之其他可治療之適應徵,係爲因分流手術或移 植物所造成之限制腦部功能,不良之血液供應至腦部,脊 髓傷害,頭部傷害,因懷孕所造成之缺氧,心動停止及低 血糖。其他可治療之適應徵爲慢性與急性疼痛,亨丁頓氏 舞蹈症,肌萎縮性側索硬化(ALS),因AIDS所造成之痴呆症 -6- (請先閱讀背面之注意事項再 裝 頁) _ .線_ 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 12552661255266 A7 B7 V. INSTRUCTIONS (1) The present invention relates to a compound of the formula I, r1, 乂------------- (please read the notes on the back and then ^1^4) Wherein X is a single bond or an ethylenic diyl group, wherein if X is a single bond, R1 is a dentate or a phenyl group, which is optionally a ruthenium, a lower alkyl group, a decyl lower alkyl group, and a lower Alkalkoxy, halo lower alkoxy or cyano substituted; if X is acetylene diyl, then R1 is phenyl, optionally _, lower alkyl, decyl lower alkyl, lower carbon Cycloalkyl, lower alkoxy or fluorenyl lower alkoxy substituted; .R 2 is a self group; hydroxy; lower alkyl; lower _alkyl; lower alkoxy; hydroxymethyl; Ethoxy; lower alkoxy-(ethoxy)n (n = 1 to 4); alkoxymethyl; cyanomethoxy; Trolopinyl; thiolofosfolininyl, 1-mercaptothionorfos-4-yl; 1,1-dimercaptothiopheneline-4*•yl; 4-anthracene - hexahydro ρ-pred-1-yl; 4-alkoxy-hexahydrop-p-but-1-yl; 4-light-hexahydro-p-pred-l-yl; 4-3⁄4 ethoxy- 7ΤNitrogen ρ than precipitate-1-yl; 4-lower calcinyl-7Τchloropyrene than -1-yl; alkoxycarbonyl; 2-dialkylamino-ethylthio-; Ν, Ν-double low carbon Alkylamino-based lower alkyl; amine-mercaptomethyl; alkylsulfonyl; lower alkoxycarbonyl-low carbon: group; nucleyl-low carbon: fe-based; rebel-low carbon Calcination; oxycarbonylmethylthio; carboxymethylthio; 1,4-dioxo-8.nitro-spiro[4.5]dec-8-yl; alkyl-lowstone anti-pitoxy; gas-low Carbon: 13⁄4 base; 2,j-one per base-low carbon pit oxygen; amine-4 - This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1255266 A7 B7 Ministry of Economic Affairs Intellectual Property Bureau Employees' Consumption Cooperatives Printed 5, Inventions (2) Mercaptomethoxy; 2-keto-[1,3]-dioxosyl-4-yl-lower alkoxy; (2-based Low carbon alkyl)-low carbon amine group; light amine amine methyl ketone-low carbon oxy group; 2,2-dimethyl-tetrahydro-[1,3] dioxo oxime [4,5 cp Bilo-5-yl; lower alkoxy alkoxy-amine-mercapto-lower carbon oxy; 3R-#i-yl-tetrahydrop-pyrrolidyl; 3,4-di-light-tetrahydropyrrole- 1-yl; 2-keto-J-oxazolidin-3-yl; lower alkyl-amine-methyl fluorenyl An oxy group; or an aminoamine carbaryl-lower alkoxy group; R.5 is a 5 or 6 membered aryl or heteroaryl group, which is optionally halogen, cyano, nitro, azide or hydroxy. , a carboxyl group, a phenanthroline-4.carbonyl group, an amine carbaryl group, an amine thioglycolyl group, an N-alkylamine sulfhydryl group, a trimethyl sulphate-ethyl group; or a lower alkyl group; Carboalkoxy; fluorenyl-lower alkyl; 4-lower alkyl-7T hydrogen? a low-carboyl amine-based base, which is optionally subjected to an amine group, a lower alkylamino group, a mercaptoamine group, a ketone group, a hydroxyl group, a lower alkoxy group, a lower alkane. Substituted by a thio or carboxy group which is optionally esterified or amided; or a optionally substituted five membered aromatic heterocyclic ring which may optionally be an amine group, a lower alkylamino group or a decylamino group. a keto group, a hydroxy group, a lower alkoxy group, a low carbon thiol group or a complex or a low carbon alkyl group which is optionally esterified or aminated, and the low carbon alkyl group is sucrose, Amine group, low carbon amine group, mercaptoamine group, hydroxyl group, lower alkoxy group, lower alkyl alkyl group, decyloxy group, lower carbenyl group, low carbon alkyl group, Si group, low carbon burning A ketone group, a cyclization base, a cyclization base, an oxyalkylene group, an alkylene group, an alkyloxy group, a carboxyl group which is optionally esterified or amided, a low carbon sulfhydryl group, a ketone group. , cyano, carbamoyloxy, optionally substituted with a sulfonyl group or a fluorenyl group substituted with a low alkyl group, which is optionally a lower alkyl group, -C(NRR') = NRn (wherein R, R, and Rn are hydrogen or low carbon burned) Substitute, -5- (Please read the notes on the back and then install the page); Line · This paper scale applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1255266 A7 B7 Ministry of Economic Affairs Intellectual Property Bureau Employee Consumption Cooperatives Print 5, Invention Notes (3) and its pharmaceutically acceptable addition salts. It has surprisingly been found that the compounds of formula I are metabolically shifted glutamate receptor antagonists. The compounds of formula I are characterized by the therapeutic properties of valuable quinones. In the central nervous system (CNS), the transmission of stimulation is performed by the interaction of neurotransmitters and neuroreceptors delivered by neurons. L-glutamic acid is the most frequently occurring neurotransmitter in the CNS and plays an important role in a large number of physiological processes. Relying on the stimulating receptor for the transaminic acid g, it is divided into two main groups. The first major group constitutes the ion channel controlled by the ligand. The metabolic shifting glutamate receptor (mGluR) constitutes the second major group and is further assigned to the group of G-protein coupled receptors. Currently, eight different members of these mGluRs are known, and one of them has even subtypes. Based on the different influences on the synthesis of secondary metabolic products and the structural parameters such as the different affinities of low molecular weight chemical compounds, the eight receptors can be subdivided into three subgroups: mGluRl and mGluR5 belong to the group I group. mGluR2 and mGluR3 belong to the group II group, and mGluR4, mGluR6, mGluR7 and mGluR8 belong to the group III. A ligand belonging to the metabolically shifting glutamate receptor of Group II, which can be used to treat or prevent acute and/or chronic neurological disorders such as psychosis, schizophrenia, Alzheimer's disease, cognitive disorders And lack of memory. Other treatable indications at this point are limited brain function due to shunt surgery or grafts, poor blood supply to the brain, spinal cord injury, head injury, hypoxia due to pregnancy, Cardiac arrest and hypoglycemia. Other treatable indications are chronic and acute pain, Huntington's disease, amyotrophic lateral sclerosis (ALS), dementia caused by AIDS-6- (please read the back note and reload the page) ) _ . Line _ This paper size applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1255266

五、發明說明(4 ) 經濟部智慧財產局員工消費合作社印製 ’眼睛傷¥ ’視網膜病,原發性巴金生氏徵候簇或因藥劑 所造成之巴金生氏徵候簇,以及會導致麩胺酸酯缺乏功能 之症狀,譬如肌肉痙攣、驚厥、偏頭痛、尿失禁、菸癮、 阿片癮、焦慮、嘔吐、運動困難及抑鬱。 本發明之目的爲式I化合物及其藥學上可接受之鹽本身, 及作烏醫藥活性物質,其製造,以根據本發明化合物爲基 礎之藥劑及其製造’以及根據本發明化合物在控制或預防 削述種類疾病上之用途,及個別關於相應藥劑之製造。 在本發明範圍内之較佳式I化合物,係爲其中R3爲苯基者 ,此苯基係在間位被取代,取代基爲氰基,自素,或視情 況被低碳垸基或甲硫基取代之咪唑基,1,2,孓三唑基,Γ,2,4_ 二峻基’或視情況被低碳烷基取代之異呤唑基。 下列爲此種化合物之實例: 3-(8-氯基-4-酮基-7-苯基乙炔基-4,5-二氫-3Η-苯并[b][l,4]二吖庚 因-2-基)-苯甲腈; 3-[8-(4-甲基-六氫吡嗜小基)冰酮基:苯基乙炔基_4,5_二氫_3h_ 苯并[b][l,4]二吖庚因:基]_苯甲腈; 3-(心氯基酮基-7-苯基-4,5-二氫-3H-苯幷[b][l,4]二吖庚因_2_基)-苯甲腈; ^ [4-(3-氰基-苯基)-2-酮基各苯基乙決基-2,3-二氫-1H-苯并[b][l,4] 一叶庚因-7-基硫基]-醋酸甲酉旨; 2- [4-(3-氰基-苯基)_2_酮基各苯基乙炔基-2,3-二氫-苯幷叫⑴4] 二吖庚因-7-基]-乙醯胺; 3- (8-甲氧基-4-酮基-7-苯基乙炔基-4,5-二氫-3H-苯幷[b][i,4]二口丫 -7 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) (請先閱讀背面之注意事項再 頁) 訂· ί線- 1255266 A7V. Description of invention (4) Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed 'eye wounds' 'retinopathy, primary Bajinsheng's syndrome or Bajinsheng's syndrome caused by drugs, and will lead to glutamine Acid esters lack symptoms of function such as muscle spasms, convulsions, migraine, urinary incontinence, cravings, opioid addiction, anxiety, vomiting, difficulty in movement, and depression. The object of the present invention is a compound of the formula I and a pharmaceutically acceptable salt thereof, and a pharmaceutically active substance, which is produced, a medicament based on the compound according to the invention and a process for its manufacture, and a compound according to the invention for controlling or preventing The use of the type of disease and the manufacture of the corresponding agent. Preferred compounds of formula I within the scope of the invention are those wherein R3 is phenyl, the phenyl group is substituted at the meta position, the substituent is cyano, self-primed, or optionally lower thiol or a Thio-substituted imidazolyl, 1,2, oxatriazole, anthracene, 2,4-distenyl' or an isoxazolyl group optionally substituted by a lower alkyl group. The following are examples of such compounds: 3-(8-Chloro-4-keto-7-phenylethynyl-4,5-dihydro-3indole-benzo[b][l,4]dioxane 4-yl)-benzonitrile; 3-[8-(4-methyl-hexahydropyridyl)yl ketone: phenylethynyl-4,5-dihydro_3h_benzo[b ][l,4]dioxagenin:yl]_benzonitrile; 3-(cardochloroketo)-7-phenyl-4,5-dihydro-3H-benzoquinone[b][l,4 Dioxagen-2-yl)-benzonitrile; ^[4-(3-cyano-phenyl)-2-oneylphenylethyl-2,3-dihydro-1H-benzene And [b][l,4] hexylglycine-7-ylthio]-acetic acid formazan; 2-[4-(3-cyano-phenyl)-2- ketophenylphenylethynyl- 2,3-Dihydro-benzoquinone (1)4] Dioxepin-7-yl]-acetamide; 3-(8-methoxy-4-keto-7-phenylethynyl-4,5 -Dihydro-3H-benzoquinone [b][i,4]Two 丫-7 - This paper size applies to China National Standard (CNS) A4 specification (210 X 297 mm) (please read the notes on the back first) Page) set · ί line - 1255266 A7

五、發明說明(5 ) 庚因-2-基)-苯甲腈; 3- (8-氰基甲基+酮基·7-苯基乙块基_4,5_二氫-讯_苯幷间[以]二 吖庚因-2-基)-苯甲腈; ’ 4_(3_破苯基>7-(2·甲氧基-乙氧基)-8-苯基乙炔基-1,3-二氫苯并 [b][l,4]二口丫庚因 _2·酉同; 4- (3-咪唑-i-基-苯基>7_(2_甲氧基_乙氧基>8_苯基乙块基_丨,3_二 氫苯幷[b][l,4]二吖庚因-2-酮; [RS]各[4_酮基冬(2_酮基-[I,3]二氧伍圜冰基甲氧基苯基乙炔 基-4,5-二氫-3H-苯幷[b][l,4]二吖庚因j基]-苯甲腈; 7- 羥甲基-4-(3-咪唑小基-苯基)各苯基乙炔基],3_二氫苯幷 [b][l,4]二吖庚因-2-酮; [4-(3-咪唑-1-基-苯基>2-酮基各苯基乙炔基_2,3_二氫_ih-苯幷 [b][l,4]二吖庚因基氧基]_乙腈; 8- (4-氟苯基乙炔基羥甲基冰(3_咪唑小基_苯基p,3_二氫苯 幷[b][l,4]二 σ丫庚因 酮; 7- (2-¾基-乙氧基)冰(3_咪唑-1-基-苯基)各苯基乙炔基_丨,3_二氫 苯并[b][l,4]二吖庚因_2_酮; 經濟部智慧財產局員工消費合作社印製 8- (4-氟苯基)-7-[4-(2-經基-乙氧基)-六氫吡啶小基]_4_(3』米唑+基 -苯基)-1,3-二氫苯幷[b][1,4]二吖庚因1酮; 8-(4-氟苯基)-7-羥基-4-(3-咪唑小基-苯基)-i,3-二氫苯并[b][l,4]二 吖庚因-2-酮; H2-氟苯基)-7-甲氧基_4-[3-(2-甲基-咪唑小基)_苯基;μ,3_二氫苯 幷[b][l,4]二吖庚因_2_酮; 8-(2-氟苯基)-7-羥基冰(3-[1,2,3]三唑+基-苯基Η》二氫苯幷 -8- 本紙張尺度適用中國國家標準(CNS)A4規格(21〇 X 297公爱)" ""V. Description of the invention (5) Glycine-2-yl)-benzonitrile; 3-(8-cyanomethyl+keto-7-phenylethylidene-4,5-dihydro-infrared_benzene幷 [to] dioxin-2-yl)-benzonitrile; '4_(3_ phenylene) 7-(2. methoxy-ethoxy)-8-phenylethynyl- 1,3-Dihydrobenzo[b][l,4]dioxapyrene_2·酉; 4-(3-imidazolium-i-yl-phenyl)7_(2_methoxy_ Ethoxy>8-phenylethylidene-丨,3_dihydrophenylhydrazine[b][l,4]dioxepin-2-one; [RS]each [4-keto-based winter (2) -keto-[I,3]dioxosyloxy-yloxyphenylethynyl-4,5-dihydro-3H-benzoquinone [b][l,4]dioxine j-based]- Benzoonitrile; 7-hydroxymethyl-4-(3-imidazolyl-phenyl)phenylphenylethynyl],3-dihydrophenylhydrazone [b][l,4]dioxine-2- Ketone; [4-(3-imidazol-1-yl-phenyl)-2-ketophenylphenylethynyl-2,3-dihydro-ih-benzoquinone[b][l,4]dioxin Insyloxy]-acetonitrile; 8-(4-fluorophenylethynylhydroxymethyl ice (3_imidazole small group_phenyl p,3_dihydrophenylhydrazone [b][l,4]diσ丫Heptinone; 7-(2-3⁄4-yl-ethoxy) ice (3_imidazol-1-yl-phenyl) phenyl ethynyl 丨, 3_dihydrobenzo[b][l,4 ] Dioxin 2 -1 ketone; 8-(4-fluorophenyl)-7-[4-(2-trans)-ethoxy)-hexahydropyridine small base printed by the Intellectual Property Office of the Ministry of Economic Affairs ]_4_(3"Mizozol+yl-phenyl)-1,3-dihydrophenylhydrazine[b][1,4]dioxine-1-one; 8-(4-fluorophenyl)-7-hydroxyl -4-(3-imidazolyl-phenyl)-i,3-dihydrobenzo[b][l,4]dioxan-2-one; H2-fluorophenyl)-7-methoxy 4-[3-(2-methyl-imidazolyl)-phenyl; μ,3-dihydrophenylhydrazone [b][l,4]dioxine-2-one; 8-(2 -Fluorophenyl)-7-hydroxy ice (3-[1,2,3]triazole+yl-phenylhydrazine" dihydrophenylhydrazine-8- This paper scale applies to China National Standard (CNS) A4 specification (21 〇X 297 public))"""

I 255266I 255266

五、 發明說明(6 [b][l,4]二吖庚因-2-酮; 8-(2-氟苯基>7_羥基_4_[3_(2-甲基_咪唑_丨_基)_笨基]_丨,3_二氫苯幷 [b][l,4]二吖庚因-2,; 8-(2_氟苯基>7,基冰[3-(2-甲硫基-咪唑小基)·笨基Η,、二氫苯 幷[b][l,4]二吖庚因_2_酮; 1(2,5-二氟苯基甲氧基冬(h1,2,3]三唑小基_苯基p,3_二氫苯 幷[b][l,4]二吖庚因_2_酮; 8-(2-氟苯基>7_羥基冬[3_(3_甲基_異呤唑_5_基)_笨基]_丨,3_二氫苯 幷[b][l,4]二吖庚因-2-酮; 3-[7-(2,5-二氟苯基)各羥基·4_酮基_4>二氫_3H_笨并问二吖 庚因-2-基]-苯甲腈; 8-(4-氣苯基乙块基)_7_經基邻_咪唑小基_苯基阳心氫苯幷 [b][l,4]二吖庚因-2-酮;及 =4-氟苯基乙炔基>7_#基邻似3]三峻]_基-苯基)二氯 苯幷[b][l,4]二〆「庚因酮。 式I化合物,其中以口塞吩基,較佳爲口塞吩_2-基,其係視 情況被氰基或ή素取代;或尺3爲峨咬基,較佳爲说咬_4_基 ,其係視情況在2-位置上被氰基或_素取代,或其中R3爲 嗓唑基’其係視情在2-位置上被咪唑基或4_甲基咪唑基取 代,亦爲較佳的。 下列化合物係爲特佳的: 5仰'氟苯基>8·甲氧基.4_酮基4,5·二氫视笨幷_,4]二叮庚 因-2-基]-屢吩-2-甲腈; 2-[7-(2-氟苯基)-8-羥基I酮基_4,5_二氫_m_苯幷[b][i,4]二吖庚因- ___ ·9- I紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公髮— -------------裝—— (請先閱讀背面之注意事項再頁) •線· 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明(7 ) 2-基]<塞吩-3-甲腈; --------------裝i I (請先閱讀背面之注咅?事項再頁) ‘[Η2·氟苯基甲氧基-4-酮基-4,5-二氫—3H-苯幷[b][l,4]二,丫庚 因-2-基]-吡啶甲月青; 4·!>(4-氟苯基)-8-¾基-4-酮基-4,5-二氫-3H-苯幷[b][l,4]二吖庚因· 2-基]-吡啶-2-甲腈; 4_[7-(2-氟苯基)冬羥基-4-酮基-4,5-二氫-3H-苯幷[b][l,4]二吖庚因_ 2-基]-吡啶-2-甲腈;及 8-(2-氟苯基)_4-[2-(4-甲基-咪唑-1-基)_嘍唑4-基]_1,3_二氫苯幷 [bB,4]二吖庚因-2-酮。 本發明化合物之所有互變異構物形式,亦包含於此。 於本説明文中使用之”低碳烷基”一詞,係表示直鏈或分 枝狀飽和烴殘基,具有1-7個碳原子,較佳係具有1-4個碳 原子’譬如甲基、乙基、正-丙基、異-丙基等。 於本説明文中使用之”低碳環烷基"一詞,係表示環狀飽 和烴殘基’具有3-5個碳原子,較佳係具有3個碳原子,譬 如環丙基。 π低碳燒氧基,,一詞,係表示低碳烷基殘基,其具有前文 定義之意義,經由氧原子結合。 經濟部智慧財產局員工消費合作社印製 Π鹵素” 一詞包含氟、氣、溴及碘。 ”5或6員芳基或雜芳基”一詞,包含苯基、噻吩基、吡啶 、邵份水合之ρ比淀。 五員芳族雜環’’之措辭,係包含吱喃、魂Ρ坐、咪σ坐、Ρ比 唑、1,3-0塞唑、1,3_巧峻、1,2-巧。坐、ι,2〇塞唑、l52,3-三峻、 1,2,4-二唆、ι,2,4-吟二唑、ι,2,3-呤二唑、ι,2,4-噻二唑、1,2,3- -10 ΜΆ - 、 * 公 97 2 X 10 2 /V 格 規 A4 S) N (C ί 保 1255266 A7 經濟部智慧財產局員工消費合作社印製 _____ B7_ ____五、發明說明(8 ) 口塞二吐及四峻。 通式I化合物及其藥學上可接受之鹽,可根據下述方法製 成: 圖示A 2 + r3^^〇 〇r r3^c〇2r F^/^^NHBoc 回流 IVa , > R = Et, Bu« 一般程序 下FA Γί苯酸) 一般程序 Ρ 根據圖示A,通式I化合物,其中X、ri、r2及R3均如上 述,其可經由醯化-去保護-環化順序,製自通式Π化合物: 例如,使通式II化合物與二氧陸圜烯酮IV反應,其中r3 係如上述,於惰性溶劑中,譬如甲苯或二甲苯,在高溫下 ,較佳係在80 C與160 C下進行,而獲致通式化合物。 或者,通式ΙΠ化合物亦可經由例如通式π化合物與少酮 酯(通式IVa)之反應而製成,其中R3係如上述,使用如關於 與二氧陸圜晞嗣反應所述之相同條件進行。 然後,使通式III化合物中之BOC保護基分裂,及伴隨著 已去除保護之化合物之環化作用,產生所要之通式丨化合物 。或者,可以任何其他適當胺基保護基,譬如Fm〇c或芊氧 羰基(Z),代替BOC基團。 此去保護-環化步驟,可經由以例如布朗司特酸,譬如三 氟醋酸,於惰性溶劑譬如二氣甲烷(DCM)中,處理通式冚 -11 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公髮)—--:---—V. DESCRIPTION OF THE INVENTION (6 [b][l,4] Dioxepin-2-one; 8-(2-fluorophenyl>7_hydroxy_4_[3_(2-methyl-imidazole_丨_) Base)_stupyl]_丨,3_dihydrophenylhydrazine[b][l,4]dioxine-2,; 8-(2-fluorophenyl>7, base ice [3-(2) -methylthio-imidazole small group), stupid base, dihydrophenylhydrazine [b][l,4]dioxine-2-one; 1 (2,5-difluorophenylmethoxy winter (h1,2,3)triazole small group_phenyl p,3_dihydrophenylhydrazine[b][l,4]dioxepin-2-one; 8-(2-fluorophenyl>7 _hydroxy winter [3_(3_methyl_isoxazole_5_yl)_styl]_丨, 3_dihydrophenylhydrazine [b][l,4]dioxepin-2-one; 3 -[7-(2,5-difluorophenyl)each hydroxy-4-ylketo group_4>dihydro_3H_ stupid and dioxin-2-yl]-benzonitrile; 8-(4 - phenylphenyl group) _7_ carbyl o-imidazolyl phenyl phenyl phenyl hydrazine [b] [l, 4] dioxin-2-one; and = 4-fluorophenyl acetylene Base >7_#基邻似3]三峻]_yl-phenyl)dichlorophenylhydrazine [b][l,4]dioxin "heptinone. Compound of formula I, which is a thiophene group, Preferably, it is substituted by a cyano group or a halogen; or the ruler 3 is a bite base, preferably a bite_4_ base, It is also preferred to be substituted at the 2-position with a cyano group or a cyano group, or wherein R3 is a carbazolyl group, which is optionally substituted with an imidazolyl group or a 4-methylimidazolyl group at the 2-position. The following compounds are particularly preferred: 5 fluoro fluorophenyl > 8 methoxy. 4 keto 4,5 · dihydro spectroscopy _, 4] dioxepin-2-yl]- Phen-2-carbonitrile; 2-[7-(2-fluorophenyl)-8-hydroxylketo- 4,5-dihydro-m_benzoquinone[b][i,4]dioxine - ___ ·9-I paper size applies to China National Standard (CNS) A4 specification (210 X 297 cc - ------------- installed - (please read the back note first page) • Line· Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 A7 B7 V. Description of Invention (7) 2-Based] <Cenphene-3-carbonitrile; ------------ --Install i I (please read the note on the back first? Click again) '[Η2·Fluorophenylmethoxy-4-keto-4,5-dihydro-3H-benzoquinone[b][l , 4] 2, azepine-2-yl]-pyridinecaricillin; 4·!>(4-fluorophenyl)-8-3⁄4yl-4-keto-4,5-dihydro-3H -benzoquinone [b][l,4]dioxine-2-yl]-pyridine-2-carbonitrile; 4_[7-(2-fluorophenyl)-hydroxy-4-keto-4,5 -dihydro-3 H-benzoquinone [b][l,4]dioxine-2-yl]-pyridine-2-carbonitrile; and 8-(2-fluorophenyl)_4-[2-(4-methyl- Imidazol-1-yl)-indazole 4-yl]_1,3-dihydrophenylhydrazone [bB,4]dioxine-2-one. All tautomeric forms of the compounds of the invention are also included herein. The term "lower alkyl" as used in this specification, denotes a straight or branched saturated hydrocarbon residue having from 1 to 7 carbon atoms, preferably having from 1 to 4 carbon atoms, such as methyl. , ethyl, n-propyl, iso-propyl and the like. The term "lower cycloalkyl" as used in this specification means that the cyclic saturated hydrocarbon residue has 3-5 carbon atoms, preferably 3 carbon atoms, such as cyclopropyl. Carbon alkoxy, the term, means a lower alkyl residue which has the meaning defined above and is bonded via an oxygen atom. The Ministry of Economic Intelligence's Intellectual Property Office employee consumption cooperative prints halogen halogen. The term contains fluorine, gas, Bromine and iodine. The term "5 or 6 membered aryl or heteroaryl" includes phenyl, thienyl, pyridine, and hydrazine. The wording of the five-membered aromatic heterocyclic ring '' includes 吱 、, Ρ Ρ sit, σ 坐 sit, Ρ azole, 1,3-0 stopper, 1, 3 _ _ _ _ _ _ _ _ _ Sitting, ι, 2 〇 oxazole, l52, 3-sanjun, 1,2,4-dioxime, ι, 2,4-oxadiazole, iota, 2,3-oxadiazole, ι, 2, 4 -thiadiazole, 1,2,3- -10 ΜΆ - , * public 97 2 X 10 2 /V Grid A4 S) N (C ί保1255266 A7 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing _____ B7_ ____ V. INSTRUCTIONS (8) Oral sputum and Sijun. The compound of formula I and its pharmaceutically acceptable salt can be prepared according to the following method: Figure A 2 + r3^^〇〇r r3 ^c〇2r F^/^^NHBoc reflux IVa , > R = Et, Bu« FA Γ 苯 benzoic acid under normal procedure General procedure Ρ According to the diagram A, a compound of formula I, where X, ri, r2 and R3 As described above, it can be prepared from a general oxime compound via a deuteration-deprotection-cyclization sequence: for example, a compound of the formula II is reacted with dioxostrenone IV, wherein r3 is as described above, in an inert solvent. For example, toluene or xylene is obtained at a high temperature, preferably at 80 C and 160 C, to give a compound of the formula. Alternatively, the oxime compound of the formula can also be prepared, for example, by reacting a compound of the formula π with a ketone ester (Formula IVa), wherein R3 is as described above, using the same as described for the reaction with dioxanthine Conditions are carried out. The BOC protecting group in the compound of formula III is then cleaved and the cyclization of the compound which has been removed is accompanied to produce the desired compound of the formula 。. Alternatively, any other suitable amine protecting group, such as Fm〇c or 芊oxycarbonyl (Z), may be substituted for the BOC group. This deprotection-cyclization step can be carried out by treating the formula 冚-11 with, for example, a bronzee acid such as trifluoroacetic acid in an inert solvent such as di-methane (DCM) - the paper size is applicable to the Chinese national standard (CNS) ) A4 size (210 X 297 mil) ---:----

-------------裝—— (請先閱讀背面之注意事項再15^4頁) 0 線· 1255266 A7 B7 五 經濟部智慧財產局員工消費合作社印製-------------Installation - (Please read the notes on the back and then 15^4 pages) 0 Line · 1255266 A7 B7 Five Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing

發明說明(9 ) 化合物,以進行之。反應較佳係在0°C與50°C間之溫度下進 行。可有利地亦在此反應混合物中,使用甲苯醚或1,3-二甲 氧基苯,作爲碳陽離子清除劑。 圖 TJT B ΛΑDESCRIPTION OF THE INVENTION (9) Compounds are carried out. The reaction is preferably carried out at a temperature between 0 ° C and 50 ° C. It is advantageously also possible to use toluene ether or 1,3-dimethoxybenzene as a carbocation scavenger in this reaction mixture. Figure TJT B ΛΑ

NHBoc VNHBoc V

根據圖示B,通式II化合物,其中R1爲如上文關於其中X 爲單键之化合物所述,且R2如上述,其可經由不同途徑, 依R1之性質而定,製自通式V之碘化合物,其中R2係如上 -12- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -------------裝--- 請先閱讀背面之注意事項再頁) · 丨線- 1255266 A7 五、發明說明(10 ) 述。如圖示B中所示,主要步驟爲Suzuki_與Stiue_型之偶合 反應,於一氧化碳存在或不存在下進行。關於個別通式π 化合物之正確條件,可參閱實驗部份。 通式V化合物,其中R2如上述,其可經由不同途徑製備 ,依個別殘基R2而定:According to the formula B, a compound of the formula II, wherein R1 is as described above for a compound wherein X is a single bond, and R2 is as defined above, which may be derived from a different route, depending on the nature of R1, from the formula V Iodine compounds, of which R2 is as above -12- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) -------------Installation --- Please read the back first Precautions (page 2) · 丨 line - 1255266 A7 V. Description of invention (10). As shown in Figure B, the main step is a coupling reaction of Suzuki_ with a Stiue_ type, carried out in the presence or absence of carbon monoxide. For the correct conditions for individual π compounds, see the experimental section. Compounds of the general formula V, wherein R2 is as defined above, may be prepared via various routes depending on the individual residue R2:

ίΓΥΝαr2人〆Ν比 XIΓΥΝαr2 human 〆Ν XI

NaOAc/ HOAc -般程序 A R2NaOAc/ HOAc - General procedure A R2

ΧΠ 圖示C no2 NK ·ΧΠ Picture C no2 NK ·

一般程序 BGeneral procedure B

RR

no2 NHBoc Va (請先閱讀背面之注意事項再1 裝No2 NHBoc Va (please read the notes on the back and then install 1

GP B,方法a :雙光氣,EtOAc,77°C ;然後是t-BuOHGP B, method a: diphosgene, EtOAc, 77 ° C; then t-BuOH

GP B,方法 b : Boc2 0, Cs2 C03,2- 丁酮,52°CGP B, method b: Boc2 0, Cs2 C03, 2-butanone, 52 ° C

GP B,方法 c : i) b〇c2 〇, DMAP,THF ; ii) TFA,DCM, 0°C 如圖示C中所示,通式Va化合物,其中R2爲低碳烷基、 鹵素或烷氧羰基,其可經由碘化作用,製自已知之通式沿 化合物,及具有通式XII之合成中間物之後續保護作用。 此碘化步驟可經由例如使用氯化碘,在醋酸中,於醋酸 鈉存在下進行。此反應可例如在2(rc與8(rc間之溫度下進 行0 胺耳能基之保護,可經由例如通式XJJ化合物與碳酸二_第 三-丁酯之反應,於鹼譬如碳酸绝存在下達成。此反應可在 極性溶劑中,譬如丙酮或丁酮等,在2(rc與6(rc間之溫度 下進行。 如圖示D中所示,通式Vb與%之化合物,其中R2係個別 經由硫或氮原子連接(R2表示例如嗎福啉斗基;硫代嗎福啉 · :線· 經濟部智慧財產局員工消費合作社印製 -13- 1255266 A7 B7 五、發明說明(11 ) 基斗基;二烷胺基;羧甲硫基等),其可於適當鹼存在下, 經由與個別胺類或硫醇之親核性取代反應,製自中間物 XIII。 --------------裝--- (請先閱讀背面之注意事項再^1^4頁) · 圖示D 氮親核劑 q|A^Anhb〇c RR,NH 不含溶劑或 1 丫γΝ〇2 DIPEA/PhMe Δ RFTN^^^NHBoc ΧΠΙ 一般程序 C Vb 硫親核劑 Cl 人〆 NHBoc RSH NaOMe DMF Ji 1 RS^^NHBoc ΧΠΙ 一般程序 D Vc 經濟部智慧財產局員工消費合作社印製 此反應較佳係於極性非質子性溶劑中進行,譬如二甲基 甲醯胺、N-甲基-四氫吡咯酮或二甲亞颯等。此鹼可選自立 體位阻之胺類,譬如Hunig氏鹼,烷氧化物,譬如甲醇鈉與 第三-丁醇鈉,或氫化物,譬如氫化鈉。此反應可在20°C與 110°C間之溫度下進行,依欲被合成之個別化合物而定。 通式Vd化合物,其中R2係經由氧原子連接(R2表示例如低 碳烷氧基、低碳i烷氧基、低碳環烷氧基、低碳烷氧基-低 碳烷氧基等),其可按例如圖示E中所示製成: :線. -14- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266 A7 B7 五、發明說明(12 ) 氧親核劑GP B, Method c: i) b〇c2 〇, DMAP, THF; ii) TFA, DCM, 0 °C As shown in Figure C, a compound of the formula Va wherein R2 is lower alkyl, halogen or alkane An oxycarbonyl group which can be prepared by iodination from a known general formula, and a subsequent protection of a synthetic intermediate of the formula XII. This iodination step can be carried out, for example, by using iodine chloride in acetic acid in the presence of sodium acetate. This reaction can be carried out, for example, at a temperature between 2 (rc and 8 (rrc) to protect the amine group, which can be carried out, for example, by reaction of a compound of the formula XJJ with di-tert-butyl carbonate, in the presence of a base such as carbonic acid. This reaction can be carried out in a polar solvent such as acetone or methyl ethyl ketone, etc., at 2 (rc and 6 (temperature between rc. As shown in Figure D, the compound of the formula Vb and %, where R2 Each is linked via sulfur or a nitrogen atom (R2 represents, for example, morphine porphyrin; thiomorphine: line · Ministry of Economic Affairs, Intellectual Property Office, Staff Consumer Cooperative, Printing - 13 - 1255266 A7 B7 V. Inventions (11) Base group; dialkylamino group; carboxymethylthio group, etc., which can be prepared from the intermediate XIII by nucleophilic substitution reaction with a specific amine or thiol in the presence of a suitable base. ---------装--- (Please read the precautions on the back and then ^1^4 pages) · Figure D Nitrogen nucleophile q|A^Anhb〇c RR, NH does not contain solvents or 1 丫γΝ〇2 DIPEA/PhMe Δ RFTN^^^NHBoc ΧΠΙ General procedure C Vb Sulfur nucleophile Cl Human 〆 NHBoc RSH NaOMe DMF Ji 1 RS^^NHBoc ΧΠΙ General procedure D Vc This reaction is preferably carried out in a polar aprotic solvent such as dimethylformamide, N-methyl-tetrahydropyrrolidone or dimethyl hydrazine, etc. It may be selected from sterically hindered amines such as Hunig's base, alkoxides such as sodium methoxide and sodium tributoxide, or hydrides such as sodium hydride. The reaction may be between 20 ° C and 110 ° C. The temperature is carried out depending on the individual compound to be synthesized. The compound of the formula Vd wherein R2 is bonded via an oxygen atom (R2 represents, for example, a lower alkoxy group, a lower alkoxy alkoxy group, a lower alkoxy alkoxy group, Lower alkoxy-lower alkoxy, etc.), which can be made, for example, as shown in Figure E: -14. - This paper scale applies to the Chinese National Standard (CNS) A4 specification (210 X 297 PCT) 1255266 A7 B7 V. Description of invention (12) Oxygen nucleophile

CI XX。2CI XX. 2

ROH KOHROH KOH

圖示E .N0oIllustration E.N0o

XIVXIV

DMSO 一般程序 EDMSO General Procedure E

R〇、^、NhL XVR〇, ^, NhL XV

一般程序 B R〇 v 'NHBoc YdGeneral procedure B R〇 v 'NHBoc Yd

GP B,方法a :雙光氣,EtOAc, 77°C ;然後是t-Bu〇H GP B,方法 b : Boc2 〇,Cs2 C〇3,2-丁酮,52°C GP B,方法 c : i) Boc2 0, DMAP,THF ; ii) TFA,DCM,0°C 氧烷基化GP B, Method a: diphosgene, EtOAc, 77 ° C; then t-Bu〇H GP B, Method b: Boc2 〇, Cs2 C〇3, 2-butanone, 52 ° C GP B, Method c : i) Boc2 0, DMAP, THF ; ii) TFA, DCM, 0 ° C oxyalkylation

(PPh^RhCI DABCO NO. R-X KHCO, -------------裝--- (請先閱讀背面之注意事項再頁) NHBOC EtOH 一般程序(PPh^RhCI DABCO NO. R-X KHCO, ------------- Pack--- (Please read the notes on the back page again) NHBOC EtOH General procedure

HO NHBocHO NHBoc

XIXXIX

XX DMF 一般程序 sXX DMF general procedure s

RcrRcr

Vd .no2 "NHBoc · 於適當鹼存在下,經由與個別醇之親核性芳香族取代反 應,及接著爲胺官能基之保護作用。該鹼可選自布朗司特 鹼種類,譬如氫氧化鉀等。此反應較佳係於極性非質子性 溶劑中,譬如二曱基甲醯胺、N-甲基-四氫吡咯酮或二甲亞 石風等,在20°C與100°C間之溫度下進行。 胺官能基之保護作用,可於鹼譬如碳酸铯存在下,經由 例如通式XV化合物與碳酸二-第三-丁氧基酯反應而達成。 此反應可在極性溶劑中,譬如丙酮或丁酮等,在20°C與60 °C間之溫度下進行。 達成此保護步驟之另一種方法,是首先使具有通式XV之 化合物中之胺官能基,轉變成異氰酸酯,其方式是與光氣 或光氣等效物,於適當鹼存在下反應,然後將其以第三-丁 -15- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) :線- 經濟部智慧財產局員工消費合作社印製 經濟部智慧財產局員工消費合作社印製 1255266 A7 _B7_ 五、發明說明(13 ) 醇處理,而得所要之通式Vd化合物。 達成此保護步驟之另一種適當方法,是首先使具有通式 XV之化合物中之胺官能基,轉變成其相應之二-Boc化合物 ,其方式是於4-二甲胺基吡啶(DMAP)存在下,與過量碳酸 二-第三-丁氧基酯反應,然後在二氯甲烷中,將其以2當量 TFA處理,而得所要之通式Vd化合物。 此步驟之逆轉,意即首先在主要中間物XIV上進行親核性 芳族取代,及胺官能基之第二次保護,如合成圖示E中所 示,亦可應用於具有通式Vb與Vc之化合物(合成圖示D)。 製備通式Vd化合物之又另一種方法,係使用〇_烯丙基化 合物XIX,及進行脱烯丙基化-烷基化順序,如圖示E中所 概述。脱烯丙基化作用較佳係經由過渡金屬催化異構化作 用,於例如铑(I)-鹽,例如Wilkinson氏觸媒[(PPh3 )3 RhCl],或 I巴(II)-鹽,譬如[(PPh3 )2PdCl2 ]存在下進行,接著爲所形成乙 烯醚之含水酸水解作用。此程序之實例可參閱J. Org. Chem. 1973, 38, 3224。酚XX烷基化成所要之通式Vd化合物,可在適 當溶劑中,於鹼存在下,以通式R-X之親電子性試劑進行 ,其中R具有低碳烷基、低碳烯基、醋酸烷基酯或芊基之 意義,且X表示脱離基,例如峨根、溴根、甲燒續酸根或 甲苯續酸根,。此反應較佳係在極性非質子性溶劑中進行, 例如氣化溶劑,譬如二氯甲烷、氣仿或二氯乙烷,或醯胺 ,例如二甲基甲醯胺、二甲基乙醯胺及N-甲基-四氫吡咯酮 ,或亞ί風,例如二甲亞颯。鹼可選自立體位阻之胺類,譬 如Hunig氏驗,燒氧化物,譬如甲醇納與第三-丁醇鈉,氫 -16- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ----- I 1--------· I I (請先閱讀背面之注意事項再頁) 訂· _ -·丨線· 1255266 A7 B7 五、發明說明(14 ) 化物,譬如氫化鈉,氫氧化物,譬如氫氧化鉀,碳酸鹽, 譬如碳酸钾,或氫碳酸鹽,譬如碳酸氫钾。此反應可在-20 °C與80°C間之溫度下進行,依欲被合成之個別化合物而定 。爲合成具有通式Vd之〇-第三-丁基化合物,可將酚XX以 DMF -二-第三-丁基縮醛,在甲苯或苯中,於80°C下處理, 如在合成期刊1983, 135中所述者。 根據合成圖不F ’Vd .no2 "NHBoc · The reaction with a nucleophilic aromatic substitution with an individual alcohol in the presence of a suitable base, followed by protection of the amine functional group. The base may be selected from the group consisting of bronzee bases such as potassium hydroxide and the like. Preferably, the reaction is carried out in a polar aprotic solvent such as dimethylformamide, N-methyl-tetrahydropyrrolidone or dimethyl sulphur, at temperatures between 20 ° C and 100 ° C. get on. The protection of the amine functional group can be achieved by reacting, for example, a compound of the formula XV with di-tertiary-butoxycarbonate in the presence of a base such as cesium carbonate. This reaction can be carried out in a polar solvent such as acetone or methyl ethyl ketone at a temperature between 20 ° C and 60 ° C. Another way to achieve this protection step is to first convert the amine functional group in the compound of formula XV to an isocyanate by reacting it with phosgene or phosgene equivalent in the presence of a suitable base, and then It applies the Chinese National Standard (CNS) A4 specification (210 X 297 mm) on the third-D-15-sheet scale: Line - Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Print Economy Ministry Intellectual Property Bureau Staff Consumption Cooperative Print 1255266 A7 _B7_ V. Description of the invention (13) Alcohol treatment to obtain the desired compound of the formula Vd. Another suitable method for achieving this protection step is to first convert the amine functional group of the compound of formula XV to its corresponding bis-Boc compound by the presence of 4-dimethylaminopyridine (DMAP). The reaction is carried out with an excess of di-tertiary-butoxyl carbonate and then treated with 2 equivalents of TFA in dichloromethane to give the desired compound of formula Vd. The reversal of this step means that the nucleophilic aromatic substitution and the second protection of the amine functional group are first carried out on the main intermediate XIV, as shown in the synthetic scheme E, and can also be applied to have the general formula Vb and Compound of Vc (Synthesis Figure D). Yet another method of preparing the compound of formula Vd is to use the oxime-allyl compound XIX, and to carry out the deallylation-alkylation sequence, as outlined in Figure E. Deallylation is preferably via a transition metal catalytic isomerization such as a ruthenium (I) salt, such as a Wilkinson's catalyst [(PPh3)3 RhCl], or an Ib (II)-salt, such as The reaction is carried out in the presence of [(PPh3)2PdCl2] followed by aqueous acid hydrolysis of the vinyl ether formed. An example of such a procedure can be found in J. Org. Chem. 1973, 38, 3224. Alkylation of phenol XX to the desired compound of formula Vd can be carried out in the presence of a base in the presence of a base in the presence of a base, wherein R has a lower alkyl group, a lower alkenyl group, an alkyl acetate group. The meaning of an ester or a thiol group, and X represents a cleavage group such as valerate, bromide, decanoate or toluene. Preferably, the reaction is carried out in a polar aprotic solvent such as a gasifying solvent such as dichloromethane, gas or dichloroethane, or a guanamine such as dimethylformamide or dimethylacetamide. And N-methyl-tetrahydropyrrolidone, or argon, such as dimethyl hydrazine. The base may be selected from sterically hindered amines such as Hunig's test, calcined oxides such as sodium methoxide and sodium terbutyrate, hydrogen-16-. The paper size applies to the Chinese National Standard (CNS) A4 specification (210 X 297). ----) I 1--------· II (Please read the notes on the back page again) Order · _ -·丨线· 1255266 A7 B7 V. Description of invention (14) For example, sodium hydride, hydroxide, such as potassium hydroxide, carbonate, such as potassium carbonate, or hydrogen carbonate, such as potassium hydrogencarbonate. This reaction can be carried out at a temperature between -20 ° C and 80 ° C depending on the individual compound to be synthesized. For the synthesis of a ruthenium-tertiary-butyl compound of the formula Vd, the phenol XX can be treated with DMF-di-tertiary-butyl acetal in toluene or benzene at 80 ° C, as in the synthesis journal Said in 1983, 135. According to the composite map, F ’

圖示F 碳親核劑 -------------裝 i I (請先閱讀背面之注意事項再頁)Figure F Carbon nucleophile ------------- Install i I (please read the notes on the back first page)

丨' •nhfT丨' •nhfT

r-ch2co2r, KOBu1 DMSO 100 °CR-ch2co2r, KOBu1 DMSO 100 °C

RO,CRO, C

n〇2 NHR R R”=H XVII R"=BocXVIN〇2 NHR R R”=H XVII R"=BocXVI

LiCILiCI

DMSO H20 100 0CDMSO H20 100 0C

no2 NHR RM=H Vf RM= Boc Ve R”=H R,,= BocNo2 NHR RM=H Vf RM= Boc Ve R”=H R,,= Boc

XIV XIII 「|gpbXIV XIII ”|gpb

Cl-moietyCl-moiety

MeQ2C ,〇cMeQ2C, 〇c

no2 NhU ICI NaOAcNo2 NhU ICI NaOAc

HOAc GP A 3-胺基-4-磧基 苯甲酸甲酯HOAc GP A 3-Amino-4-mercaptobenzoic acid methyl ester

Me〇2C R = H XXIMe〇2C R = H XXI

,n〇2 "NHR,n〇2 "NHR

ubh4 MeOHUbh4 MeOH

THF 0eCTHF 0eC

no2 NHBoc X X = OH X = OTHP -X = C1 Vk—I Χ = ΝΜ^ :線· R:L?fNo2 NHBoc X X = OH X = OTHP -X = C1 Vk—I Χ = ΝΜ^ : Line · R:L?f

Vh —] Vi 經濟部智慧財產局員工消費合作社印製 通式Ve與Vf化合物,其中R2係經由碳原子連接(R2表示例 如低碳烷氧基-羰基-甲基;氰基-甲基等),其可製自化合 物XIII或XIV,其方式是例如於鹼存在下,與丙二酸酯或丙 二酸半酯反應,接著經由脱羧作用,移除羧酸烷基酯之一 。正確反應條件係隨著個別化合物之身分而改變,且係描 述於實例中。 -17- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266 A7 _B7_ 五、發明說明(15 ) 主要中間物XIII與XIV可按照已於圖示C中所述之方式製 成。 對於帶有一個碳部份之通式Vh至VI化合物而言,此合成 係從已知之3-胺基-4-硝基苯甲酸甲酯開始。如在合成圖示C 中所述之標準碘化作用,會獲致碘化物XXI,其依次可以 Boc-基團保護。此曱酯之還原,可例如經由以硼氫化鋰、 硼氫化鋼或氫化二異丁基銘處理,在非質子性溶劑,例如 THF、醚或甲苯中進行。醇之存在,譬如甲醇、乙醇或異 丙醇,是有利的。此還原作用較佳係在-20°C與0°C間之溫度 下進行。所形成苄基醇Vh之進一步官能基化,例如轉化成 氣化物(Vk),係按照熟諳此藝者已知之標準程序進行。正 確反應條件係隨著個別化合物之身分而改變,且係描述於 實例中。Vh —] Vi Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperatives prints compounds of the general formulas Ve and Vf, in which R2 is linked via a carbon atom (R2 represents, for example, lower alkoxy-carbonyl-methyl; cyano-methyl, etc.) It can be prepared from compound XIII or XIV by, for example, reacting with a malonate or a malonic acid half ester in the presence of a base, followed by removal of one of the alkyl carboxylates via decarboxylation. The correct reaction conditions vary with the identity of the individual compounds and are described in the examples. -17- This paper size is applicable to China National Standard (CNS) A4 specification (210 X 297 mm) 1255266 A7 _B7_ V. Description of invention (15) The main intermediates XIII and XIV can be as described in Figure C. production. For compounds of the formula Vh to VI having a carbon moiety, the synthesis begins with the known methyl 3-amino-4-nitrobenzoate. As described in the standard iodination described in Scheme C, the iodide XXI is obtained, which in turn can be protected by a Boc-group. The reduction of the oxime ester can be carried out, for example, by treatment with lithium borohydride, hydroborated steel or diisobutyl hydride in an aprotic solvent such as THF, ether or toluene. The presence of an alcohol, such as methanol, ethanol or isopropanol, is advantageous. This reduction is preferably carried out at a temperature between -20 ° C and 0 ° C. Further functionalization of the formed benzyl alcohol Vh, e.g., conversion to a vapor (Vk), is carried out according to standard procedures known to those skilled in the art. The correct reaction conditions vary with the identity of the individual compounds and are described in the examples.

圖示G --------------I (請先閱讀背面之注意事項再^!^頁) - R2〆Illustration G --------------I (Please read the notes on the back and then ^!^ page) - R2〆

V ,no2 、NHBocV , no2 , NHBoc

Aj~= PdCyPPhg)^ PPh3 Cul, EtjN THF 60 eC 一般程序 R1、 、X、 ^N〇2 SnC!2%H20 、NHB〇c R\vAj~= PdCyPPhg)^ PPh3 Cul, EtjN THF 60 eC General procedure R1, X, ^N〇2 SnC!2%H20, NHB〇c R\v

EtOH 70 eC mh2 、NHBoc !線- 一般程序 U方法b Π Φ 經濟部智慧財產局員工消費合作社印製EtOH 70 eC mh2 , NHBoc ! Line - General procedure U method b Π Φ Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing

Me3Si—= PdCI^PPhg)^ PPh3 Cul, E^N THF, 50 eC 一般程序 KMe3Si—= PdCI^PPhg)^ PPh3 Cul, E^N THF, 50 eC General procedure K

然後 NaOH, MeOHThen NaOH, MeOH

Ar—X PdCI2(PPh3)2, PPh3 Cul, EtgN THF 60 eC 一般程序 κAr-X PdCI2(PPh3)2, PPh3 Cul, EtgN THF 60 eC General procedure κ

R2〃 ▽ 'NHBoc ΧΥΠΙ 根據圖示G,通式II化合物,其中R1係如上文關於其中X 爲乙炔二基之化合物所述,其可藉由不同途徑,製自碘化 -18- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266 A7 B7 經濟部智慧財產局員工消費合作社印製 發明說明(16 ) 合物V,依R1與R2之性質而定。如圖示G中所示,此轉變 可例如以下述方式進行 a) 經由Sonogashira型偶合,使R1 -炔二基取代基直接連接至通 式V化合物,接著爲硝基之還原,或 b) 藉由兩次逐步Sonogashira型偶合,其中係首先使三甲基石夕 烷基-乙块偶合至通式V化合物,於甲醇中,以氫氧化鈉去 保護後,產生中間物XVIII,然後可經由第二次Sonogashira型 偶合,使用適當反應物R1 -I、R1 -Br或R1 -0S02CF3,及使硝 基還原,使其轉變成所要之通式Η化合物。 關於個別化合物之正確條件,可參閱實驗部份。 圖示ΗR2〃 ▽ 'NHBoc ΧΥΠΙ According to the formula G, a compound of the formula II, wherein R1 is as described above for a compound wherein X is an acetylenediyl group, which can be prepared from iodide-18-sheet by different routes Applicable to China National Standard (CNS) A4 Specification (210 X 297 mm) 1255266 A7 B7 Ministry of Economic Affairs Intellectual Property Bureau Employees Consumption Cooperatives Printing Instructions (16) Compound V, depending on the nature of R1 and R2. As shown in Figure G, this transformation can be carried out, for example, in the following manner: a) via a Sonogashira type coupling, the R1 - alkynediyl substituent is directly attached to the compound of formula V, followed by reduction of the nitro group, or b) By a two-step Sonogashira type coupling, in which a trimethyl sulphate-ethyl block is first coupled to a compound of the formula V, after deprotection with sodium hydroxide in methanol, an intermediate XVIII is produced, which can then be carried out a second time. Sonogashira type coupling, using the appropriate reactants R1 -I, R1 -Br or R1 -0S02CF3, and reducing the nitro group to convert it to the desired oxime compound. See the experimental section for the correct conditions for individual compounds. Graphic

A 方法a) κ"〇'A method a) κ"〇'

MgClj, Et3N C02R* ch3cn Et. But 丄 --------------裝 i I (請先閱讀背面之注意事項再15|^4頁) ·- R = Cl, OH, OMe, OEt 上 C〇,R, IVa R,= H,But 方法b) 方法c) ΛMgClj, Et3N C02R* ch3cn Et. But 丄-------------- Install i I (please read the notes on the back and then 15|^4 pages) ·- R = Cl, OH, OMe, OEt on C〇, R, IVa R, = H, But method b) Method c) Λ

LDA, LiOBut OBut THF,,78 eC c〇2r, Vila R* = H, Et, ButLDA, LiOBut OBut THF,,78 eC c〇2r, Vila R* = H, Et, But

Me3Si02C、^C02SiMe3 1.) LiBr. Et3N,CH3CN 3 2 ^ 2 3 或 2.) BuLi, Etp 一般程序 方法a〉醋酸異丙烯酯 _濃 H2S04 方法b) TFAA,TFA,丙酮Me3Si02C, ^C02SiMe3 1.) LiBr. Et3N, CH3CN 3 2 ^ 2 3 or 2.) BuLi, Etp General procedure Method a> Isopropyl acetate _Concentration H2S04 Method b) TFAA, TFA, acetone

一般程序 N :線·General procedure N : line ·

IV 根據圖示Η,具有通式IV與IVa之二氧陸圜烯酮與酮;I 酯結構單位,可藉熟諳此藝者已知之方法製自其相應之義 酸衍生物R3 -COR,意即自由態酸、甲基或乙基酯及氯化SI 。關於其相應化合物之正確條件,可參閱實驗部份。 -19 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266 A7 五、發明說明(17 ) 製備通式I化合物之另一種合成途後,其中Ri、R2及X具 有如上述之意義,且R3爲通式C(0)NR4R5脲,其中R4與R5爲 氫、低碳烷基,或R4與R5 一起形成嗎福啉基殘基或N-甲基-六氫吡畊,其係概述於圖示I中: 圖示I R1、v> Η /P R4R5NH. CO Pd(OAc>2, PPh3 或 dpppIV. According to the diagram, dioxin ketene and ketone of formula IV and IVa; I ester structural unit, which can be prepared from the corresponding acid derivative R3 -COR by the method known to the artist. That is, free acid, methyl or ethyl ester and SI chloride. See the experimental section for the correct conditions for the corresponding compounds. -19 This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1255266 A7 V. Inventive Note (17) After the synthesis of the compound of formula I, Ri, R2 and X have the same The above meaning, and R3 is a general formula C(0)NR4R5 urea, wherein R4 and R5 are hydrogen, lower alkyl, or R4 and R5 together form a morpholinyl residue or N-methyl-hexahydropyrrole , which is summarized in Figure I: Figure I R1, v > Η /P R4R5NH. CO Pd (OAc>2, PPh3 or dppp

laLa

DMF •般程序 QDMF • General procedure Q

請 先 閱 讀 背 δ 之 注 意 事 項 再 裝 頁 關於個別化合物之正確條件,可參閱實驗部份。 藥學上可接受之鹽,可容易地根據本質上已知之方法, 及考量欲被轉化成鹽之化合物性質而製成。無機或有機酸 ,例如鹽酸、氬溴酸、硫酸、硝酸、磷酸或檸檬酸、甲酸 、、烯二酸、順丁烯二酸、醋酸、琥珀酸、酒石酸、甲 燒=酸、對-甲苯磺酸等,均適合用以形成鹼性式I化合物 之藥子上可接文之鹽。式〗化合物及其藥學上可接受之鹽, :爲代谢私’交麩胺酸酯受體拮抗劑,並可用於治療或預防 i f生及/或忮性神經病症,譬如精神病、精神分裂症、阿 "•,犬氏疾病、忍知病症及記憶不足。其他可治療之適 應欲、’係音因分流手術或移植物所造成之限制腦部功能, =良I血液供應至腦部,脊髓傷害,頭部傷害,因懷孕所 氧匕動停止及低血糖。其他可治療之適應徵爲 慢性與急性疼痛’亨丁頓氏舞蹈症,ALS,因娜所造成 之痴呆症’眼睛傷害,視網膜病,原發性巴金生氏徵候簇 -20- 297公釐) 訂 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明(18) 或因藥劑所造成之巴金生氏徵候簇, ^ 吹 以及會導致麩胺酸酯 缺功能之症狀,譬如肌肉痙攣、彆 ^ 馬厥、偏頭痛、尿失禁 、於癮、精神病、阿片癮、隹慮、中Please read the notes on δ first and then install the page. For the correct conditions for individual compounds, please refer to the experimental section. The pharmaceutically acceptable salts can be readily prepared according to methods known per se and by considering the nature of the compound to be converted into a salt. Inorganic or organic acids, such as hydrochloric acid, argonic acid, sulfuric acid, nitric acid, phosphoric acid or citric acid, formic acid, enedic acid, maleic acid, acetic acid, succinic acid, tartaric acid, methylation = acid, p-toluene Acids and the like are suitable for the salt of the pharmaceutically acceptable salt of the compound of the formula I. a compound and a pharmaceutically acceptable salt thereof, which are metabolic private glutamate receptor antagonists and are useful for treating or preventing if and/or spastic neurological disorders such as psychosis, schizophrenia, A "•, canine disease, tolerance to illness and lack of memory. Other treatable adaptations, 'systemic shunt surgery or grafts to limit brain function, = good I blood supply to the brain, spinal cord injury, head injury, oxygenation due to pregnancy and hypoglycemia . Other treatable indications are chronic and acute pain 'Hendington's disease, ALS, dementia caused by Inna' eye damage, retinopathy, primary Parkinson's syndrome - 20-297 mm) Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 A7 B7 V. Description of Invention (18) or Bajinsheng's syndrome caused by medicinal agents, ^ Blowing and symptoms that may cause glutamate deficiency, such as muscle spasm , don't ^ horse, migraine, urinary incontinence, addiction, mental illness, opioid addiction, worry, middle

At ’心 ^吐、運動困難及抑鬱。 式!化合物及其藥學上可接受之鹽,可作爲藥劑使用,例 :呈醫藥製劑形式。此醫藥製劑可以口服方式投藥,例如 呈片劑、塗層片劑、糖衣錠、硬與軟 寸人洌膠膠囊、落政、乳 化液或懸浮液形式。但是,㈣亦可以直腸方式達成,例 如呈栓劑形式,或以非經腸方式,例如呈注射溶液形式。 式I化合物及其藥學上可接受之_ 子 按又I现,可以藥學上惰性之無 機或有機載劑處理,以製造醫藥製劑。Λ ^ y Ν 礼糖、玉米澱粉或 其衍生物、滑石、硬脂酸或其鹽等, j作馬例如片劑、塗 層片劑、糖衣錠及硬明膠膠囊之载劑侈 、、,、 Λ N 1更用。軟明膠膠囊用 之適當載劑’係爲例如植物油、壤翔 'Λ 脂肪、半固體盥液 體多元醇等;但是,依活性物質之性皙 ’、 貝性貝而疋,在軟明膠膠 囊Ih /兄中’通系不需要載劑。用於製 木菩十丨„ 、Ik〉谷夜與糖漿之適 备載浏,係爲例如水、多元醇、蔗糖、 ^ 野化糖、葡萄换菩 。佐劑,譬如醇類、多元醇、甘油、 " I由寺,可用於^ 了 化合物水溶性鹽之注射水溶液,但通常3益、 ., 疋操必要的。供於 經濟部智慧財產局員工消費合作社印製 劑用之適當載劑,係爲例如天然或硬化、< 、 ’靖、樣類、脂肤 、半液體或液體多元醇等。 此外,此醫藥製劑可含有防腐劑、择心 、 曰心W、安定劑、潤 濕劑、乳化劑、增甜劑、著色劑、矯味 ” 用以改樂洗《秀 壓鹽、緩衝劑、掩蔽劑或抗氧化劑。其人 夕 療上有價値之物質。 σ σ有又其他治 -21 - 1255266 A7 B7 五、發明說明(19 如前文所述,含有式I化合物或其藥學上可接受之鹽及治 療上惰性賦形劑之藥劑,亦爲本發明之一項目的,嬖如— 種製造此種藥劑之方法,係包括使一或多種式I化合物或其 藥學上可接受之鹽,及若需要時使用之一或多種其他治療 上有價値之物質,與一或多種治療上惰性之載劑,一起製 成蓋伶劑量形式。 此劑量可在寬廣範圍内改變,且於各特定情況中,當然 係配合個別要求條件。一般而言,供口服或非經腸投藥之 有效劑量,係在0 01-20毫克/公斤/天之間,其中以01_10 毫克/公斤/天之劑量,對於所述之所有適應徵係爲較佳 的。因此’對於體重爲70公斤之成年人類之日服劑量,係 在於母天0.7-1400毫克之間,較佳係在每天7與700亳克之間。 本發明亦關於式I化合物及其藥學上可接受之鹽於藥劑製 造上之用途,尤其是用於控制或預防前述種類之急性及/ 或慢性神經病症。 本發明化合物爲第Π族群之mGhl受體拮抗劑。當在下文 所述之檢測中度量時,此等化合物顯示活性爲5〇 或較 低’典型上爲3 aM或較低,且理想上爲〇·5 或較低。在 --------------裝--- C請先閱讀背面之注意事項再頁) 訂 :線· 經濟部智慧財產局員工消費合作社印製 4匕合物 KimGlu2 (uM) 3:(8-氯基-4-酮基-7-苯基乙炔基-4,5-二氫-3H-苯 并[b][l,4]二吖庚因:基)-苯甲腈 0.028 3一[8-(4-甲基-六氫吡畊-1-基)-4-酮基-7-苯基乙炔 基-4,5-二氫-3H-苯幷[b][l,4]二吖庚因-2-基]-苯 甲腈 0.305 22- 本Λ張尺度適用中國國家標準(CNS)A4規格(21〇 χ 297公釐 1255266 A7 B7 五、發明說明(20) 經濟部智慧財產局員工消費合作社印製 3-(8-氣基-4-酮基-7-苯基-4,5-二氫-3H-苯幷 [b][l,4]二吖庚因-2-基)-苯甲腈 0.120 [4-(3-夜基-冬基)-2-i同基-8-冬基乙块:基-2,3-二氮 1H-苯幷[b][l,4]二吖庚因-7-基硫基]-醋酸甲醋 0.051 2-[4-(3-散基-冬基)-2-S同基-8-冬基乙块基-2,3-二 氫-1H-苯幷[b][l,4]二吖庚因-7-基]-乙醯胺 0.037 3-(8-甲氧基-4-酮基-7-苯基乙炔基-4,5-二氫-3H-苯幷[b][l,4]二吖庚因-2-基)-苯甲腈 0.046 3-(8-氰基甲基-4-酮基-7-苯基乙炔基)-4,5-二氫-3H-苯并[b][l,4]二吖庚因-2-基)-苯甲月青 0.016 4-(3-破冬基)-7-(2-甲乳基乙氧基)-8-本基乙块 基-1,3-二氫苯幷[b][l,4]二吖庚因-2-酮 0.021 4-(3-味哇-1-基-冬基)-7-(2-甲氧i基-乙氧基)-8-表 基乙炔基-1,3-二氫苯并[b][l,4]二吖庚因-2-酮 0.012 [RS]-3-[4-酮基-8-(2-酮基-[1,3]二氧伍圜-4-基甲 氧基)-7-苯基乙炔基-4,5-二氫-3H-苯幷[b][l,4]二 吖庚因-2-基]-苯甲腈 0.035 7-¾甲基-4-(3-味。坐-1-基-苯基)-8-苯基乙決基_ 1,3-二氫苯幷[b][l,4]二吖庚因-2-酮 0.018 [4-(3-咪唑小基-苯基>2-酮基-8-苯基乙炔基-2,3-二氫-1H-苯幷[b][l,4]二吖庚因-7-基氧基]-乙腈 0.009 8-(4-氟苯基乙炔基)-7-羥甲基-4-(3-咪唑小基-苯 基)-1,3-二氫苯幷[b][l,4]二吖庚因-2-酮 0.009 7-(2-羥基-乙氧基)-4-(3-咪唑-1-基-苯基)-8-苯基 乙炔基-1,3-二氫苯幷[b][l,4]二吖庚因-2-酮 0.032 8-(4-氣冬基)-7-[4-(2-無基-乙乳基鼠p比淀-1-基]·4-(3-咪唑-1-基-苯基)-1,3-二氫苯并[b][l,4]二 吖庚因-2-酮 0.100 8-(4-氟苯基)-7-羥基-4-(3-咪唑小基-苯基)-1,3-二 氫苯幷[b][l,4]二吖庚因-2-酮 0.007 -23- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -----------------裝--- (請先閱讀背面之注意事項再本頁) . ί線_ 1255266 A7 B7 五、發明說明(21At ‘ heart vomiting, difficulty in movement and depression. formula! The compound and a pharmaceutically acceptable salt thereof can be used as a medicament, for example, in the form of a pharmaceutical preparation. The pharmaceutical preparations can be administered orally, for example, in the form of tablets, coated tablets, dragees, hard and soft silicone gelatin capsules, tablets, emulsions or suspensions. However, (iv) may also be achieved rectally, for example in the form of a suppository, or parenterally, for example in the form of an injection solution. The compounds of formula I and pharmaceutically acceptable pharmaceutically acceptable pharmaceutically acceptable pharmaceutically acceptable pharmaceutically acceptable pharmaceutically acceptable pharmaceutically acceptable pharmaceutical preparations. Λ ^ y Ν sugar, corn starch or its derivatives, talc, stearic acid or its salts, etc., j for tablets, coated tablets, sugar-coated tablets and hard gelatin capsules for the carrier,,,, Λ N 1 is more useful. The appropriate carrier for soft gelatin capsules is, for example, vegetable oil, lyophilized fat, semi-solid sputum liquid polyol, etc.; however, depending on the nature of the active substance 、', shellfish and oysters, in soft gelatin capsules Ih / In the brothers, there is no need for carriers. It is used to make wood, botanical, and yoghurt, such as water, polyol, sucrose, ^ wild sugar, grape for botanical. Adjuvants, such as alcohols, polyols, Glycerin, "I by the temple, can be used to inject the aqueous solution of the compound water-soluble salt, but usually 3 benefits, ., necessary for the chastity. For the Ministry of Economic Affairs, the Intellectual Property Office staff consumption cooperatives to use the appropriate carrier, For example, it is natural or hardened, <, 'jing, sample, fat, semi-liquid or liquid polyol, etc. In addition, the pharmaceutical preparation may contain a preservative, a core, a heart, a stabilizer, a wetting agent. Emulsifiers, sweeteners, colorants, flavors are used to change the salt, buffer, masking agent or antioxidant. His people have a pricey substance. σ σ有其他治-21 - 1255266 A7 B7 V. INSTRUCTIONS (19) As mentioned above, a medicament containing a compound of formula I or a pharmaceutically acceptable salt thereof and a therapeutically inert excipient is also a A method of making such an agent, for example, comprising administering one or more compounds of formula I, or a pharmaceutically acceptable salt thereof, and, if desired, one or more other therapeutically valuable substances, Formulated in a wide range with one or more therapeutically inert carriers. This dosage can vary over a wide range and, in each particular case, will of course be matched to the individual requirements. In general, for oral or non-administrative The effective dose for enteral administration is between 0 01-20 mg/kg/day, with a dose of 01_10 mg/kg/day, which is preferred for all of the indications described. The daily dose of a 70 kg adult is between 0.7 and 1400 mg per day, preferably between 7 and 700 g per day. The invention also relates to a compound of formula I and a pharmaceutically acceptable salt thereof. Manufacturing use In particular for the control or prevention of acute and/or chronic neurological disorders of the aforementioned classes. The compounds of the invention are mGhl receptor antagonists of the steroidal group. These compounds exhibit activity of 5 when measured in the assays described below. 〇 or lower 'typically 3 aM or lower, and ideally 〇·5 or lower. In -------------- loading --- C please read the back Precautions and then page) Order: Line · Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed 4 KKimGlu2 (uM) 3: (8-chloro-4-keto-7-phenylethynyl-4,5 -dihydro-3H-benzo[b][l,4]dioxine:yl)-benzonitrile 0.028 3-[8-(4-methyl-hexahydropyrrol-1-yl)-4 -keto-7-phenylethynyl-4,5-dihydro-3H-benzoquinone[b][l,4]dioxan-2-yl]-benzonitrile 0.305 22- 本Λ张尺度Applicable to China National Standard (CNS) A4 Specification (21〇χ 297 mm 1255266 A7 B7 V. Invention Description (20) Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 3-(8-Alkyl-4-keto-7 -phenyl-4,5-dihydro-3H-benzoquinone [b][l,4]dioxan-2-yl)-benzonitrile 0.120 [4-(3-Nitentyl-Winter)- 2-i homo--8-winter Block B: yl-2,3-diaza 1H-benzoquinone [b][l,4]dioxine-7-ylthio]-acetic acid methyl ketone 0.051 2-[4-(3-propyl-冬基)-2-S synthyl-8-winteryl-yl-2,3-dihydro-1H-benzoquinone[b][l,4]dioxepin-7-yl]-acetamide 0.037 3-(8-Methoxy-4-keto-7-phenylethynyl-4,5-dihydro-3H-benzoquinone [b][l,4]dioxan-2-yl) -benzonitrile 0.046 3-(8-Cyanomethyl-4-keto-7-phenylethynyl)-4,5-dihydro-3H-benzo[b][l,4]dioxin In-2-yl)-benzalamide 0.016 4-(3-Drosyl)-7-(2-methyllacylethoxy)-8-benylethylidene-1,3-dihydrobenzene幷[b][l,4]dioxine-2-one 0.021 4-(3-flavor-1-yl-winter)-7-(2-methoxyi-yl-ethoxy)-8 -epi-ethynyl-1,3-dihydrobenzo[b][l,4]dioxepin-2-one 0.012 [RS]-3-[4-keto-8-(2-keto -[1,3]dioxoindol-4-ylmethoxy)-7-phenylethynyl-4,5-dihydro-3H-benzoquinone[b][l,4]dioxapene- 2-yl]-benzonitrile 0.035 7-3⁄4 methyl-4-(3-flavor. -1--1-yl-phenyl)-8-phenylethylidene _ 1,3-dihydrophenylhydrazine [b][l,4]dioxine-2-one 0.018 [4-(3-imidazole) Small base-phenyl>2-keto-8-phenylethynyl-2,3-dihydro-1H-benzoquinone [b][l,4]dioxine-7-yloxy]- Acetonitrile 0.009(8-(4-fluorophenylethynyl)-7-hydroxymethyl-4-(3-imidazolyl-phenyl)-1,3-dihydrophenylhydrazone [b][l,4] Azepine-2-one 0.009 7-(2-hydroxy-ethoxy)-4-(3-imidazol-1-yl-phenyl)-8-phenylethynyl-1,3-dihydrophenylhydrazine [b][l,4] Dioxepin-2-one 0.032 8-(4-Gaolyl)-7-[4-(2-N-yl-ethyl lactyl p-Pent-1-yl) 4-(3-imidazol-1-yl-phenyl)-1,3-dihydrobenzo[b][l,4]dioxepin-2-one 0.100 8-(4-fluorophenyl) -7-Hydroxy-4-(3-imidazolyl-phenyl)-1,3-dihydrophenylhydrazone [b][l,4]dioxine-2-one 0.007 -23- This paper size applies China National Standard (CNS) A4 specification (210 X 297 mm) -----------------Installation--- (Please read the back note before this page). ί Line _ 1255266 A7 B7 V. Description of invention (21

4-[7-(2-氟苯基)各甲氧基4-酮基5 氣-3]9_笨 幷[b][M]二吖庚因|基]_吡啶1甲腈Λ讯冬 0.033 ?12:氣产3上7邊基冰(3-[1,2,3]三"坐小基-苯基)-1,3-一虱苯幷[b][i,4]二吖庚因:酮 0.028 8-(2-氟苯基)-7-幾基_4-[3-(2-甲基-咪唑_ι·基分苯 基]-1,3-二氫苯幷[b][1,4]二吖庚因丨酮 0.108 -------------—裝--- (請先閱讀背面之注意事項再頁) 1(2-氟苯基)_7邊基_4-[3-(2-甲硫基-咪唑_1_基)-苯基H,3-二氫苯幷[b][丨,4]二。丫庚因-2-酮 0.0214-[7-(2-fluorophenyl) methoxy 4-keto 5 gas-3]9_ awkward [b][M]dioxeine|yl]-pyridine 1 acetonitrile 0.033 ?12: Gas production 3 on 7-side base ice (3-[1,2,3]three"sitting small base-phenyl)-1,3-anthracenequinone [b][i,4]吖gyne: ketone 0.028 8-(2-fluorophenyl)-7-monoyl_4-[3-(2-methyl-imidazolium)-based phenyl]-1,3-dihydrophenylhydrazine [b][1,4] Dioxetanone 0.108 ----------------- (Please read the notes on the back page again) 1 (2-fluorobenzene) Base)_7 side group _4-[3-(2-methylthio-imidazol-1-yl)-phenyl H,3-dihydrophenylhydrazine [b][丨,4]二.丫庚因-2 -ketone 0.021

3-[7·(2,5-二氟-苯基)-8-羥基-4-酮基-4,5-二氫 3H- 苯幷[b][l,4]二吖庚因-2-基]-苯甲腈 0.006 8-(4-氟苯基乙炔基)_7_羥基斗(3-咪唑-1-基-苯基 )-1,3-二氫苯幷[b][l,4]二吖庚因-2-酮 8-(4-氟苯基乙炔基)_7_羥基-4_(3-[ΐ,2,3]三唑-1-基 -苯基)-1,3-二氫苯幷[b][l,4]二吖庚因·2-酮 0.013 0.010 :線' 經濟部智慧財產局員工消費合作社印製 J^-|j[]-LY354740結合於mGlu2轉染之CHO細胞膜上 轉移感染與細胞培養 在pBluescript II中之cDNA編碼之老鼠mGlu2受體蛋白,係得 自S. Nakanishi敎授(曰本Kyoto),並於得自Invitr〇gen (荷蘭购 Leek)之具核細胞表現載體pcDNA I-amp中進行次代無性繁杳 。藉由Chen & Okayama所述之經修改5粦酸鈣方法(1988),使 載體構造(pcDlmGR2)與psvNeo質粒編碼之對新徵素具#藥 -24- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) A7 1255266 B7_ 五、發明說明(22) --------------裝--- (請先閱讀背面之注意事項再5^||4頁)3-[7·(2,5-Difluoro-phenyl)-8-hydroxy-4-keto-4,5-dihydro 3H-benzoquinone [b][l,4]dioxine-2 -yl]-benzonitrile 0.006 8-(4-fluorophenylethynyl)-7-hydroxyl (3-imidazol-1-yl-phenyl)-1,3-dihydrophenylhydrazine [b][l, 4] Dioxepin-2-one 8-(4-fluorophenylethynyl)-7-hydroxy-4_(3-[indol, 2,3]triazol-1-yl-phenyl)-1,3 -Dihydrophenylhydrazine [b][l,4]Dioxeine·2-ketone 0.013 0.010 : Line 'Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed J^-|j[]-LY354740 combined with mGlu2 transfection CHO cell membrane transfer infection and cell culture The mouse mGlu2 receptor protein encoded by cDNA in pBluescript II was obtained from S. Nakanishi (Sakamoto Kyoto) and obtained from Invitr〇gen (Leek, Netherlands). The nucleated cell expression vector pcDNA I-amp was used for secondary generation asexual plague. Using the modified calcium citrate method described by Chen & Okayama (1988), the vector construct (pcDlmGR2) and the psvNeo plasmid encoding the new serotonin #药-24- This paper scale applies to the Chinese National Standard (CNS) A4 size (210 X 297 mm) A7 1255266 B7_ V. Invention description (22) -------------- Pack--- (Please read the notes on the back and then 5^| |4 pages)

之基因,共轉染至CHO細胞中。將此等細胞保持在Dulbecco 氏變性Eagle培養基中,其中具有減少之L-麩醯胺(2 mM最後 濃度)及1〇°/。經透析之牛胎兒血清,得自Gibco BRL (瑞士 Basel) 。於G-418存在下(最後爲1000微克/毫升)進行選擇。藉由 總共5微克RNA之逆轉錄作用,確認無性繁殖系’接著爲 PCR,使用 mGlu2 受體專一之引物 5'-atcactgcttgggtttctggcactg-3'與 5’-agcatcactgtgggtggcataggagc-3’,在 60 mM Tris HC1 (pH 10)、 15 mM (NH4)2S〇4、2mMMgCl2、25單位/毫升Taq聚合酶中,其中 30次循環退火在60°C下歷經1分鐘,在72°C下延長30秒,及 1分鐘95°C變性作用。 細胞膜製備 線· 採集按上述培養之細胞,並以冷PBS洗滌三次,及在-80 °C下冷)東。使丸粒再懸浮於含有10 mM EDTA之冷20 mM HEPES-Na〇H 緩衝劑(pH 7.4)中,並以 polytron (Kinematica,AG,Littau, Switzerland)在10000 rpm下均化10秒0於4°C下,離心30分鐘後 ,將丸粒以相同缓衝劑洗滌一次,及以含有0.1 mM EDTA之 冷20 mM HEPES-NaOH緩衝劑(pH 7.4)洗滌一次。使用Pierce方 法(Socochim,Lausanne, Switzerland),度量蛋白質含量,使用牛血 清白蛋白作爲標準物。 經濟部智慧財產局員工消費合作社印製 [3H]-LY354740 結合 於解凍後,使細胞膜再懸浮於含有2 mM MgCl2與2mM CaCl2 之冷50 mM Tris-HCl緩衝劑(pH 7)(結合緩衝劑)中。細胞膜在 檢測中之最後濃度爲25微克蛋白質/毫升。抑制作用實驗 係使用已在室溫下,以10 nM [3 H]-LY354740培養之細胞膜, -25- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 經濟部智慧財產局員工消費合作社印製 1255266 A7 _B7_五、發明說明(23) 於不同濃度之待測化合物存在下進行1小時。在培養後, 於Whatmann GF/C玻璃纖維濾器上過濾細胞膜,以冷結合緩 衝劑洗滌5次。於10 β M DCG IV存在下,度量非專一性結合 。在;慮器轉移至含有10毫升Ultima-金色閃爍流體(Packard, Zurich,Switzerland)之塑膠小玻瓶後,在 Tri-Carb 2500 TR 計數器 (Packard, Zurich,Switzerland)中,藉由液體閃爍度量放射活性。 數據分析 抑制作用曲線係以四參數計算術方程式吻合,獲得IC5 〇 値及Hill係數。 實例 下述實例係關於(4-碘基-2-硝基-苯基)-胺甲基酸第三-丁醋 之製備(合成圖示C): 一般程序A 藉由2-硝基苯胺之碘化作用以製備4-碘基冬硝基苯胺[根據 Wilson, J. Gerald ; Hunt, Frederick C. Aust. J. Chem. 1983, 36, 2317-25] 於2-硝基苯胺(1.0莫耳)在HOAc (500毫升)中,含有無水 NaOAc(93-103克,1J25-1.25莫耳)之經攪拌溶液内,於60分鐘 内,添加H〇Ac (300毫升)中之單氣碘(59-66毫升,1.125-1.25莫 耳)。將反應混合物加熱至特定溫度,直到薄層層析法(TLC) 顯示起始物質完全轉化爲止,於23°C再攪拌30分鐘,然後 以H20 (1000毫升)慢慢稀釋,其會造成結晶性產物分離。持 續攪拌1小時,並將產物濾出,洗除HOAc,並於60°C下, 在眞空中乾燥。 實例A1 -26- --------------裝 i I (請先閱讀背面之注意事項再41k頁) _ :線· 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266 A7 B7 五、發明說明(24) &quot; 一 5-氯基-4-?典基-2-硝基-苯胺 根據一般程序A(8(TC ),在H0Ac/Na0Ac中,以 丄1 干乳化蹲藉 由足、化作用,製自5-氯基-2-硝基苯胺。獲得橘色固體。 MS (EI) 298 (M+)與 300 [(M+2)+ ];熔點 202-203°C (分解)。 實例A2 4- 碘基-5-甲基-2-硝基-苯胺 根據一般程序A (80°C ),在HOAc/NaOAc中,以單氯化碘藉 由碘化作用,製自5-甲基-2-硝基苯胺。獲得紅色固體。曰 MS (EI) 278 (M+);熔點 154°C (分解)。 實例A3 5- 胺基-2-碘基-4-硝基苯甲酸甲酯 根據一般程序A (35°C ),在HOAc/NaOAc中,以單氯化碘藉 由碘化作用,製自3-胺基-4-硝基苯甲酸甲酯(22.25克{ CAS-編 號[99512-09-1];在兩步驟中按下述製成:將3-羥基斗硝基苯 甲酸(30克,164毫莫耳)、順4〇(21,91克,410毫莫耳)在25 。’。NH3水溶液(180毫升)中,於鋼製熱壓鋼内,在16〇。〇下加 熱7小時(内部壓力:23巴)。經冷卻至23°C並蒸發至乾燥。 溶於H2〇(200毫升)中,以濃h2S04調整pH値至PH1,以NaCl 飽和,並以EtOAc萃取(6 X 750毫升),使合併之有機層以 MgS〇4脱水乾燥。過濾及在眞空中移除溶劑,留下足夠純 之3-胺基-4-硝基苯甲酸(22.26克,75% ),爲橘色固體。使此 物質懸浮於Me〇H (500毫升)中,添加濃H2 S04 (3毫升),並將 混合物加熱至65°C歷經2.5天。在眞空中移除溶劑,使固體 殘留物落於EtOAc中,以飽和NaHC〇3溶液及鹽水洗滌,接著 -27- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ------------- Μ—— (請先閱讀背面之注意事項再頁) Η^τ ·_ 線· 經濟部智慧財產局員工消費合作社印製 1255266The gene was co-transfected into CHO cells. These cells were maintained in Dulbecco's denatured Eagle medium with reduced L-glutamate (2 mM final concentration) and 1 〇 °. Dialyzed bovine fetal serum obtained from Gibco BRL (Basel, Switzerland). The selection was made in the presence of G-418 (final 1000 micrograms per milliliter). The clonal propagation line was confirmed by a total of 5 micrograms of RNA reverse transcription followed by PCR using the mGlu2 receptor-specific primer 5'-atcactgcttgggtttctggcactg-3' and 5'-agcatcactgtgggtggcataggagc-3' at 60 mM Tris HC1 ( pH 10), 15 mM (NH4)2S〇4, 2mMMgCl2, 25 units/ml Taq polymerase, 30 cycles of annealing at 60 ° C for 1 minute, 72 ° C for 30 seconds, and 1 minute Denaturation at 95 °C. Cell membrane preparation line • Cells cultured as described above were collected and washed three times with cold PBS and cold at -80 °C. The pellet was resuspended in cold 20 mM HEPES-Na〇H buffer (pH 7.4) containing 10 mM EDTA and homogenized with a polytron (Kinematica, AG, Littau, Switzerland) at 10,000 rpm for 10 seconds 0 to 4 After centrifugation for 30 minutes at ° C, the pellets were washed once with the same buffer and once with cold 20 mM HEPES-NaOH buffer (pH 7.4) containing 0.1 mM EDTA. The protein content was measured using the Pierce method (Socochim, Lausanne, Switzerland) using bovine serum albumin as a standard. Ministry of Economic Affairs, Intellectual Property Bureau, Staff Consumer Cooperative Printed [3H]-LY354740 After thawing, resuspend the cell membrane in cold 50 mM Tris-HCl buffer (pH 7) containing 2 mM MgCl2 and 2 mM CaCl2 (binding buffer) in. The final concentration of the cell membrane in the assay was 25 μg protein/ml. The inhibition test was performed using a cell membrane that had been cultured at 10 nM [3 H]-LY354740 at room temperature, -25- This paper scale was applied to the Chinese National Standard (CNS) A4 specification (210 X 297 mm). Bureau employee consumption cooperative printed 1255266 A7 _B7_5, invention description (23) carried out in the presence of different concentrations of the test compound for 1 hour. After the incubation, the cell membrane was filtered on a Whatmann GF/C glass fiber filter and washed 5 times with a cold binding buffer. Non-specific binding was measured in the presence of 10 β M DCG IV. After the device was transferred to a plastic vial containing 10 ml of Ultima-gold scintillation fluid (Packard, Zurich, Switzerland), the radiation was measured by liquid scintillation in a Tri-Carb 2500 TR counter (Packard, Zurich, Switzerland). active. Data analysis The inhibition curve was consistent with the four-parameter calculation equation to obtain IC5 〇 H and Hill coefficient. EXAMPLES The following examples relate to the preparation of (4-iodo-2-nitro-phenyl)-amine methyl acid tert-butyl vinegar (Synthesis Scheme C): General Procedure A by 2-nitroaniline Iodination to prepare 4-iodohexylnitroanilide [according to Wilson, J. Gerald; Hunt, Frederick C. Aust. J. Chem. 1983, 36, 2317-25] to 2-nitroaniline (1.0 mol) Adding a single gas of iodine in H〇Ac (300 ml) in a stirred solution of anhydrous NaOAc (93-103 g, 1 J25-1.25 mol) in HOAc (500 mL) -66 ml, 1.125-1.25 m). The reaction mixture is heated to a specific temperature until thin layer chromatography (TLC) shows complete conversion of the starting material, stirring at 23 ° C for another 30 minutes, then slowly diluting with H20 (1000 ml), which causes crystallinity The product was isolated. Stirring was continued for 1 hour, and the product was filtered off, washed with HOAc and dried at room temperature at 60 ° C. Example A1 -26- -------------- Install i I (please read the note on the back and then page 41k) _ : Line · This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1255266 A7 B7 V. INSTRUCTIONS (24) &quot; A 5-chloro-4-yl-yl-2-yl-aniline according to the general procedure A (8(TC), at H0Ac/ In Na0Ac, dry emulsified hydrazine was prepared from 5-chloro-2-nitroaniline by foot and hydration to obtain an orange solid. MS (EI) 298 (M+) and 300 [(M+2) +]; melting point 202-203 ° C (decomposition). Example A2 4-iodo-5-methyl-2-nitro-aniline according to the general procedure A (80 ° C), in HOAc / NaOAc, monochloro Iodine was prepared from 5-methyl-2-nitroaniline by iodination to give a red solid. 曰MS (EI) 278 (M+); mp 154 ° C (decomposition). Example A3 5-Amino- Methyl 2-iodo-4-nitrobenzoate was prepared from 3-amino-4-nitrate according to the general procedure A (35 ° C) in HOAc/NaOAc with iodine monochloride by iodination. Methyl benzoate (22.25 g { CAS-No. [99512-09-1]; made in two steps as follows: 3-hydroxyindole nitrobenzoic acid (30 g, 164 mmol) , cis 4 〇 (21, 91 g, 410 mmol) in 25 ° '. NH3 aqueous solution (180 ml), in steel hot-pressed steel, heated at 16 〇 under the armpit for 7 hours (internal pressure: 23 The mixture was cooled to 23 ° C and evaporated to dryness. EtOAc EtOAc (EtOAc) (EtOAc) The organic layer was dried over <RTIgt; </RTI> <RTIgt; </RTI> <RTIgt; </RTI> <RTIgt; </RTI> <RTIgt; </RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; The material was suspended in MeOH (500 mL). EtOAc (EtOAc)EtOAc. Saturated NaHC〇3 solution and brine, then -27- This paper scale applies to Chinese National Standard (CNS) A4 specification (210 X 297 mm) ------------- Μ - (please Read the precautions on the back page again) Η^τ ·_ Line · Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266

以MgS04脫水乾燥。移除溶劑,留下足夠純之I胺基冰硝基 苯甲酸甲醋(22.25克,93%),爲橘色固體。}獲得橘 (29.38 克,80% )。 MS (EI) 322 (M+);熔點 168°c (分解)。 一般程序B ·· 自硝基苯胺製備(2_硝基-苯基)-胺甲基酸第三-丁酯 万法a ·於雙光氣(41毫升,341毫莫耳)在段⑽(4〇亳升) 中之溶液内,在(TC下,添加‘碘基冬 在麻(綱〇毫升)中之溶液,並將混合物㈣至 經18小日寺。在眞空中移除溶劑,留下褐色固體,將其以熱 己烷(200毫升)研製。濾出固體物質,使濾液在減壓下濃縮 ,留下,,氰酸4-碘基冬硝基苯醋,爲黃色固體。將此物 貝在過量第二-BuOH與CH2 (¾之混合物中回流2 5小時。移除 溶劑,留下橘色固體,將其藉矽膠管柱層析純化,使用己 烷/ EtOAc,而得(4-碘基-2-硝基-苯基胺甲基酸第三_丁酯, 爲黃色固體。 方法b :於4-碘基-2-硝基苯胺(142毫莫耳)與碳酸铯(55 5克 ,Π0毫莫耳)在2-丁酮(740毫升)中之混合物内,逐滴添加 Β〇(:2〇 (37.8克,173毫莫耳)在2- 丁酮(170毫升)中之溶液,並 將所形成之混合物於52°C下攪掉26小時。在眞空中移除溶 劑,殘留物以Hp (240毫升)與MeOH (240毫升)之混合物處理 ’並以己:t元萃取(3 X 500毫升)。將合併之己燒層,以鹽水 (200毫升)洗條’並將所有水層以己、j:充(3〇〇毫升)再萃取。使 所有合併之己層以MgS〇4脱水乾燥,過攄,及在眞空中 28 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) — (請先閱讀背面之注意事項再^||^4頁) , · ··線· 經濟部智慧財產局員工消費合作社印製Dehydrated and dried with MgS04. The solvent was removed leaving a sufficiently pure I-amino ice nitrobenzoic acid methyl acetonate (22.25 g, 93%) as an orange solid. }Get orange (29.38 grams, 80%). MS (EI) 322 (M+); mp 168 (dec.). General procedure B · · Preparation of nitroaniline (2_nitro-phenyl)-amine methyl acid third-butyl ester method a · in diphosgene (41 ml, 341 mmol) in the section (10) In a solution of 4 liters, in (TC), add a solution of 'iodo-based winter in hemp (ml), and mix the mixture (four) to the 18-day temple. Remove the solvent in the air, leaving The product was triturated with EtOAc (EtOAc)EtOAc.EtOAc. This was refluxed for a period of 25 hours in excess of a mixture of the second-BuOH and CH2 (3⁄4). The solvent was removed to leave an orange solid which was purified by column chromatography using hexane / EtOAc. 4-iodo-2-nitro-phenylamine methyl acid tert-butyl ester as a yellow solid. Method b: 4-iodo-2-nitroaniline (142 mmol) with cesium carbonate ( 55 5 g, Π 0 mmol) in a mixture of 2-butanone (740 ml), Β〇(:2〇(37.8 g, 173 mmol) in 2-butanone (170 ml) Solution in the solution The mixture was stirred for 26 hours at 52 ° C. The solvent was removed in the sputum and the residue was taken up in a mixture of H.sub.2 (240 mL) and MeOH (240 mL). The combined burned layers were washed with brine (200 ml) and all the aqueous layers were re-extracted with hexanes (3 liters), and all the combined layers were dehydrated and dried with MgS〇4. , too, and in the air 28 paper standards apply to the Chinese National Standard (CNS) A4 specifications (210 X 297 mm) — (please read the precautions on the back and then ^||^4 pages), · ·· · Ministry of Economic Affairs, Intellectual Property Bureau, employee consumption cooperative, printing

1255266 五、發明說明(26) 蒸發溶劑,而得橘色固體,將其藉石夕膠管柱層析純化,使 用己烷/ EtOAc而得(4-破基_2_硝基_苯基)_胺甲基酸第三-丁酯 ,爲黃色固體。 方法C:於‘碘基1硝基苯胺(550毫莫耳)與DMAP(1.22克, 1〇毫莫耳)在THF (1000毫升)中之溶液内,於23χ:下,在7〇分 鐘内,逐滴添加B〇C2〇(246克,1128毫莫耳)在THF(5〇〇毫升) 中之溶液,並於23。(:下持續攪拌75分鐘。使整體混合物蒸 發至乾涸,並於HV下乾燥,留下深褐色固體(253 59克)。使 此物質溶於DCM(1100毫升)中,經冷卻至〇χ:,並逐滴添加 TFA(84毫升,1100毫莫耳)。將混合物於〇。〇下攪拌2小時, 倒入冰冷飽和NaHCOs溶液中,以DCM萃取,以鹽水洗滌, 及以MgS〇4脱水乾燥。在眞空中移除溶劑,留下深褐色固 體(199.71克),將其塗覆於矽膠上,並藉矽膠管柱層析純化 ,使用己烷/ EtOAc,而得(4-碘基_2-硝基-苯基)_胺甲基酸第 三-丁酯,爲黃色固體。 實例B1 (5-氯基-4-琪基-2-硝基-苯基)_胺甲基酸第三_丁酯 根據一般程序B (方法a),自5-氯基冰碘基-2-硝基-苯胺(實 例Α1)(7·0克’ 23.45毫莫耳)與雙光氣(2.12毫升,17.6毫莫耳) 在EtOAc (3〇毫升)中,接著以第三-BuOH (100毫升)在 CH2C12(100毫升)中處理,製備此異氰酸酯。獲得黃色固體 (7.1 克,76% ) 〇 MS (EI) 398 (M+)與 400 [(M+2)+ ];熔點 82-84Ό。 實例B2 -29- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公爱) -------------^ · 11 (請先閱讀背面之注意事項再^||^頁) 訂· :線- 經濟部智慧財產局員工消費合作社印製 1255266 經濟部智慧財產局員工消費合作社印製 A7 五、發明說明(27 (4-破基-5-甲基-2-硝基-苯基)-胺甲基酸第三-丁酯 根據一般程序B (方法a),自4-碘基-5-甲基-2-硝基-苯胺(實 例Α2)(13·51克,48.6毫莫耳)與雙光氣(4.4毫升,36.4毫莫耳) 在EtOAc (50毫升)中,接著以第三_Bu〇h (150毫升)與Ch2 % (150耄升)處理,製備此異氰酸酯。獲得黃色固體(m i克, 77% ) 〇 MS (EI) 378 (M+);熔點 99-l〇〇DC。 實例B3 5-第三-丁氧羰基胺基_2_碘基斗硝基-苯甲酸甲酯 根據一般程序B (方法a),自5-胺基-2-碘基-4-硝基-苯甲酸 甲酯(實例A3)(5.5克,17毫莫耳)與雙光氣(155毫升,13毫莫 耳)在EtOAc (135毫升)中,接著以第三-Bu〇H (2〇毫升)與 CH2 % (70毫升)處理,製備此異氰酸酯。獲得黃色固體(5 2 克,72%)。 MS(ISP)440 [(M+NH4)+];溶點 i26°C。 實例B4 (5-烯丙氧基-4-碘基-2-硝基-苯基)_胺甲基酸第三_丁酯 根據一般程序B (方法a),自5-烯丙氧基-4-碘基-2-硝基-苯 胺(實例Ε1)(9·0克,28.2毫莫耳)與雙光氣(2·6毫升,212毫莫 耳)在KOAc (150毫升)中,接著以第三_Bu〇H (8〇毫升)與 CH2 C丨2 (80毫升)處理,製備此異氰酸酯。獲得黃色固體 (9.16 克,77%) 〇 MS (ISP) 421 [(M+H)+ ]與 438 [(M+NH4)+ ];溶點 93-95Ό。 實例B5 I----丨 11丨1丨! — I I (請先閱讀背面之注意事項再頁) · · :線. -30- 1255266 A7 B7 五、發明說明(28) (4-琪基-5·甲氧基-2-硝基-苯基)-胺甲基酸第三-丁酯 根據一般程序B (方法a),自4-碘基-5-甲氧基-2-硝基-苯胺( 實例E2)(2.85克,9.69毫莫耳)與雙光氣(0.88毫升,7.27亳莫耳) 在EtOAc (52毫升)中,接著以第三_Bu〇H (25毫升)與CH2 Cl2 (25 毫升)處理,製備異氰酸酯。獲得黃色固體(3.0克,79% )。 MS(EI) 394 (M+);熔點 171°C。 實例B6 [4-破基-5-(2-甲氧基-乙氧基)-2-硝基-苯基]-胺甲基酸第三-丁酯 根據一般程序B (方法a),自4-碘基-5_(2-曱氧基-乙氧基)-2-硝基-苯胺(實例E3)(2.73克,8·08毫莫耳)與雙光氣(0.8毫升, 6.06毫莫耳)在EtOAc (50毫升)中,接著以第三-BuOH (25毫升) 與CH2C12(25毫升)處理,製備此異氰酸酯。獲得黃色固體 (3·0 克,86% )。 MS (ISP) 439 [(Μ+Η). ],456 [(Μ+ΝΗ4)+]及 461 [(M+Na)+];熔點 109- lire 〇 實例B7 [4-硪基-5-(2-{2-[2-(2-甲氧基-乙氧基)-乙氧基]-乙氧基}_乙氧基)_ 2-硝基-苯基]-胺甲基酸第三-丁酉旨 根據一般程序B (方法a),自4-碘基-5-(2-{2-[2-(2-甲氧基-乙 氧基)-乙氧基]-乙氧基}-乙氧基)-2-硝基-苯胺(實例E4)(8.0克, 17毫莫耳)與雙光氣(1_54毫升,13毫莫耳)在EtOAc (100毫升) 中,接著以第三-BuOH (25毫升)與CH2C12 (25毫升)處理,製 備此異氰酸酯。獲得黃色油(8.6克,890/。)。 MS(ISP) 588 [(M+NH4)+] 〇 -31 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 x 297公釐) (請先閱讀背面之注意事項再13^4頁) 40 Γ 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明(29) 實例B8 --------------裝—— (請先閱讀背面之注意事項再13^本頁) (RS)-[5-(2,2-二甲基-[1,3]二氧伍圜冰基甲氧基)!硝基冬苯基乙 块基-苯基]-胺甲基酸第三-丁酉旨 根據一般程序B (方法b),於52°C下,製自(RS)-5-(2,2-二甲 基-[1,3]二氧伍圜-4-基甲氧基)-2-硝基冰苯基乙炔基-苯胺(實 例K14)(2.678克,5.7毫莫耳)、Cs2C〇3(2.23克,6.8毫莫耳)及 Boh 0 (1.52克,7.0毫莫耳)在2- 丁酮(36.5毫升)中。獲得黃色 泡沫物(2.0克,75% )。 MS (ISP) 469 [(M+H).]與 486[(M+NH4)+ ];溶點 32°C。 實例 B9 fVe (R=CN ; R,,=Boc)| (5-氰基甲基-4-碘基-2-硝基-苯基 &gt;胺甲基酸第三_丁酯 -線· 根據一般程序B (方法a),自(5-胺基-2-碘基斗硝基-苯基)-乙 腈(實例Vf (R=CN ; R”=H))(5.15克,17毫莫耳)與雙光氣(2〇5毫 升,17毫莫耳)在EtOAc (150毫升)中,接著以第三_Bu〇H (25 笔升)與CH2 (¾ (25笔升)處理,製備此異氰酸酯。獲得黃色 固體(4.0 克,58% )。 MS (ISN) 402 [(Μ-ΗΠ ;熔點 124-126。(:。 實例B10 經濟部智慧財產局員工消費合作社印製 [5-(2-第三-丁氧基-乙氧基)冬碘基:硝基-苯基胺甲基酸第三 -丁酯 根據一般程序B(方法c),自5-(2-第三_丁氧基_乙氧基)冰碘 基硝基-苯胺(實例Ε6)(13·9克,36.6毫莫耳)與Β〇〇2 〇 (16·35克 ,75毫莫耳),接著以2當量TFA在CH2%中處理,製備二_1255266 V. Description of the invention (26) Evaporation of the solvent to give an orange solid, which was purified by chromatography eluting with hexane / EtOAc to give (4-diyl-2-nitro-phenyl) Amino-methyl 3-butyrate is a yellow solid. Method C: in a solution of 'iodo-1-nitroaniline (550 mmol) and DMAP (1.22 g, 1 mM mmol) in THF (1000 mL) at 23 χ: A solution of B〇C2〇 (246 g, 1128 mmol) in THF (5 mL) was added dropwise. (Stirring was continued for 75 minutes. The whole mixture was evaporated to dryness and dried <RTI ID=0.0></RTI> to </RTI> <RTI ID=0.0> TFA (84 ml, 1100 mmol) was added dropwise. The mixture was stirred in EtOAc. EtOAc (EtOAc m.). The solvent was removed in the sputum, leaving a dark brown solid (199.71 g), which was applied to silica gel and purified by column chromatography using hexane / EtOAc -Nitro-phenyl)-amino acid tert-butyl ester as a yellow solid. Example B1 (5-chloro-4-pyridyl-2-nitro-phenyl)-amine methyl acid _Butyl ester according to the general procedure B (method a), from 5-chloro-bromoiodo-2-nitro-phenylamine (example Α1) (7·0 g ' 23.45 mmol) and diphosgene (2.12 ml, This isocyanate was prepared in EtOAc (3 mL) EtOAc (3 mL) 6%) 〇MS (EI) 398 (M+) and 400 [(M+2)+ ]; melting point 82-84Ό. Example B2 -29- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 Love) -------------^ · 11 (Please read the notes on the back and then ^||^ page) Order: Line - Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 Economy Ministry of Intellectual Property Bureau employee consumption cooperative printed A7 V. Description of invention (27 (4-Alkyl-5-methyl-2-nitro-phenyl)-amine methyl acid tert-butyl ester according to the general procedure B ( Method a), from 4-iodo-5-methyl-2-nitro-phenylamine (Example Α 2) (13. 51 g, 48.6 mmol) with diphosgene (4.4 mL, 36.4 mmol) This isocyanate was prepared by treatment with EtOAc (50 mL) EtOAc (EtOAc) (EtOAc) M+); melting point 99-l 〇〇 DC. Example B3 5-tris-butoxycarbonylamino 2 -iodoyl nitro-benzoic acid methyl ester according to the general procedure B (method a), from 5-amino Methyl 2-iodo-4-nitro-benzoate (Example A3) (5.5 g, 17 mmol) with diphosgene (155 mL, 1 This isocyanate was prepared by treatment with EtOAc (135 mL) EtOAc (EtOAc:EtOAc) Obtained as a yellow solid (5 2 g, 72%). MS (ISP) 440 [(M+NH4)+]; melting point i26 °C. Example B4 (5-allyloxy-4-iodo-2-nitro-phenyl)-amine methyl acid tert-butyl ester according to General Procedure B (Method a) from 5-Allyloxy- 4-iodo-2-nitro-aniline (Example Ε1) (9·0 g, 28.2 mmol) with diphosgene (2.6 mL, 212 mmol) in KOAc (150 mL), then This isocyanate was prepared by treatment with a third _Bu 〇 H (8 mL) and CH 2 C 丨 2 (80 mL). Obtained a yellow solid (9.16 g, 77%) 〇 MS (ISP) 421 [(M+H)+] and 438 [(M+NH4)+]; melting point 93-95 Ό. Example B5 I----丨 11丨1丨! — II (Please read the precautions on the back page again) · · : Line. -30- 1255266 A7 B7 V. Description of invention (28) (4-Qi-5-methoxy-2-nitro-phenyl - Aminomethyl 3-butyrate according to General Procedure B (Method a), from 4-iodo-5-methoxy-2-nitro-phenylamine (Example E2) (2.85 g, 9.69 mmol) Isocyanate was prepared by treatment with diphosgene (0.88 mL, 7.27 mmol) in EtOAc (EtOAc) (EtOAc) Obtained as a yellow solid (3.0 g, 79%). MS (EI) 394 (M+); mp. Example B6 [4-Butyl-5-(2-methoxy-ethoxy)-2-nitro-phenyl]-amine methyl acid tert-butyl ester according to General Procedure B (Method a), 4-iodo-5-(2-decyloxy-ethoxy)-2-nitro-phenylamine (Example E3) (2.73 g, 8.08 mmol) with diphosgene (0.8 mL, 6.06 mmol) The isocyanate was prepared by treatment with EtOAc (50 mL) eluting EtOAc (EtOAc) Obtained a yellow solid (3.0 g, 86%). MS (ISP) 439 [(Μ+Η). ],456 [(Μ+ΝΗ4)+] and 461 [(M+Na)+]; melting point 109- lire 〇Example B7 [4-硪基-5-( 2-{2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxy}-ethoxy) 2-nitro-phenyl]-amine methyl acid - 酉 酉 according to the general procedure B (method a), from 4-iodo-5-(2-{2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxy} -ethoxy)-2-nitro-phenylamine (Example E4) (8.0 g, 17 mmol) with diphosgene (1 - 54 mL, 13 mmol) in EtOAc (100 mL) This isocyanate was prepared by treatment with -BuOH (25 mL) and CH2C12 (25 mL). Obtained yellow oil (8.6 g, 890 /.). MS(ISP) 588 [(M+NH4)+] 〇-31 - This paper size is applicable to China National Standard (CNS) A4 specification (210 x 297 mm) (please read the notes on the back and then 13^4 pages) 40 Γ Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 A7 B7 V. Invention Description (29) Example B8 -------------- Installation - (Please read the notes on the back first) 13^This page) (RS)-[5-(2,2-Dimethyl-[1,3]dioxosyl glacial methoxy)! Nitro-t-phenylphenyl-phenyl-phenyl]-amine methyl acid, the third-butyr, according to the general procedure B (method b), at 52 ° C, from (RS)-5-(2,2- Dimethyl-[1,3]dioxoindol-4-ylmethoxy)-2-nitro- ice phenylethynyl-aniline (Example K14) (2.678 g, 5.7 mmol), Cs2C〇3 (2.23 g, 6.8 mmol) and Boh 0 (1.52 g, 7.0 mmol) in 2-butanone (36.5 mL). Obtained yellow foam (2.0 g, 75%). MS (ISP) 469 [(M+H).] and 486 [(M+NH4)+]; melting point 32 °C. Example B9 fVe (R=CN; R,,=Boc)| (5-Cyanomethyl-4-iodo-2-nitro-phenyl&gt; Aminomethyl acid tert-butyl ester-line·According to General Procedure B (Method a) from (5-Amino-2-iodopiperidinyl-phenyl)-acetonitrile (Example Vf (R=CN; R"=H)) (5.15 g, 17 mmol) Prepared with diphosgene (2〇5 ml, 17 mmol) in EtOAc (150 mL) followed by a third _Bu〇H (25 L) and CH2 (3⁄4 (25 L) Isocyanate. Obtained as a yellow solid (4.0 g, 58%). MS (ISN) 402 [(Μ-ΗΠ; melting point 124-126. (:. Example B10 Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative Printed [5-(2- Tertiary-butoxy-ethoxy)methanol iodide: nitro-phenylamine methyl acid tert-butyl ester according to the general procedure B (method c), from 5-(2-tri-butoxy) _Ethoxy) ice iodo nitro-aniline (Example Ε 6) (13·9 g, 36.6 mmol) and Β〇〇2 〇 (16.35 g, 75 mmol) followed by 2 equivalents of TFA Processed in CH2%, prepared two

Boc-化合物。獲得黃色固體(14.96克,85% )。 -32- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公楚) 1255266 經濟部智慧財產局員工消費合作社印製 A7 B7 五、發明說明(3Q) MS(ISP)481[(M+H)+];熔點 113-116T:。 實例B11 [4-破基-5-(4-甲氧基氧基)-2-硝基-苯基]_胺甲基酸第三_丁醋 根據一般程序B (方法c),自‘碘基-5-(4-甲氧基-爷氧基)_2-硝基-苯胺(實例E7)(2.88克,7.20毫莫耳)與BoC2〇 (3·3〇克, 15.12毫莫耳),接著以2當量TFA在CH2C12中處理,製備二一 Boc-化合物。獲得蟻狀黃色固體(ι·74克)。 MS (ISN) 499 [(M-H)-]。 下述程序係關於在5-位置上帶有氮取代基之(4-破基硝 基-苯基)-胺甲基酸第三-丁酯之製備(圖示D)。 一般程序C : 5-N-取代-(4-琪基-2-硝基-苯基)-胺甲基酸第三_丁酯之製備: 方法a :自(5-氯基-4-蛾基-2-硝基-苯基)-胺甲基酸第三_丁酉旨 將(5-氣基-4-峨基-2-硝基-苯基)-胺甲基酸第三-丁酯(實例β1) 與所要之胺,視情況與甲苯或DMSO及/或DIPEA,在23°C 至100-130 C之溫度下攪;拌,直到tic顯示氯化物完全消失爲 止。使反應物冷卻至23°C,倒入冰水中,濾出沉澱物,以 水洗滌並在眞空中乾燥。在產物不會沉澱之情況中,將混 合物以EtOAc萃取,以水及鹽水洗滌,以Na2 s〇4脱水乾燥。 過濾及在眞2中移除溶劑,留下粗產物,將其藉矽膠管柱 層析純化,使用己烷/ EtOAc,而得純標題化合物。 方法b :自5-氯基-4_碘基-2-硝基-苯胺 將5-氣基-4-峨基-2-硝基-苯胺(實例Al)(l.49克,5.0毫莫耳) ’所要之肢(6-25愛莫耳)及適當驗,例如NaHCO;、Κ2 CC^、 -33- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) --------------裝--- (請先閱讀背面之注意事項再1^114頁) 訂: •丨線- 1255266 A7 --- B7__ 五、發明說明(31 )Boc-compound. Obtained as a yellow solid (14.96 g, 85%). -32- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 public Chu) 1255266 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed A7 B7 V. Invention description (3Q) MS (ISP) 481 [(M +H)+]; melting point 113-116T:. Example B11 [4-Alkyl-5-(4-methoxyoxy)-2-nitro-phenyl]-amine methyl acid third-butyl vinegar according to General Procedure B (Method c), from 'Iodine 5-O-(4-methoxy-l-oxy)_2-nitro-aniline (Example E7) (2.88 g, 7.20 mmol) with BoC 2 〇 (3·3 g, 15.12 mmol), The di-Boc-compound is then prepared by treatment with 2 equivalents of TFA in CH2C12. An ant yellow solid (1·4 g) was obtained. MS (ISN) 499 [(M-H)-]. The following procedure pertains to the preparation of (4-pyridylnitro-phenyl)-amine methyl acid tert-butyl ester with a nitrogen substituent at the 5-position (Figure D). General procedure C: Preparation of 5-N-substituted-(4-picyl-2-nitro-phenyl)-amine methyl acid tert-butyl ester: Method a: from (5-chloro-4-pyrene Benzyl-2-nitro-phenyl)-amine methyl acid, the third-butyl phthalate (Example β1) With the desired amine, optionally with toluene or DMSO and/or DIPEA, stir at a temperature of 23 ° C to 100-130 C; mix until tic shows complete disappearance of the chloride. The reaction was cooled to 23 ° C, poured into ice water, and the precipitate was filtered, washed with water and dried in the air. In the case where the product did not precipitate, the mixture was extracted with EtOAc, washed with water and brine, and dried over Na 2 s. Filtration and removal of the solvent in EtOAc (EtOAc m. Method b: 5-Alkyl-4-mercapto-2-nitro-phenylamine (Example Al) from 5-chloro-4-iodo-2-nitro-phenylamine (1.49 g, 5.0 mmol) Ear) 'The desired limb (6-25 Amor) and appropriate test, such as NaHCO;, Κ2 CC^, -33- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) -- ------------装--- (Please read the notes on the back and then 1^114 pages) Order: • 丨 line - 1255266 A7 --- B7__ V. Invention description (31)

Ey N或DIPEA (10-15毫莫耳)之混合物,於DMS〇、DMF或甲 苯(20-50耄升)中,在60-130°C下攪拌,直到tlc顯示氣化物完 全消失爲止。使反應物冷卻至23。(:,倒入冰水中,以in HC1 中和,濾出沉澱物,以水洗滌並在眞空中乾燥。在產物不 會/冗表之情泥中’將混合物以Et〇Ac萃取,以水及鹽水洗務 ,以Na] SO4脱水乾燥。過遽及在眞空中移除溶劑,留下粗 產物,將其藉矽膠管柱層析純化,使用己烷/ Et〇Ac,而得 純標題化合物。胺基之保護係按照一般程序B達成。 實例C1 [4-碘基-5-(4-甲基-六氫吡畊+基)-2_硝基-苯基胺甲基酸第三_ 丁酉旨 根據一般程序C (方法a),製自(5-氯基冰碘基冬硝基_苯基&gt; 胺甲基酸第三-丁酯(實例Bl)(2.39克,6.0毫莫耳)與μ甲基六 氫说畊(1.60毫升,15毫莫耳)在甲苯(4·5毫升)中,於 18小時。獲得黃色固體(2.2克)。 MS (ISP) 463 [(Μ+Η)+ ];熔點 i34-136°C。 實例C2 (4-破基-2-硝基-5-硫代嗎福琳·4_基-苯基)_胺甲基酸第三_丁酉旨 根據一般程序C (方法a),製自(5_氣基斗碘基:硝基_苯基 胺甲基酸第三-丁酯(實例Β1)(2·〇克,5·〇毫莫耳)與硫代嗎福 啉(2.6毫升)在甲苯(3.8毫升)、DIPEA(1.7毫升)中,於H5°C 下48小時。獲得黃色固體(ι·ι克)。 MS (ISP) 466 [(M+H)+ ];熔點 132-134°C。 實例C3 -34- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -------------裝—— (請先閱讀背面之注意事項再1!^^頁) 訂: :線. 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明(32) (4-破基-5-嗎福淋-4-基-2-確基-苯基)-胺甲基酸第三_丁酉旨 根據一般程序C (方法a),製自(5-氯基冰碘基-2-硝基-苯基)-胺甲基酸第三-丁醋(貫例Bl)(2.0克,5.0毫莫耳)與嗎福琳(1〇 毫升),於回流下3小時。獲得黃色固體(0·805克)。 MS (ISP) 450 [(Μ+Η)+ ];熔點 43-44°C。 實例C4 [5-(1,4-二氧-8-氮-螺[4.5]癸-8-基&gt;4-碘基-2-硝基-苯基]-胺甲基酸 第三-丁酯 根據一般程序C(方法a),製自(5-氣基斗碘基-2-硝基-苯基)-胺甲基酸第三-丁酯(實例Β1)(3·0克,7.53毫莫耳)、;ι,4-二氧-8-氮-螺(4,5)癸燒(4.82毫升,37.63毫莫耳)及DIPEA (2.58毫升, 15.0毫莫耳)在甲苯(4毫升)中,於回流下6小時。獲得橘色 固體(4.0克)。 MS (ISP) 506 [(Μ+Η)+];熔點 132-134°C。 實例C5 [4-蛾基-5-(4-甲氧基-7T氫p比症-1-基)-2-硝基-苯基]_胺甲基酸第 三-丁酯 根據一般程序C (方法b),製自5-氣基-4-琪基-2-硝基-苯胺( 實例Α)(6·91克,23.15毫莫耳)、4_甲氧基六氫吡啶(4 〇克, 34.73 毫莫耳)及 NaHC03 (5.83 克,69.45 毫莫耳)在 DMSO (230 毫 升)中,於100°C下。根據一般程序B (方法c),使所獲得之 褐色固體(7.95克)轉化成標題化合物。獲得黃色固體(6 55克)。 MS (ISP) 478 [(M+H)+];熔點 133-135°C。 實例C6 -35- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ------------ 1 I (請先閱讀背面之注意事項再1?^4頁) 訂· :線_ 經濟部智慧財產局員工消費合作社印製 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明(33) {5-[(2-羥基-乙基)-甲基-胺基]_4-碘基冬硝基-苯基卜胺甲基酸第 三-丁酯 根據一般程序C (方法a) ’製自(5-氯基-4-琪基-2-硝基-苯基)_ 胺甲基酸第三-丁酯(實例B1X1.99克,5.0毫莫耳)與2_甲胺基 乙醇(2.00亳升,25.0毫莫耳)在DMSO (2.5毫升)中,於23°c下 。獲得黃色膠質(1.88克)。 MS(ISP) 438 [(M+H)+] 0 實例C7 [5-(4-#呈基-六氫ρ比淀-1-基)-4-破基-2-硝基-苯基]-胺甲基酸第三_ 丁酯 根據一般程序C(方法a),製自(5-氯基斗碘基冬硝基_苯基&gt; 胺甲基酸第三-丁酯(實例Β1)(1·99克,5毫莫耳)與4_輕基六 氫吡啶(2.53克,25毫莫耳)在DMSO (2.5毫升)中,於23下 。獲得黃色固體(1.88克)。 MS (EI) 463 (M+);熔點 58-60°C。 實例C8 {5-[4-(2-羥基-乙氧基)-六氫吡啶-1-基]冰碘基1硝基_苯基}-胺 甲基酸第三-丁酯 根據一般程序C (方法a),製自(5-氯基-4-蛾基_2_硝基-苯基)_ 胺甲基酸第三-丁酯(實例Β1)(2·2克,5.5毫莫耳)、4-(2_經乙 氧基)六氫吡啶{CAS-編號[40256-14_2]}(800毫克,55毫莫耳)及 Et3N(2.3毫升,16.5毫莫耳)在DMSO(2.3毫升)中,於2yC下。 獲得黃色固體(1.65克)。 MS (EI) 507 (M+);熔點 64-65°C。 -36- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公爱) --------------裝--- (請先閱讀背面之注意事項再1^4頁) 訂: -•丨線· 1255266 A7 B7 五、發明說明(34) tjHC9 [5-(順式-3,4-二羥基-四氫吡洛小基)-4-碘基-2-硝基-苯基]-胺甲 基酸第三-丁酯A mixture of Ey N or DIPEA (10-15 mmol) was stirred at 60-130 ° C in DMS oxime, DMF or toluene (20-50 liters) until tlc showed that the gas disappeared completely. The reaction was cooled to 23. (:, pour into ice water, neutralize with in HC1, filter out the precipitate, wash with water and dry in the sputum. In the product will not be / redundant, extract the mixture with Et〇Ac, with water And brine washing, dehydration and drying with Na]SO4. The solvent is removed in the hydrazine and the crude product is obtained, which is purified by column chromatography using hexane / Et. The protection of the amine group was achieved according to the general procedure B. Example C1 [4-iodo-5-(4-methyl-hexahydropyrazine + yl)-2_nitro-phenylamine methyl acid _酉 酉 according to the general procedure C (method a), prepared from (5-chloro- ice-iodoyl winter nitro-phenyl) amine methyl acid third-butyl ester (example Bl) (2.39 g, 6.0 mmol) ) with μMethyl hexahydropropane (1.60 ml, 15 mmol) in toluene (4.5 ml) for 18 hours to give a yellow solid (2.2 g). MS (ISP) 463 [(Μ+Η) )]]; melting point i34-136 ° C. Example C2 (4-ceptyl-2-nitro-5-thiofenoflavin-4-yl-phenyl)-amine methyl acid third_丁酉General Procedure C (Method a), prepared from (5_ gas base iodine: nitro-phenylamine A Acidic tri-butyl ester (Example Β1) (2·〇克, 5·〇 mmol) and thiomorpholine (2.6 ml) in toluene (3.8 ml), DIPEA (1.7 ml) at H5° 48 hours under C. Obtained a yellow solid (1·1g) MS (ISP) 466 [(M+H)+]; melting point 132-134 ° C. Example C3 -34- This paper scale applies to the Chinese National Standard (CNS) )A4 size (210 X 297 mm) -------------Installation - (Please read the notes on the back and then 1!^^ page) Order: :Line. Ministry of Economics intellectual property Bureau employee consumption cooperative printing 1255266 A7 B7 V. Description of invention (32) (4-Bulk-5-iflupreo-4-yl-2-decyl-phenyl)-amine methyl acid third_丁酉According to the general procedure C (method a), from (5-chloro-bromoiodo-2-nitro-phenyl)-amine methyl acid, third-butyl vinegar (consistent example B1) (2.0 g, 5.0 mmol) Ears with holphaline (1 ml), refluxed for 3 hours to give a yellow solid (0. 805 g) MS (ESI) 450 [(Μ+Η)+]; melting point 43-44 ° C. C4 [5-(1,4-Dioxo-8-nitro-spiro[4.5]dec-8-yl&gt; 4-iodo-2-nitro-phenyl]-amine methyl acid tert-butyl ester According to the general procedure C (method a) Made from (5-gas-based iodine-2-nitro-phenyl)-amine methyl acid tert-butyl ester (Example Β 1) (3.00 g, 7.53 mmol), ι, 4- Dioxo-8-aza-spiro(4,5) oxime (4.82 mL, 37.63 mmol) and DIPEA (2.58 mL, 15.0 mmol) in toluene (4 mL). Obtained an orange solid (4.0 g). MS (ISP) 506 [(Μ+Η)+]; melting point 132-134 °C. Example C5 [4-Mothyl-5-(4-methoxy-7T hydrogen p ratio-1-yl)-2-nitro-phenyl]-amine methyl acid tert-butyl ester according to the general procedure C (Method b), prepared from 5-oxyl-4-picyl-2-nitro-phenylamine (example Α) (6.91 g, 23.15 mmol), 4-methoxy pyridine (4 〇) Gram, 34.73 mM) and NaHC03 (5.83 g, 69.45 mmol) in DMSO (230 mL) at 100 °C. The obtained brown solid (7.95 g) was converted to the title compound according to General procedure B (Method C). Obtained a yellow solid (6 55 g). MS (ISP) 478 [(M+H)+]; mp. Example C6 -35- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) ------------ 1 I (Please read the notes on the back and then 1?^ 4 pages) Order · Line _ Ministry of Economic Affairs Intellectual Property Bureau Employees Consumption Cooperatives Ministry of Printing and Economy Ministry Intellectual Property Bureau Employees Consumption Cooperatives Printed 1255266 A7 B7 V. Description of Invention (33) {5-[(2-Hydroxy-ethyl) -Methyl-amino]-4-iodo-butyryl-phenyl-p-methylamino acid tert-butyl ester according to the general procedure C (method a) 'made from (5-chloro-4-pyryl-2 -Nitro-phenyl)-Aminomethyl-tert-butyl ester (Example B1X 1.99 g, 5.0 mmol) with 2-methylaminoethanol (2.00 liters, 25.0 mmol) in DMSO (2.5 In ml), at 23 ° C. Obtained yellow gum (1.88 g). MS(ISP) 438 [(M+H)+] 0 Example C7 [5-(4-#-based-hexahydro-p-pred-1-yl)-4-bromo-2-nitro-phenyl] -Aminomethyl acid third-butyl ester according to the general procedure C (method a), from (5-chloropiperidinyl iodide-phenyl) &gt; amine methyl acid tert-butyl ester (example Β 1) (1·99 g, 5 mmol) and 4_light hexahydropyridine (2.53 g, 25 mmol) in DMSO (2.5 mL). EI) 463 (M+); m.p. 58-60 ° C. Example C8 {5-[4-(2-hydroxy-ethoxy)-hexahydropyridin-1-yl] ice iodoyl 1 nitro-phenyl} -Aminomethyl acid tert-butyl ester according to the general procedure C (method a), from (5-chloro-4-homyl-2-nitro-phenyl)-amine methyl acid tert-butyl ester (Example Β 1) (2.2 g, 5.5 mmol), 4-(2_ethoxylated) hexahydropyridine {CAS-number [40256-14_2]} (800 mg, 55 mmol) and Et3N (2.3 ml, 16.5 mmol) in DMSO (2.3 mL) EtOAc (EtOAc: EtOAc) The scale applies to the Chinese National Standard (CNS) A4 specification (210 X 297 public) -------- ------Installation--- (Please read the notes on the back and then 1^4 pages) Order: -•丨线·1255266 A7 B7 V. Invention description (34) tjHC9 [5-(cis-3 , 4-dihydroxy-tetrahydropyrrolidyl)-4-iodo-2-nitro-phenyl]-amine methyl acid tert-butyl ester

在兩步驟中按下述製成:根據一般程序C (方法a),使(5-氯基-4-碘基-2-硝基-苯基)_胺甲基酸第三-丁酯(實例Bl)(8.73克 ’ 21·9毫莫耳)與3-吡咯啉(2.0毫升,26.3毫莫耳,70%純, 含有30%四氫吡咯)、Et3N(9.12毫升,65_7毫莫耳)在DMSO (14毫升)與EtOH (5毫升)中,在23°C下反應,而得[5-(2,5-二氫 吨咯-1-基)-4-鐵基-2-硝基-苯基]-胺甲基酸第三-丁酯與(4-碘基-2-硝基-5-四氫吡咯小基-苯基胺甲基酸第三-丁酯之7 : 3混 合物。所獲得爲黃色固體(8·57克)。使一部份(4.31克)此物 質進行二羥基化,其方式是與&gt;〇^〇(1.28克,11.0毫莫耳), 2.5% 〇s〇4在t-BuOH (1毫升,0.1毫莫耳)中,及K2〇s〇4 (40毫克 ,0.1毫莫耳)在丙酮(250毫升)與H2 0(100毫升)中,於23 °C 下反應6天。獲得標題化合物,爲非晶質黃色物質(2.50克)。 MS (ISP) 466 [(M+H)+ ]。Made in two steps as follows: according to the general procedure C (method a), (5-chloro-4-iodo-2-nitro-phenyl)-amine methyl acid tert-butyl ester ( Example Bl) (8.73 g '21.9 mmol) with 3-pyrroline (2.0 mL, 26.3 mmol, 70% pure, containing 30% tetrahydropyrrole), Et3N (9.12 mL, 65_7 mmol) The reaction was carried out in DMSO (14 ml) and EtOH (5 ml) at 23 ° C to give [5-(2,5-dihydrotol-l-yl)-4-ironyl-2-nitro a 7:3 mixture of 3-phenyl]-aminomethyl acid tert-butyl ester and (4-iodo-2-nitro-5-tetrahydropyrrole small-phenylamine methyl acid tert-butyl ester) Obtained as a yellow solid (8·57 g). A portion (4.31 g) of this material was dihydroxylated by &gt; 〇^〇 (1.28 g, 11.0 mmol), 2.5% 〇 S〇4 in t-BuOH (1 ml, 0.1 mmol), and K2〇s〇4 (40 mg, 0.1 mmol) in acetone (250 ml) and H2 0 (100 ml), at 23 The reaction was carried out for 6 days at <RTI ID=0.0></RTI> </RTI> <RTI ID=0.0></RTI> <RTIgt;

實例CIOInstance CIO

[5-(2-羥基_乙胺基)冰碘基-2-硝基-苯基]-胺甲基酸第三-丁醋 根據一般程序C (方法a),製自(5-氣基-4-破基-2-硝基-苯基)_ 胺甲基酸第三-丁酯(實例Bl)(3_99克,1〇亳莫耳)與乙醇胺 (3.01毫升,50毫莫耳)在DMSO (20毫升)中,於2yC下。獲得 黃色固體(4.5.3克)。 MS (ISP) 424 [(M+H)+ ];熔點 130-148°C。[5-(2-Hydroxy-ethylamino) gladonyl-2-nitro-phenyl]-amine methyl acid, third-butyl vinegar, according to the general procedure C (method a), from (5-gas base) 4--4-bromo-2-nitro-phenyl)-aminomethyl acid tert-butyl ester (Example Bl) (3_99 g, 1 mol) with ethanolamine (3.01 mL, 50 mmol) In DMSO (20 ml) at 2 yC. Obtained a yellow solid (4.5.3 g). MS (ISP) 424 [(M+H)+]; mp. 130-148.

實例CU -37 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ----I---. 1 1 (請先閱讀背面之注意事項再13^4頁) 訂-- ;線_ 經濟部智慧財產局員工消費合作社印製 1255266 經濟部智慧財產局員工消費合作社印製 A7 B7 五、發明說明(35) [5-((R)-3-j%基-四鼠p比嘻-1-基)-4-破基-2-硝基-苯基]_胺甲基酸第 三-丁酯 根據一般程序C (方法a),製自(5-氣基-4-破基-2-硝基-苯基)一 胺甲基酸第三-丁酯(實例Bl)、(R)-3-羥基四氫吡咯鹽酸鹽及 Et3 N,在DMSO中,於23°C下。獲得黃色固體(3 · 153克)。 MS (ISP) 450 [(M+H)+ ];熔點 158°C (分解)。 下述程序係關於在5-位置上帶有硫取代基之(4_破基j硝 基-禾基)-胺甲基酸第三-丁醋之製備(合成圖示D): 一般程序D : 自(5-氣基-4-碘基-2-硝基-苯基)-胺甲基酸第三·丁酯,製備5_s_ 取代-(4-埃基-2-硝基-苯基)-胺甲基酸第三_丁酯 於硫醇(2.2毫莫耳)在DMF中之溶液内,添加Na〇Me溶液 (5.4M,在MeOH中,0.41毫升,2.2毫莫耳),接著爲氯基_ 4-破基-2-硝基-苯基)_胺甲基酸第三_丁酯(實例Bi)(797毫克, 2.0耄莫耳),並在23°C下持續攪拌,直到tlc顯示氯化物完全 消失爲止,倒入冰冷5%擰檬酸中,以Et〇Ac萃取,以飽和 NaHC〇3落液、鹽水洗滌,以MgS〇4脱水乾燥。移除溶劑, 留下橘色油’將其藉矽膠管柱層析純化,使用己烷/ Et〇Ac ’而仔純標題化合物。 實例D1 [5-(2-一甲胺基-乙硫基)4_破基硝基_苯基]_胺甲基酸第三-丁 酯 根據一般程序D,製自(5_氣基+碘基j硝基_苯基)_胺甲基 酸第三-丁酯(實例Bl)(399毫克,1.〇毫莫耳)、2_二甲胺基乙 -38- 本紙張尺度適財關家標準(CNS)A4規格(21〇 X 297公爱) --------------裝--- (請先閱讀背面之注意事項再1^114頁) 訂: 線· 1255266 A7 B7 五、發明說明(36) §予乙硫醇鹽酸鹽(312毫克,2.2毫莫耳)及Na〇Me溶液(5 4M, ---------------裝--- (請先閱讀背面之注意事項再1311^頁) 在MeOH中)(0.8毫升’ 8.8毫莫耳)在DMF (2毫升)中。獲得黃 色固體(306毫克)。 MS (ISP) 468 [(M+H)+ ];熔點 i44°C。 實例D2 (5-第二-丁氧羰基胺基-2-碘基冰硝基_苯硫基 &gt;醋酸甲酯 根據一般程序D,製自(5-氣基_4-碘基冬硝基_苯基)_胺甲基 酸第三-丁 g旨(實例Bl)(797毫克,2.0毫莫耳)、硫代乙醇酸甲 酯(0.2耄升’ 2.2毫莫耳)及NaOMe溶液(5.4M,在MeOH中) (0.41笔升’ 2.2愛莫耳)在DMF (2毫升)中。獲得黃色固體(847 毫克)。 MS (EI) 468 (M+);熔點 li〇-ii2°C。 下述程序係關於在5-位置上帶有氧取代基之(4-破基_2-硝 基·苯基)-胺甲基酸第三-丁酯之製備(圖示E): 一般程序E : :線· 自5-氣基-4-破基-2-梢基-苯胺,製備5-0-取代-4-磁基-2-硝基-苯 基胺 於 KOH (85 % ’ 3.62-7.96 克,55-121 毫莫耳)在 DMSO (50 毫升) 經濟部智慧財產局員工消費合作社印製 中之懸浮液内,添加醇(125-500毫莫耳),並將混合物於23。(: 下攪拌,直到所有KOH均已溶解爲止。以少量分次添加5_ 氣基-4-碘基-2-硝基-苯胺(實例Al)(15.0克,50毫莫耳),並將 所形成之深紅色透明溶液於23-60°C下攪拌,直到tic顯示氣 化物完全消失爲止。倒入冰冷INHCr或冰冷飽和NH4C1溶液 中,以EtOAc或CHC13萃取,以1NHC1或飽和NH4C1溶液及鹽 -39- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266 A7 五、發明說明(37 水洗務’以MgS〇4脱水乾燥。移除溶劑,留下深紅色固體 ,將其藉矽膠管柱層析純化,而得純^題化合物。 實例E1 烯丙氧基-4-碘基-2-硝基-苯胺 根據一般程序E,製自5-氯基斗碘基净硝基-苯胺(實例A1) (15.0克,50耄莫耳)' 晞丙醇(5〇毫升)及K〇H (7.96克,121毫 莫耳)在DMSO (50毫升)中。獲得橘色固體(9·38克)。 MS (ΕΙ) 320 (Μ+);熔點 74°C。 實例E2 4-碘基-5-甲氧基-2-硝基-苯胺 根據一般程序E,製自5-氯基斗碘基-2-硝基-苯胺(實例A1) (2.98克’ 10爱莫耳)、甲醇(1〇毫升)及K〇H (145克,22毫莫 耳)在DMSO (10毫升)中。獲得橘色固體(2·9克)。 MS (ISP) 295 [(Μ+ΗΠ 與 312 [(Μ+ΝΗ4)+ ];熔點 i 89χ:。 實例E3 4-碘基-5-(2-甲氧基-乙氧基)-2-硝基-苯胺 根據一般程序E,製自5-氯基-4-碘基-2-硝基-苯胺(實例A1) (2·98克,10毫莫耳)、2-甲氧基乙醇(7.9亳升,ι〇〇毫莫耳)及 Κ〇Η(1·45克,22愛莫耳)在DMSO (8毫升)中。獲得橘色固體 (2.8 克)。 &quot; MS (ISN) 337 [(M-Η)-];熔點 121-122°C。 實例E4 4-破基-5-(2-{2-[2-(2-甲氧基-乙氧基)-乙氧基]_乙氧基卜乙氧基)· 2-硝基-苯胺 -40- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 請 先 閱 讀 背 之 注 意 事 項 再 I# 本 頁 裝 訂 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明(38) 根據一般私序E,製自5-氯基冰碘基-2-硝基-苯胺(實例A1) (9.48克,32¾莫耳)、四乙二醇單甲基醚⑴克,%毫莫耳) 及K〇H(2.31克,35毫莫耳)在DMS〇(25亳升)中,於6〇Ό下。 獲得紅色油(8.4克)。 MS(ISP)471 [(Μ+Η)+]。 實例Ε5 (RS)-5-(2,2-_^甲基-[1,3]二氧伍圜基甲氧基)冰碘基硝基_苯 胺 根據一般程序E ’製自5-氣基-4-碘基-2-硝基-苯胺(實例A1) (4.48克’ 15耄莫耳)、D,L- α,/?-亞異丙基-甘油(1〇毫升,μ毫 莫耳)及ΚΟΗ (1.01克’ 18毫莫耳)在DMSO (10毫升)中,於23 °C下。獲得黃色固體(4.9克)。 MS (ISN) 393 [(M-H)· ] ·,熔點 i51°C。 實例E6 5-(2-第三-丁氧基-乙氧基)-4-破基-2-硝基-苯胺 根據一般私序E ’製自5-氣基-4-破基-2-硝基-苯胺(實例A1) (14.9克,50毫莫耳)、2-第三-丁氧基乙醇(29.5克,250毫莫耳) 及KOH (3.99克,60毫莫耳)在DMSO (25毫升)中,於23°C下。 獲得黃色固體(14.3克)。 MS (ISP) 381 [(M+H)+];熔點 144-146°C。 實例E7 4-破基-5-(4-甲氧基氧基)-2-硝基-苯胺 根據一般私序E ’製自5-氣基-4-破基-2-硝基-苯胺(實例A1) (5.97克,20毫莫耳)、4-甲氧基苯甲醇(4.98毫升,40毫莫耳) -41 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) --------------S--- (請先閱讀背面之注意事項再^®本頁) · .丨線· 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 經濟部智慧財產局員工消費合作社印製 五、發明說明(39 及Κ〇Η(1·58克,24毫莫耳)在DMS〇(30毫升)中,於23°C下。 獲得黃褐色固體(2.94克)。 MS (ISN) 399 [(M-Η)·];熔點 183°C。 下述實例係關於(5-第三-丁氧羰基胺基碘-4-硝基-苯基)· 醋酸曱醋與(5-氰基甲基_4_碘基_2_硝基-苯基)-胺甲基酸第三· 丁酉旨之製備(合成圖示F): —實例 XVI (R=C〇iMe ; R&gt;Me ; R,,=Boc、 2-(5-第三-丁氧羰基胺基冬碘基冰硝基-苯基丙二酸二甲酯 於KOBut (0.56克,5.02毫莫耳)在DMSO (3毫升)中之溶液内 ,添加丙二酸二甲酯(0·58毫升,5 〇2毫莫耳),接著爲(5_氣 基-4-破基-2-硝基-苯基)-胺甲基酸第三_丁酯(實例Β1)(1〇〇克, 2.51耄莫耳)’並將所形成之深紅色透明溶液於丨⑻。c下攪掉 ,直到tic顯示氯化物完全消失爲止。倒入冰冷5。/。擰檬酸 (100毫升)中,以Et0Ac萃取(2 χ 1〇〇毫升),以鹽水洗滌,以 MgS〇4乾燥。移除溶劑,留下黃色油,將其藉矽膠管柱層 析純化,使用己烷/ EtOAc 4 : 1,獲得純標題化合物,爲黃 色膠質(U3克,91% )。 MS (ISP) 512 [(M+NH4)+ ]與 517 [(M+Na)+ ]。 實例 XVII (R=CN ; R&gt;Et ; Rn=H) (RS&gt;(5-胺基-2-碘基-4-硝基-苯基 &gt;氰基-醋酸乙酯 按貝例XVI所述’製自5-氯基-4-破基-2-硝基-苯胺(實例μ) (14.9克,50毫莫耳)、氰基醋酸乙酯(14.7毫升,1〇〇毫莫耳) 及KOBut (11.2克,100毫莫耳)在DMSO (60毫升)中,於1〇(rc 下2小時。獲得深褐色膠質。 --------------裝--- (請先閱讀背面之注意事項頁) · ,-線- 42 1255266Example CU -37 - This paper size applies to China National Standard (CNS) A4 specification (210 X 297 mm) ----I---. 1 1 (Please read the note on the back and then 13^4 pages) -- Line _ Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 1255266 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing A7 B7 V. Invention description (35) [5-((R)-3-j% base-four Mouse p-pyridin-1-yl)-4-bromo-2-nitro-phenyl]-amine methyl acid tert-butyl ester according to the general procedure C (method a), from (5-gas-based 4-Butyl-2-nitro-phenyl)-aminomethyl acid tert-butyl ester (Example Bl), (R)-3-hydroxytetrahydropyrrole hydrochloride and Et3 N in DMSO, At 23 ° C. Obtained a yellow solid (3 · 153 g). MS (ISP) 450 [(M+H)+]; mp 158 (dec.). The following procedure pertains to the preparation of (4-framo-j-nitro-heyl)-amine methyl acid tert-butyl vinegar with a sulfur substituent at the 5-position (Synthesis Figure D): General Procedure D : Preparation of 5_s_substituted-(4-Ethyl-2-nitro-phenyl) from (3-(yl)-4-iodo-2-nitro-phenyl)-amine methyl acid, third butyl ester -Aminomethyl acid tert-butyl ester in a solution of thiol (2.2 mmol) in DMF, Na 〇Me solution (5.4 M in MeOH, 0.41 mL, 2.2 mmol), followed by Chloro- 4-cyl-2-nitro-phenyl)-amine methyl acid tert-butyl ester (Example Bi) (797 mg, 2.0 Torr), and stirring was continued at 23 ° C until Tlc showed that the chloride completely disappeared, poured into ice-cold 5% citric acid, extracted with Et〇Ac, washed with saturated NaHC〇3, brine, and dried with MgS〇4. The solvent was removed to leave an orange oil, which was purified by column chromatography eluting with hexane / Et. Example D1 [5-(2-Methylamino-ethylthio) 4-degraded nitro-phenyl]-amino acid tert-butyl ester according to the general procedure D, from (5_ gas base + Iodoethyl j nitro-phenyl)-amine methyl acid third-butyl ester (Example Bl) (399 mg, 1. 〇 millimol), 2-dimethylaminoethyl-38- Guanjia Standard (CNS) A4 specification (21〇X 297 public) --------------Installation--- (Please read the notes on the back and then 1^114 pages) Line · 1255266 A7 B7 V. Description of the invention (36) § Ethyl mercaptan hydrochloride (312 mg, 2.2 mmol) and Na〇Me solution (5 4M, ------------ --- Pack--- (Please read the notes on the back and then 1311^) in MeOH (0.8 ml '8.8 mmol) in DMF (2 mL). Obtained a yellow solid (306 mg). MS (ISP) 468 [(M+H)+]; mp. Example D2 (5-Second-butoxycarbonylamino-2-iodoylnitroso-phenylthio]&gt; Methyl acetate was prepared according to the general procedure D from (5-carbyl-4-iodobutyryl) _Phenyl)-Aminomethyl acid No. 3 - butyl g (Example Bl) (797 mg, 2.0 mmol), methyl thioglycolate (0.2 liters '2.2 mmol) and NaOMe solution (5.4 M, in MeOH (0.41 liters &lt;RTI ID=0.0&gt;>&&&&&&&&&&&&&&&&&&&& The procedure for the preparation of (4-cyl-2-bromophenyl)-amine methyl acid tert-butyl ester with an oxygen substituent at the 5-position (Figure E): General procedure E : :Line · From 5-Gasyl-4-bromo-2-propenyl-aniline, Preparation of 5-0-Substituted-4-Mercapto-2-nitro-phenylamine in KOH (85 % ' 3.62- 7.96 g, 55-121 mmol) In a suspension of DMSO (50 ml) printed by the Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative, add alcohol (125-500 mmol) and mix the mixture at 23. : Stir under until all KOH has dissolved. Add 5_ gas-based 4-iodo-2-nitro-benzene in small portions Amine (Example Al) (15.0 g, 50 mmol), and the resulting dark red transparent solution was stirred at 23-60 ° C until tic showed complete disappearance of the gas. Pour into ice-cold INHCr or ice-cold saturated NH4C1 In solution, extract with EtOAc or CHC13, with 1NHC1 or saturated NH4C1 solution and salt-39- This paper scale applies Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1255266 A7 V. Description of invention (37 Washing Service' Drying with MgS〇4, removing the solvent, leaving a dark red solid, which was purified by column chromatography to give a pure compound. Example E1 allyloxy-4-iodo-2-nitro - Aniline according to the general procedure E, prepared from 5-chloropiperidinyl nitro-aniline (Example A1) (15.0 g, 50 耄 Mo Er)' 晞propanol (5 〇 ml) and K〇H (7.96 g) , 121 mM in DMSO (50 ml). Obtained an orange solid (9·38 g). MS (ΕΙ) 320 (Μ+); melting point 74 ° C. Example E2 4-iodo-5-A Oxy-2-nitro-aniline was prepared according to the general procedure E from 5-chloropiped iodo-2-nitro-phenylamine (Example A1) (2.98 g of &lt;RTI ID=0.0&gt; And K〇 H (145 g, 22 mmol) in DMSO (10 mL) afforded an orange solid (2·9 g) MS (ISP) 295 [(Μ+ΗΠ and 312 [(Μ+ΝΗ4)+]; Melting point i 89χ:. Example E3 4-iodo-5-(2-methoxy-ethoxy)-2-nitro-aniline according to the general procedure E from 5-chloro-4-iodo-2-nitro-aniline (Example A1) (2·98 g, 10 mmol), 2-methoxyethanol (7.9 liters, ι〇〇mole) and Κ〇Η (1·45 g, 22 Amol) In DMSO (8 ml). Obtained an orange solid (2.8 g). &quot; MS (ISN) 337 [(M-Η)-]; melting point 121-122 ° C. Example E4 4-Alkyl-5-(2-{2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxy ethoxy) 2-nitro-aniline -40- This paper size is applicable to China National Standard (CNS) A4 specification (210 X 297 mm). Please read the notes on the back and then I#. Page Binding Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 A7 B7 V. Description of the invention (38) According to the general private sequence E, from 5-chloro-bromoiodo-2-nitro-phenylamine (Example A1) (9.48 g, 323⁄4 mol), tetraethylene glycol monomethyl ether (1) g , % mM) and K〇H (2.31 g, 35 mM) in DMS 亳 (25 liters) at 6 。. Obtained red oil (8.4 g). MS (ISP) 471 [(Μ+Η)+]. Example Ε5 (RS)-5-(2,2-_^methyl-[1,3]dioxoindolylmethoxy)- ice iodo-nitro-aniline according to the general procedure E 'from 5-gas 4-iodo-2-nitro-phenylamine (Example A1) (4.48 g '15 耄 Moel), D, L-α, /?-isopropylidene-glycerol (1 〇 ml, μ mmol) And ΚΟΗ (1.01 g '18 mmol) in DMSO (10 ml) at 23 °C. A yellow solid (4.9 g) was obtained. MS (ISN) 393 [(M-H).], m.p. Example E6 5-(2-Terti-butoxy-ethoxy)-4-bromo-2-nitro-phenylamine was prepared according to the general private order E' from 5-carbyl-4-bromo-2- Nitro-aniline (Example A1) (14.9 g, 50 mmol), 2-tris-butoxyethanol (29.5 g, 250 mmol) and KOH (3.99 g, 60 mmol) in DMSO ( 25 ml) at 23 °C. A yellow solid (14.3 g) was obtained. MS (ISP) 381 [(M+H)+]; mp 144-146. Example E7 4-Alkyl-5-(4-methoxyoxy)-2-nitro-phenylamine was prepared according to the general private order E' from 5-carbyl-4-bromo-2-nitro-phenylamine ( Example A1) (5.97 g, 20 mmol), 4-methoxybenzyl alcohol (4.98 ml, 40 mmol) -41 - This paper size applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) ) --------------S--- (Please read the precautions on the back and then ^® this page) · .丨线· Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 A7 B7 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 5, invention instructions (39 and Κ〇Η (1 · 58 g, 24 mmol) in DMS 〇 (30 ml), at 23 ° C. Obtained a tan Solid (2.94 g) MS (ISN) 399 [(M - Η)·]; mp 183 ° C. The following example relates to (5-tris-butoxycarbonylamino iodo-4-nitro-phenyl ) · Preparation of vinegar acetate and (5-cyanomethyl_4_iodo-2-nitro-phenyl)-amine methyl acid III · Dingzhi (Synthesis Figure F): - Example XVI ( R=C〇iMe ; R&gt;Me ; R,,=Boc, 2-(5-tris-butoxycarbonylamino-t-butyryl glacial nitro-phenylmalonic acid dimethyl ester in K OBut (0.56 g, 5.02 mmol) in DMSO (3 mL), add dimethyl malonate (0·58 mL, 5 〇 2 mmol), followed by (5-gas-based) 4-Butyl-2-nitro-phenyl)-amine methyl acid tert-butyl ester (Example Β1) (1 gram, 2.51 耄mol) and the dark red transparent solution formed in 丨(8). C. Stir down until tic shows that the chloride has completely disappeared. Pour into ice-cold 5/min. (100 ml), extract with Et0Ac (2 χ 1 〇〇 ml), wash with brine, with MgS The residue was dried <RTI ID=0.0></RTI> <RTI ID=0.0></RTI> </RTI> <RTIgt; </RTI> <RTIgt; ISP) 512 [(M+NH4)+] and 517 [(M+Na)+]. Example XVII (R=CN; R&gt;Et; Rn=H) (RS&gt;(5-Amino-2-iodo) 4-Nitro-phenyl&gt;Cyano-acetic acid ethyl ester was prepared as described in Shell XVI from 5-chloro-4-pyridyl-2-nitro-phenylamine (example μ) (14.9 g, 50 Millol), ethyl cyanoacetate (14.7 ml, 1 mmol) and KOBut (11.2 g, 100 mmol) in DMSO ( In 60 ml), at 1 〇 (rc for 2 hours) to obtain a dark brown gum. -------------- Pack --- (Please read the note on the back first) · , - Line - 42 1255266

五、發明說明(4Q) MS(EI) 375 (M+)。 實例 Ve (RCO? Me ; R丨丨=Boc) --------------裝--- (請先閱讀背面之注意事項再頁) (5-第三-丁氧談基胺基-2-碘基冰硝基-苯基)_醋酸甲酯 將2-(5-第三-丁氧羰基胺基-2-碘基_4_硝基-苯基)_丙二酸二甲 醋(實例 XVI (R=C02Mr R’=Me H〇c))(3.34 克,6 76 毫莫耳) 、LiCl(573毫克,13.52毫莫耳)&amp;h2〇(〇122毫升,6 76毫莫耳) 在DMSO(46毫升)中之混合物,於1〇(rc下攪拌7小時。倒入 冰水中,以EtOAc萃取兩次,以鹽水洗滌,以MgS〇4脱水乾 燥。移除溶劑,留下黃色油,將其藉矽膠管柱層析純化, 使用己院/ Et〇Ac9 : 1,獲得純標題化合物,爲黃色固體 (1.37 克,470/〇 )。 MS (EI) 436 (M+);熔點 93°C。 實例 Vf (R=CN ; Rn-H) (5-胺基-2-碘基-4-硝基·苯基)-乙腈 :線· 按貫例Ve所述’製自(RS)-(5-胺基-2-琪基-4-硝基-苯基)_氰基 -酷酸乙酯(實例 XVII (R=CN ; R’HEt ; R&quot;=H))(20.62 克,55 毫莫耳) 與LiCl (9·33克,220毫莫耳)在〇?^〇(370毫升)與112〇(4.4毫升) 中,於120°C下2.5小時。獲得綠褐色固體。 經濟部智慧財產局員工消費合作社印製 MS (EI) 303 (M+);熔點 145-183X:。 下述實例係關於(5-羥甲基-4-碘基-2-硝基-苯基y胺甲基酸第 二-丁醋,其相應THP-酸,以及(5-二甲胺基甲基冬破基硝 基-苯基)-胺甲基酸第三_丁酯經由中間氣化物之製備(合成 圖示F): 實例Vh -43- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 經濟部智慧財產局員工消費合作社印製 1255266 A7 -----SI_____五、發明說明(41) (5-&amp;甲基-4-碘基·2-硝基-苯基)·胺甲基酸第三-丁酯 將LlBH4(〇.32克,14.78亳莫耳)於〇。〇下加入5•第三_ 丁氧幾 基胺基-2-碘基斗硝基-苯甲酸甲酯(實例B3)(3 i2克,I%毫莫 耳)與MeOH(0.6毫升,14.78毫莫耳)在THF(44毫升)中之溶液 内。將反應混合物在(TC下攪拌15分鐘,倒入5%檸檬酸中 ,以EtOAc萃取兩次,以飽和NaHC〇3溶液及鹽水洗滌,以 MgS〇4水乾燥。移除溶劑,留下黃色油,將其藉矽膠管 柱層析純化,使用環己院/Et〇Ac4: i,而得純標題化合物 ,爲黃色固體(2.64克,91% )。 MS (ISP) 412 [(M+NH4)+ ];熔點 &gt;25〇°C。 實例Vi (RS)-[4-碘基-2-硝基-5-(四氫-哌喃-2_基氧基甲基)_苯基 &gt;胺甲基 酸第三-丁酯 土 於(5-羥甲基-4·碘基-2-硝基-苯基)_胺甲基酸第三-丁酯(實例 Vh)(394見克’ 1.〇毫莫耳)與3,4_二氫-2H-嗓喃(0.11毫升,1 2亳 莫耳)在DCM (5毫升)中之混合物内,在〇°C下添加對_Ts〇H · Η2〇(約5毫克),並將反應物於〇°c下攪掉1小時。以段〇&amp; 稀釋,以飽和NaHC〇3溶液及鹽水洗滌,以MgS〇4脱水乾燥 。在眞空中移除溶劑,留下黃色油,將其藉矽膠管柱層析 純化,使用己烷/ EtOAc 9 : 1,獲得純標題化合物,爲黃色 膠質(470毫克,98%)。 ~MS (ISN) 477 [(M-H)-]。 實例VI (5-一甲胺基甲基-4-读基-2-硝基-本基)-胺甲基酸第三-丁酉旨 -44-V. Description of the invention (4Q) MS (EI) 375 (M+). Example Ve (RCO? Me; R丨丨=Boc) -------------- Pack--- (Please read the notes on the back page again) (5-Third-butoxy Talk to arylamino-2-iodyl nitro-phenyl)-methyl acetate to 2-(5-tris-butoxycarbonylamino-2-iodo-4-phenyl-phenyl)-propyl Diacid diacetate (example XVI (R=C02Mr R'=Me H〇c)) (3.34 g, 6 76 mmol), LiCl (573 mg, 13.52 mmol) & h2〇 (〇122 ml) The mixture was stirred at EtOAc (46 mL) over EtOAc (EtOAc)EtOAc. The title compound was obtained as a yellow solid ( 1.37 g, 470 / EtOAc). (M+); melting point 93 ° C. Example Vf (R=CN; Rn-H) (5-Amino-2-iodo-4-nitrophenyl)-acetonitrile: s. 'Manufactured from (RS)-(5-Amino-2-pyridyl-4-nitro-phenyl)-cyano-succinic acid ethyl ester (Example XVII (R=CN; R'HEt; R&quot;=H )) (20.62 grams, 55 millimoles) with LiCl (9 33 g, 220 mM) in 〇?^〇 (370 ml) and 112 〇 (4.4 ml) at 2.5 ° C for 2.5 hours. Obtained a green-brown solid. Printed by the Ministry of Economic Affairs, Intellectual Property Bureau, Consumer Cooperatives MS (EI) 303 (M+); melting point 145-183X: The following example relates to (5-hydroxymethyl-4-iodo-2-nitro-phenylyaminemethyl acid second-butyl vinegar, Preparation of the corresponding THP-acid, and (5-dimethylaminomethyl-glycolyl nitro-phenyl)-amine methyl acid tert-butyl ester via an intermediate vapor (Synthesis Figure F): Example Vh - 43- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 A7 -----SI_____ V. Invention Description (41) (5- &amp;methyl-4-iodo-2-nitro-phenyl)-aminomethyl acid tert-butyl ester LlBH4 (〇.32 g, 14.78亳莫耳) is added to the 〇. Tri-butoxymethylamino-2-iodopiperidine nitro-benzoic acid methyl ester (Example B3) (3 i2 g, 1% mmol) with MeOH (0.6 mL, 14.78 mmol) in THF ( In a solution of 44 ml), the reaction mixture was stirred at (TC for 15 minutes, It was poured into 5% citric acid, extracted twice with EtOAc, washed with aq. The solvent was removed, EtOAc (EtOAc m. MS (ISP) 412 [(M+NH4)+]; mp. &lt;25 〇 °C. Example Vi (RS)-[4-iodo-2-nitro-5-(tetrahydro-pyran-2-yloxymethyl)-phenyl&gt; Aminomethyl 3-butyrate (5-Hydroxymethyl-4·iodo-2-nitro-phenyl)-amine methyl acid third-butyl ester (Example Vh) (394 see gram ' 1. 〇 millimol) and 3, 4 _Dihydro-2H-furan (0.11 ml, 1 2 mol) in a mixture of DCM (5 ml), add _Ts〇H · Η2〇 (about 5 mg) at 〇 ° C, and The reaction was stirred at 〇 ° c for 1 hour. Dilute with Duan 〇 &amp;, wash with saturated NaHC〇3 solution and brine, and dry with MgS〇4. The solvent was removed in vacuo, EtOAc (EtOAc)EtOAc. ~MS (ISN) 477 [(M-H)-]. Example VI (5-monomethylaminomethyl-4-indol-2-nitro-benyl)-amine methyl acid 3rd-butyryl-44-

--------I--- (請先閱讀背面之注意事項再頁) · ·.線. 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266 A7 B7 五、發明說明(42) 於(5-羥甲基-4-碘基-2-硝基-苯基)-胺甲基酸第三-丁酯(實例 Vh)、LiCl (3當量)及吡啶(2當量)在DMF中之混合物内,在0 °C下添加氯化甲烷磺醯(1·5當量),並將反應物於23°C下攪 拌24小時。添加EtOH中之Me2NH (10當量),並持續攪拌24 小時。以EtOAc稀釋,以飽和NaHC〇3溶液及鹽水洗滌,以 MgS04脱水乾燥。在眞2中移除溶劑,留下黃色油,將其 藉矽膠管柱層析純化,使用環己烷/ Et〇Ac 3 : 1,而得純標 越化合物’爲黃色油(421毫克)。 MS (ISP) 422 [(M+H)+ ]。 下述實例係關於以區域異構物上純方式,製備(2-胺基-4-芳基-苯基)-胺曱基酸第三-丁酯、[2_胺基冰(1_烯基 &gt;苯基 &gt;胺 甲基酸第三-丁酯及(2·胺基-4-芳醯基-苯基)-胺曱基酸第三-丁 酯(合成圖示B): 一般程序F : 藉由(4-破基-2-硝基-苯基)-胺甲基酸第三-丁酯與芳基二輕基 硼烷之直接Suzuki偶合,製備(4-芳基-2-硝基-苯基)-胺甲基酸 第三-丁酯 使(4-碘基-2-硝基·苯基)-胺甲基酸第三-丁酯(3.〇毫莫耳)、 經濟部智慧財產局員工消費合作社印製 --------------裝—— (請先閱讀背面之注意事項再6本頁) :線· 芳基二羥基硼烷(4.5毫莫耳)及PdCl2 (PPh3 )2 (2莫耳。,。)之混合 物’於1,4-二氧陸圜(25毫升)與2M Na2 C03溶液(7.5毫升)中回 流[或者,使用1M NaHC03溶液(7.5毫升)、LiCl (6·0毫莫耳)及 (Ph3 P)4 Pd (3莫耳% )在DME (3〇毫升)中;亦可使用叫ν (9.0毫 莫耳)、Pd(〇Ac)2(3 莫耳。。)、pph3 (6 莫耳。/。)在 DMF (10 毫升) 中’於100°C下],直到tic顯示碘化物完全轉化爲止。將混 -45- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266 A7 B7 五、發明說明(43) 合物轉移至分液漏斗中,添加H20 (25毫升),並將產物以 醚或EtOAc萃取(3 X 30毫升)。合併之有機層以鹽水洗滌(5〇 愛升)’並以Na〗S〇4脱水乾燥。移除溶劑,留下褐色殘留物 ’將其藉矽膠管柱層析純化,使用環己烷/醚或環己烷/ Et〇Ac ,而得標題化合物。 實例F1 (2-氯基-5-硝基-聯苯基-4-基)-胺甲基酸第三-丁酯 根據一般程序F,製自(5-氯基-4-硤基-2-硝基-苯基)-胺甲基 酸第三-丁酯(實例Bl)(L2〇克,3.00毫莫耳)與苯基二羥基硼 垸(0·62克,3.30毫莫耳)。獲得黃色油(843毫克)。 MS (ΕΙ) 348 (Μ+)與 350 [(Μ+2)+ ]。 實例F2 (2·甲基-5-硝基-聯苯基斗基)-胺甲基酸第三-丁酯 根據一般程序F,製自(4-碘基-5-甲基-2-硝基-苯基)-胺甲基 酸第三-丁酯(實例B2)(L135克,3毫莫耳)與苯基二羥基硼烷 (630毫克,3.3毫莫耳)。獲得黃色油(971毫克)。 MS(EI) 328(M+) 〇 實例F3 (RS)-{4’_氟基-5-硝基-2-[4-(四氫-喊喃-2-基氧基)-六氫p比淀-1-基]_ 聯秦基-4-基丨-胺甲基酸第二-丁酉旨 根據一般程序F,製自(RS)-{4-碘基-2-硝基-5-[4-(四氫-哌喃-2-基氧基)-六氫p比咬-1-基]-苯基}-胺甲基酸第三-丁酯[RO-69-4319/000,製自[5-(4-羥基-六氫吡啶小基)冬碘基-2-硝基-苯基]-胺甲基酸第三-丁酯(實例C7)經由以3,4-二氫-2H-哌喃及觸媒 -46 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公爱) -------------裝--- 請先閱讀背面之注意事項再本頁) · · ί線· 經濟部智慧財產局員工消費合作社印製 1255266 A7 ---------B7__ 五、發明說明(44)--------I--- (Please read the notes on the back page again) · ·. Line. This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1255266 A7 B7 5. Description of the invention (42) Tris-butyl (5-hydroxymethyl-4-iodo-2-nitro-phenyl)-amine methylate (Example Vh), LiCl (3 equivalents) and pyridine (2 eq.) In a mixture of DMF, methanesulfonyl chloride (1.5 equivalents) was added at 0 °C, and the reaction was stirred at 23 ° C for 24 hours. Me2NH (10 equivalents) in EtOH was added and stirring was continued for 24 hours. It was diluted with EtOAc, washed with aq. The solvent was removed in hydrazine 2 to leave a yellow oil which was purified by EtOAc EtOAc EtOAc EtOAc EtOAc MS (ISP) 422 [(M+H)+ ]. The following examples relate to the preparation of (2-amino-4-aryl-phenyl)-amine mercapto acid tert-butyl ester, [2-amino-based ice (1-alkenyl) in a pure manner on a regioisomeric basis. Base &gt;Phenyl&gt; Amino acid tert-butyl ester and (2.Amino-4-arylindenyl-phenyl)-amine mercapto acid tert-butyl ester (Synthesis Figure B): General Procedure F: Preparation of (4-aryl-2) by direct Suzuki coupling of (4-c-yl-2-nitro-phenyl)-amine methyl acid tert-butyl ester with aryl dilight borane -nitro-phenyl)-amine methyl acid, third-butyl ester, (4-iodo-2-nitrophenyl)-amine methyl acid, third-butyl ester (3. 〇 millimolar) , Ministry of Economic Affairs, Intellectual Property Bureau, employee consumption cooperatives, printing ------------------- (Please read the notes on the back and then 6 pages): Line · Aryl dihydroxyborane (4.5 mmol) and a mixture of PdCl2(PPh3)2 (2 mol.,.) was refluxed in 1,4-dioxane (25 ml) with 2M Na2 C03 solution (7.5 mL). Use 1M NaHC03 solution (7.5 ml), LiCl (6·0 mmol) and (Ph3 P)4 Pd (3 mol%) in DME (3 mL); also use ν (9.0 mmol) ), Pd(〇Ac) 2 (3 mol.), pph3 (6 mol./.) in DMF (10 ml) 'at 100 ° C] until tic shows complete conversion of iodide. Mixed-45- This paper size is applicable to China National Standard (CNS) A4 specification (210 X 297 mm) 1255266 A7 B7 V. Inventive Note (43) The compound is transferred to a separatory funnel, H20 (25 ml) is added, and The product was extracted with ether or EtOAc (3.times.30 mL). The combined organic layer was washed with brine (5 EtOAc) and dried over Na. Purify by column chromatography on EtOAc EtOAc EtOAc (EtOAc) Amino-methyl 3-butyrate was prepared according to the general procedure F from (3-chloro-4-indolyl-2-nitro-phenyl)-amine methyl acid tert-butyl ester (Example Bl) L2 gram, 3.00 mmol, and phenyldihydroxyboron (0.62 g, 3.30 mmol). Obtained a yellow oil (843 mg). MS (ΕΙ) 348 (Μ+) and 350 [(Μ +2)+]. Example F2 (2·methyl-5-nitro-biphenyl bucket --Aminomethyl 3-butyrate was prepared according to the general procedure F from (4-iodo-5-methyl-2-nitro-phenyl)-amine methyl acid tert-butyl ester (Example B2) (L135 g, 3 mmol) with phenyl dihydroxyborane (630 mg, 3.3 mmol). Obtained yellow oil (971 mg). MS(EI) 328(M+) 〇Example F3(RS)-{4'_Fluoro-5-nitro-2-[4-(tetrahydro-pyran-2-yloxy)-hexahydrop ratio淀-1-yl]-bimethylidene-4-ylindole-amine methyl acid second-butyryl is prepared according to the general procedure F, from (RS)-{4-iodo-2-nitro-5-[ 4-(tetrahydro-piperidin-2-yloxy)-hexahydrop-biti-1-yl]-phenyl}-amine methyl acid tert-butyl ester [RO-69-4319/000, made From [5-(4-hydroxy-hexahydropyridinyl)-t-iodo-2-nitro-phenyl]-amine methyl acid to the third-butyl ester (Example C7) via 3,4-dihydro- 2H-pyran and catalyst-46 - This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 public) -------------Installation --- Please read the back first Precautions on this page) · · ί线· Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 1255266 A7 ---------B7__ V. Invention description (44)

TsOH · H20在DCM中,於οχ:下處理](1 〇9克,2 〇毫莫耳)與 4-氟苯基二羥基硼烷。獲得橘色固體(894毫克)。 MS (ISP) 516 [(M+H)+];熔點 i44-146°C。 實例F4 (RS)-(4,-氟基冬硝基-2-{4-[2-(四氫-旅喃_2_基氧基)_乙氧基]—六氫 叶匕淀-l-基}•聯苯基斗基)-胺甲基酸第三_丁酯 根據一般程序F,製自(rs)-(4-碘基-2-硝基-5-{4-[2-(四氫-哌 喃-2-基氧基)-乙氧基]-六氫吡啶小基卜苯基)_胺甲基酸第三-丁 醋[RO-69-4355/000 ’製自{5-[4_(2-羥基-乙氧基)_六氫吡啶小基]_ 4-破基-2-硝基-苯基胺甲基酸第三-丁酯(實例C8),經由以 3,4-二氫-2H-哌喃及觸媒TsOH · H2〇,在DCM中,於0。(:下處 理](950爱克’ 1.87毫莫耳)與4-氟苯基二羥基硼烷(314毫克 ,2.25毫莫耳)。獲得黏稠橘色油(93〇毫克)。 MS (ISP) 560 [(M+H)+];熔點 144-146Ό。 實例F5 (RS)-[4L氟基-5-硝基-2-(四氫^瓜喃-2-基氧基甲基)-聯苯基冰基]_ 胺甲基酸第三-丁酯 根據一'般社序F ’製自(RS)-[4-破基-2-硝基_5-(四氯-♦喃-2-基 氧基甲基)-苯基]-胺甲基酸第三-丁酯(實例Vi)與4-氟苯基二 羥基硼烷。獲得橘色油(1.24克)。 實例F6 (2-氰基曱氧基-4'-氟基-5-硝基-聯苯基-4-基)-胺曱基酸第三-丁酯 根據一般程序F,製自(5-氰基甲氧基-4-碘基:硝基-苯基)-胺甲基酸第三-丁酯(實例S2)(838毫克,2.0毫莫耳)與‘氟苯 -47- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公髮) &quot; ^ · I I (請先閱讀背面之注意事項再13||^4頁) - :線_ 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明(45 基二羥基硼烷(392毫克,2.8毫莫耳)。獲得黃色固體(333毫 克)。 MS (ISP) 405 [(M+NH4)+];熔點 148。(:。 實例F7 (2-二甲胺基甲基-4’-氟基-5-硝基-聯苯基斗基)-胺甲基酸第三- 丁酉旨 根據一般程序F,製自(5-二甲胺基甲基冰碘基-2-硝基-苯 基)-胺甲基酸第三-丁酯(實例VI)與4-氟苯基二羥基硼烷。獲 得黃色固體(1·〇1克)。 實例F8 [2-(2,2-二甲基-四氫-[1,3]二氧伍圜烯基[4,5-c&gt;比咯-5-基)-4f-氟基-5-硝基-聯苯基-4-基]-胺甲基酸第三-丁酯 根據一般程序F,製自[5-(順式-2,2-二甲基-四氫-[1,3]二氧伍 圜烯基[4,5-c]吡咯-5·基)-4-峨基-2-硝基-苯基]-胺甲基酸第三-丁 酯[RO-69-4741/000,製自[5-(順式-3,4-二羥基-四氫吡咯-1-基)_4- 石典-2-硝基-苯基]-胺甲基酸第三_丁 @旨(實例C9),經由以2,2-二 曱氧基丙烷及觸媒丁sOH · Η2 Ο,在DMF中,於23°C下處理] (845毫克,1.67毫莫耳)與4-氟苯基二羥基硼烷(327毫克, 2.34毫莫耳)。獲得黃色固體(643毫克)。 MS (ISP) 474 [(M+H)+ ];熔點 119°C。 實例F9 (4’-氟基-2-甲氧基-5-硝基-聯苯基_4_基)-胺甲基酸第三·丁酉旨 根據一般程序F,製自(4-碘基-5-甲氧基-2-硝基-苯基胺甲 基酸第三-丁 S旨(實例B5)(3.68克,9.34毫莫耳)與4-氟苯基二 48- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 請 先 閱 讀 背 面 之 注 意 事 項 再 f裝 頁 訂 線 經濟部智慧財產局員工消費合作社印製 1255266 A7 ______B7___ 五、發明說明(46) 羥基硼烷(3.61克,25.8毫莫耳)。獲得黃色固體(2.69克)。 MS (ISN) 361 [(M-H)·];熔點 25(TC。 實例F10 [2-(1,4-二氧-8-氮-螺[4.5]癸-8-基)冬氟基-5-硝基-聯苯基-4-基]-胺 甲基酸第三-丁酯 根據一般程序F,製自[5-(1,4-二氧-8-氮-螺[4.5]癸-8-基)-4-碘 基-2-硝基-苯基]-胺甲基酸第三-丁 g旨(實例¢4)(4.0克,7.02毫 莫耳)與4-氟苯基二羥基烷(1.33克,9.5毫莫耳)。獲得黃 色固體(2.43克)。 熔點213°C (分解)。 實例F11 (4L氟基-2-甲基-5-硝基-聯苯基-4-基)-胺甲基酸第三-丁 g旨 根據一般程序F,製自(4-碘基-5-甲基-2-硝基-苯基)-胺甲基 酸第三-丁酯(實例B2)(756毫克,2.0毫莫耳)與4-氟苯基二羥 基硼烷(420毫克,3.0毫莫耳)。獲得非晶質黃色物質(611毫 克)。 MS (ISN) 345 [(M-Η)·]。 實例F12 (4-第三-丁氧羧基胺基-4’-氟基-5-硝基-聯苯基-2-基氧基)-醋酸 第三-丁酯 根據一般程序F,製自(5-第三-丁氧羰基胺基_2_碘基-4-硝 基-苯氧基)-醋酸第三-丁酯(實例Sl)(2.14克,4.33毫莫耳)與4-氟苯基二羥基硼烷(728毫克,5.2毫莫耳)。獲得橘色固體 (1.80 克)。 -49- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) --------------裝i I (請先閱讀背面之注意事項再頁) . :線_ 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 ^;__ 經濟部智慧財產局員工消費合作社印製 發明說明(47) MS (ISN) 461 [(M-H)-];熔點 92-93X:。 實例F13 --------------裝_! (請先閱讀背面之注意事項再本頁) (2-氯基-4’-氟基-5-硝基-聯苯基冰基)·胺甲基酸第三_丁酯 根據一般程序F,製自(5-氯基+碘基-2-硝基-苯基)-胺甲基 酸第三-丁酯(實例B1)與4-氟苯基二羥基硼烷。獲得黃色固 體(625毫克)。 MS(EI) 366 (M+) 〇 實例F14 [I-氟基-2-(2-甲氧基-乙氧基)_5-硝基-聯苯基基]-胺甲基酸第 三-丁酯 根據一般程序F,製自[4-碘基-5-(2-曱氧基-乙氧基)-2-硝基-苯基]-胺甲基酸第三-丁酯(實例B6)與4-氟苯基二羥基硼烷 。獲得黃色固體(1.833克)。 MS(EI)406 (M+)。 實例F15 ·-線· [2-(2-第三-丁氧基-乙氧基)-4’-氟基-5-硝基-聯苯基-4-基]-胺甲基 酸第三-丁酯 根據一般程序F,製自[5-(2-第三-丁氧基-乙氧基)冰碘基-2-硝基-苯基]-胺甲基酸第三-丁酯(實例B10)與4-氟苯基二羥基 硼烷。獲得黃色固體(735毫克)。 MS (ISP) 449 [(M+H)+ ]。 實例F16 [4'-氟基-5-硝基-2-(2-酮基号吐淀-3-基)-聯苯基-4-基]-胺甲基酸 第三-丁酯 -50-本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266 經濟部智慧財產局員工消費合作社印製 A7 B7 五、發明說明(48) 根據一般程序F,製自[4_碘基-2-硝基-5-(2-酮基4唑啶-3-基) -苯基]-胺甲基酸第三-丁酯[r〇_69-6758/000,製自[5-(2-羥基-乙 胺基)-4·破基-2-硝基苯基]-胺甲基酸第三-丁酯(實例cl〇),經 由以1,Γ-羰基二咪唑在二氧陸圜中,然後在吡啶中,以觸 媒DMAP處理,各在i〇〇°C下](503毫克,1.12毫莫耳)與4-氟 苯基二舍基·燒(235毫克,1·68毫莫耳)。獲得黃色固體(31〇 毫克)。 MS(ISN)416[(M-H)·];熔點201。(:。 實例F17 (4L氟基_2·甲氧基-2f-甲基-5-硝基-聯苯基-4-基)-胺甲基酸第三_ 丁醋 根據一般程序F,製自(4-碘基-5-甲氧基-2-硝基-苯基)_胺甲 基酸第三-丁酯(實例B5)與4-氟基-2-甲基-苯基二羥基硼烷。 獲得黃色固體(699毫克)。 MS(EI) 376 (M+)。 實例F18 (2-第二-丁氧基-4’-氟基-5-硝基-聯苯基-4-基)-胺甲基酸第三_ 丁酉旨 根據一般程序F,製自(5-第三-丁氧基-4-碘基-2-硝基-苯基)_ 胺甲基酸第三-丁酯(實例S4)(1.4克,3.21毫莫耳)與4_氟苯基 二羥基硼烷(0.67克,4.42毫莫耳)。獲得非晶質黃色物質(12 克)。 MS(EI)404 (M+)。 實例F19 (2-第二-丁氧基-2f-氟基-5-硝基-聯冬基-4-基)-胺甲基酸第三_ 丁酉旨 -51 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) --------------裝—— (請先閱讀背面之注意事項再頁) . -.-線 _ 1255266 A7 ____ B7__ 五 經濟部智慧財產局員工消費合作社印製 發明說明(49 ) -------------裝·-- (請先閱讀背面之注意事項再1^本頁) 根據一般程序F,製自(5-第三-丁氧基-4-礎基-2-硝基-苯基)-胺甲基酸第三-丁酯(實例S4)(1.4克,3.21毫莫耳)與2_氟苯基 二羥基硼烷(0.67克,4.83毫莫耳)。獲得非晶質黃色物質 (960毫克)。 MS(EI)404(M+)。 實例F20 (RS)-{4-氟基-5-硝基-2-[(11)-3-(四氫-成喃-2-基氧基)_四氫p比p各小 基]-聯苯基-4-基}-胺甲基酸第三-丁酯 根據一般程序F,製自(RS)-{4_破基-2-硝基-5-[(R)-3-(四氫-喊 喃-2-基氧基)-四氫吡咯小基]-苯基卜胺甲基酸第三-丁酯[r〇-69_ 6376/000 ’製自[5-((R)-3-#i基-四氫p比洛-1-基)_4_破基_2_硝基-苯 基]-胺甲基酸第三-丁酯(實例C11),經由以3,4-二氫-2H-喊喃 及觸媒TsOH ·叫0,在DCM中,於(TC下處理]與4-氟苯基 二羥基硼烷。獲得黃色固體(丨.053克)。 MS (ISP) 502 [(M+H)+ ]。 .線· 實例F21 P氟基-2-甲氧基-5-硝基-聯苯基冰基 &gt;胺甲基酸第三_丁酯 根據一般程序F,製自(4-碘基-5-甲氧基-2-硝基-苯基)-胺甲 基酸第三-丁醋(實例B5)(L〇〇克,2.54毫莫耳)與2-氟苯基二 每基硼反(0.60克’ 4.32毫莫耳)。獲得非晶質黃色物質(687 毫克)。 MS(EI) 362 (M+)。 實例F22 [2-(1,4-二氧-8-氮-螺[4.5]癸各基)_2’_氟基-5-硝基-聯苯基-4-基]-胺 -52- 本紙張尺度適用中國國豕標準(CNS)A4規格(21〇 X 297公楚) 1255266 A7 B7 五、發明說明(50) 甲基酸第三-丁酯 根據一般程序F,製自[5-(1.4-二氧-8-氮-螺[4.5]癸-8-基)-4-破 基-2-硝基-苯基]-胺甲基酸第三-丁裔(實例C4)(1.89克,3.47毫 莫耳)與2-氟苯基二經基棚燒(〇·63克,4.49毫莫耳)。獲得黃 色固體(1.46克)。 MS (ISP) 474 [(Μ+Η)+ ];熔點 164°C。 實例F23 (2’,二氟-2-甲氧基-5-硝基-聯苯基-4-基)-胺甲基酸第三-丁酯 根據一般程序F,製自(4-碘基-5-曱氧基-2-硝基-苯基)-胺甲 基酸第三-丁酯(實例Β5)(3·94克,10毫莫耳)與2,5-二氟苯基 二羥基硼烷(2.21克,14毫莫耳)。獲得非晶質黃色物質(丨.05 克)。 MS (ISN) 379 [(Μ-ΗΠ。 實例F24 [2L氟基-2-(2-甲氧基-乙氧基)-5-硝基苯基《4-基]-胺甲基酸第 三-丁酯 經濟部智慧財產局員工消費合作社印製 -------------裝--- (請先閱讀背面之注意事項再本頁) •線 _ 根據一般程序F,製自[4-碘基-5-(2-甲氧基-乙氧基)_2_硝基_ 苯基]-胺甲基酸第三-丁醋(實例B6)與2-氟苯基二羥基硼燒 。獲得黃色固體(3.63克)。 MS (ISN) 405 [(M-H)·]。 實例F25 (RS)-[2’-氟基硝基么(四氫·咬喃基氧基甲基聯苯基冰基]_ 胺甲基酸第三-丁酯 根據一般程序F,製自(RSH4-碘基!硝基冰(四氫_哌喃:基 -53-TsOH · H20 is treated in DCM under οχ: (1 〇 9 g, 2 〇 mmol) with 4-fluorophenyl dihydroxyborane. Obtained an orange solid (894 mg). MS (ISP) 516 [(M+H)+]; mp. Example F4 (RS)-(4,-Fluorobutyryl-2-{4-[2-(tetrahydro-bran-2-yloxy)-ethoxy]-hexahydrophyllin-l -Based on the basis of the general procedure F, from (rs)-(4-iodo-2-nitro-5-{4-[2- (tetrahydro-pyran-2-yloxy)-ethoxy]-hexahydropyridine small phenyl)-amine methyl acid third-butane vinegar [RO-69-4355/000 'made from { 5-[4_(2-hydroxy-ethoxy)-hexahydropyridine small group]_ 4-c-yl-2-nitro-phenylamine methyl acid tert-butyl ester (example C8), via 3 , 4-Dihydro-2H-pyran and catalyst TsOH · H2〇, in DCM, at 0. (:Under treatment) (950 Aike ' 1.87 mmol) with 4-fluorophenyl dihydroxyborane (314 mg, 2.25 mmol). Obtained a thick orange oil (93 mg). MS (ISP) 560 [(M+H)+]; melting point 144-146 Ό. Example F5 (RS)-[4L-fluoro-5-nitro-2-(tetrahydro-guaran-2-yloxymethyl)-linked Phenyl glayl]_Aminomethyl acid third-butyl ester according to a general procedure F 'made from (RS)-[4- deradyl-2-nitro-5-(tetrachloro-♦-an-2 -Phenoxymethyl)-phenyl]-amine methyl acid, third-butyl ester (Example Vi) and 4-fluorophenyldihydroxyborane. An orange oil (1.24 g) was obtained. Example F6 (2- Cyano-methoxy-4-'-fluoro-5-nitro-biphenyl-4-yl)-amine mercapto acid tert-butyl ester according to the general procedure F, from (5-cyanomethoxy) 4-iodo:nitro-phenyl)-amine methyl acid third-butyl ester (example S2) (838 mg, 2.0 mmol) and 'fluorobenzene-47- this paper scale applies to Chinese national standards ( CNS)A4 specification (210 X 297 mil) &quot; ^ · II (Please read the note on the back and then 13||^4 pages) - : Line _ Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 1255266 A7 B7 five , invention description (45 Dihydroxyborane (392 mg, 2.8 mmol) afforded a yellow solid (333 mg). MS (ESI) 405 [(M+NH4)+]; mp 148. Aminomethyl-4'-fluoro-5-nitro-biphenyl phenyl)-amine methyl acid 3 - butyl hydrazine according to the general procedure F, prepared from (5-dimethylaminomethyl ice iodine) 3-Chloro-phenyl)-amine methyl acid tert-butyl ester (Example VI) and 4-fluorophenyl dihydroxyborane. Obtained a yellow solid (1·1 g). Example F8 [2] -(2,2-dimethyl-tetrahydro-[1,3]dioxoindolyl[4,5-c>pyr-5-yl)-4f-fluoro-5-nitro-linked Phenyl-4-yl]-amine methyl acid tert-butyl ester was prepared from [5-(cis-2,2-dimethyl-tetrahydro-[1,3]dioxane according to the general procedure F. Terpenyl [4,5-c]pyrrole-5-yl)-4-mercapto-2-nitro-phenyl]-amine methyl acid tert-butyl ester [RO-69-4741/000, made From [5-(cis-3,4-dihydroxy-tetrahydropyrrole-1-yl)_4-石典-2-nitro-phenyl]-amine methyl acid third_丁@旨(Example C9 ), treated with 2,2-dimethoxypropane and catalyst butyl sOH · Η2 Ο in DMF at 23 ° C] (845 mg, 1.67 mmol) and 4- Phenyl dihydroxyborane (327 mg, 2.34 mmol). Obtained as a yellow solid (643 mg). MS (ISP) 474 [(M+H)+]; mp. Example F9 (4'-Fluoro-2-methoxy-5-nitro-biphenyl-4-yl)-amine methyl acid, the third group, according to the general procedure F, from (4-iodo) -5-Methoxy-2-nitro-phenylamine methyl acid Third-butyr S (Example B5) (3.68 g, 9.34 mmol) and 4-fluorophenyl di 48- This paper scale applies China National Standard (CNS) A4 Specification (210 X 297 mm) Please read the notes on the back first and then install the page. Order the Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 A7 ______B7___ V. Invention Description (46) Hydroxyl boron Alkane (3.61 g, 25.8 mmol) afforded a yellow solid (2.69 g). MS (ISN) 361 [(MH)·]; melting point 25 (TC). Example F10 [2-(1,4-dioxo-8) -Nitro-spiro[4.5]dec-8-yl)t-fluoro-5-nitro-biphenyl-4-yl]-amine methyl acid tert-butyl ester according to the general procedure F, manufactured from [5- (1,4-Dioxo-8-nitro-spiro[4.5]dec-8-yl)-4-iodo-2-nitro-phenyl]-amine methyl acid third-butyr (example ¢ 4) (4.0 g, 7.02 mmol) and 4-fluorophenyldihydroxyalkane (1.33 g, 9.5 mmol) afforded a yellow solid (2.43 g). Example F11 (4L fluoro-2-methyl-5-nitro-biphenyl-4-yl)-amine methyl acid, third-butyr, according to the general procedure F, from (4-iodo) -5-Methyl-2-nitro-phenyl)-amine methyl acid tert-butyl ester (Example B2) (756 mg, 2.0 mmol) and 4-fluorophenyl dihydroxyborane (420 mg) , 3.0 mmol; obtained amorphous yellow material (611 mg). MS (ISN) 345 [(M-Η)·]. Example F12 (4-T-butoxycarboxyamino-4'-fluoro 3--5-nitro-biphenyl-2-yloxy)-acetic acid tert-butyl ester according to the general procedure F, from (5-tris-butoxycarbonylamino-2-iodo-4- Nitro-phenoxy)-acetic acid tert-butyl ester (Example Sl) (2.14 g, 4.33 mmol) and 4-fluorophenyldihydroxyborane (728 mg, 5.2 mmol). Solid (1.80 g). -49- This paper size applies to Chinese National Standard (CNS) A4 specification (210 X 297 mm) -------------- Install i I (please read the back first) Note: page _ : Line _ Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 1255266 A7 B7 ^; __ Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing invention Ming (47) MS (ISN) 461 [(M-H) -]; mp 92-93X :. Example F13 -------------- Install _! (Please read the notes on the back and then on this page) (2-Chloro-4'-fluoro-5-nitro-biphenyl Alkyl-based amino acid tert-butyl ester according to the general procedure F, from (5-chloro + iodo-2-nitro-phenyl)-amine methyl acid, third-butyl ester (example B1) with 4-fluorophenyldihydroxyborane. A yellow solid (625 mg) was obtained. MS (EI) 366 (M+) 〇 Example F14 [I-fluoro-2-(2-methoxy-ethoxy)_5-nitro-biphenyl]-amine methyl acid tert-butyl ester According to the general procedure F, from [4-iodo-5-(2-decyloxy-ethoxy)-2-nitro-phenyl]-amine methyl acid tert-butyl ester (example B6) 4-fluorophenyl dihydroxyborane. Obtained a yellow solid (1.833 g). MS (EI) 406 (M+). Example F15 ·-Line·[2-(2-Terti-butoxy-ethoxy)-4'-fluoro-5-nitro-biphenyl-4-yl]-amine methyl acid -Butyl ester according to the general procedure F, from [5-(2-tris-butoxy-ethoxy) ice iodo-2-nitro-phenyl]-amine methyl acid tert-butyl ester ( Example B10) with 4-fluorophenyldihydroxyborane. Obtained a yellow solid (735 mg). MS (ISP) 449 [(M+H)+ ]. Example F16 [4'-Fluoro-5-nitro-2-(2-keto-dip-3-yl)-biphenyl-4-yl]-amine methyl acid tert-butyl ester-50 -This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1255266 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed A7 B7 V. Invention description (48) According to the general procedure F, from [4_ Iodo-2-nitro-5-(2-keto-4-oxazolidin-3-yl)-phenyl]-amine methyl acid tert-butyl ester [r〇_69-6758/000, manufactured from [ 3-(2-hydroxy-ethylamino)-4. keto-2-nitrophenyl]-amine methyl acid tert-butyl ester (example cl〇) via 1, fluorene-carbonyldiimidazole In dioxane, then in pyridine, treated with catalyst DMAP, each at i〇〇°C] (503 mg, 1.12 mmol) and 4-fluorophenyl biszepine (235 mg, 1.68 millimoles). Obtained a yellow solid (31 mg). MS (ISN) 416 [(M-H).]. (:. Example F17 (4L fluoro-2-bromo-2f-methyl-5-nitro-biphenyl-4-yl)-amine methyl acid third _ vinegar according to the general procedure F, From (4-iodo-5-methoxy-2-nitro-phenyl)-amine methyl acid to the third-butyl ester (Example B5) and 4-fluoro-2-methyl-phenyl dihydroxyl Borane. Obtained as a yellow solid ( 699 mg). MS (EI) 376 (M+). Example F18 (2-2-butoxy-4'-fluoro-5-nitro-biphenyl-4-yl )-Aminomethyl acid third _ 酉 酉 according to the general procedure F, made from (5-tris-butoxy-4-iodo-2-nitro-phenyl)_amine methyl acid third-butyl Ester (Example S4) (1.4 g, 3.21 mmol) and 4-fluorophenyldihydroxyborane (0.67 g, 4.42 mmol). Obtained amorphous yellow material (12 g). MS (EI) 404 (M+). Example F19 (2-second-butoxy-2f-fluoro-5-nitro-biindyl-4-yl)-amine methyl acid third_ 酉 酉-51 - paper scale Applicable to China National Standard (CNS) A4 specification (210 X 297 mm) -------------- Packing - (Please read the notes on the back page again) -.-Line_ 1255266 A7 ____ B7__ Five Ministry of Economic Affairs Intellectual Property Bureau staff consumption Instructions for printing the invention (49) ------------- Loading ·-- (Please read the notes on the back and then 1^ this page) According to the general procedure F, from (5- Third-butoxy-4-carbenyl-2-nitro-phenyl)-amine methyl acid, third-butyl ester (Example S4) (1.4 g, 3.21 mmol) and 2-fluorophenyl di Hydroxyborane (0.67 g, 4.83 mmol). Obtained amorphous yellow material (960 mg). MS (EI) 404 (M+). Example F20 (RS)-{4-Fluoro-5-nitro- 2-[(11)-3-(tetrahydro-m-butan-2-yloxy)-tetrahydrop ratio p each small group]-biphenyl-4-yl}-amine methyl acid third-butyl The ester is prepared according to the general procedure F from (RS)-{4_bromo-2-nitro-5-[(R)-3-(tetrahydro-pyran-2-yloxy)-tetrahydropyrrole Benzyl-p-phenylamine methyl acid, third-butyl ester [r〇-69_ 6376/000 'from [5-((R)-3-#i-yl-tetrahydro-p-l-l-yl) _4_ _ _ _ nitro-phenyl]-amine methyl acid third-butyl ester (example C11), via 3,4-dihydro-2H- snoring and catalyst TsOH · called 0, in In DCM, under (TC) and 4-fluorophenyldihydroxyborane. Obtained as a yellow solid ( </ </ </ /> Fluoro-2-methyl 5--5-nitro-biphenylyl ice-based amino acid tert-butyl ester according to the general procedure F, prepared from (4-iodo-5-methoxy-2-nitro-phenyl) - Aminomethyl acid third-butyl vinegar (Example B5) (L gram, 2.54 mmol) and 2-fluorophenyl di-barrium boron (0.60 g ' 4.32 mmol). Obtained an amorphous yellow material (687 mg). MS (EI) 362 (M+). Example F22 [2-(1,4-Dioxo-8-nitro-spiro[4.5]fluorenyl)_2'-fluoro-5-nitro-biphenyl-4-yl]-amine-52- Paper scale applies to China National Standard (CNS) A4 specification (21〇X 297 public Chu) 1255266 A7 B7 V. Invention description (50) Methyl acid third-butyl ester according to the general procedure F, made from [5-(1.4 -Dioxo-8-nitro-spiro[4.5]dec-8-yl)-4-bromo-2-nitro-phenyl]-amine methyl acid, third-butyl (example C4) (1.89 g, 3.47 millimolar) with 2-fluorophenyl di-base shed (〇·63 g, 4.49 mmol). Obtained as a yellow solid (1.46 g). MS (ISP) 474 [(Μ+Η)+]; mp 164 ° C. Example F23 (2', Difluoro-2-methoxy-5-nitro-biphenyl-4-yl)-amine methyl acid, tert-butyl ester, according to the general procedure F, from 4-iodo -5-decyloxy-2-nitro-phenyl)-amine methyl acid tert-butyl ester (example Β5) (3·94 g, 10 mmol) and 2,5-difluorophenyl di Hydroxyborane (2.21 g, 14 mmol). Obtained an amorphous yellow material (丨.05 g). MS (ISN) 379 [(Μ-ΗΠ. Example F24 [2L fluoro-2-(2-methoxy-ethoxy)-5-nitrophenyl "4-yl]-amine methyl acid third -Butyl ester Ministry of Economics Intellectual Property Bureau employee consumption cooperative printing ------------- loading --- (please read the back note before this page) • Line _ according to the general procedure F, From [4-iodo-5-(2-methoxy-ethoxy)_2_nitro-phenyl]-amine methyl acid, third-butyl vinegar (example B6) and 2-fluorophenyl two Hydroxyboron. Obtained as a yellow solid (3.63g). MS (ISN) 405 [(MH)·]. Example F25 (RS)-[2'-Fluoro-nitro-(tetrahydro-glyoxymethyl) Biphenyl butyl]-aminomethyl acid tert-butyl ester according to the general procedure F, prepared from (RSH4-iodo! nitro ice (tetrahydro-pyrano: yl-53-

1255266 A7 B71255266 A7 B7

經濟部智慧財產局員工消費合作社印製 五、發明說明(51 ) 氧基甲基)-苯基]胺甲基酸第三-丁酯(實例Vi)與2-氣苯基二 藉基硼烷。獲得黃色液體(2.606克)。 MS (ISN) 445 [(Μ-Η)- ] 〇 實例F26 基-2-(4-甲氧基氧基)-5-硝基-聯苯基-4-基]-胺甲基酸第 三-丁酯 根據一般程序F ’製自[4-破基-5-(4-甲氧基·爷氧基)_2_硝基_ 冬基]-胺甲基敗弟二-丁自旨(貫例B11)(1.69克,3.38毫莫耳)與 2-氟苯基二羥基硼烷(0.61克,4.39毫莫耳)。獲得黃色泡床 物(940毫克)。 MS (ISP) 469 [(M+H)+ ]。 實例F27 (2-第三-丁氧基-2,,5,-二氟-5-硝基-聯苯基-4-基)-胺甲基酸第三_ 丁酉旨 根據一般程序F,製自(5-第三-丁氧基-4-碘基冬硝基-苯基)· 胺曱基酸第三-丁酯(實例S4)(3.00克,6.88毫莫耳)與2,5-二氟 苯基二羥基硼烷(2·23克,14.1毫莫耳)。獲得非晶質黃色物 質(2.30 克)。 MS (ISN) 421 [(Μ-Η)-]。 一般程序G : 藉由(4-碘基-2-硝基-苯基)-胺甲基酸第三-丁酯與雙(二甲基丁 酸基)二硼之Suzuki偶合,及接著與芳基||化物反應,製備 (4-芳基-2-硝基·苯基)-胺甲基酸第三-丁 g旨 將(4-峨基-2-硝基-苯基)-胺甲基酸第三-丁 g旨(2.0 ^:莫耳)、 -54 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) --------------裝i I (請先閱讀背面之注意事項再6本頁) ιδι·- :線· 1255266 A7 五、發明說明(52 ) 雙(二甲基丁酸基)二硼(2 2毫莫耳)' K〇Ac(6 〇毫莫耳)及 Pd〇2 (PPh3 )2 (3莫耳% )在丨,‘二氧陸圜(25毫升)中之混合物, 於loo c下撥拌’直到tlc顯示碘化物完全轉化爲止[參閱Ministry of Economic Affairs, Intellectual Property Bureau, Staff Consumer Cooperatives, Printing 5, Inventions (51) Oxymethyl)-phenyl]amine methyl acid, third-butyl ester (example Vi) and 2-phenylphenyl diborane borane . Obtained a yellow liquid (2.606 g). MS (ISN) 445 [(Μ-Η)- ] 〇 Example F26-based 2-(4-methoxyoxy)-5-nitro-biphenyl-4-yl]-amine methyl acid -Butyl ester is prepared according to the general procedure F' from [4-pyridyl-5-(4-methoxy-l-yloxy)_2-nitro-m-yl]-amine methyl-di-di-di- Example B11) (1.69 g, 3.38 mmol) with 2-fluorophenyldihydroxyborane (0.61 g, 4.39 mmol). A yellow blister (940 mg) was obtained. MS (ISP) 469 [(M+H)+ ]. Example F27 (2-Terti-butoxy-2,5,-difluoro-5-nitro-biphenyl-4-yl)-amine methyl acid _ _ _ _ _ _ _ _ From (5-T-butoxy-4-iodohexylnitro-phenyl)· Amidinoic acid tert-butyl ester (Example S4) (3.00 g, 6.88 mmol) and 2,5- Difluorophenyl dihydroxyborane (2.23 g, 14.1 mmol). Obtained an amorphous yellow material (2.30 g). MS (ISN) 421 [(Μ-Η)-]. General procedure G: Suzuki coupling with (4-iodo-2-nitro-phenyl)-amine methyl acid tert-butyl ester and bis(dimethylbutyric acid) diboron, and then with aromatic Preparation of (4-aryl-2-nitrophenyl)-amine methyl acid, third-butyr, (4-mercapto-2-nitro-phenyl)-amine A Base acid - Ding G (2.0 ^: Moer), -54 - This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) ------------ --Install i I (please read the notes on the back and then 6 pages) ιδι·- :Line · 1255266 A7 V. Description of invention (52 ) Bis(dimethylbutyric acid) diboron (2 2 mmol) ) 'K〇Ac (6 〇 millimolar) and Pd 〇 2 (PPh3 ) 2 (3 mol %) in a mixture of 二, 'dioxane (25 ml), mix under loo c' until Tlc shows complete conversion of iodide [see

Teti*· Lett· 1997, 38, 3841-3844]。在添加芳基鹵化物(4 〇 毫莫耳)、Teti*· Lett· 1997, 38, 3841-3844]. Adding an aryl halide (4 毫 millimolar),

PdCl2 (PPh3 )2 (3莫耳% )及2M c〇3溶液(7·5毫升)後,將混合 物於loo c下攪拌,直到tlc顯示中間物二羥基硼烷酯完全轉 化爲止。將混合物轉移至分液漏斗中,添加馬〇 (3〇毫升) ,並將產物以醚或EtOAc萃取(3 X 50毫升)。合併之有機層以 皿水洗I (100耄升),並以他2 s〇4脱水乾燥。移除溶劑,留 下褐色K田物’將其藉矽膠管柱層析純化,使用環己烷/ 醚或環己烷/ EtOAc,而得標題化合物。 一般程序Η : 藉由(4-碘基:硝基-苯基)_胺甲基酸第三-丁酯與芳基二羥基 硼烷之羰基Suzuki偶合,製備(4_芳醯基冬硝基-苯基)_胺甲基 酸第三-丁酯 將(4-換基-2-硝基-苯基)_胺甲基酸第三-丁酯〇 〇毫莫耳)、 方基二羥基硼烷(U毫莫耳)、心⑺旧力毫莫耳)及 PdCL (PPh3 &amp; (3莫耳。/。)在曱苯醚(6毫升)中之混合物,於8〇t 及CO大氣下攪拌,直到薄層層析法顯示碘化物完全轉化爲 止[參閱Tetr· Lett· 1993, 34, 7595-7598]。將混合物轉移至分液漏 斗中,添加Ηρ (30毫升),並將產物以Et〇Ac萃取χ 1〇〇毫 升)。合併之有機層以鹽水洗滌(50毫升),並以犯0〇4脱水 乾燥。移除溶劑,留下黃色殘留物,將其藉矽膠管柱層析 純化,使用己烷/ EtOAc,而得標題化合物。 --------------裝--- (請先閱讀背面之注意事項再本頁) :線' 經濟部智慧財產局員工消費合作社印製 55- 1255266After PdCl2(PPh3)2 (3 mol%) and 2M c〇3 solution (7.5 ml), the mixture was stirred under loo c until tlc showed complete conversion of the intermediate dihydroxyborane ester. The mixture was transferred to a sep. funnel, EtOAc (3 mL). The combined organic layers were washed with water (100 liters) and dehydrated with 2 s 〇4. The solvent was removed, and the title compound was obtained from EtOAc EtOAc. General procedure Η : Preparation of (4_aryl fluorenyl nitroso) by carbonyl Suzuki coupling of (4-iodo:nitro-phenyl)-amine methyl acid to the carbonyl group of aryl dihydroxyborane -phenyl)-amine methyl acid, third-butyl ester, (4-transyl-2-nitro-phenyl)-amine methyl acid, third-butyl ester, 〇〇 millimolar, square dihydroxy Borane (U millimolar), heart (7) old force millimolar) and PdCL (PPh3 &amp; (3 moles / /) in a mixture of decyl ether (6 ml), at 8 〇t and CO atmosphere Stir under until the thin layer chromatography shows complete conversion of the iodide [see Tetr· Lett 1993, 34, 7595-7598]. Transfer the mixture to a separatory funnel, add Ηρ (30 ml), and Et〇Ac extraction χ 1〇〇 ml). The combined organic layers were washed with brine (50 mL) and dried with EtOAc. The solvent was removed, the title compound was purified eluting elut elut elut elut --------------装--- (Please read the note on the back and then this page): Line 'Ministry of Economics Intellectual Property Bureau employee consumption cooperative printing 55- 1255266

五、發明說明(53) 二_^程序J : 藉由(2-硝基-4-三丁基錫烷基-苯基)-胺甲基酸第三_丁酯與芳 基鹵化物或三氟甲烷磺酸乙烯酯之StiUe偶合或士碘基_2_硝 基苯基)-胺甲基酸第三-丁酯與三烷基芳基錫烷之Stme偶合 ’製備(4-芳基-2-硝基-苯基)-胺甲基酸第三_丁酯或(4乂晞基、 環晞基-或雜環稀基}-2-硝基-苯基)_胺甲基酸第三_丁酉旨 將(2-硝基-4-三丁基錫烷基-苯基)_胺甲基酸第三·丁酯(525毫 克 ’ 1.0毫莫耳;根據Bull.Chem. Soc.Jpn.l983,56,3855-3856,製 自其相應之(4-破基-2-硝基-苯基)_胺甲基酸第三_丁 g旨(實例b) (10毫莫耳),經由與六丁基二錫烷(7.5毫升,15毫莫耳)及 Pd(PPh3)4(116毫克,0.1毫莫耳)在甲苯(20毫升)中,於6〇τ下 反應5天)、芳基鹵化物或三氟曱烷續酸乙烯酯(〇·95_6 〇毫莫 耳)、無水LiCl(126毫克,3.0毫莫耳)及Pd(PPh3)4(5莫耳。/。)在 DME (3毫升)中之混合物,於100°C及氬大氣下攪拌,直到如 顯示錫烷完全消耗爲止。使此反應冷卻至23°C,與飽和kf 水溶液(5耄升)一起攪拌45分鐘,經過矽藻土過濾,以酸洗 滌,及將濾液以MgS〇4脱水乾燥。在眞空中移除溶劑,留 下褐色/甴’將其藉碎膠管柱層析純化,使用己纟完/ Et〇Ac, 而得標題化合物。 下述貫例係關於以區域異構物上純之方式,製備胺基_ 4-芳基乙炔基-苯基)-胺甲基酸第三_丁酯(合成圖示G): 一般程序K : 藉由(4-碘基-2-硝基-苯基)-胺甲基酸第三-丁酯與乙炔性化合 物之Sonogashira偶合; -56- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) hi—·----------裝—— (請先閱讀背面之注意事項再本頁) .- 線· 經濟部智慧財產局員工消費合作社印製 1255266V. DESCRIPTION OF THE INVENTION (53) II_^ Procedure J: by (2-nitro-4-tributylstannyl-phenyl)-amine methyl acid tert-butyl ester with aryl halide or trifluoromethane Preparation of Styrene Coupling of StiUe Coupling of Vinyl Sulfonate or Stme Coupling of Tri-Butyl Ester Methylate with Trialkyl Arylstannane (4-Aryl-2- Nitro-phenyl)-amine methyl acid third-butyl ester or (4-mercapto, cyclodecyl- or heterocyclic)}-2-nitro-phenyl)-amine methyl acid third_ Ding Yuzhi (2-nitro-4-tributylstannyl-phenyl)-amine methyl acid, third butyl ester (525 mg '1.0 mmol; according to Bull.Chem. Soc. Jpn.l983, 56 , 3855-3856, prepared from its corresponding (4-ceptyl-2-nitro-phenyl)-amine methyl acid, the third _ butyl g (example b) (10 millimolar), via with six butyl Base distannane (7.5 ml, 15 mmol) and Pd(PPh3) 4 (116 mg, 0.1 mmol) in toluene (20 ml) at 6 °τ for 5 days), aryl halide Or trifluorodecane vinyl acetate (〇·95_6 〇 millimolar), anhydrous LiCl (126 mg, 3.0 mmol) and Pd(PPh3) 4 (5 mol.) in DME (3) The mixture liter) and the mixture was stirred at 100 ° C for an argon atmosphere, until the display until the complete consumption of the stannane. The reaction was cooled to 23 ° C, stirred with a saturated aqueous solution of kf (5 liters) for 45 minutes, filtered over celite, washed with acid, and the filtrate was dried with EtOAc. The solvent was removed in the sputum, and the title compound was obtained eluting with EtOAc EtOAc. The following example is for the preparation of amino-4-tetraethethynyl-phenyl)-amine methyl acid tert-butyl ester as a homogeneous on a regioisomer (Synthesis Scheme G): General Procedure K : Sonogashira coupling with (4-iodo-2-nitro-phenyl)-amine methyl acid tert-butyl ester and acetylene compound; -56- This paper size is applicable to China National Standard (CNS) A4 specification (210 X 297 mm) hi—·------------ (Please read the notes on the back and then on this page) .- Line· Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 1255266

五、發明說明( 亦藉由(4-乙炔基-2-硝基-苯基)-胺甲基酸第三_丁酯與芳基函 化物之Sonogashira偶合; 及8-碘基-4-芳基-l,3-二氫苯幷[b][l,4]二吖庚因酮與乙炔性 化合物之Sonogashira偶合,製備(4-炔基-2-硝基-苯基)-胺甲基 酸第三-丁酯。 將鹵化物(3.0-4.5毫莫耳)、乙炔性化合物(3.0-4.5毫莫耳)、5. Description of the invention (also by Sonogashira coupling of (3-ethynyl-2-nitro-phenyl)-amine methyl acid tert-butyl ester with aryl complex; and 8-iodo-4-aryl Preparation of (4-alkynyl-2-nitro-phenyl)-aminomethyl group by coupling Sonogashira of keto-l,3-dihydrophenylhydrazone [b][l,4]dioxanone with acetylene compound Acidic third-butyl ester. Halide (3.0-4.5 millimolar), acetylene compound (3.0-4.5 millimolar),

Et3N(13.5 毫莫耳)、PdCl2(PPh3)2(5 莫耳。/。)及 pph3(2.5 莫耳 〇/〇 ) 在THF (12毫升)[其中可添加極不落性物質dmp (至高12毫升) ]中之混合物,於23°C下攪拌20分鐘,同時以氬滌氣。添加 Cul (1.2莫耳% ),並於60°C及氬大氣下持續攪拌,直到此顯 示較少量之成份完全轉化爲止[參閱j. 0rg· Chem 1998, 63, 8551] 。將混合物轉移至分液漏斗,添加5%擰檬酸(5〇毫升),並 將產物以EtOAc萃取(2 X 100毫升)。合併之有機層以飽和 NaHC〇3溶液(50毫升)及鹽水(50毫升)洗滌,接著以乂妨〜脱 水乾燥。移除溶劑,留下黃色殘留物,將其藉矽膠管柱層 析純化,使用己烷/ EtOAc,及/或以己烷或EtOH水溶液研 製,而得標題化合物。 實例K1 (5-鼠基-2-硝基-4-苯基乙块:基-苯基)-胺甲基酸第三_丁酉旨 根據一般私序K ’製自(5-氣基-4-換基-2-硝基-苯基)-胺甲基 酸第三-丁酯(實例Β1)(1·2克,3.0毫莫耳)與苯乙块(ο」毫升 ,4.5毫莫耳)。獲得黃色固體(944毫克)。 MS (ISN) 371 [(Μ-ΗΠ 與 373 [(Μ-Η+2Π ;熔點 166-167°C。 實例K2 -57- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) --------------裝 i I (請先閱讀背面之注意事項再本頁) 訂_ · -_線_ 經濟部智慧財產局員工消費合作社印製 1255266Et3N (13.5 millimolar), PdCl2 (PPh3) 2 (5 moles / /) and pph3 (2.5 moles / oxime) in THF (12 ml) [where a very non-falling substance dmp can be added (up to 12) The mixture in ML) was stirred at 23 ° C for 20 minutes while scrubbing with argon. Cul (1.2 mol%) was added and stirring was continued at 60 ° C under argon until a small amount of the component was completely converted [see j. 0rg. Chem 1998, 63, 8551]. The mixture was transferred to a sep. funnel, 5% citric acid (5 mL) was added and the product was extracted with EtOAc (2 X 100 mL). The combined organic layers were washed with aq. NaHC.sub.3 (50 mL) and brine (50 mL). The solvent was removed to give a yellow residue which was purified eluting eluting eluting eluting eluting Example K1 (5-muro-2-nitro-4-phenylethyl block: phenyl-phenyl)-amine methyl acid third _ 酉 酉 according to the general private order K 'made from (5-gas base-4 -transyl-2-nitro-phenyl)-amine methyl acid tert-butyl ester (example Β1) (1.2 g, 3.0 mmol) and phenyl bromide (ο" ml, 4.5 mmol ). Obtained as a yellow solid (944 mg). MS (ISN) 371 [(Μ-ΗΠ with 373 [(Μ-Η+2Π ; melting point 166-167 ° C. Example K2 -57- This paper scale applies to Chinese National Standard (CNS) A4 specification (210 X 297 mm) ) -------------- Install i I (please read the note on the back and then this page) Order _ · -_线_ Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 1255266

五、發明說明(55) (5-甲基-2-硝基-4-苯基乙炔基_苯基)_胺甲基酸第三叮酯 根據一般程序K,製自(4-碘基净甲基:硝基-苯基)_胺甲基 酸第三-丁酯(實例B2)(1.13克,3.〇毫莫耳)與苯乙炔(〇 5毫升 ,4.5耄莫耳)。獲得綠黃色固體(794毫克)。 MS (EI) 352 (M+);熔點 16Η64τ。 實例K3 [5-(4-甲基-六氫吡畊-1-基)冬硝基冬苯基乙炔基-苯基]_胺甲基 酸第三-丁酯 根據一般程序K,製自[4-碘基_5普甲基_六氫吡畊小基)-2-硝基-苯基]-胺曱基酸第三-丁酯(實例C1)(134克,3 〇毫莫导) 與苯乙块(0.5毫升,4.5毫莫耳)。獲得綠黃色固體(u克)。 MS (ISP) 437 [(M+H)+ ];熔點 170°c。 實例K4 (5-嗎福啉-4-基-2-硝基-4-苯基乙炔基-苯基)_胺甲基酸第三-丁酯 根據一般程序K,製自(4-碘基-5-嗎福啉斗基-2-硝基-苯基)-胺甲基酸第三-丁酯(實例C3)(890毫克,2.0毫莫耳)與苯乙炔 (0.33毫升,3.0毫莫耳)。獲得橘色固體(58〇毫克)。 MS (ISP) 424 [(M+H)+ ];熔點 190-191°C。 實例K5 (2-硝基-4-苯基乙块基-5-硫代嗎福琳-4·基-苯基)-胺甲基酸第三 -丁醋 根據一般程序K,製自(4-峨基-2-硝基-5-硫代嗎福淋-4-基-苯基)-胺甲基酸第三-丁酯(實例C2)(1.0克,2.15毫莫耳)與笨 乙炔(0.36毫升,3.22毫莫耳)。獲得橘色固體(62〇毫克)。 -58- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -------------裝--- (請先閱讀背面之注意事項再本頁) 訂- —線 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明(56) MS (ISP) 440 [(M+H)+ ]與 462 [(M+Na)+];熔點 2〇rc (分解)。 實例K6 [5-(1,1-二酮基-硫代嗎福啉斗基&gt;2_硝基斗苯基乙块基·苯基] 胺甲基酸第三-丁酯 在兩步驟中按下述製成: 於(4-碘基-2-硝基j硫代嗎福啉基-苯基)_胺曱基酸第三 丁酯(實例C2)(465毫克,1毫莫耳)在丙酮(25毫升)與Η2〇(1 笔升)中之落液内,在〇°C下添加〇·3Μ鉬酸銨溶液⑼3毫升 與33% Η2〇2(2·3毫升),並將混合物於23χ:下攪拌i小時。獲 仔[5 (1,1 —配基代嗎福琳-4-基)-4-叾典基-2-硝基-苯基]-胺甲 基酸第二-丁酯(497毫克,1.〇毫莫耳),爲非晶質黃色物質 ,根據一般程序κ,使其與苯乙块(0·17毫升,15毫莫耳)反 應。獲得黃色固體(245毫克)。 MS (ISP) 472 [(Μ+Η)+ ];熔點 217-22IX:。 實例K7 〇(1,4-二氧-8-氮-螺[4.5]癸-8-基&gt;2-硝基-4-苯基乙炔基_苯基]_胺 甲基酸第三-丁酯 根據一般程序K,製自[5-(1,4-二氧-8-氮-螺[4.5]癸-8-基)-4-破 基硝基-苯基]-胺甲基酸第三-丁酯(實例C4)(3.80克,7.53毫 莫耳)與苯乙块(1.24毫升,11.3毫莫耳)。獲得橘色固體(18 克)。 MS (ISN) 478 [(Μ-ΗΠ ;熔點 179-180X:。 實例K8 [5-(2-一甲胺基-乙硫基)-2-硝基-4-苯基乙決基-苯基]_胺甲基酸 -59 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -----r---------裝--- (請先閱讀背面之注意事項再6本頁) 訂· · 丨—線. 經濟部智慧財產局員工消費合作社印製 Α7 Β7 1255266 五、發明說明(57) 第三-丁酯 根據一般程序K,製自[5-(2-二甲胺基-乙硫基)冰碘基-2-硝 基-苯基]-胺甲基酸第三-丁酯(實例Dl)(721毫克,1.54毫莫耳) 與苯乙炔(0.25毫升,2.31毫莫耳)。獲得非晶質黃色物質(595 毫克)。 MS (ISP) 442 [(M+H)+ ];熔點 179-180°C。 實例K9 (5-第三-丁氧羰基胺基-4-硝基-2-苯基乙炔基-苯硫基)-醋酸甲酯 根據一般程序K,製自(5-第三-丁氧羰基胺基-2-碘基-4-硝 基-苯硫基)-醋酸甲酯(實例D2)(780毫克,1.67毫莫耳)與苯乙 炔(0·27毫升,2·5毫莫耳)。獲得橘色固體(700毫克)。 MS (ISP) 460 [(Μ+ΝΗ4)+];熔點 125-127°C。 實例K10 [5-(2-甲氧基-乙氧基)-2-硝基-4-苯基乙炔基·苯基]-胺甲基酸第 三-丁酯 根據一般程序K,製自[4-碘基-5-(2甲氧基-乙氧基)-2_硝基_ 苯基]-胺甲基酸第三-丁酯(實例B6)(876毫克,2毫莫耳)與苯 乙块(0.33毫升,3毫莫耳)。獲得黃色固體(569毫克)。 MS (ISP) 413 [(M+H)+ ]與 430 [(M+NH4)+ ];熔點 118-119。(:。 實例K11 (5-甲氧基-2-硝基-4-苯基乙炔基-苯基胺甲基酸第三_丁酯 根據一般程序K,製自(4-碘基-5-甲氧基-2-硝基-苯基)_胺甲 基故弟二-丁酯(實例Β5)(1·18克,3.00毫莫耳)與苯乙決(ο % 毫升,4·5毫莫耳)。獲得黃色固體(U克)。 -60- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) L丨—卜---------裝--- (請先閱讀背面之注意事項再本頁) · 線· 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明(58) MS(EI) 368 (M+);熔點 129°C。 實例K12 [5-(2-{2-[2-(2-甲氧基-乙氧基)_乙氧基]_乙氧基}_乙氧基)_2_硝基_ 4-苯基乙決基-苯基]-胺甲基酸第三_ 丁酉旨 根據一般程序K,製自[4_碘基甲氧基_乙氧基&gt; 乙氧基]-乙氧基}-乙氧基)-2-硝基-苯基]_胺甲基酸第三_丁酯( 貫例Β7)(5·7克’ 10.0耄莫耳)與苯乙块([Μ亳升,Μ毫莫耳) 。獲得黃色油(5.2克)。 MS (ISN) 543 [(M-Η)·]。 實例K13 (5-第三-丁氧羰基胺基-4-硝基-2-苯基乙炔基-苯氧基)·醋酸第 三-丁酯 根據一般程序K,製自(5-第三-丁氧羰基胺基-2-碘基-4-硝 基-苯氧基)-醋酸第三-丁酯(實例Sl)(1.46克,2.99毫莫耳)與 苯乙炔(0.49毫升,4.49毫莫耳)。獲得黃色固體(1·4克)。 MS (ISP) 486 [(Μ+ΝΗ4)+];熔點 130°C。 實例K14 (RS)-5-(2,2-二甲基-[1,3]二氧伍圜-4-基甲氧基)-2-硝基-4-苯基乙 块基-苯胺 根據一般程序K,製自(RS)-5-(2,2-二甲基-[1,3]二氧伍圜-4-基 甲氧基)-4-琪基-2-硝基-苯胺(實例Ε5)(4·5克,11.4毫莫耳)與苯 乙炔(1·88毫升,17.1毫莫耳)。獲得橘色固體(5.4克)。 MS(ISN) 367[(M-H)·];熔點 147-149°C。 實例K15 -61 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -----r-------I -裝--- (請先閱讀背面之注意事項再^►本頁) --丨線- 經濟部智慧財產局員工消費合作社印製 1255266 經濟部智慧財產局員工消費合作社印製 A7 B7 五、發明說明(59) (5-弟二-丁乳談基胺基-4-硝基-2-苯基乙块基-苯甲酸甲酉旨 根據般程序K ’製自5-第二-丁氧碳基胺基破基冰確基 -苯甲酸甲酯(實例Β3)(1·22克,2.89毫莫耳)與苯乙炔(〇 48毫 升,4.34毫莫耳)。獲得黃色固體(793毫克)。 MS (ISP) 397 [(Μ+Η)+ ]與 414 [(Μ+ΝΗ4)+ ];熔點 173Χ:。 實例Κ16 (5-第三-丁氧黢基胺基-4-硝基-2-苯基乙炔基-苯基)·醋酸甲酯 根據一般程序Κ,製自(5-第三-丁氧羰基胺基碘基冰硝 基-苯基)-醋酸甲酯(實例 Ve (R=C02Me ; R&quot;=Boc))(1.32 克,3.03 毫莫耳)與苯乙块(0.5毫升,4.55毫莫耳)。獲得黃色固體(i.i 克)。 MS (ISP) 411 [(M+H)+ ],428 [(M+NH4)+ ]及433 [(M+Na)+ ];熔點 134°C。 實例K17 (5-氰基甲基-2-硝基-4-苯基乙炔基-苯基)-胺甲基酸第三-丁酯 根據一般程序K,製自(5_氰基甲基-4-碘基-2-硝基-苯基)-胺 甲基酸第三-丁酯(實例 B9 [Ve (R=CN ; R”=Boc)])(3.97 克,9.85 毫 莫耳)與苯乙块(3.24毫升,29_56毫莫耳)。獲得橄欖色固體 (1.6 克)。 MS (ISP) 395 [(M+NH4)+];熔點 166°C。 實例K18 (RS)-[5-(2,3-二羥基-丙氧基)-2-硝基-4-苯基乙炔基-苯基]-胺甲基 酸第三-丁酯 根據一般程序K,製自(RS)-[5-(2,3-二羥基-丙氧基)-4-破基-2-硝基-苯基]-胺甲基酸第三-丁酯(RO-68-5451/000 (3.23克,7.11毫 -62- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -------------好^--- (請先閱讀背面之注意事項再15 本頁) 言·V. Description of the invention (55) (5-Methyl-2-nitro-4-phenylethynyl-phenyl)-amine methyl acid terpyl ester according to the general procedure K, prepared from (4-iodo) Methyl: nitro-phenyl)-amine methyl acid third-butyl ester (Example B2) (1.13 g, 3. 〇 millimol) and phenylacetylene (〇 5 mL, 4.5 Torr). A greenish yellow solid (794 mg) was obtained. MS (EI) 352 (M+); m.p. Example K3 [5-(4-Methyl-hexahydropyrylene-1-yl)-t-nitro-t-phenylphenylethynyl-phenyl]-aminomethyl acid tert-butyl ester according to the general procedure K, manufactured from [ 4-iodo- 5 benzylidene hexahydropyrazine small base)-2-nitro-phenyl]-amine hydrazinoic acid tert-butyl ester (Example C1) (134 g, 3 〇 mmol) Block with benzene (0.5 ml, 4.5 mmol). Obtained a greenish yellow solid (u). MS (ISP) 437 [(M+H)+]; mp. 170. Example K4 (5-morpholine-4-yl-2-nitro-4-phenylethynyl-phenyl)-amine methyl acid tert-butyl ester according to the general procedure K, from 4-iodo 5-5-fosfosin-2-yl-phenyl)-amine methyl acid tert-butyl ester (example C3) (890 mg, 2.0 mmol) and phenylacetylene (0.33 ml, 3.0 mmol) ear). Obtained an orange solid (58 mg). MS (ISP) 424 [(M+H)+]; mp 190-191. Example K5 (2-nitro-4-phenylethylidene-5-thiofenofin-4-yl-phenyl)-amine methyl acid third-butyl vinegar according to the general procedure K, manufactured from (4 - mercapto-2-nitro-5-thiofenofo-4-yl-phenyl)-amine methyl acid tert-butyl ester (example C2) (1.0 g, 2.15 mmol) and stupid acetylene (0.36 ml, 3.22 mmol). Obtained an orange solid (62 mg). -58- This paper size is applicable to China National Standard (CNS) A4 specification (210 X 297 mm) -------------Installation--- (Please read the back note first. ) - Line Ministry of Economics Intellectual Property Office Staff Consumer Cooperative Printed 1255266 A7 B7 V. Description of Invention (56) MS (ISP) 440 [(M+H)+ ] and 462 [(M+Na)+]; Melting Point 2〇rc (decomposed). Example K6 [5-(1,1-dione-thio-fosfosin bucket base&gt;2_nitro-phenylphenyl-phenyl) phenylmethyl-tert-butyl ester in two steps Made as follows: (4-iodo-2-nitroj thiomorpholine-phenyl)-amine decyl methacrylate (Example C2) (465 mg, 1 mmol) In a drop of acetone (25 ml) and Η2〇 (1 liter), add 〇·3Μ ammonium molybdate solution (9) 3 ml and 33% Η2〇2 (2.3 ml) in 〇 °C, and The mixture was stirred at 23 °: for 1 hour. Obtained [5 (1,1 - ligand, dyfosin-4-yl)-4-indolyl-2-nitro-phenyl]-amine methyl acid Di-butyl ester (497 mg, 1. 〇 millimol), an amorphous yellow material which was reacted with benzene b (0·17 mL, 15 mmol) according to the general procedure κ. (245 mg) MS (ISP) 472 [(Μ+Η)+]; m.p. 217-22IX:. Example K7 〇(1,4-dioxo-8-nitro-spiro[4.5]癸-8-yl] ; 2-nitro-4-phenylethynyl-phenyl]-amino acid tert-butyl ester according to the general procedure K, prepared from [5-(1,4-dioxo-8-nitrogen-spiro[ 4.5]癸-8-yl)-4-bromo nitro-phenyl]- Methyl acid tert-butyl ester (Example C4) (3.80 g, 7.53 mmol) and phenyl b. (1.24 mL, 11.3 mmol). Obtained orange solid (18 g). MS (ISN) 478 [ (Μ-ΗΠ; melting point 179-180X: Example K8 [5-(2-Methylamino-ethylthio)-2-nitro-4-phenylethyl-phenyl]-amine methyl acid -59 - This paper size is applicable to China National Standard (CNS) A4 specification (210 X 297 mm) -----r---------Installation--- (Please read the notes on the back first) 6 Page) Book · · 丨-line. Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed Α7 Β7 1255266 V. Invention description (57) Third-butyl ester according to the general procedure K, from [5-(2- two Methylamino-ethylthio) bromoiodo-2-nitro-phenyl]-amine methyl acid tert-butyl ester (Example Dl) (721 mg, 1.54 mmol) with phenylacetylene (0.25 mL, 2.31 mmol) Obtained amorphous yellow material (595 mg) MS (ISP) 442 [(M+H)+]; mp 179-180 ° C. Example K9 (5-tris-butoxycarbonylamine Methyl 4-nitro-2-phenylethynyl-phenylsulfanyl)-acetate is prepared according to the general procedure K from (5-tris-butoxycarbonylamino-2- Iodophenyl-4-nitro-phenylthio)-acetic acid methyl ester (Example D2) (780 mg, 1.67 mmol) and phenylacetylene (0. 27 mL, 2.5 mM). Obtained an orange solid (700 mg). MS (ISP) 460 [(Μ+ΝΗ4)+]; mp. 125-127. Example K10 [5-(2-Methoxy-ethoxy)-2-nitro-4-phenylethynylphenyl]-amine methyl acid tert-butyl ester according to the general procedure K, manufactured from [ 3-iodo-5-(2methoxy-ethoxy)-2-nitro-phenyl]-amine methyl acid tert-butyl ester (Example B6) (876 mg, 2 mmol) and Phenylene block (0.33 ml, 3 mmol). A yellow solid (569 mg) was obtained. MS (ISP) 413 [(M+H)+] and 430 [(M+NH4)+]; mp. (:. Example K11 (5-methoxy-2-nitro-4-phenylethynyl-phenylamine methyl acid tert-butyl ester according to the general procedure K, from (4-iodo-5-) Methoxy-2-nitro-phenyl)-amine methyl benzoate di-butyl ester (example Β 5) (1·18 g, 3.00 mmol) and phenylacetate (ο % 毫升, 4·5 毫Moer). Obtained a yellow solid (Ug). -60- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) L丨-卜---------Installation-- - (Please read the notes on the back and then the page) · Line · Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 A7 B7 V. Description of Invention (58) MS (EI) 368 (M+); Melting point 129 °C. Example K12 [5-(2-{2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxy}-ethoxy]_2_nitro-4-phenylene Benzyl-phenyl]-amine methyl acid _ 酉 酉 according to the general procedure K, from [4_iodomethoxy-ethoxy] ethoxy]-ethoxy}-ethoxy )-2-nitro-phenyl]-amine methyl acid third-butyl ester (conventional Β7) (5·7 g '10.0 耄m) and phenyl bromide ([Μ亳升,Μ毫莫耳Obtained yellow oil (5.2 g). MS (ISN) 543 [(M-Η)·]. Example K13 (5-Terti-butoxycarbonylamino-4-nitro-2-phenylethynyl-phenoxy)·T-butyl acetate According to the general procedure K, from (5-tris-butoxycarbonylamino-2-iodo-4-nitro-phenoxy)-acetic acid tert-butyl ester (Example Sl) (1.46 g, 2.99 m) Mole) and phenylacetylene (0.49 ml, 4.49 mmol). Obtained a yellow solid (1·4 g) MS (ISP) 486 [(Μ+ΝΗ4)+]; melting point 130 ° C. Example K14 (RS) -5-(2,2-dimethyl-[1,3]dioxoindol-4-ylmethoxy)-2-nitro-4-phenylethylidene-aniline according to the general procedure K From (RS)-5-(2,2-dimethyl-[1,3]dioxoindol-4-ylmethoxy)-4-pyridyl-2-nitro-phenylamine (Example Ε5) 4·5 g, 11.4 mmol, and phenylacetylene (1·88 ml, 17.1 mmol). Obtained an orange solid (5.4 g). MS (ISN) 367 [(MH)·]; melting point 147-149 °C. Example K15 -61 - This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) -----r-------I-install--- (please read first Precautions on the back ^►►) - 丨线 - Ministry of Economic Affairs Intellectual Property Bureau employee consumption Printed by the Society 1255266 Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed A7 B7 V. Inventions (59) (5-di-di-butyl sylvestreyl-4-nitro-2-phenylethylidene) Benzoic acid methacrylate is prepared according to the general procedure K' from 5-second-butoxycarbylamino-based thioglycol-methyl benzoate (Example Β3) (1·22 g, 2.89 mmol) and benzene Acetylene (〇 48 ml, 4.34 mmol). A yellow solid (793 mg) was obtained. MS (ISP) 397 [(Μ+Η)+ ] and 414 [(Μ+ΝΗ4)+ ]; melting point 173Χ:. Example Κ16 (5-Terti-butoxymethylamino-4-nitro-2-phenylethynyl-phenyl)·methyl acetate was prepared according to the general procedure from (5-tri-butoxycarbonyl) Amino iodohydridyl nitro-phenyl)-methyl acetate (Example Ve (R=C02Me; R&quot;=Boc)) (1.32 g, 3.03 mmol) with phenyl bromide (0.5 mL, 4.55 mmol) ). Obtained a yellow solid (i.i gram). MS (ISP) 411 [(M+H)+], 428 [(M+NH4)+] and 433 [(M+Na)+]; mp. Example K17 (5-Cyanomethyl-2-nitro-4-phenylethynyl-phenyl)-amine methyl acid tert-butyl ester according to the general procedure K, from (5-cyanomethyl- 4-iodo-2-nitro-phenyl)-amine methyl acid tert-butyl ester (Example B9 [Ve (R=CN; R"=Boc)]) (3.97 g, 9.85 mmol) and Phenyl bromide (3.24 ml, 29-56 mmol). Obtained olive solid (1.6 g) MS (ESI) 395 [(M+NH4)+]; mp 166 ° C. Example K18 (RS)-[5- (2,3-Dihydroxy-propoxy)-2-nitro-4-phenylethynyl-phenyl]-amine methyl acid tert-butyl ester according to the general procedure K, from (RS)-[ 5-(2,3-dihydroxy-propoxy)-4-bromo-2-nitro-phenyl]-amine methyl acid tert-butyl ester (RO-68-5451/000 (3.23 g, 7.11 毫-62- This paper size is applicable to China National Standard (CNS) A4 specification (210 X 297 mm) ------------- Good ^--- (Please read the notes on the back first) 15 more on this page)

1255266 A7 B7 五、發明說明(6(}) 莫耳)·’製自(5-晞丙氧基·4-破-2-硝基-苯基)_胺甲基酸第三·丁 酯(實例Β4)(4·20克,1〇·〇毫莫耳),經由與NM〇(128克,11〇 毫莫耳)、〇s〇42.5%在t-BuOH (1 ^:升,〇.;[毫莫耳)中及k2〇s〇4 (40毫克,0.1毫莫耳)在丙酮(250毫升)與h20 (1〇〇毫升)中, 於23°C下反應6天)與苯乙炔(1.17毫升,10.67毫莫耳)。獲得 黃色固體(2.74克)。 MS (ISP) 429 [(M+H)+ ];熔點 157°C (分解)。 實例K19 (5-#至甲基-2-硝基-4-苯基乙炔基-苯基)胺甲基酸第三-丁酯 根據一般程序K,製自(5-羥甲基-4-碘基-2-硝基-苯基)-胺曱 基酸第三-丁酯(實例Vh)(2.61克,6.62毫莫耳)與苯乙块(1.10 毫升,9.93毫莫耳)。獲得黃色固體(176克)。 MS (ISP) 386 [(M+NH4)+ ];熔點 177°C (分解)。 實例K20 [5-(4-甲氧基-六氫p比淀-1-基)-2-硝基-4-苯基乙炔基-苯基]-胺甲 基酸第三-丁酯 根據一般程序K,製自[4-碘基-5-(4-甲氧基-六氫吡啶小基)_ 2-硝基-苯基]-胺甲基酸第三-丁酯(實例C5x1〇克,21毫莫耳) 與苯乙炔(0.35毫升,3.15毫莫耳)。獲得黃色固體(799毫克)。 熔點 147-150°C。 實例K21 (5-氰基甲氧基-2-硝基-4-苯基乙決基-苯基)_胺甲基酸第三-丁酯 根據一般程序K,製自(5-氰基甲氧基-4-碘基-2-硝基-苯基)-胺甲基酸第三-丁酯(實例S2)(605毫克,1.44毫莫耳)與苯乙 -63- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) (請先閱讀背面之注意事項再mr本頁) 裝 訂--------^-線- 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 經濟部智慧財產局員工消費合作社印製 五、發明說明(61 ) 炔(0.24毫升,2.16毫莫耳)。獲得黃色固體(5〇8毫克)。 MS (EI) 393 (M+);熔點 170°C。 實例K22 [4-(4-氟冬基乙块基)-5-¾甲基·2-硝基-苯基]_胺甲基酸第三_丁酉旨 根據一般程序K,製自(5-羥甲基-4-碘基-2-硝基-苯基)_胺甲 基酸第三-丁酯(實例Vh)(2.00克,5.07毫莫耳)與4-氟苯基乙 炔(0.91克,7.61毫莫耳)。獲得黃色固體(155克)。 MS (ISN) 385 [(M-H)-];熔點 198°C。 實例K23 (RS)-(4-(4-氟苯基乙決基)-5-{曱基-[2-(四氫碌喃-2-基氧基)_乙基] -胺基1-2-硝基-苯基)-胺甲基酸第三-丁酯 根據一般程序K,製自(RS)-(4-碘基-5-{甲基-[2-(四氫-哌喃-2-基氧基)-乙基]-胺基硝基-苯基)-胺甲基酸第三-丁酯[R〇_69_ 3820/000,製自{5-[(2-經基-乙基)-甲基-胺基]破基硝基•苯 基}-胺甲基酸第三-丁酯(實例C6),經由以3,4_二氫-2沁哌喃 及觸媒TsOH · Η2 Ο,在DCM中,於〇°C下處理](2·〇9克,4.01 毫莫耳)與4-氟苯基乙炔(0.72克,6.02毫莫耳)。獲得黃褐色 固體(1.84克)。 MS (ISP) 514 [(M+H)+];熔點 134°C。 實例K24 (RS)-{2-硝基-4-苯基乙炔基-5-[2-(四氫-喊喃-2-基氧基)-乙氧基]_ 苯基h胺甲基酸第三-丁酯 根據一般程序K,製自(RS&gt;{4-琪基-2_硝基-5-[2-(四氫-岐喃-2-基氧基)-乙氧基]•私基}-胺甲基酸第三-丁 g旨(實例83)(743毫 -64- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -- (請先閱讀背面之注意事項再@本頁) 裝 :線_ 1255266 A7 五、發明說明(62) 克,1.46毫莫耳)與苯乙炔(〇·24毫升,219毫莫耳)。獲得普 褐色黏網油(429毫克)。 MS(EI) 393 (M+)。 實例K25 根據一般程序κ,製自[5_(2_第三-丁氧基_乙氧基&gt;4嘀基j 硝基-苯基]-胺甲基酸第三-丁酯(實例B1〇)(144克,3 〇亳莫耳) 與4-氟苯基乙炔(541毫克,4.5毫莫耳)。獲得黃色固體(777 毫克)。 MS (EI) 472 (M+);熔點 96-98°C。 實例K26 [5-第二-丁氧基-4-(4-氟苯基乙块基硝基-苯基 &gt;胺甲基酸第 三-丁酯 根據一般程序K,製自(5-第三-丁氧基冰破基-2-硝基-苯基)_ 胺甲基酸第三-丁酯(實例S4)(i.4〇克,3·21毫莫耳)與‘氟苯 基乙炔(0.66克,5.46毫莫耳)。獲得褐色固體(52〇亳克)。 MS (El) 428(Μ+);溶點 201°C。 一般程序L : 藉由(2-硝基-苯基)-胺甲基酸第三_丁酯之還原作用,製備(^ 胺基·•苯基)-胺甲基酸第三_ 丁酯; 亦藉由3-芳基-N-(2-硝基-苯基)-3-g同基-丙醯胺之還原及伴隨之 環化作用,製備4-芳基-1,3-二氫苯幷二吖庚因_2_酮 方法a ··催化氫化 將硝基化合物(1.0毫莫耳)在MeOH或EtOH與THF (1 : 1,約 20毫升)中,及10%鈀/碳(20毫克)或阮尼_Ni(2〇毫克)之混 LIIU----------裝--- (請先閱讀背面之注意事項再本頁) · 線· 經濟部智慧財產局員工消費合作社印製 12552661255266 A7 B7 V. INSTRUCTIONS (6(}) Moer)·'made from (5-fluorenyloxy-4-c--2-nitro-phenyl)-amine methyl acid tert-butyl ester ( Example Β 4) (4·20 g, 1〇·〇 mmol), via NM〇 (128 g, 11〇 mmol), 〇s〇42.5% in t-BuOH (1 ^: liter, 〇. ; [mole] and k2〇s〇4 (40 mg, 0.1 mmol) in acetone (250 ml) and h20 (1 ml), reacted at 23 ° C for 6 days) with phenylacetylene (1.17 ml, 10.67 mmol). Obtained a yellow solid (2.74 g). MS (ISP) 429 [(M+H)+]; mp. 157 (dec.). Example K19 (5-# to methyl-2-nitro-4-phenylethynyl-phenyl)amine methyl acid tert-butyl ester according to the general procedure K, from (5-hydroxymethyl-4- Iodo-2-nitro-phenyl)-amine mercapto acid tert-butyl ester (Example Vh) (2.61 g, 6.62 mmol) and phenyl b. (1.10 mL, 9.93 mmol). A yellow solid (176 g) was obtained. MS (ISP) 386 [(M+NH4)+]; mp 177 (dec.). Example K20 [5-(4-methoxy-hexahydrop-pred-1-yl)-2-nitro-4-phenylethynyl-phenyl]-amine methyl acid tert-butyl ester according to general Procedure K, prepared from [4-iodo-5-(4-methoxy-hexahydropyridine small) 2-nitro-phenyl]-amine methyl acid tert-butyl ester (example C5x1 gram , 21 mM) with phenylacetylene (0.35 ml, 3.15 mmol). A yellow solid (799 mg) was obtained. Melting point 147-150 ° C. Example K21 (5-Cyanomethoxy-2-nitro-4-phenylethyl-phenyl)-amine methyl acid tert-butyl ester according to the general procedure K, from (5-cyanomethyl) Oxy-4-iodo-2-nitro-phenyl)-amine methyl acid tert-butyl ester (Example S2) (605 mg, 1.44 mmol) and phenylethyl-63- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) (Please read the note on the back and then mr page) Binding--------^-Line - Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 1255266 A7 B7 Ministry of Economic Affairs, Intellectual Property Bureau, Staff Consumer Cooperatives, Printing 5, Inventions (61) Alkyne (0.24 ml, 2.16 mmol). Obtained a yellow solid (5 〇 8 mg). MS (EI) 393 (M+); mp. 170. Example K22 [4-(4-Fluoro-butyryl)-5-3⁄4 methyl·2-nitro-phenyl]-amine methyl acid _ _ 酉 根据 根据 根据 根据 根据 根据 根据 根据Hydroxymethyl-4-iodo-2-nitro-phenyl)-amine methyl acid tert-butyl ester (Example Vh) (2.00 g, 5.07 mmol) and 4-fluorophenylacetylene (0.91 g) , 7.61 millimoles). A yellow solid (155 g) was obtained. MS (ISN) 385 [(M-H)-]; mp. Example K23 (RS)-(4-(4-Fluorophenylethyl)-5-{indolyl-[2-(tetrahydrofuran-2-yloxy)-ethyl]-amino-1 2-Nitro-phenyl)-amine methyl acid tert-butyl ester according to the general procedure K, from (RS)-(4-iodo-5-{methyl-[2-(tetrahydro-pyran) -2-yloxy)-ethyl]-aminonitro-phenyl)-amine methyl acid tert-butyl ester [R〇_69_ 3820/000, manufactured from {5-[(2-yl) -ethyl)-methyl-amino]-based nitro-phenyl}-aminomethyl acid tert-butyl ester (example C6) via 3,4-dihydro-2-indole and catalyst TsOH · Η2 Ο, treated in DCM at 〇 ° C (2·〇9 g, 4.01 mmol) and 4-fluorophenylacetylene (0.72 g, 6.02 mmol). Obtained a tan solid (1.84 g). MS (ISP) 514 [(M+H)+]; mp. Example K24 (RS)-{2-Nitro-4-phenylethynyl-5-[2-(tetrahydro-pyran-2-yloxy)-ethoxy]-phenylh-amine methyl acid The third-butyl ester is prepared according to the general procedure K from (RS &gt; {4-picyl-2_nitro-5-[2-(tetrahydro-indol-2-yloxy)-ethoxy] Private base}-Aminomethyl acid third-buty g (Example 83) (743 mA-64- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) -- (Please read the back first Precautions again @ this page) Packing: Line _ 1255266 A7 V, invention description (62) grams, 1.46 millimoles) and phenylacetylene (〇 · 24 ml, 219 millimoles). Obtained brown cohesive oil ( 429 mg) MS (EI) 393 (M+). </RTI> </RTI> <RTI ID=0.0></RTI> Amino-methyl 3-butyrate (Example B1) (144 g, 3 mmol) and 4-fluorophenylacetylene (541 mg, 4.5 mmol) afforded a yellow solid (777 mg). (EI) 472 (M+); m.p. 96-98 ° C. Example K26 [5-Se-butoxy-4-(4-fluorophenylethylidene-phenyl)-amine methyl acid Tri-butyl ester according to the general course K, produced from (5-tris-butoxysuccinyl-2-nitro-phenyl)-aminomethyl-tert-butyl ester (example S4) (i.4 gram, 3.21 mil Mole) with 'fluorophenylacetylene (0.66 g, 5.46 mmol). Obtained a brown solid (52 g). MS (El) 428 (Μ+); melting point 201 ° C. General procedure L : Preparation of (^-aminophenyl)-amine methyl acid third-butyl ester by reduction of (2-nitro-phenyl)-amine methyl acid tert-butyl ester; also by 3- Preparation of 4-aryl-1,3-dihydrobenzoquinone dioxime by reduction of aryl-N-(2-nitro-phenyl)-3-g-iso-propionamide and concomitant cyclization Catalytic hydrogenation of the nitro compound (1.0 mmol) in MeOH or EtOH with THF (1:1, approximately 20 mL), and 10% palladium/carbon (20 mg) or hydrazine Ni _Ni (2 〇 mg) of mixed LIIU---------- Pack--- (Please read the back of the note before this page) · Line · Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 1255266

五、發明說明(63) 3物,於23°C及氫大氣下激烈攪拌,直到tic顯示完全轉化 爲止。濾出觸媒,以Me〇H或Et〇H與丁HF (1 : 1)充分洗條, 在眞空中移除溶劑,而得標題化合物,其大致上足夠純, 以供進一步轉變。 方法b :以SnCl2 · 2H2 0之還原作用 將硝基化合物(1.0毫莫耳)與SnCl2 · 2H20 (5.0毫莫耳)之混 合物’在EtOH (30毫升)中,於70-80T:下攪掉,或者,在咐 &lt;(3毫升)與DMF(12毫升)中,於23°C及氬大氣下攪拌,直 到tic顯示完全轉化爲止[參閲丁血[饥1984,25,839]。藉由添 加飽和NaHC〇3溶液,使反應混合物達到pH 8,並以EtOAc萃 取(2 X 1〇〇毫升)。合併之有機層以鹽水洗滌,並以s〇4脱 水乾燥。移除溶劑,留下黃色固體,若必要可將其藉石夕膠 管柱層析純化。 方法c :以Zn及NH4 C1之還原作用 於此硝基化合物(1.0毫莫耳)在EtOH / THF /飽和NH4 C1溶 液(1 : 1 : 1,30毫升)中之混合物内,添加鋅粉(3 〇毫莫耳) ,並將混合物於70Ό及氬大氣下攪拌,直到tlc顯示完全轉 化爲止。按方法B中所述,進行水溶液處理。 方法d :以Fe及HOAc之還原作用 於此硝基化合物(1.0毫莫耳)在THF/I^O (4 :丨,10_50毫升)中 之混合物内,添加Fe粉末(6.0毫莫耳),並將混合物於7〇。〇 及致大氣下攪拌’直到tic顯示冗全轉化爲止。按方法b中 所述,進行水溶液處理。 實例L1 -66- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) —.----------裝—— (請先閱讀背面之注意事項再本頁) · -*線· 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明(64) (2胺基-4-破基-5-硫代嗎福琳4-基-苯基)-胺甲基酸第三_丁酯 根據一般程序L (方法b),經由以SnCl2 · 2H2〇(2·54克, 11.3毫莫耳)之還原作用,製自⑷碘基_2_硝基_5-硫代嗎福啉-4-基-苯基)-胺甲基酸第三-丁酯(實例C2)(1〇5克,2 25毫莫耳) 。獲得淡黃色固體(993毫克)。 MS (ISP) 436 [(M+H)+];熔點 i25-127°C。 實例L2 (2-胺基-4-碘基-5-嗎福啉-4-基-苯基)-胺甲基酸第三-丁酯 根據一般程序L (方法b),經由以SnCl2 · 2H2 0 (1.9克,8.27 毫莫耳)之還原作用,製自(4-碘基-5-嗎福啉斗基-2-硝基-苯基) -胺甲基酸第三-丁酯(實例C3)(753克,1.65毫莫耳)。獲得黃 色固體(696毫克)。 MS (ISP) 420 [(M+H)+];熔點 Π9-143Χ:。 實例L3 (2-胺基-5-氯基-4-苯基乙炔基-苯基胺甲基酸第三-丁酯 根據一般程序L (方法b),經由以SnCl2 · 2Η2 Ο (2.245克,10 毫莫耳)之還原作用,製自(5-氯基-2-硝基-4-苯基乙炔基-苯基) -胺甲基酸第三-丁酯(實例Kl)(742毫克,2.0毫莫耳)。獲得 橘色固體(483毫克)。 MS (ISP) 343 [(M+H)+ ]與 345 [(M+2+H)+ ]。 實例L4 (2-胺基-5-甲基-4-苯基乙块基-苯基)·胺甲基酸第三-丁酯 根據一般程序L (方法b),經由以SnCl2 · 2H20 (2.37克,10.3 毫莫耳)之還原作用,製自(5-甲基-2-硝基斗苯基乙炔基-苯基) -67- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -------------裝--- (請先閱讀背面之注意事項再本頁) . •線- 經濟部智慧財產局員工消費合作社印製 1255266V. INSTRUCTIONS (63) 3, vigorously stirred at 23 ° C under a hydrogen atmosphere until tic shows complete conversion. The catalyst was filtered off and the strip was washed well with Me 〇H or Et 〇H and hexanes HF (1:1) and solvent was removed from the hexane to give the title compound which was substantially pure enough for further conversion. Method b: a mixture of a nitro compound (1.0 mmol) and SnCl 2 · 2H20 (5.0 mmol) in the reduction of SnCl 2 · 2H 2 0 in EtOH (30 ml), at 70-80 T: Or, in 咐 &lt;(3 ml) and DMF (12 ml), stir at 23 ° C under argon atmosphere until tic shows complete conversion [see Ding Xue [Hung 1984, 25, 839]. The reaction mixture was brought to pH 8 and then extracted with EtOAc (2×1······ The combined organic layers were washed with brine and dried with EtOAc EtOAc. The solvent is removed, leaving a yellow solid which can be purified by chromatography on silica gel column if necessary. Method c: reduction of Zn and NH4 C1 to a mixture of this nitro compound (1.0 mmol) in EtOH / THF / saturated NH4 C1 solution (1:1: 1, 30 ml), zinc powder added ( 3 〇 mmol; and the mixture was stirred at 70 Torr and argon atmosphere until tlc showed complete conversion. The aqueous solution treatment was carried out as described in Method B. Method d: reduction of Fe and HOAc to a mixture of this nitro compound (1.0 mmol) in THF/I^O (4: 丨, 10-50 ml), Fe powder (6.0 mmol), And the mixture was at 7 〇. 〇 Stir to the atmosphere until tic shows a redundant conversion. The aqueous solution treatment was carried out as described in Method b. Example L1 -66- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) —.----------Installation - (Please read the back note first. · -* Line · Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 A7 B7 V. Description of Invention (64) (2 Amino-4-keken-5-thiofenofin 4-yl-phenyl) -Aminomethyl acid tert-butyl ester was prepared according to the general procedure L (Method b) by reduction with SnCl 2 · 2H 2 〇 (2·54 g, 11.3 mmol) from (4) iodine-2-nitro _5-Thiofosolin-4-yl-phenyl)-amine methyl acid tert-butyl ester (Example C2) (1 〇 5 g, 2 25 mmol). Obtained as a pale yellow solid (993 mg). MS (ISP) 436 [(M+H)+]; mp. Example L2 (2-Amino-4-iodo-5-morpholine-4-yl-phenyl)-amine methyl acid tert-butyl ester according to the general procedure L (Method b), via SnCl2 · 2H2 Reduction of 0 (1.9 g, 8.27 mmol) from (4-iodo-5-morphobordol-2-nitro-phenyl)-amine methyl acid tert-butyl ester (example) C3) (753 grams, 1.65 millimoles). Obtained a yellow solid (696 mg). MS (ISP) 420 [(M+H)+]; melting point Π9-143Χ:. Example L3 (2-Amino-5-chloro-4-phenylethynyl-phenylaminemethyl acid tert-butyl ester according to the general procedure L (Method b), via SnCl 2 · 2 Η 2 Ο (2.245 g, Reduction of 10 mM) from (3-chloro-2-nitro-4-phenylethynyl-phenyl)-amine methyl acid tert-butyl ester (Example Kl) (742 mg, 2.0 mmol. Obtained an orange solid (483 mg). MS (ESI) 343 [(M+H)+] and 345 [(M+2+H)+]. Example L4 (2-Amino-5) -Methyl-4-phenylethylidene-phenyl)-aminomethyl acid tert-butyl ester according to the general procedure L (method b), via reduction with SnCl2 · 2H20 (2.37 g, 10.3 mmol) Function, made from (5-methyl-2-nitrophenylphenylethynyl-phenyl) -67- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) ----- --------装--- (Please read the back note before this page). • Line - Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed 1255266

五、發明說明(65) -胺甲基酸第三-丁酯(實例K2)(741毫克,21毫莫耳)。獲得 淡褐色固體(419毫克)。 MS (ISP) 323 [(M+H)+];溶點 172-173°C。 實例L5 [2-胺基-5-(4-甲基-六氫吡畊小基)_4_苯基乙炔基_苯基]_胺甲基 酸第三-丁酯 根據一般程序L(方法b),經由以SnCl2 ·2Η2Ο(2,820克,12.4 毫莫耳)之還原作用,製自[5_(4-甲基_六氫吡畊小基&gt;2_硝基_ 4-苯基乙炔基-苯基]_胺甲基酸第三·丁酯(實例Κ3χ1〇8克, 2.48毫莫耳)。獲得橘色固體(1〇克)。 MS (ISP) 407 [(M+H)+ ];熔點 81-85Ό。 實例L6 (5-胺基-2-氯-聯苯基-4-基)-胺甲基酸第三-丁酯 根據一般程序L (方法b),經由以SnCl2 · 2H2 0 (2.53克,11.2 毫莫耳)之還原作用,製自(2-氯基-5-硝基-聯苯基-4-基)-胺甲 基酸第三-丁酯(實例Fl)(783毫克,2.24毫莫耳)。獲得黃色 固體(684毫克)。 MS(EI)318(M+)與 320 [(M+2)+];熔點 l〇9-lirC。 實例L7 (5-胺基-2-甲基-聯苯基-4-基)-胺曱基酸第三-丁酯 根據一般程序L (方法a),經由以Pd/C之催化氫化,製自 (2-甲基-5-硝基-聯苯基-4-基)-胺甲基酸第三-丁酯(實例F2)(921 毫克,2·8毫莫耳)。獲得白色固體(796毫克)。 MS (ΕΙ) 298 (Μ+);熔點 122°C。 -68- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ----U----------裝 i I (請先閱讀背面之注意事項再本頁) · --線_ 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明(66) 實例L8 [2-胺基-5-(2-二曱胺基-乙硫基)_‘苯基乙炔基-苯基]-胺甲基酸 第三-丁酯 根據一般程序L (方法b),經由以SnCl2 · 2H2 0 (1.41克,6.25 毫莫耳)之還原作用,製自[5-(2-二甲胺基-乙硫基)-2-硝基-4-苯基乙炔基-苯基]-胺甲基酸第三-丁酯(實例K8)(551毫克, 1.25毫莫耳)。獲得橘色泡沫物(51〇毫克)。 MS(ISP)412[(M+H)+];熔點 115-117°C。 實例L9 (4-胺基-5-第三-丁氧羰基胺基_2_苯基乙炔基-苯硫基)_醋酸甲酯 根據一般程序L (方法b),經由以SnCl2 · 2Η2 Ο (1.62克,7·16 毫莫耳)之還原作用,製自(5·第三-丁氧羰基胺基-4-硝基-2-苯 基乙炔基-苯硫基)醋酸甲酯(實例Κ9)(634毫克,1.43毫莫耳) 。獲得橘色膠質(590毫克)。 MS (ISP) 413 [(Μ+Η)+ ],435 [(M+Na)+ ]及 451 [(Μ+Κ)+ ]。 實例L10 (4-胺基-5-第三-丁氧談基胺基-2-苯基乙块基-苯基)-醋酸甲酉旨 根據一般程序L (方法b),經由以SnCl2 · 2Η2 Ο (3.00克,13.28 毫莫耳)之還原作用,製自(5-第三-丁氧羰基胺基-4-硝基-2-苯 基乙炔基-苯基)-醋酸曱酯(實例K16)(1.09克,2.66毫莫耳)。 獲得淡黃色固體(900毫克)。 MS (ISP) 381 [(M+H)+ ]與 403 [(M+Na)+ ];熔點 130。(:。 實例L11 [2-胺基-5-(2-甲氧基-乙氧基&gt;4-苯基乙炔基-苯基]-胺甲基酸第 -69- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ----K----------裝--- (請先閱讀背面之注意事項再—本頁) 訂- :線· 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明(67) 三-丁酯 根據一般程序L (方法b),經由以SnCl2 · 2H2〇(3.88克,17.2 毫莫耳)之還原作用,製自[5-(2-甲氧基-乙氧基)-2-硝基-4-苯 基乙炔基-苯基]-胺甲基酸第三-丁酯(實例Κ10)(1.417克,3·44 毫莫耳)。獲得灰白色固體(1.04克)。 MS (El) 382(Μ+);熔點 l〇5-l〇7°C。 實例L12 (2-胺基-5-嗎福啉-4-基-4-苯基乙炔基-苯基)-胺甲基酸第三-丁酉旨 根據一般程序L (方法b),經由以SnCl2 · 2Η2 Ο (1.5克,6.65 毫莫耳)之還原作用,製自(5-嗎福啉斗基-2-硝基斗苯基乙炔 基-苯基)-胺甲基酸第三-丁酯(實例K4)(563毫克,1.329毫莫耳) 。獲得紅褐色固體(488毫克)。 MS (ISP) 394 [(M+H)+];熔點 174-176°C。 實例L13 (2-胺基-5-甲氧基-4-苯基乙炔基-苯基)-胺甲基酸第三-丁酯 根據一般程序L (方法b),經由以SnCl2 · 2Η2 Ο (3.06克,13.57 毫莫耳)之還原作用,製自(5-甲氧基-2-硝基-4-苯基乙炔基-苯 基)-胺甲基酸第三-丁酯(實例Κ11)(1·00克,2.71毫莫耳)。獲 得黃色固體(870毫克)。 MS(EI) 338 (M+);熔點 158°C。 實例L14 4-胺基-5-第三-丁乳談基胺基-2-表基乙块基-苯甲酸甲酉旨 根據一般程序L (方法b),經由以SnCl2 · 2H2 0 (2.15克,9.51 毫莫耳)之還原作用,製自(5-第三-丁氧羰基胺基-4-硝基-2-苯 -70- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) --------------裝--- (請先閱讀背面之注意事項再本頁) 二π· !線· 經濟部智慧財產局員工消費合作社印製 1255266 A7 _____B7__ 五、發明說明(68 ) 基乙炔基-苯甲酸甲酯(實例K15)(754毫克,丨·^毫莫耳)。獲 得粉紅色固體(431毫克)。 MS (EI) 366 (M+);熔點 164°C。 實例L15 [2-胺基-5-(2-{2-[2_(2-甲氧基-乙氧基)-乙氧基]_乙氧基卜乙氧基&gt; 4-苯基乙炔基苯基]-胺甲基酸第三-丁酯 根據一般程序L (方法b),經由以SnCl2 · 2H2 0 (6.2克,27.54 毫莫耳)之還原作用,製自[5-(2-{2-[2-(2-甲氧基-乙氧基)_乙氧 基]-乙乳基}-乙氧基)-2-硝基-4-苯基乙块基-苯基]-胺甲基酸第 三-丁酯(實例K12)(3.0克,5.51毫莫耳)。獲得褐色油(2·9克)。 MS(ISP)515 [(Μ+Η)+]。 實例L16 (4-胺基-5-第三-丁氧羰基胺基-2-苯基乙炔基-苯氧基)_醋酸第 三-丁酯 根據一般程序L (方法b),經由以SnCl2 · 2Η2 0 (3.18克,14.10 毫莫耳)之還原作用,製自(5-第三-丁氧羰基胺基-4-硝基-2-苯 基乙炔基-苯氧基)-醋酸第三丁酯(實例Κ13)(1.32克,2.82毫 莫耳)。獲得非晶質橘色物質(1.2克)。 MS (ISP) 439 [(Μ+Η)+ ]與 461 [(M+Na)+ ]。 實例L17 (2-胺基-5-氰基甲基-4-苯基乙炔基-苯基)-胺甲基酸第三-丁酯 根據一般程序L (方法b),經由以SnCl2 · 2H20 (1.13克,5.0 毫莫耳)之還原作用,製自(5-氰基甲基-2-硝基-4-苯基乙炔基_ 苯基)-胺甲基酸第三-丁酯(實例K17)(377毫克,1_〇毫莫耳)。 -71 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ----:--------- I I (請先閱讀背面之注意事項再6本頁) 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明(69) 獲得橘色固體(338毫克)。 MS (ISP) 348 [(M+H)+ ]與 37〇 [(M+Na)+ ];、]:容點 143°C。 實例L18 [2-胺基-5-(1,4·二氧-8-氮·螺[4.5]癸-8-基)-4-苯基乙炔基-苯基]-胺 甲基酸第三-丁酯與[2-胺基-5-(4,4-二乙氧基-六氫吡啶小基)-4-苯基乙炔基-苯基]-胺曱基酸第三-丁酯 根據一般程序L (方法b),經由以SnCl2 · 2H2 0 (4.0克,18.0 毫莫耳)之還原作用,在EtOH中,製自[5-(1,4-二氧-8-氮-螺[4.5] 癸-8-基)-2-硝基-4-苯基乙炔基-苯基]_胺甲基酸第三·丁酯(實 例Κ7)(1·73克,3.6毫莫耳)。個別獲得褐色固體(418毫克)與 深褐色固體(379毫克)。 MS (ISP) 450 [(Μ+Η)+ ];熔點 79-82°C ; MS (ISP) 480 [(Μ+Η)+ ]。 實例L19 [2_胺基-5-(1,1-二酮基-6-硫代嗎福啉_4-基)-4-苯基乙炔基-苯基]-胺甲基酸第三-丁酯 根據一般程序L (方法1)),經由以311&lt;1;12*2112〇(564毫克, 2.5毫莫耳)之达原作用’製自[5_(丨,1_二g同基-硫代嗎福淋-4-基) -2-硝基-4-苯基乙块基-苯基]-胺甲基酸第三-丁酯(實例Κ6)(235 毫克,0.5毫莫耳)。獲得褐色固體(418毫克,不純物質,直 接使用於實例6中,無需純化及特徵鑒定)。 實例L20 [2-胺基-5-(2,2-二甲基-[1,3]二氧伍圜基甲氧基)-4-苯基乙炔基 -苯基]-胺甲基酸第三-丁 g旨 根據一般程序L (方法b),經由以SnCl2 · 2Η2 Ο (4.6克,20.32 -72- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公餐) J.II.卜---------裝--- (請先閱讀背面之注意事項再¥本頁) 線 經濟部智慧財產局員工消費合作社印製V. INSTRUCTIONS (65) - Aminomethyl 3-butyrate (Example K2) (741 mg, 21 mmol). Obtained as a pale brown solid (419 mg). MS (ISP) 323 [(M+H)+]; melting point 172-173 °C. Example L5 [2-Amino-5-(4-methyl-hexahydropyridinyl)-4-phenylethynyl-phenyl]-amino acid tert-butyl ester according to the general procedure L (method b ), by reduction with SnCl 2 ·2Η2Ο (2,820 g, 12.4 mmol), from [5_(4-methyl-hexahydropyrazine)&gt;2_nitro-4-phenylethynyl- Phenyl]-amine methyl acid, third butyl ester (example Κ3χ1〇8 g, 2.48 mmol). Obtained an orange solid (1 g) MS (ISP) 407 [(M+H)+]; Melting point 81-85 Ό. Example L6 (5-Amino-2-chloro-biphenyl-4-yl)-amine methyl acid tert-butyl ester according to the general procedure L (method b), via SnCl2 · 2H2 0 Reduction of (2.53 g, 11.2 mmol) from (2-chloro-5-nitro-biphenyl-4-yl)-amine methyl acid tert-butyl ester (Example Fl) (783 </ RTI> </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; 2-Methyl-biphenyl-4-yl)-amine mercapto acid tert-butyl ester according to the general procedure L (method a), via catalytic hydrogenation with Pd/C, from (2-methyl-5) -nitro-biphenyl-4-yl)-aminomethyl Third-butyl ester (Example F2) (921 mg, 2.8 mmol) obtained as a white solid (796 mg). MS ( s) 298 ( Μ+); melting point 122 ° C. -68- Applicable to China National Standard (CNS) A4 specification (210 X 297 mm) ----U----------Install i I (please read the precautions on the back page again) · --Line _ Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 A7 B7 V. Description of Invention (66) Example L8 [2-Amino-5-(2-diamino-ethylthio)_'phenylethynyl- Phenyl]-aminomethyl acid tert-butyl ester was prepared according to the general procedure L (method b) by reduction with SnCl 2 · 2H 2 0 (1.41 g, 6.25 mmol) from [5-(2-) Methylamino-ethylthio)-2-nitro-4-phenylethynyl-phenyl]-amine methyl acid tert-butyl ester (Example K8) (551 mg, 1.25 mmol). Color foam (51 mg) MS (ISP) 412 [(M+H)+]; mp. 115-117 ° C. Example L9 (4-amino-5-tri-butoxycarbonylamino-2- _Phenylethynyl-phenylthio)-acetic acid methyl ester according to the general procedure L (method b), via SnCl2 · 2Η2 Ο (1.62 g, 7.16 mmol) Effect, prepared from (5-tertiary - butoxycarbonyl-amino-4-nitro-2-phenyl-ethynyl - phenylthio) acetate (Example Κ9) (634 mg, 1.43 mmol). Obtained orange gum (590 mg). MS (ISP) 413 [(Μ+Η)+ ], 435 [(M+Na)+ ] and 451 [(Μ+Κ)+ ]. Example L10 (4-Amino-5-tris-butoxyamino-2-phenylethylidene-phenyl)-acetic acid methyl hydrazine according to the general procedure L (Method b), via SnCl2 · 2Η2 Reduction of hydrazine (3.00 g, 13.28 mmol) from (5-tris-butoxycarbonylamino-4-nitro-2-phenylethynyl-phenyl)-decyl acetate (example K16) ) (1.09 g, 2.66 mmol). Obtained as a pale yellow solid (900 mg). MS (ISP) 381 [(M+H)+] and 403 [(M+Na)+]; (:. Example L11 [2-Amino-5-(2-methoxy-ethoxy]&lt;4-phenylethynyl-phenyl]-amine methyl acid No. -69- This paper scale applies to China Standard (CNS) A4 specification (210 X 297 mm) ----K----------Install--- (Please read the note on the back again - this page) Order - : Line · Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 A7 B7 V. INSTRUCTIONS (67) Tri-butyl ester was reduced according to the general procedure L (method b) by SnCl2 · 2H2 〇 (3.88 g, 17.2 mmol) Effect, prepared from [5-(2-methoxy-ethoxy)-2-nitro-4-phenylethynyl-phenyl]-amine methyl acid tert-butyl ester (Example Κ 10) (1.417克, 3·44 mmol. Obtained as an off-white solid (1.04 g). MS (El) 382 ( Μ+); mp l -5-l 〇 7 ° C. Example L12 (2-Amino-5-? Folinac-4-yl-4-phenylethynyl-phenyl)-amine methyl acid, the third-butyr, according to the general procedure L (method b), via SnCl2 · 2Η2 Ο (1.5 g, 6.65 mmol) Reducing effect, prepared from (5-morpholine)-2-amino-phenylphenylethynyl-phenyl)-aminomethyl acid tert-butyl ester (example K4) (563 mg , </ RTI> </ RTI> </ RTI> </ RTI> </ RTI> </ RTI> </ RTI> </ RTI> </ RTI> <RTIgt; 4-Phenylethynyl-phenyl)-amine methyl acid tert-butyl ester was prepared according to the general procedure L (Method b) by reduction with SnCl 2 · 2Η2 Ο (3.06 g, 13.57 mmol). From (5-methoxy-2-nitro-4-phenylethynyl-phenyl)-amine methyl acid tert-butyl ester (Example Κ 11) (1·00 g, 2.71 mmol). Yellow solid (870 mg) MS (EI) 338 (M+); mp 158 ° C. Example L14 4-amino-5-tris-butyl- succinylamino-2-ethylidene-benzoic acid The hydrazine was prepared according to the general procedure L (method b) by reduction with SnCl 2 · 2H 2 0 (2.15 g, 9.51 mmol) from (5-tris-butoxycarbonylamino-4-nitro- 2-Benzene-70- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) -------------- Pack--- (Please read the back of the note first) Matters again page) π·! Line· Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 1255266 A7 _____B7__ V. Invention description (68) Ethynylidene-benzoic acid methyl ester (Example K15) (754 mg, 丨·^ mmol). A pink solid (431 mg) was obtained. MS (EI) 366 (M+); mp. 164. Example L15 [2-Amino-5-(2-{2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxy ethoxy]&gt; 4-phenylethynyl Phenyl]-aminomethyl acid tert-butyl ester was prepared according to the general procedure L (method b) by reduction with SnCl 2 · 2H 2 0 (6.2 g, 27.54 mmol) from [5-(2-{ 2-[2-(2-methoxy-ethoxy)-ethoxy]-ethylidyl}-ethoxy)-2-nitro-4-phenylethylidene-phenyl]-amine Methyl acid tert-butyl ester (Example K12) (3.0 g, 5.51 mmol). Obtained brown oil (2·9 g). MS (ISP) 515 [(Μ+Η)+]. Example L16 (4) -Amino-5-tris-butoxycarbonylamino-2-phenylethynyl-phenoxy)-acetic acid tert-butyl ester according to the general procedure L (method b), via SnCl2 · 2Η2 0 (3.18克, 14.10 mmol, reduction from (5-tris-butoxycarbonylamino-4-nitro-2-phenylethynyl-phenoxy)-acetic acid tert-butyl ester (Example Κ13 (1.32 g, 2.82 mmol). Obtained amorphous orange material (1.2 g) MS (ISP) 439 [(Μ+Η)+] and 461 [(M+Na)+]. Example L17 ( 2-amino-5-cyanomethyl-4-phenylethynyl-phenyl)-amine methyl acid -Butyl ester was prepared according to the general procedure L (Method b) by reduction with SnCl2 · 2H20 (1.13 g, 5.0 mmol) from (5-cyanomethyl-2-nitro-4-phenylacetylene) Base _ phenyl)-amine methyl acid third-butyl ester (Example K17) (377 mg, 1 〇 millimolar) -71 - This paper scale applies to China National Standard (CNS) A4 specification (210 X 297) ----)---------- II (Please read the notes on the back and then 6 pages) Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 1255266 A7 B7 V. Invention description (69 Obtained an orange solid (338 mg) MS (ISP) 348 [(M+H)+] and 37 〇[(M+Na)+];,]: 143 ° C. Example L18 [2-amine 5-(1,4.dioxa-8-nitrospiro[4.5]dec-8-yl)-4-phenylethynyl-phenyl]-amine methyl acid tert-butyl ester and [2 -Amino-5-(4,4-diethoxy-hexahydropyridine small)-4-phenylethynyl-phenyl]-amine mercapto acid tert-butyl ester according to the general procedure L (Method b ), by reduction with SnCl 2 · 2H 2 0 (4.0 g, 18.0 mmol), in EtOH, from [5-(1,4-dioxo-8-nitro-spiro[4.5] 癸-8- 2-nitro-4-phenylacetylene - phenyl] _ acid tert Butyl (Examples Κ7) (1 · 73 g, 3.6 mmol). Individually obtained brown solid (418 mg) and dark brown solid (379 mg). MS (ISP) 450 [(Μ+Η)+]; m.p. 79-82°C; MS (ISP) 480 [(Μ+Η)+]. Example L19 [2-amino-5-(1,1-dione-6-thiomorpholine-4-yl)-4-phenylethynyl-phenyl]-amine methyl acid third- Butyl ester is prepared according to the general procedure L (method 1)) from [5_(丨,1_二格同基- by the action of 311 &lt;1;12*2112〇(564 mg, 2.5 mmol) Thiofuron-4-yl)-2-nitro-4-phenylethylidene-phenyl]-amine methyl acid tert-butyl ester (Example Κ6) (235 mg, 0.5 mmol) . Obtained as a brown solid (418 mg, imp., used directly in Example 6 without purification and characterization). Example L20 [2-Amino-5-(2,2-dimethyl-[1,3]dioxoindolylmethoxy)-4-phenylethynyl-phenyl]-aminemethyl acid The three-buter g is based on the general procedure L (method b), via SnCl2 · 2Η2 Ο (4.6 g, 20.32 -72- this paper scale applies the Chinese National Standard (CNS) A4 specification (210 X 297 public meals) J.II . Bu---------Install--- (Please read the notes on the back and then on this page) Printed by the Department of Intellectual Property of the Intellectual Property Department of the Ministry of Economic Affairs

1255266 五、發明說明(70) 愛莫耳)之還原作用,製自(叫[5似二曱基仰]:氧伍園斗 基曱氧基)-2-硝基斗苯基乙炔基_苯基]_胺甲基酸第三-丁酯( 實例Β8)(1·90克,4.06毫莫耳)。經由與2,2_二甲氧基丙烷(5毫 升)及對_Ts〇H· H2〇(U當量)在DMF(5毫升)中,於2yC下攪 拌4小時,使粗產物再保護。獲得褐色固體(11克)。 MS (ISP) 439 [(M+H)+ ],461 [(M+Na)+ ]及 477 [(M+K)+ ]。 實例L21 4-胺基-5-第三-丁氧羰基胺基-2-碘-苯甲酸甲酉旨 根據一般程序L (方法b),經由以SnCl2 · 2Η2 Ο (8_02克,35.55 愛莫耳)之還原作用,製自5-第三-丁氧羰基胺基碘基-4-硝 基-苯甲酸甲酯(實例Β3)(3·00克,7.11毫莫耳)。獲得淡紅色 泡末物(1.9克)。 MS (ISP) 393 [(Μ+Η)+ ];熔點 60-78°C。 實例L22 [RS]-[2-胺基-5-(2-酮基-[1,3]二氧伍圜-4-基甲氧基)-4-苯基乙決基 -苯基]-胺甲基酸第三-丁酯 根據一般程序L (方法b),經由以SnCl2 · 2Η2 Ο (1.02克,4.5 毫莫耳)之還原作用,製自[RS]-[2-硝基-5-(2-酮基-[1,3]二氧伍 圜-4-基甲氧基)斗苯基乙炔基-苯基]-胺甲基酸第三-丁酯[RO-68-8108/000 (411毫克,0.9毫莫耳),經由以1,Γ-羰基二咪唑, 在THF中,於0至23°C下處理,製自(rs)-[5-(2,3-二羥基-丙氧 基)-2-硝基-4-苯基乙块基-苯基]-胺甲基酸第三-丁酯(實例K18)] 。獲得杏色固體(370毫克)。 MS (ISP) 425 [(M+H)+];熔點 140°C。 -73- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ----^---------裝--- (請先閱讀背面之注意事項再頁) 訂· Φ 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 經濟部智慧財產局員工消費合作社印製 五、發明說明(71) 實例L23 (2-胺基-5-乙氧基甲基-4-苯基乙炔基·苯基)_胺甲基酸第三-丁酯 根據一般程序L (方法b),經由以snCl2 · 2H2〇之還原作用 ,製自碳酸5-第三-丁氧羰基胺基-4-硝基-2-苯基乙块基-爷基 酯甲酯[RO-68-8481/000,製自(5邊甲基-2-硝基-4-苯基乙炔基-苯基)-胺甲基酸第三-丁酯(實例K19),經由以氣甲酸甲酯及 Et3N,在THF中,於0°C下處理]。獲得非晶質褐色物質(139 毫克)。 MS (ISP) 367 [(M+H)+]。 實例L24 2,2-二甲基-丙酸4-胺基-5-第三-丁氧羰基胺基苯基乙炔基一 芊酯 根據一般程序L (方法b),經由以SnCl2 · 2H2 0之還原作用 ,製自2,2-二甲基-丙酸5-第三-丁氧羰基胺基冰硝基-2-苯基乙 块基-爷酯[RO-68-9779/000,製自(5-#甲基-2-硝基-4-苯基乙块 基-苯基)-胺甲基酸第三-丁 @旨(實例K19),經由以氯化三曱基 乙酿及觸媒DMAP,在p比淀中,於〇至23°C下處理]。獲得非 晶質黃色物質(182毫克)。 MS(ISN)421 [(M-Η)-]。 實例L25 (RS)-[2-胺基-4-苯基乙炔基-5-(四氫-喊喃-2-基氧基甲基)_苯基]_ 胺甲基酸第三-丁酯 根據一般程序L (方法b),經由以SnCl2 · 2H,0之還原作用 ’製自(RS)-[2-硝基-4-苯基乙炔基-5-(四氫-喊喃-2-基氧基甲基)_ -74- ----^----------裝--- (請先閱讀背面之注意事項本頁) Φ 訂: --線- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266 經濟部智慧財產局員工消費合作社印製 A7 B7 五、發明說明(72)1255266 V. Description of invention (70) Amol's reduction, produced from (called [5 like 曱 曱 仰]: Oxygen 斗 曱 曱 曱) oxy) 2-nitro phenyl ethynyl benzene Base]-Aminomethyl-tert-butyl ester (Example Β8) (1·90 g, 4.06 mmol). The crude product was reprotected by stirring with 2,2-dimethoxypropane (5 mL) and _Ts s H H2 (U eq.) in DMF (5 mL) at EtOAc. A brown solid (11 g) was obtained. MS (ISP) 439 [(M+H)+ ], 461 [(M+Na)+ ] and 477 [(M+K)+ ]. Example L21 4-Amino-5-t-butoxycarbonylamino-2-iodo-benzoic acid formazan according to the general procedure L (Method b), via SnCl2 · 2Η2 Ο (8_02 g, 35.55 Amor The reduction was carried out from methyl 5-tris-butoxycarbonylaminoiodo-4-nitro-benzoate (Example Β3) (3.00 g, 7.11 mmol). A light red bubble (1.9 g) was obtained. MS (ISP) 393 [(Μ+Η)+]; mp 60-78 °C. Example L22 [RS]-[2-Amino-5-(2-keto-[1,3]dioxoindol-4-ylmethoxy)-4-phenylethyl-phenyl]- Aminomethyl acid tert-butyl ester was prepared from [RS]-[2-nitro-5 by reduction with SnCl2 · 2Η2 Ο (1.02 g, 4.5 mmol) according to the general procedure L (Method b) -(2-keto-[1,3]dioxoindol-4-ylmethoxy)-phenylphenylethynyl-phenyl]-amine methyl acid tert-butyl ester [RO-68-8108/ 000 (411 mg, 0.9 mmol), prepared from (rs)-[5-(2,3-dihydroxy) by treatment with 1, fluorene-carbonyldiimidazole in THF at 0 to 23 °C. -propoxy)-2-nitro-4-phenylethylidene-phenyl]-amine methyl acid tert-butyl ester (Example K18)]. Obtained an amber solid (370 mg). MS (ISP) 425 [(M+H)+]; mp. -73- This paper size is applicable to China National Standard (CNS) A4 specification (210 X 297 mm) ----^---------Installation--- (Please read the back note first. ) · Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 A7 B7 Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 5, Invention Description (71) Example L23 (2-Amino-5-ethoxymethyl- 4-Phenylethynylphenyl)-amino acid tert-butyl ester was prepared from the 5-carbonate-butoxycarbonyl group by reduction with snCl 2 · 2H 2 oxime according to the general procedure L (method b). Amino-4-nitro-2-phenylethylidene-yl ester methyl ester [RO-68-8481/000, made from (5-mole methyl-2-nitro-4-phenylethynyl- Phenyl)-aminomethyl acid tert-butyl ester (Example K19) was treated with methyl formate and Et3N in THF at 0 °C. Amorphous brown material (139 mg) was obtained. MS (ISP) 367 [(M+H)+]. Example L24 2,2-Dimethyl-propionic acid 4-Amino-5-tris-butoxycarbonylaminophenylethynyl-monodecyl ester according to the general procedure L (Method b), via SnCl 2 · 2H 2 0 Reduction, from 2,2-dimethyl-propionic acid 5-tris-butoxycarbonylamine-based nitro-2-phenylethylidene-yl ester [RO-68-9779/000, made from (5-#methyl-2-nitro-4-phenylethylidene-phenyl)-amine methyl acid third-buty@ (example K19), via trichlorinated chloride The media DMAP was treated at p to 23 ° C in p-precipitate. A non-crystalline yellow material (182 mg) was obtained. MS (ISN) 421 [(M-Η)-]. Example L25 (RS)-[2-Amino-4-phenylethynyl-5-(tetrahydro-pyran-2-yloxymethyl)-phenyl]-aminomethyl acid tert-butyl ester According to the general procedure L (method b), from (RS)-[2-nitro-4-phenylethynyl-5-(tetrahydro-pyran-2-) via reduction with SnCl2 · 2H,0氧基oxymethyl)_ -74- ----^---------- Pack--- (Please read the back note on this page first) Φ Order: --Line - Paper size Applicable to China National Standard (CNS) A4 specification (210 X 297 mm) 1255266 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed A7 B7 V. Invention description (72)

苯基]-胺甲基酸第三-丁酯[RO-69-2829/000,製自(5-羥甲基-2-硝基-4-苯基乙炔基-苯基胺甲基酸第三-丁酯(實例K19),經 由以3,4-二氫-2H-哌喃及觸媒Ts〇H · H2 0,在DCM中,於CTC 下處理]。獲得黃色固體(1.78克)。 MS (ISN) 421 [(Μ-ΗΠ ;熔點 158°C。 實例L26 [2-胺基-5-(4-甲氧基-六氫吡啶小基)冰苯基乙炔基-苯基]-胺甲 基酸第三-丁酯 根據一般程序L (方法b),經由以SnCl2 · 2H2 0之還原作用 ’製自[5-(4-甲氧基-六氫吡啶-1-基)-2-硝基-4-苯基乙炔基-苯基] -胺甲基酸第三-丁酯(實例K20)(727毫克,1.61毫莫耳)。獲得 黃色固體(489毫克)。 MS (ISP) 422 [(M+H)+];熔點 173-176°C。 實例L27 (2-胺基-5-氰基甲氧基-4-苯基乙炔基-苯基)_胺甲基酸第三-丁酯 根據一般程序L (方法b),經由以SnCl2 · 2H2 0之還原作用 ,製自(5-氰基甲氧基-2-硝基-4-苯基乙块基-苯基)_胺甲基酸 第三-丁酯(實例K21)(395毫克,0.91毫莫耳)。獲得非晶質黃 色物質(219毫克)。 MS (ISP) 364 [(M+H)+ ] 〇 實例L28 (RS)-[2-胺基-4-(4-氟苯基乙決基)-5-(四氫^辰喃_2-基氧基甲基)-苯基]胺甲基酸第三-丁酯 根據一般程序L (方法b),經由以SnCl2 · 2Η2 Ο之還原作用 -75- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ---3^. (請先閱讀背面之注意事項再本頁) 言Phenyl]-aminomethyl acid tert-butyl ester [RO-69-2829/000, made from (5-hydroxymethyl-2-nitro-4-phenylethynyl-phenylamine methyl acid) Tri-butyl ester (Example K19) was treated with 3,4-dihydro-2H-pyran and catalyst Ts 〇 H.H.sub.2 in DCM in DCC. MS (ISN) 421 [(Μ-ΗΠ ; mp 158 ° C. Example L26 [2-amino-5-(4-methoxy-hexahydropyridinyl) phenylphenylethynyl-phenyl]-amine The third-butyl methacrylate was prepared from [5-(4-methoxy-hexahydropyridin-1-yl)-2- via the reduction of SnCl 2 · 2H 2 0 according to the general procedure L (Method b). Tri-butyl nitro-4-phenylethynyl-phenyl]-aminemethyl acid (Example K20) (727 mg, 1.61 mmol). [(M+H)+]; melting point 173-176 ° C. Example L27 (2-amino-5-cyanomethoxy-4-phenylethynyl-phenyl)-amine methyl acid third - Butyl ester is prepared according to the general procedure L (method b) from (5-cyanomethoxy-2-nitro-4-phenylethylidene-phenyl)-amine via reduction with SnCl 2 · 2H 2 0 Methyl acid third-butyl ester (example K21) (395 mil , 0.91 mmol, obtained amorphous yellow material (219 mg). MS (ISP) 364 [(M+H)+] 〇 Example L28 (RS)-[2-Amino-4-(4-fluoro Phenylethyl)-5-(tetrahydro^chen-2-yloxymethyl)-phenyl]aminomethyl acid tert-butyl ester according to the general procedure L (method b), via SnCl2 2Η2 还原Reduction -75- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) ---3^. (Please read the back note before this page)

1255266 A7 B7 五、發明說明(73) ----Γ---------裝i I (請先閱讀背面之注意事項再^r本頁) ’製自(RSH4-(4·氟苯基乙決基)-2-硝基-5-(四氫-哌喃-2-基氧基 甲基)-苯基]-胺甲基酸第三_ 丁酯[R〇_69_3877/〇〇〇,製自[心(I氟 苯基乙块基)-5-經甲基冬硝基-苯基]-胺甲基酸第三·丁酯(實1255266 A7 B7 V. Invention description (73) ----Γ---------Install i I (please read the precautions on the back and then ^r page) 'Manufactured from (RSH4-(4· Fluorophenylethyl)-2-nitro-5-(tetrahydro-pyran-2-yloxymethyl)-phenyl]-amine methyl acid third-butyl ester [R〇_69_3877/ 〇〇〇, made from [heart (I fluorophenylethyl)-5-methyl-methyl nitro-phenyl]-amine methyl acid, third butyl ester (real

例K22),經由以3,4_二氫-2H-哌喃及觸媒TsOH · H2〇,在DCM 中,於o°c下處理]。獲得非晶質淡褐色物質(99〇毫克)。 MS (ISP) 441 [(M+H)+ ]。 實例L29 (RSM2-胺基-4-(4-氟苯基乙炔基)_5_{甲基-[2_(四氫_哌喃基氧 基)·乙基]-胺基}-苯基)-胺甲基酸第三-丁酯 根據一般程序L (方法b),經由以SnCl2 · 2H2 0之還原作用 ,製自(RS)-(4-(4-氟冬基乙块基)_5-{甲基-[2-(四氫-喊喃-2-基氧 基)-乙基]-胺基}-2-硝基-苯基)_胺甲基酸第三-丁酯(實例 K23)(1.79克,3.49毫莫耳)。獲得非晶質淡褐色物質(12〇克)。 MS(ISP)484 [(M+H)+]。 實例L30 -·線- (RS)-{2-胺基-4-苯基乙炔基-5-〇(四氫4喃基氧基)-乙氧基]_ 苯基}-胺曱基酸第三·丁酉旨 經濟部智慧財產局員工消費合作社印製 根據一般程序L (方法b),經由以SnCl2 · 2H2〇之還原作用 ,製自(RS)-{2-硝基-4-苯基乙块基_5-[2-(四氫4喃-2-基氧基)_ 乙氧基]-苯基卜胺甲基酸第三-丁酯(實例K24)(42〇毫克,〇 87 毫莫耳)。獲得淡褐色固體(346毫克)。 MS(ISP) 453 [(Μ+Η)+]。 實例L31 (RS)-{5-胺基-4’-轨基-2-[4-(四氫-喊喃-2-基氧基)-六氫ρ比咬-1-基]_ -76- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266 A7 B7 五、發明說明(74) 聯苯基-4-基]-胺甲基酸第三-丁酯 根據一般程序L (方法a),經由以Pd/C之催化氫化作用, 製自(RS)-{4f-氟基-5-硝基-2-[4-(四氫-旅喃-2-基氧基)-六氫p比咬-1-基]-聯苯基冰基}-胺甲基酸第三-丁醋(實例F3)(845毫克, 1.64毫莫耳)。獲得淺綠色固體(758毫克)。 MS (ISP) 486[(M+H)+];熔點 157-161Ό。 實例L32 [2-胺基-5-(2-第三-丁氧基-乙氧基)-4-(4-氟苯基乙炔基)-苯基]-胺 甲基酸第三-丁酯 根據一般程序L (方法b),經由以SnCl2 · 2H2 0之還原作用, 製自[5-(2-第三-丁氧基-乙氧基)_4_(4-氟苯基乙決基&gt;2-硝基-苯 基]-胺曱基酸第三-丁酯(實例K25)(744毫克,1.57毫莫耳)。 獲得淡黃色固體(575毫克)。MS (ISP) 443 [(M+H)+ ];熔點149-15CTC 〇 實例L33 (RS)-(5-胺基-4’-氟基-2-{4-〇(四氫4喃-2-基氧基)-乙氧基]•六氫 p比呢-1-基}-聯苯基-4-基)-胺甲基酸第三-丁酯 根據一般程序L (方法a),經由以Pd/C之催化氫化作用, 製自(RS)-(4f-氟基士硝基-2_{4-[2-(四氫喃冬基氧基 &gt; 乙氧基&gt; 7T氫p比呢-l-基}-聯苯基冰基 &gt;胺甲基酸第三_丁酯(實例F4)(9〇〇 毫克,1.61毫莫耳)。獲得淡褐色泡沫物(779毫克)。 MS (ISP) 530[(M+H)+];熔點 56-58°C。 實例L34 (RS)-[5-胺基|氟基冬(四氫4喃-2-基氧基甲基)_聯苯基_4_基]- -77- 本Λ張尺度週用T國國豕標準(CNS)A4規格(210 X 297公釐) ——!/----------裝—— (請先閱讀背面之注意事項本頁) · •線· 經濟部智慧財產局員工消費合作社印製 1255266 經濟部智慧財產局員工消費合作社印製 A7 B7 五、發明說明(75) 胺甲基酸第三-丁酯 根據一般程序L (方法b),經由以SnCl2 · 2H?〇之還原作用 ,製自(RS)-[4’_氟基-5-硝基-2-(四氫-嗓喃-2-基氧基甲基)-聯苯基 -4-基]-胺甲基酸第三-丁酯(實例F5)。獲得橘色固體(1.15克)。 熔點 139-142°C。 實例L35 (5-胺基-2-氰基甲氧基-4’-氟-聯苯基-4-基)-胺甲基酸第三-丁酉旨 根據一般程序L (方法b),經由以SnCl2 · 2H2 0之還原作用 ’製自(2-氧基甲氧基-4^氟基-5-硝基-聯苯基-4-基)-胺甲基酸 第三-丁酯(實例F6)(310毫克,0.8毫莫耳)。獲得淡褐色固體 (220毫克)。 MS (ISN) 356 [(M-H)-];熔點 118-119。(:。 實例L36 (5-胺基-2-二甲胺基甲基-4f-氟基·聯苯基-4-基)_胺甲基酸第三-丁酯 根據一般程序L (方法b),經由以SnCl2 · 2Η2 Ο之還原作用 ,製自(2-二甲胺基甲基-4’-氟-5-硝基-聯苯基冬基)-胺甲基酸 第三-丁酯(實例F7)。獲得黃色固體(9〇8毫克)。 熔點 97-125°C。 實例L37 [5-胺基-2-(2,2-二甲基-四氫-[1,3]二氧伍圜幷[4,5-c]p比咯-5-基)-4f- 氣-聯私基-4-基]-胺甲基酸弟三-丁酉旨 根據一般程序L (方法a),經由以pd/c之催化氫化作用, 製自[2-(2,2-二甲基-四氫-[1,3]二氧伍圜幷[4,5_c]吡咯基心氟 -78- 本紙張尺度適用令國國家標準(CNS)A4規格(210 X 297公釐) ----,----------裝 i I (請先閱讀背面之注意事項本頁) 訂: --線· 1255266 A7 B7 五、發明說明(76) 基-5-硝基聯苯基冰基]-胺甲基酸第三_丁酯(實例F8^1〇毫克 ’ 1.29耄莫耳)。獲得灰白色泡沫物(578毫克)。 (請先閱讀背面之注意事項本頁) MS (ISP) 444 [(M+H)+ ]。 實例L38 (5-胺基-4’-氟基-2-甲氧基-聯苯基冰基)-胺甲基酸第三-丁酯 根據一般程序L (方法a),經由以pd/c之催化氫化作用, 製自(4-氟基-2-甲氧基-5-石肖基-聯苯基_4·基)_胺甲基酸第三_丁 醋(實例F9)(2.64克,7.29毫莫耳)。獲得灰白色固體(2.36克)。 MS (ISP) 333 [(M+H)+ ];熔點 155°C (分解)。 實例L39 〇胺基-2-(l,4-二氧-8-氮-螺[4.5]癸各基)-4,-氟-聯苯基-4-基]-胺甲 基酸第三-丁酯 根據一般程序L (方法a),經由以Pd/C之催化氫化作用, 製自[2-(1,4-二氧-8-氮-螺[4.5]癸-8-基)-4’-氟基-5-硝基-聯苯基-4- 基]-胺甲基酸第三-丁酯(實例F10)(2.4克,5·0毫莫耳)。獲得 綠色固體(2.37克)。 MS(ISP)444 [(M+H)+]。 實例L40 經濟部智慧財產局員工消費合作社印製 (5-胺基-4’-氟基-2-甲基-聯苯基基)-胺甲基酸第三_丁酉旨 根據一般程序L (方法a),經由以Pd/C之催化氫化作用, 製自(4’-氟基-2-甲基-5-硝基-聯苯基-4-基)-胺甲基酸第三-丁酉旨( 實例Fll)(560毫克,1.62毫莫耳)。獲得淡褐色固體(512毫克)。 MS (ISP) 317 [(M+H)+];熔點 112°C。 實例L41 -79- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266 A7 B7 五、發明說明(77) (5-胺基-4-第三-丁氧羰基胺基-4,-氟-聯苯基-2-基氧基)-醋酸第 三-丁酯 根據一般程序L (方法a),經由以Pd/C之催化氫化作用, 製自(4-第三-丁氧羰基胺基-心氟-5-硝基-聯苯基-2-基氧基)_醋 酸第三-丁酯(實例F12)(2.29克,4.95毫莫耳)。獲得深藍色固 體(2.14 克)。 MS (ISP) 433 [(M+H)+ ];熔點 30-33°C。 實例L42 (5-胺基-2-氣基砟-氟-聯苯基-4-基)-胺甲基酸第三-丁酯 根據一般程序L (方法b),經由以SnCl2 · 2H2 0之還原作用 ,製自(2-氣基-4'-氟基-5-硝基-聯苯基斗基)-胺甲基酸第三-丁 酯(實例F13)。獲得淡紅色固體(544毫克)。 MS(ISP) 337 [(M+H)+]。 實例L43 [5-胺基-4’-氟基-2-(2-甲氧基-乙氧基)-聯苯基4-基]-胺甲基酸第 三-丁酯 根據一般程序L (方法a),經由以pd/c之催化氫化作用, 製自[4’-氟基-2-(2-甲氧基-乙氧基)-5-確基-聯苯基-4-基]-胺甲基 酸第三-丁酯(實例F14)。獲得淡褐色固體(1.652克)。 MS(ISP) 377 [(M+H)+]。 實例L44 [5-胺基-2-(2-第三-丁氧基-乙氧基&gt;4’-氟·聯苯基-4-基]-胺甲基酸 第三··丁酯 根據一般程序L (方法a),經由以pd/c之催化氫化作用, -80- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ----r---------裝--- (請先閱讀背面之注意事項再本頁) · •線· 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明(78) ----P--I--- - - I I (請先閱讀背面之注意事項本頁) 製自[2-(2-第三-丁氧基-乙氧基)冬氟-5-硝基-聯苯基_4-基]-胺甲 基酸第三·•丁酯(實例F15)。獲得紫色固體(547毫克)。 MS (ISP) 419 [(M+H)+ ];熔點 133°C (分解)。 實例L45 [5-胺基-41-氟基_2-(2-酮基^号唑淀-3-基)_聯苯基4-基]-胺甲基酸 第三-丁酯 根據一般程序L (方法a),經由以Pd/c之催化氫化作用, 製自[4^氟基-5-硝基-2_(2-酮基j号唾淀-3-基)-聯苯基-4-基]-胺甲 基酸第三-丁酯(實例F16)(280毫克,〇·67毫莫耳)。獲得黃色 固體(277毫克)。 MS (ISP) 388 [(M+H)+ ];熔點 210°C。 實例L46 (5-胺基-4’-氟基-2-甲氧基-2’-甲基-聯苯基-4-基)-胺甲基酸第三_ 丁酉旨 --線_ 根據一般程序L (方法a),經由以Pd/C之催化氫化作用, 製自(4f-氟基-2-甲氧基-2'-甲基-5-硝基-聯苯基-4-基)-胺甲基酸 第三-丁酯(實例FH)。獲得褐色固體(588毫克)。 MS(ISP) 347 [(M+H)+]。 經濟部智慧財產局員工消費合作社印製 實例L47 (5-胺基-2-第三-丁氧基-4f-氟-聯苯基-4-基)-胺甲基酸第三·丁 @旨 根據一般程序L (方法a),經由以Pd/C之催·化氫化作用, 製自(2-第二-丁氧基-4'-氟基-5-硝基-聯苯基-4-基)-胺甲基酸第 •三-丁酯(實例F18)(1.15克,2.84毫莫耳)。獲得粉紅色固體 (747毫克)。 -81 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266 A7 B7 五、發明說明(79) MS (ISP) 375 [(M+H)+];熔點 139°C。 實例L48 ----:----------裝—— (請先閱讀背面之注意事項本頁) (5-胺基-2-第三-丁氧基-2,-氟-聯苯基-4-基)-胺甲基酸第三-丁酯 根據一般程序L (方法a),經由以Pd/C之催化氫化作用, 製自(2-第三-丁氧基-2’-氟基-5-硝基-聯苯基-4-基)-胺甲基酸第 二-丁酯(實例F19)(930毫克,2.3毫莫耳)。獲得粉紅色固體 (649毫克)。 MS (ISP) 375 [(M+H)+ ];熔點 13(TC。 實例L49 (RS)-{5-胺基-4’-氟基-2-[(R)-3-(四氫-哌喃-2-基氧基)-四氫吡咯小 基]-聯苯基冰基}-胺甲基酸第三-丁酯 根據一般程序L (方法a),經由以Pd/C之催化氫化作用, 製自(RS)-{4,-氟基-5-硝基-2-[(R)-3_(W氫-成喃-2-基氧基)-四氫吡 咯小基]-聯苯基-4-基}-胺甲基酸第三-丁酯(實例F20)。獲得深 綠色固體(852毫克)。 --線- MS (ISP) 472 [(M+H)+ ]。 實例L50 經濟部智慧財產局員工消費合作社印製 (5-胺基氟基-2-甲氧基-聯苯基-4-基)-胺甲基酸第三-丁酯 根據一般程序L (方法a),經由以Pd/C之催化氫化作用, 製自(2’-氟基-2-甲氧基-5-硝基-聯苯基-4-基)-胺甲基酸第三-丁 酯(實例F21)(649毫克,1.79毫莫耳)。獲得淡褐色固體(352毫 克)。 MS (ISP) 333 [(M+H)+];熔點 161°C。 實例L51 -82- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266 A7 ----- B7 _ 五、發明說明(80) [5-胺基-2-(1,4-二氧-8-氮-螺Μ]癸各基)_2,_氟礪苯基斗基]_胺甲 基酸第三-丁酯 根據一般程序L (方法a),經由以pd/c之催化氫化作用, 製自〇(1,4-二氧—8-氮-螺[4.5]癸-心基)_2L氟基j硝基,苯基斗 基]胺甲基酸第三-丁酯(實例F22)(U9克,2·94毫莫耳)。獲得 淡米黃色固體(1.01克)。 MS (ISP) 444 [(Μ+Η)+ ];熔點 198。(:。 實例L52 (5-月女基-2’,5f-二氟-2-甲氧基·聯苯基冰基胺甲基酸第三-丁酯 根據一般程序L (方法a),經由以pd/c之催化氫化作用, 製自(2’,5’-二氟-2-甲氧基-5-硝基-聯苯基冰基)_胺甲基酸第三· 丁酯(貫例F23)(1.05克’ 2.76毫莫耳)。獲得米黃色固體(618 毫克)。 MS (ISN) 349 [(Μ-ΗΠ ;熔點 144°C。 實例L53 [5-胺基-2’-氟基-2-(2-甲氧基-乙氧基)_聯苯基_4_基]_胺甲基酸第 三-丁酯 根據一般程序L (方法a),經由以Pd/C之催化氫化作用, 製自[2f-氟基-2-(2-甲氧基-乙氧基)士硝基·聯苯基冬基]-胺甲基 酸第三-丁酯(實例F24)。獲得紫色固體(2·581克)。 實例L54 (RS)-〇胺基-2’-氟基-2-(四氫-喊喃-2-基氧基甲基)_聯苯基-4-基]-胺甲基酸第三-丁酯 根據一般程序L· (方法b),經由以SnCl2 · 2Η2 Ο之還原作用 -83- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) (請先閱讀背面之注意事項再本頁) —裝 ------訂--------:線. 經濟部智慧財產局員工消費合作社印製 1255266 A7 -------— B7_____ 五、發明說明(81 ) ’製自(RS)-[2’_氟基-5-硝基-2-(四氫-旅喃-2-基氧基甲基)_聯苯 基斗基]-胺甲基酸第三-丁酯(實例F25)。獲得黃色液體 克)。 MS (ISP) 439 [(M+Na)+ ]。 實例L55 [5-fe基-2-氟基-2-(4-甲氧基-爷氧基)_聯苯基|基]_胺甲基酸第 三-丁酯 根據一般程序L (方法b),經由以SnCl2 · 2H2 0之還原作用 ’製自[2f-氟基-2-(4-甲氧基氧基)-5-硝基-聯苯基冰基]邊甲 基酸第三-丁酯(實例F25)(0.90克,1.92毫莫耳)。獲得米黃色 固體(719毫克)。 MS(ISP) 439 [(M+H)+]。 實例L56 (5-胺基-2-第三-丁氧基-2,,5,-二氟-聯苯基-4-基)-胺甲基酸第三_ 丁酉旨 根據一般程序L (方法a),經由以Pd/C之催化氫化作用, 製自(2-第三-丁氧基二氟-5-硝基-聯苯基斗基)-胺甲基酸 第三-丁酯(實例F27)。獲得非晶質灰藍色物質(2 37克)。 MS(ISP) 393[(M+H)+]。 實例L57 [2-胺基-5-第三-丁氧基-4-(4-氟苯基乙炔基)-苯基]-胺甲基酸第 三-丁酯 根據一般程序L (方法b),經由以SnCl2 · 2H2 0之還原作用 ,製自[5-第三-丁氧基-4-(4-氟苯基乙炔基)-2-硝基-苯基]-胺甲 -84- 本紙張尺度適用中國國家標準(CNS)A4規格(210 x 297公釐) -----·---------裝--- (請先閱讀背面之注意事項再6本頁) 訂·· --線· 經濟部智慧財產局員工消費合作社印製 1255266 經濟部智慧財產局員工消費合作社印製 A7 B7 五、發明說明(82) 基酸第三-丁酯(實例K26)(649毫克,1.51毫莫耳)。獲得淡黃 色固體(410毫克)。 MS (ISP) 399 [(M+H)+] ; J:容點 183。(:。 下述實例係關於3-芳基_3-酮基-丙酸乙酯或第三-丁醋(通式Example K22) was treated with 3,4-dihydro-2H-pyran and catalyst TsOH.H2 oxime in DCM at EtOAc. An amorphous light brown material (99 mg) was obtained. MS (ISP) 441 [(M+H)+ ]. Example L29 (RSM2-Amino-4-(4-fluorophenylethynyl)_5_{methyl-[2_(tetrahydro-pyranoyloxy)ethyl]-amino}-phenyl)-amine The third-butyl methyl methate is prepared from (RS)-(4-(4-fluoromethylene-yl)-5-{A via the reduction of SnCl2 · 2H2 0 according to the general procedure L (method b) Base-[2-(tetrahydro-pyran-2-yloxy)-ethyl]-amino}-2-nitro-phenyl)-amine methyl acid tert-butyl ester (example K23) 1.79 grams, 3.49 millimoles). Amorphous light brown material (12 g) was obtained. MS (ISP) 484 [(M+H)+]. Example L30 -·Line-(RS)-{2-Amino-4-phenylethynyl-5-indole (tetrahydrotetrayloxy)-ethoxy]-phenyl}-amine hydrazinoic acid 3. Ding Ding, Ministry of Economic Affairs, Intellectual Property Bureau, Staff Consumer Cooperatives, printed according to the general procedure L (method b), via the reduction of SnCl2 · 2H2〇, from (RS)-{2-nitro-4-phenyl Block base_5-[2-(tetrahydrotetram-2-yloxy)-ethoxy]-phenyl-p-methylamino acid tert-butyl ester (example K24) (42 〇 mg, 〇87 毫Moore). Obtained as a pale brown solid (346 mg). MS (ISP) 453 [(Μ+Η)+]. Example L31 (RS)-{5-Amino-4'-orbito-2-[4-(tetrahydro-pyran-2-yloxy)-hexahydrop-butyl-1-yl]_-76 - This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1255266 A7 B7 V. Description of invention (74) Biphenyl-4-yl]-amine methyl acid third-butyl ester according to general Procedure L (Method a), via catalytic hydrogenation with Pd/C, from (RS)-{4f-fluoro-5-nitro-2-[4-(tetrahydro-l-butan-2-yloxy) Base)-hexahydrop to butyl-1-yl]-biphenylyl yl}-amine methyl acid third-butyl vinegar (Example F3) (845 mg, 1.64 mmol). Obtained as a light green solid (758 mg). MS (ISP) 486 [(M+H)+]; mp 157-161. Example L32 [2-Amino-5-(2-tris-butoxy-ethoxy)-4-(4-fluorophenylethynyl)-phenyl]-aminomethyl acid tert-butyl ester According to the general procedure L (method b), from [5-(2-tris-butoxy-ethoxy)_4_(4-fluorophenylethylidene) by reduction with SnCl 2 · 2H 2 0 2-Nitro-phenyl]-aminocarbamic acid tert-butyl ester (Example K25) (744 mg, 1.57 mmol). Obtained as a pale yellow solid (575 mg). MS (ISP) 443 [(M+ H)+]; melting point 149-15CTC 〇 Example L33 (RS)-(5-Amino-4'-fluoro-2-{4-indole (tetrahydrotetram-2-yloxy)-ethoxy • • hexahydro p-but-1-yl}-biphenyl-4-yl)-amine methyl acid tert-butyl ester according to the general procedure L (method a), via catalytic hydrogenation with Pd/C, From (RS)-(4f-Fluorosylnitro-2_{4-[2-(tetrahydrofuranyloxy) ethoxy] 7T Hydrogen p-l-yl}-biphenyl Base ice base &gt; Amino acid tert-butyl ester (Example F4) (9 mg, 1.61 mmol). Obtained a pale brown foam (779 mg). MS (ISP) 530 [(M+H +]; melting point 56-58 ° C. Example L34 (RS)-[5-Amino group | Fluoryl winter (tetrahydrotetram-2-yloxymethyl)_ Biphenyl _4_yl]- -77- This Λ 尺度 week uses the T National Standard (CNS) A4 specification (210 X 297 mm) ——!/---------- —— (Please read the note on the back page first) · • Line · Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed 1255266 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed A7 B7 V. Description of invention (75) Aminomethyl The acid tert-butyl ester is prepared from (RS)-[4'-fluoro-5-nitro-2-(tetrahydro-) by reduction with SnCl 2 · 2H? 根据 according to the general procedure L (method b). Triamyl-2-yloxymethyl)-biphenyl-4-yl]-amine methyl acid (Example F5). Obtained an orange solid (1.15 g). mp 139-142. Example L35 (5-Amino-2-cyanomethoxy-4'-fluoro-biphenyl-4-yl)-amine methyl acid, the third-butyr, according to the general procedure L (method b), Reduction of SnCl2 · 2H2 0' from (2-oxymethoxy-4^fluoro-5-nitro-biphenyl-4-yl)-amine methyl acid tert-butyl ester (example) F6) (310 mg, 0.8 mmol). m. m. (:. Example L36 (5-Amino-2-dimethylaminomethyl-4f-fluoro-biphenyl-4-yl)-amine methyl acid tert-butyl ester according to the general procedure L (method b ), from (2-dimethylaminomethyl-4'-fluoro-5-nitro-biphenylmethylene)-amine methyl acid tert-butyl ester by reduction with SnCl 2 · 2Η 2 Ο (Example F7) Obtained as a yellow solid (9·························· Oxygen oxime [4,5-c]p is more than 5-(5-yl)-4f-gas-linked keto-4-yl]-amine methyl benzoate-tert- ing according to the general procedure L (method a) By catalytic hydrogenation with pd/c, from [2-(2,2-dimethyl-tetrahydro-[1,3]dioxosyl[4,5-c]pyrrolylfluoro-78- This paper scale applies to the national standard (CNS) A4 specification (210 X 297 mm) ----,----------Install i I (please read the back note on this page first) : -- Line · 1255266 A7 B7 V. Description of the invention (76) Benz-5-nitrobiphenyl yl]-amine methyl acid third butyl ester (example F8^1 〇 mg ' 1.29 耄 Mo Er) Obtain an off-white foam (578 mg). (Please read the back first) Note on this page) MS (ISP) 444 [(M+H)+]. Example L38 (5-Amino-4'-fluoro-2-methoxy-biphenylyl)-aminomethyl The acid tert-butyl ester is prepared according to the general procedure L (method a) by catalytic hydrogenation with pd/c from (4-fluoro-2-methoxy-5-stone schottyl-biphenyl-4-yl) - _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ C (decomposition). Example L39 Amidino-2-(l,4-dioxo-8-nitro-spiro[4.5]indole)-4,-fluoro-biphenyl-4-yl]-amine A The tert-butyl ester of the acid is prepared from [2-(1,4-dioxo-8-nitro-spiro[4.5]癸-8 by catalytic hydrogenation with Pd/C according to the general procedure L (method a)). -yl)-4'-fluoro-5-nitro-biphenyl-4-yl]-amine methyl acid tert-butyl ester (Example F10) (2.4 g, 5.00 mmol). Green solid (2.37 g) MS (ISP) 444 [(M+H)+]. Example L40 Printed by the Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative (5-Amino-4'-fluoro-2-methyl- Biphenyl)-amine methyl acid third _ 酉 酉 according to the general procedure L (method a), From the catalytic hydrogenation with Pd/C, from (4'-fluoro-2-methyl-5-nitro-biphenyl-4-yl)-amine methyl acid, the third-butanthene (example Fll) ) (560 mg, 1.62 mmol). Obtained as a pale brown solid (512 mg). MS (ISP) 317 [(M+H)+]; mp. Example L41 -79- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1255266 A7 B7 V. Inventive Note (77) (5-Amino-4-tris-butoxycarbonylamino group -4,-Fluoro-biphenyl-2-yloxy)-acetic acid tert-butyl ester according to the general procedure L (method a), via catalytic hydrogenation with Pd/C, from 4-tetra- Butoxycarbonylamino-cardiofluoro-5-nitro-biphenyl-2-yloxy)-acetic acid tert-butyl ester (Example F12) (2.29 g, 4.95 mmol). Obtained a dark blue solid (2.14 g). MS (ISP) 433 [(M+H)+]; mp. 30-33. Example L42 (5-Amino-2-carbenyl-fluoro-biphenyl-4-yl)-amine methyl acid tert-butyl ester according to the general procedure L (method b), via SnCl 2 · 2H 2 0 Reduction, from (2-carbyl-4'-fluoro-5-nitro-biphenylyl)-amine methyl acid tert-butyl ester (Example F13). A pale red solid (544 mg) was obtained. MS (ISP) 337 [(M+H)+]. Example L43 [5-Amino-4'-fluoro-2-(2-methoxy-ethoxy)-biphenyl-4-yl]-amine methyl acid tert-butyl ester according to the general procedure L ( Process a), by catalytic hydrogenation with pd/c, from [4'-fluoro-2-(2-methoxy-ethoxy)-5-decyl-biphenyl-4-yl] - Aminomethyl-tert-butyl ester (Example F14). Obtained as a pale brown solid (1.652 g). MS (ISP) 377 [(M+H)+]. Example L44 [5-Amino-2-(2-tris-butoxy-ethoxy] 4'-fluoro-biphenyl-4-yl]-amine methyl acid butyl butyl ester according to General procedure L (method a), via catalytic hydrogenation with pd/c, -80- This paper scale applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) ----r----- ----装--- (Please read the notes on the back and then this page) · • Line · Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 1255266 A7 B7 V. Invention description (78) ----P- -I--- - - II (Please read the following note on the back page) Prepared from [2-(2-Terti-butoxy-ethoxy) flupros-5-nitro-biphenyl _ 4-Methoxy]-amino acid tert-butyl ester (Example F15). Obtained as a purple solid (547 mg). MS (ESI) 419 [(M+H)+]; Example L45 [5-Amino-41-fluoro-2-(2-keto-oxazolyl-3-yl)-biphenyl-4-yl]-aminomethyl acid tert-butyl ester according to the general procedure L (Method a), via catalytic hydrogenation with Pd/c, from [4^Fluoro-5-nitro-2_(2-keto-j-dis--3-yl)-biphenyl-4 -yl]-aminomethyl acid tert-butyl ester (example F16) (280 mg 67·67 mmol. Obtained as a yellow solid (277 mg). MS (ESI) 388 [(M+H)+]; mp. 210 ° C. Example L46 (5-amino-4'-fluoro-2 -Methoxy-2'-methyl-biphenyl-4-yl)-amine methyl acid _ _ 酉 - - line _ according to the general procedure L (method a), via catalytic hydrogenation with Pd / C The effect was prepared from (4f-fluoro-2-methoxy-2'-methyl-5-nitro-biphenyl-4-yl)-amine methyl acid tert-butyl ester (Example FH). Obtained a brown solid (588 mg) MS (ISP) 347 [(M+H)+]. Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative Printed Example L47 (5-Amino-2-tris-butoxy-4f -Fluoro-biphenyl-4-yl)-amine methyl acid, third, butyl, according to the general procedure L (method a), via Pd/C hydrogenation, from (2-second - Butoxy-4'-fluoro-5-nitro-biphenyl-4-yl)-amine methyl acid tricate-butyl ester (Example F18) (1.15 g, 2.84 mmol). Pink solid (747 mg) -81 - This paper size applies to Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1255266 A7 B7 V. Description of invention (79) MS (ISP) 375 [(M+H )]]; melting point 1 39 ° C. Example L48 ----:----------Installation - (Please read the back note on this page first) (5-Amino-2-tris-butoxy-2,-fluoro -biphenyl-4-yl)-amine methyl acid tert-butyl ester according to the general procedure L (method a), via catalytic hydrogenation with Pd/C, from (2-tris-butoxy- 2'-Fluoro-5-nitro-biphenyl-4-yl)-amine methyl acid second-butyl ester (Example F19) (930 mg, 2.3 mmol). Obtained a pink solid (649 mg). MS (ISP) 375 [(M+H)+]; m.p. 13 (TC). </ RTI> </ RTI> </ RTI> </ RTI> <RTIgt; Piperidine-2-yloxy)-tetrahydropyrrole small group]-biphenylyl yl}}-aminomethyl acid tert-butyl ester according to the general procedure L (method a), via catalytic hydrogenation with Pd/C Function, from (RS)-{4,-fluoro-5-nitro-2-[(R)-3_(W-hydro-m--2-yloxy)-tetrahydropyrrole small group]-linked Phenyl-4-yl}-amine methyl acid tert-butyl ester (Example F20). Obtained a dark green solid (852 mg).---MS (ESI) 472 [(M+H)+]. L50 Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative Printed (5-Aminofluoro-2-methoxy-biphenyl-4-yl)-amine methyl acid tert-butyl ester according to the general procedure L (Method a ), by catalytic hydrogenation with Pd/C, from (2'-fluoro-2-methoxy-5-nitro-biphenyl-4-yl)-amine methyl acid tert-butyl ester (Example F21) (649 mg, 1.79 mmol). m. m. m. Applicable to China National Standard (CNS) A4 specification (210 X 297 mm) 1255266 A7 ----- B 7 _ V. Description of the invention (80) [5-Amino-2-(1,4-dioxo-8-nitro-spiro) oxime)_2,_fluoroindole phenyl phenyl]-aminomethyl The acid tert-butyl ester is prepared according to the general procedure L (method a) by catalytic hydrogenation with pd/c from 〇(1,4-dioxo-8-nitro-spiro[4.5]癸-cardoyl)_2L Fluoryl J nitro, phenyl phenyl] amino acid tert-butyl ester (Example F22) (U9 g, 2.94 mmol). Obtained pale beige solid (1.01 g). MS (ISP) 444 [(Μ+Η)+ ]; melting point 198. (:. Example L52 (5-month female base-2', 5f-difluoro-2-methoxy-biphenylyl ylaminomethyl acid third -butyl ester according to the general procedure L (method a), via catalytic hydrogenation with pd/c, from (2',5'-difluoro-2-methoxy-5-nitro-biphenylyl yl _ Amino acid methyl butyl butyl ester (C3) (1.05 g, 2.76 mmol). Obtained as a beige solid (618 mg). MS (ISN) 349 [(Μ-ΗΠ; melting point 144 ° C Example L53 [5-Amino-2'-fluoro-2-(2-methoxy-ethoxy)-biphenyl-4-yl]-amino acid tert-butyl ester according to the general procedure L (method a), via catalytic hydrogenation with Pd/C, From [2f-Fluoro-2-(2-methoxy-ethoxy)-nitro-biphenylmethylene]-amine methyl acid tert-butyl ester (Example F24). Obtained a purple solid (2·581 g). Example L54 (RS)-Amidino-2'-fluoro-2-(tetrahydro-pyran-2-yloxymethyl)-biphenyl-4-yl]-amine methyl acid - Butyl ester according to the general procedure L· (Method b), via the reduction of SnCl2 · 2Η2 - -83- This paper scale applies the Chinese National Standard (CNS) A4 specification (210 X 297 mm) (please read the back note first) Matters again on this page) - Packing ------ Order -------: Line. Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 1255266 A7 ------- - B7_____ V. Invention Description (81) 'Prepared from (RS)-[2'_fluoro-5-nitro-2-(tetrahydro-ttan-2-yloxymethyl)-biphenylyl]-aminomethyl Acidic third-butyl ester (Example F25). Obtain a yellow liquid g). MS (ISP) 439 [(M+Na)+ ]. Example L55 [5-feyl-2-fluoro-2-(4-methoxy-yloxy)-biphenyl]-amino-methyl-acid tri-butyl ester according to the general procedure L (method b ), by the reduction of SnCl 2 · 2H 2 0 'from [2f-fluoro-2-(4-methoxyoxy)-5-nitro-biphenylyl)-m-methyl acid - Butyl ester (Example F25) (0.90 g, 1.92 mmol). Obtained a beige solid (719 mg). MS (ISP) 439 [(M+H)+]. Example L56 (5-Amino-2-tris-butoxy-2,5,-difluoro-biphenyl-4-yl)-amine methyl acid third_ 酉 酉 according to the general procedure L (method a) from (2-tris-butoxydifluoro-5-nitro-biphenylyl)-amine methyl acid tert-butyl ester via catalytic hydrogenation with Pd/C (example) F27). Amorphous gray-blue material (2 37 g) was obtained. MS (ISP) 393 [(M+H)+]. Example L57 [2-Amino-5-t-butoxy-4-(4-fluorophenylethynyl)-phenyl]-amine methyl acid tert-butyl ester according to the general procedure L (Method b) , by [5-tris-butoxy-4-(4-fluorophenylethynyl)-2-nitro-phenyl]-amine A-84-benz by reduction with SnCl2 · 2H20 The paper scale applies to the Chinese National Standard (CNS) A4 specification (210 x 297 mm) -----·---------Install--- (Please read the notes on the back and then 6 pages) Order··-Line· Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed A7 B7 V. Invention Description (82) Acid-terminated third-butyl ester (example K26) (649 Mg, 1.51 millimoles). Obtained as a pale yellow solid (410 mg). MS (ISP) 399 [(M+H)+] ; J: Tolerance point 183. (: The following examples are for 3-aryl-3-keto-propionic acid ethyl ester or third-butyl vinegar (general formula

Vila)之製備,其係充作標的化合物合成上之結構單位(合成 圖示H): 一般程序Μ 方法a) 3-芳基各酮基-丙酸乙酯或第三-丁酯之製備 3-芳基-3·•酮基-丙酸乙酯或第三-丁酯,係根據合成期刊 1993, 290 ’製自氣化芳酿與丙二酸乙酯或第三-丁醋卸鹽 [CAS-編號 6148-64-7 與 75486-33-8]與 Et3N 及 MgCl2,在 CH3 CN 中 ’於0 C至23 C下。右在此反應中採用自由態芳基幾酸,則 在與丙二酸鹽反應之前,經由以氯甲酸乙酯,在 THF/C H3 CN中,於0°C下處理,使其活化。 方法b) 3-芳基-3-酮基-丙酸第三-丁酯之製備 或者,3-芳基-3-酮基-丙酸第三-丁酯,係根據合成期刊 1985, 45,於第三-丁氧化鋰存在下,經由以第三-丁基醋酸 麵[經由在THF中,於-78°C下,以i里二異丙基胺處理醋酸第 三-丁醋而製成]處理,製自芳基甲酯或乙酯。若於處理後 ,產物含有殘留起始物質,則可使用Li〇H,在THF/Me〇H/ Η2〇中,於23Ό下,藉選擇性皂化作用移除之。 方法c) 3-芳基-3-酮基-丙酸之製備 3-芳基-3-酮基-丙酸,係拫據 Synth· c〇mmun· 1985, 15, 1〇39 (方 法cl) ’使用E1:3 N與LiBr在CH;3 CN中,於〇°C下,或根據合成 -85- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ----K----------裝--- (請先閱讀背面之注意事項本頁) . -線· 1255266 A7 B7 I、發明說明(83) 期刊1979, 787 (方法c2),使用n-BuLi,在醚中,於40°C至〇°C 下,製自氣化芳醯與丙二酸雙(三甲基矽烷基)酯。 實例Ml 3-酮基-3-(3-[l,2,4]二咬-4-基-苯基)_丙酸乙酉旨 R0-71-2790/000 ΟPreparation of Vila), which is the structural unit for the synthesis of the compound as a standard (Synthesis Scheme H): General Procedure Μ Method a) Preparation of 3-aryl keto-ethyl propionate or tert-butyl ester 3 - aryl-3·-keto-ethyl propionate or tri-butyl ester, according to the Synthetic Journal 1993, 290 'automated aromatized aromatic and malonate or third-butyric acid unsalted salt [ CAS-numbers 6148-64-7 and 75486-33-8] with Et3N and MgCl2, in CH3 CN 'at 0 C to 23 C. The free aryl carboxylic acid is used in this reaction, and it is activated by treatment with ethyl chloroformate in THF/C H3 CN at 0 ° C before reaction with malonic acid salt. Process b) Preparation of 3-aryl-3-keto-propionic acid tert-butyl ester, or 3-aryl-3-keto-propionic acid tert-butyl ester, according to the Synthetic Journal 1985, 45, Prepared in the presence of a third-butyric acid oxide via a third-butyl acetate surface [via a third-butyl vinegar acetate treated with diisopropylamine in THF at -78 ° C in THF Processing, from aryl methyl ester or ethyl ester. If the product contains residual starting material after treatment, it can be removed by selective saponification using THF/Me〇H/ Η2〇 at 23 Torr. Process c) Preparation of 3-aryl-3-keto-propionic acid 3-aryl-3-keto-propionic acid, according to Synth·c〇mmun·1985, 15, 1〇39 (Method cl) 'Use E1:3 N with LiBr in CH; 3 CN, at 〇 °C, or according to Synthetic-85- This paper scale applies Chinese National Standard (CNS) A4 specification (210 X 297 mm) ---- K----------装--- (Please read the note on the back page first.) - Line · 1255266 A7 B7 I, invention description (83) Journal 1979, 787 (method c2), use n-BuLi, in the ether, at 40 ° C to 〇 ° C, from the gasification of lanthanum and bis(trimethyldecyl) malonate. Example Ml 3-keto-3-(3-[l,2,4]di-p--4-yl-phenyl)-propionic acid ethyl hydrazine R0-71-2790/000 Ο

經濟部智慧財產局員工消費合作社印製 、0〜 根據一般程序Μ (方法a),經由以氯甲酸乙酯/ Et3 Ν活化 ,及使用Et3N與MgCl2,在CH3 CN中,與丙二酸乙酯鉀鹽反 應,製自3-[1,2,4]三唑-4-基·苯甲酸[r〇7i]432/000,在醋酸中 ,於120°C下,經由3-胺基苯曱酸與肼水合物及原甲酸三乙 酯之反應而製成]。獲得白色固體(5.74克)。 MS(EI) 259 (M+) 〇 實例M2 3-酮基-3-(3-[1,2,3]三。坐-1-基-苯基)-丙酸乙@旨 根據一般程序Μ (方法a),經由以氯曱酸乙酯/ Et3N活化 ,及使用Et3N與MgCl2,在CH3 CN中,與丙二酸乙酯鉀鹽反 應,製自3-[1,2,3]三唑小基-苯甲酸[RO-71-3703/000,經由3-疊 氮基苯甲酸甲酯[CAS-編號93066-93-4]在三甲基矽烷基乙炔中 回流,接著以NaOH水溶液,在回流EtOH中皂化而製成]。 獲得淡黃色固體(2.22克)。 MS (EI) 259 (M+);熔點 72-74°C。 實例M3 3-(3-氰基-苯基)-3-酮基-丙酸第三-丁酯 ----卜----------裝i I (請先閱讀背面之注意事項再本頁) ·. --線- -86- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266 A7 B7 五、發明說明( 根據一般程序Μ (方法b),經由以第三-丁基醋酸鋰處理 ’製自3-氰基苯甲酸甲酯[CAS-編號13531-48-1]。獲得淡褐色 油性半固體。 MS(EI)245 (M+) 〇 實例M4 3-(3-味峻-1-基-苯基)-3-i同基-丙酸第三·丁酉旨 根據一般程序Μ (方法b),經由以第三-丁基醋酸鋰處理 ’製自3-(1H-咪唑小基)苯甲酸甲g旨[製自3-(1]9-咪唑小基)苯甲 酸(J. Med· Chem. 1987, 30, 1342 ; CAS-編號[108035-47-8],經由在 濃H2 S04/Me0H中回流]。獲得橘褐色油。 MS (ISP) 287 [(M+H)+ ] 〇 實例M5 3-(2-味。坐-1-基-ρ比咬-4-基)-3-嗣基-丙酸第三_丁酉旨 根據一般程序Μ(方法a),使用Et3N與MgCl2,在CH3CN中 ’製自氣化2-咪嗤-1-基-異於驗酿鹽酸鹽[經由2-氣基異於驗 酸第三-丁酯與咪唑及NaH,在DMF中,於8〇。(:下反應,在50 °c下,以甲酸處理,及與二氣化亞硫醯,在甲苯中,於1〇〇 °C下反應而製成]與丙二酸第三-丁酯鉀鹽。獲得褐色固體 (1〇·8 克)。 MS (EI) 287 (M+);熔點 80°C (分解)。 tjH M6 3-酉同基-3-(3-[1,2,4]二咬-1-基-苯基)-丙酸第三_丁酉旨 根據一般程序Μ (方法b),經由以第三-丁基醋酸鐘處理 ’製自3-[1,2,4]三唑小基-苯甲酸甲g旨[CAS-編號167626_27-9]。 -87- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ----»---------^ - I I (請先閱讀背面之注意事項再頁) 1··線· 經濟部智慧財產局員工消費合作社印製 1255266 經濟部智慧財產局員工消費合作社印製 A7 B7 五、發明說明(85) 獲得橘色液體(2.41克)。 MS(EI) 287 (M+) 〇 實例M7 3-[3-(4-甲基-味峻-1-基)-苯基]-3-嗣基-丙酸第三-丁酉旨 根據一般程序Μ (方法b),經由以第三-丁基醋酸鋰處理 ,製自3-(4-甲基-咪唑小基)-苯甲酸甲酯[RO-69-6483/000,根據 J· Med. Chem· 1987, 30, 1342,由3-異硫氰基苯甲酸與2-胺基丙 醛二甲基縮醛,接著在濃H2 S04/Me0H中回流,製自其相應 酸]。獲得黃褐色油(10.69克)。MS (EI) 300 (M+)。 實例M8 3-[3-(2-甲基-咪唑-1-基)-苯基]-3-酮基•丙酸第三-丁酯 根據一般程序Μ (方法b),經由以第三-丁基醋酸鋰處理 ,製自3-(2-甲基-咪唑小基)_苯曱酸乙酯[RO-69-7480/000,經由 3-胺基苯甲酸乙酯與乙醯亞胺酸乙酯鹽酸鹽,在EtOH中, 於0°C下反應,以胺基乙醛二乙基縮醛,在EtOH中,於23°C 下直接處理,接著添加濃H2 S04及回流而製成]。獲得褐色 油(9.66 克)。 MS(ISN) 299 [(M-H:T]。 實例M9 3-[3-(2,4-二甲基-咪唑-1-基)-苯基]各酮基-丙酸第三-丁酯 根據一般程序Μ (方法b),經由以第三-丁基醋酸鋰處理 ,製自3-(2,4-二曱基-咪唑-1-基)-苯甲酸乙酯[RO-71-0583/000, 經由3-胺基苯甲酸乙酯與乙醯亞胺酸乙酯鹽酸鹽,在EtOH 中,於0°C下反應,以2-胺基丙酸二甲基縮酸’在EtOH中, -88- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ----l·---------裝—— (請先閱讀背面之注意事項本頁) · _ --線· 1255266 經濟部智慧財產局員工消費合作社印製 Α7 Β7 五、發明說明(86) 於23°C下直接處理,接著添加濃h2S04&amp;回流而製成]。獲 得黃褐色油(6.00克)。 MS(ISN)313[(M-H:T]。 實例M10 3-(2-氰基-吡啶-4-基)-3-酮基-丙酸第三-丁酯 根據一般程序Μ (方法b),經由以第三-丁基醋酸鋰處理 ,製自2-氰基-異菸鹼酸乙酯[CAS-編號58481-14-4]。獲得淡褐 色固體(7.70克)。 MS (ISN) 245 [(M-H)- ] 〇 實例Mil 3-酉同基-3-(3-[l,2,4]二。坐-4-基-苯基)-丙酸第三-丁酉旨 根據一般程序Μ (方法b),經由以第三-丁基醋酸鋰處理 ,製自3-[1,2,4]三唑-4-基-苯甲酸甲酯[經由3_胺基苯甲酸與肼 水合物及原甲酸三乙酯,在醋酸中,於12〇°C下反應,接著 以濃% S〇4,在回流MeOH中酯化而製成]。獲得淡黃色膠質 (870毫克)。 MS (ISN) 286 [(M-Η)-]。 實例M12 3-[3-(2-甲氧基甲石乂基-味吐-1-基)·木基]_3_嗣基-丙酸第三-丁酉旨 根據一般程序Μ (方法b),經由以第三-丁基醋酸鋰處理 ’製自3-(2-甲氧基曱硫基-味吐小基)_苯甲酸乙酉旨[經由以渡 H2S〇4,在EtOH中,使3-(2-甲氧基甲硫基-咪唑小基)·苯甲酸 [CAS-編號108035-46-7]酯化,接著以氣甲基甲基醚及NaH, 在THF/DMF中處理而製成]。獲得橘色油(1·82克)。 ----r---------裝—— (請先閱讀背面之注意事項本頁) =口 --線· -89-Printed by the Ministry of Economic Affairs, Intellectual Property Bureau, Staff Consumer Cooperative, 0~ according to the general procedure 方法 (method a), activated by ethyl chloroformate / Et3 oxime, and using Et3N and MgCl2, in CH3 CN, with ethyl malonate Potassium salt reaction from 3-[1,2,4]triazol-4-ylbenzoic acid [r〇7i] 432/000 in acetic acid at 120 ° C via 3-aminophenylhydrazine The acid is prepared by reacting with hydrazine hydrate and triethyl orthoformate]. Obtained as a white solid (5.74 g). MS(EI) 259 (M+) 〇 Example M2 3-keto-3-(3-[1,2,3]3.sodium-1-yl-phenyl)-propionic acid B. Method a) is carried out by reacting with ethyl chloroantimonate / Et3N, and using Et3N and MgCl2 in CH3CN, reacting with potassium malonate potassium salt, from 3-[1,2,3]triazole Base-benzoic acid [RO-71-3703/000, via 3-azidobenzoic acid methyl ester [CAS-No. 93066-93-4] in trimethyldecyl acetylene reflux followed by aqueous NaOH in reflux Made by saponification in EtOH]. Obtained as a pale yellow solid (2.22 g). MS (EI) 259 (M+); mp. Example M3 3-(3-cyano-phenyl)-3-keto-propionic acid tert-butyl ester----b---------- loaded i I (please read the back Precautions on this page) ·. --Line - -86- This paper size applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1255266 A7 B7 V. Invention description (according to the general procedure Μ (Method b) Obtained from methyl 3-cyanobenzoate [CAS-No. 13531-48-1] by treatment with lithium tri-butyl acetate. Obtained as a pale brown oily semi-solid. MS (EI) 245 (M+) 〇 Example M4 3-(3-tert-l-yl-phenyl-phenyl)-3-i-iso-propionic acid, third, butyl, according to the general procedure 方法 (method b), via treatment with lithium tributyl-butyl acetate Prepared from 3-(1H-imidazolyl)benzoic acid methyl [from 3-(1]9-imidazolyl)benzoic acid (J. Med. Chem. 1987, 30, 1342; CAS-No. [108035] -47-8], obtained by refluxing in concentrated H2S04/Me0H]. Obtained tan oil. MS (ISP) 287 [(M+H)+] 〇 Example M5 3-(2-flavor. -ρ 咬-4-yl)-3-mercapto-propionic acid _ 酉 酉 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据 根据-Base - different from the test Hydrochloride [via 2-gas group is different from acid-testing third-butyl ester with imidazole and NaH in DMF at 8 〇. (: lower reaction, treatment with formic acid at 50 °c, and with two gas Ruthenium sulfoxide was reacted in toluene at 1 ° C to prepare a potassium salt of tert-butyl malonate. A brown solid (1 〇 · 8 g) was obtained. MS (EI) 287 ( M+); melting point 80 ° C (decomposition). tjH M6 3-indolyl-3-(3-[1,2,4]dident-1-yl-phenyl)-propionic acid General Procedure Μ (Method b), prepared by treatment with a third-butyl acetate clock, from 3-[1,2,4]triazole-based-benzoic acid-methyl [CAS-No. 167626_27-9]. 87- This paper size is applicable to China National Standard (CNS) A4 specification (210 X 297 mm) ----»---------^ - II (Please read the notes on the back page again) 1 ·················································································································· 〇 Example M7 3-[3-(4-Methyl-myin-1-yl)-phenyl]-3-indolyl-propionic acid Third-butyr Procedure Μ (Method b), prepared from 3-(4-methyl-imidazolyl)-benzoic acid methyl ester [RO-69-6483/000, via J. Med Chem. 1987, 30, 1342, from 3-isothiocyanabenzoic acid and 2-aminopropionaldehyde dimethyl acetal, followed by reflux in concentrated H2S04/Me0H from the corresponding acid]. Obtained a tan oil (10.69 g). MS (EI) 300 (M+). Example M8 3-[3-(2-Methyl-imidazol-1-yl)-phenyl]-3-keto-propionic acid tert-butyl ester according to the general procedure 方法 (Method b), via the third- Treatment with lithium butyl acetate from ethyl 3-(2-methyl-imidazolyl)-benzoate [RO-69-7480/000 via ethyl 3-aminobenzoate and acetimidate Ethyl ester hydrochloride, reacted in EtOH at 0 ° C, with amino acetaldehyde diethyl acetal, directly treated in EtOH at 23 ° C, followed by addition of concentrated H 2 S04 and reflux ]. Obtained brown oil (9.66 g). MS (ISN) 299 [(MH:T]. Example M9 3-[3-(2,4-dimethyl-imidazol-1-yl)-phenyl] keto-propionic acid tert-butyl ester according to General procedure Μ (Method b), prepared from 3-(2,4-dimercapto-imidazol-1-yl)-benzoic acid ethyl ester [RO-71-0583/ 000, via ethyl 3-aminobenzoate and ethyl acetimidate hydrochloride, reacted in EtOH at 0 ° C with 2-aminopropionic acid dimethyl acetal in EtOH , -88- This paper size is applicable to China National Standard (CNS) A4 specification (210 X 297 mm) ----l·---------Installation - (Please read the note on the back first) Page) · _ -- Line · 1255266 Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed Β 7 Β 7 V. Inventive Note (86) Directly treated at 23 ° C, followed by adding concentrated h2S04 &amp; reflux to make]. Obtained a tan Oil (6.00 g) MS (ISN) 313 [(MH: T]. Example M10 3-(2-Cyano-pyridin-4-yl)-3-one-propionic acid tert-butyl ester according to the general procedure Μ (Method b), prepared from ethyl 2-cyano-isonicotinate [CAS-No. 58481-14-4] by treatment with lithium-tert-butyl acetate. Solid (7.70 g) MS (ISN) 245 [(MH)-] 〇 M M M M M M 3- 3- 3- 3- 3- 3- 3- 3- 3- 3- 3- 3- 3- 3- 3- 3- 3- 3- 3- 3- 3- 3- 3- 3- 3- 3- 3- 3- 3- Propionic acid third-butyr is prepared according to the general procedure 方法 (method b), by treatment with tri-butyllithium acetate, from 3-[1,2,4]triazol-4-yl-benzoic acid methyl ester [ Obtained by 3- 3 -aminobenzoic acid with hydrazine hydrate and triethyl orthoformate in acetic acid at 12 ° C, followed by concentration in S 〇 4, esterified in refluxing MeOH. Light yellow gum (870 mg) MS (ISN) 286 [(M-Η)-]. Example M12 3-[3-(2-methoxymethylglycosyl-sodium-1-yl)·木基]_3 _mercapto-propionic acid third-butyr is prepared according to the general procedure 方法 (method b), by treatment with tri-butyllithium acetate, from 3-(2-methoxysulfonylthio-small-small base) _benzoic acid ethyl ester [ester-transfer H2S〇4, in EtOH, 3-(2-methoxymethylthio-imidazolyl)-benzoic acid [CAS-No. 108035-46-7], Then, it was prepared by treating with methyl methyl ether and NaH in THF/DMF. Obtained orange oil (1.82 g). ----r--------- (Please read the notes on the back first) This page) = I - Line -89-

I255266 A7 _B7____ 五、發明說明(87) MS(EI) 362 (M+)。 實例M13 3-[3·(2-甲硫基-味。坐-1-基)-冬基]-3-嗣基-丙酸第二-丁酉旨 根據一般程序Μ (方法b),經由以第三-丁基醋酸鋰處理 ,製自3-(2-甲硫基-咪唑-1-基)-苯甲酸乙酯[經由以濃H2 S04, 在EtOH中,使3-(2-甲氧基甲硫基-咪唑小基)-苯甲酸[CAS-編 號108035-46-7]酯化,接著以碘化甲烷及NaH,在THF/DMF中 處理而製成]。獲得淡褐色油(4.41克)。 MS (ISP) 333 [(M+H)+] 〇 實例M14 3-[3-(3-甲基-異哼唑-5-基)-苯基]-3-酮基-丙酸第三-丁酯 根據一般程序Μ (方法b),經由以第三-丁基醋酸鐘處理 ,製自3-(3-甲基-異哼唑-5-基)-苯甲酸乙酯[根據Tetrahedron 1984, 40, 2985-2988,經由3-乙炔基苯甲酸乙酯[CAS-編號178742-95-5] 與NCS、乙酸肟、Et3 N及觸媒量π比啶之混合物,在CHC13中 ,於50°C下反應而製成]。獲得黃色固體(2.54克)。 MS (ISP) 302 [(M+H)+ ];熔點 50-56°C。 實例M15 3-酮基-3-(3-四唑-1-基-苯基)-丙酸乙酉旨 根據一般程序Μ (方法a),經由以氯甲酸乙酯/叫n活化 ,及使用Et3 N與MgCl2 ’在CH3 CN中,與丙二酸乙酯鉀鹽反 應’製自3-四唆-1-基-苯甲酸[CAS-編號204196-80-5]。獲得淡 黃色固體(211毫克)。 MS(EI) 260 (M+)。 -90- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公f - -----.---------裝--- (請先閱讀背面之注意事項再本頁) · :線· 經濟部智慧財產局員工消費合作社印製 1255266 經濟部智慧財產局員工消費合作社印製 A7 B7 發明說明(88) 實例M16 3-(3-氯-噻吩-2-基)-3-酮基-丙酸乙酯 根據一般程序Μ (方法a),使用Et3N與MgCl2,在CH3 CN中 ,經由與丙二酸乙酯鉀鹽反應,製自氯化3-氯基-2-噻吩甲 醯[CAS-編號86427-02-3]。獲得褐色油(6.84克)。 MS (EI) 232 (M+)與 234 [(M+2f ]。 實例M17 3-(5-氰基-嘍吩-2-基)-3-酮基-丙酸第三-丁酯 根據一般程序Μ (方法b),經由以第三-丁基醋酸鋰處理 ,製自5-氰基-2-噻吩羧酸乙酯[CAS-編號67808-35-9]。獲得黃 色固體(6_66克)。 MS (EI) 251 (M+);熔點 78°C。 實例M18 3-(5-氣基-2-氣冬基)-3-酉同基-丙乙酉旨 根據一般程序Μ (方法a),使用Et3N與MgCl2,在CH3 CN中 ,經由與丙二酸乙酯鉀鹽反應,製自氯化5-氰基-2-氟-苯甲 醯[經由以S〇C12,觸媒DMF在甲苯中,於80°C下處理,製自 其相應之酸[CAS-编號146328-87-2]]。獲得淡黃色固體(3.85克)。 MS (EI) 235 (M+);熔點 55-60°C。 實例M19 3-(2-味σ全-1-基-p墓σ全-4-基)-3-嗣基-丙弟二-丁酉旨 根據一般程序Μ (方法b),經由以第三-丁基醋酸鋰處理 ,製自2-咪唑小基-嘍唑-4-羧酸乙酯[CAS-編號256420-32-3]。 獲得橘色油(12.0克)。 -91 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ----^----------裝 i I (請先閱讀背面之注意事項本頁) 訂· 1255266 A7 _ B7__ 五、發明說明(89) 實例M20 3-[2-(4-甲基-咪峻-1-基)-遠峻4-基]_3·酮基-丙酸第三-丁酉旨 根據一般程序Μ (方法b),經由以第三_ 丁基醋酸鋰處理 ,製自2-(4-甲基-咪唑小基)_噻唑斗羧酸乙酯[藉由下列合成 順序.1·) NaH、2-異硫氣基-i,i-二甲氧基_丙燒、dmf,23°C ;2.)H2S04水溶液,回流;3.)Et0H、濃 h2S〇4,23χ: ; 4)3〇 0〇 Η: 〇2、HOAc,23 C,製自2_胺基塞π坐叛酸乙酉旨编 號[256420-32-3])]。獲得褐色油(8.73 克)。 MS(EI) 307 (M+) 〇 實例M21 3-[3-(1-甲基-1H-味嗤-2-基)-苯基]-3-酮基-丙酸第三-丁酉旨 根據一般程序Μ (方法b),經由以第三-丁基醋酸鍾處理 ’製自3-(1-甲基-1H-咪唑-2-基)苯甲酸乙酯[CAS-編號168422-44-4]。獲得淡黃色液體(1.26克)。 MS(ISP)301.3 [(M+H)+]。 下述實例係關於6-芳基-2,2-二甲基-[1,3]二氧陸圜烯斗酮(通 式VII)之製備’其係充作標的化合物合成上之結構單位(合 成圖示H):I255266 A7 _B7____ V. INSTRUCTIONS (87) MS(EI) 362 (M+). Example M13 3-[3·(2-Methylthio-taste.sodium-1-yl)-mungyl]-3-mercapto-propionic acid 2nd-butylpyridine according to the general procedure 方法 (Method b) Treatment with lithium tris-butyl acetate from 3-(2-methylthio-imidazol-1-yl)-benzoic acid ethyl ester [via concentrated H2 S04 in EtOH, 3-(2-methoxy) Methylthio-imidazolium)-benzoic acid [CAS-No. 108035-46-7] was esterified, followed by treatment with methane iodide and NaH in THF/DMF]. Obtained light brown oil (4.41 g). MS (ISP) 333 [(M+H)+] 〇 Example M14 3-[3-(3-Methyl-isoxazol-5-yl)-phenyl]-3- keto-propionic acid - Butyl ester is prepared according to the general procedure 方法 (Method b) from 3-(3-methyl-isoxazol-5-yl)-benzoic acid ethyl ester via a third-butyl acetate clock [according to Tetrahedron 1984, 40, 2985-2988, via a mixture of ethyl 3-ethynylbenzoate [CAS-No. 178742-95-5] with NCS, cesium acetate, Et3 N and a catalytic amount of π-pyridine, in CHC13 at 50° Made under the reaction of C]. Obtained as a yellow solid (2.54 g). MS (ISP) 302 [(M+H)+]; mp. 50-56. Example M15 3-keto-3-(3-tetrazol-1-yl-phenyl)-propionic acid ethyl hydrazine according to the general procedure 方法 (method a), via ethyl chloroformate / called n, and using Et3 N and MgCl2 'in CH3 CN, reacted with ethyl malonate potassium salt' from 3-tetrapyridin-1-yl-benzoic acid [CAS-No. 204196-80-5]. Obtained as a pale yellow solid (211 mg). MS (EI) 260 (M+). -90- This paper size is applicable to China National Standard (CNS) A4 specification (210 X 297 public f - -----.--------- loaded--- (please read the notes on the back first) On this page) · : Line · Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed A7 B7 Invention Description (88) Example M16 3-(3-Chloro-thiophen-2-yl) Ethyl-3-keto-propionate is prepared according to the general procedure 方法 (Method a) using Et3N and MgCl2 in CH3CN via a reaction with potassium malonate to form 3-chloro-2 - thiophene guanidine [CAS-No. 86427-02-3]. Obtained brown oil (6.84 g) MS (EI) 232 (M+) and 234 [(M+2f]. Example M17 3-(5-Cyano- The tert-butyl-2-yl)-3-keto-propionic acid tert-butyl ester was prepared from 5-cyano-2-thiophene according to the general procedure 方法 (Method b) by treatment with lithium-tert-butyl acetate. Ethyl carboxylate [CAS-No. 67808-35-9] Obtained as a yellow solid (6-66 g). MS (EI) 251 (M+); mp. 78 ° C. Example M18 3-(5-冬基)-3-酉同基-丙乙酉 According to the general procedure 方法 (Method a), using Et3N and MgCl2, in CH3 CN, via Ethyl diacid ethyl ester reaction, prepared from 5-cyano-2-fluoro-benzhydryl chloride [via S〇C12, catalyst DMF in toluene, treated at 80 ° C, from its corresponding Acid [CAS-No. 146328-87-2]] gave a pale-yellow solid (3.85 g). MS (EI) 235 (M+); mp. 55-60 ° C. Example M19 3-(2- 1-Base-p tomb σ all-4-yl)-3-indolyl-propionyl-di-pyrene is prepared according to the general procedure 方法 (method b) by treatment with a third-butyl lithium acetate from 2-imidazole Small base-carbazole-4-carboxylic acid ethyl ester [CAS-No. 256420-32-3]. Obtained orange oil (12.0 g) -91 - This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) ----^----------Install i I (please read the note on the back page first) Order 1255266 A7 _ B7__ V. Invention description (89) Example M20 3- [2-(4-Methyl-mithio-1-yl)-Farunary 4-yl]_3·keto-propionic acid Third-Dining is based on the general procedure 方法 (Method b), via the third _ Lithium acetate-based treatment, prepared from 2-(4-methyl-imidazolidinyl)-thiazole carboxylic acid ethyl ester [by the following synthesis sequence. 1·) NaH, 2-isosulfuryl-i, i-di Methoxy _ propyl, d Mf, 23 ° C; 2.) H2S04 aqueous solution, reflux; 3.) Et0H, concentrated h2S〇4, 23χ: ; 4) 3〇0〇Η: 〇2, HOAc, 23 C, from 2_amine plug π 坐 酸 酸 酉 酉 酉 [256420-32-3])]. Obtained brown oil (8.73 g). MS(EI) 307 (M+) 〇 Example M21 3-[3-(1-Methyl-1H-miso-2-yl)-phenyl]-3-keto-propionic acid Third-butyr Procedure Μ (Method b), prepared by treatment with a third-butyl acetate clock, from ethyl 3-(1-methyl-1H-imidazol-2-yl)benzoate [CAS-No. 168422-44-4] . A pale yellow liquid (1.26 g) was obtained. MS (ISP) 301.3 [(M+H)+]. The following examples relate to the preparation of 6-aryl-2,2-dimethyl-[1,3]dioxanthene (Formula VII) as a structural unit for the synthesis of the compound Composite illustration H):

一般程序N 6-芳基-2,2-二甲基_[1,3]二氧陸圜晞-4-酮之製備 方法a) 6-芳基-2,2-二甲基-[1,3]二氧陸圜烯-4-酮,係根據Chem. Pharm. Bull. 1983, 31,1896,於23°C下,在醋酸異丙締醋中,製自3-芳 基-3-酮基-丙酸與觸媒量之濃h2S04或三氟醋酸(TFA)。將最 -92 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) . I--1 I I (請先閱讀背面之注意事項再本頁) -ir-ά. --線· 經濟部智慧財產局員工消費合作社印製 1255266 經濟部智慧財產局員工消費合作社印製 A7 五、發明說明(9Q) 後產物藉矽膠管柱層析純化,使用己燒/ Et〇Ac。 方法b) 6-芳基-2,2-二甲基-[1,3]二氧陸圜烯斗酮,係根據 Lett. 1998, 39, 2253,於23 C下,在tfa與丙酮之混合物中,經 由以二氟醋酸酐(TFAA)處理,製自3-芳基各酮基_丙酸第三_ 丁酯。若必要則將最後產物藉矽膠管柱層析純化,使用己 燒 / EtOAc。 實例N1 2,2-二甲基-6-噻吩-2-基-[1,3]二氧陸圜烯斗酮 3·酮基-3-噻吩-2-基-丙酸,係根據一般程序M(方法c2),使 用n-BuLi(1.6M,在己烷中,62·5毫升)在醚中,於说。c至〇。〇 下,製自噻吩-2-羰基氯(5.3毫升,50毫莫耳)與丙二酸雙(三 甲基矽烷基)醋(25.6毫升,1〇〇毫莫耳)。根據一般程序Ν (方 法a),經由在醋酸異丙烯酯與TFA中攪拌,使粗製物質(7 88 克)轉皮成彳示越化合物。獲得黃色固體(4 09克)。 MS (EI) 210 (M+);熔點 42°C (分解)。 實例N2 6-(3-氯-嘧吩-2-基)-2,2-二甲基-[U]二氧陸圜烯冬酮 3-(3-氯-嘧吩-2-基)各g同基-丙酸,係根據一般程序M (方法cl) ’使用Ey N (12.65毫升,90.7毫莫耳)與LiBr (3 53克,47·5毫莫 耳)在CH3 CN中,於〇。(:下製自3-氣—塞吩冬羰基氣(7.82克, 43·2毫莫耳)與丙二酸雙(三甲基矽烷基)醋(ιι 6毫升,45 4毫 j耳)。根據一般程序Ν (方法a),經由在醋酸異丙烯酯與 濃中攪拌,使粗製物質(5.69克)轉變成標題化合物。 ____-93- 本紙張尺度適用中_家標準(CNS)A4規格(21Q χ挪公髮) ----^----------裝--- (請先閱讀背面之注意事項本頁) _ 線· 1255266 經濟部智慧財產局員工消費合作社印製 A7 B7__ 五、發明說明(91 ) 獲得橘色固體(2.3克)。 MS (EI) 244 (M+)與 246 [(M+2)+ ];熔點 88-89°C (分解)。 實例N3 6-(3-氰基-魂吩-2-基)-2,2·二甲基-[1,3]二氧陸圜缔冰酮 3-(3-氰基-p塞吩-2-基)-3-酮基-丙酸,係根據一般程序μ (方法 cl) ’ 使用 Et3N (41¾:升,295.4 毫莫耳)與LiBr (13.5克,154.7 毫 莫耳)在CH3 CN中’於0°C下製自3-氰基-遠吩_2-羰基氯(24.33 克,140.6毫莫耳)與丙二酸雙(三甲基矽烷基)g旨(38 〇毫升, 147.7耄莫耳)。根據一般程序n (方法a),經由在錯酸異丙 烯酯與濃H^SO4中攪拌,使粗製物質(24·8克)轉變化成標題 化合物。獲得橘色固體(5.6克)。 MS (ΕΙ) 235 (Μ+);熔點 116-12CTC (分解)。 實例N4 3-(2,2-二甲基-6-酮基-6H-[1,3]二氧陸圜烯-4·«基)-苯甲腈 3-(3-氰基-苯基)-3-酮基-丙酸,係根據一般程序M (方法c2) ,使用n-BuLi (1.6M,在己烷中,6.25毫升)在醚中,於_6(rc 至下製自氣化3-氰基苯甲酿(828毫克,5毫莫耳)與丙二 酸雙(三甲基矽烷基)醋(2.56毫升,10毫莫耳)。根據一般程 序N (方法a),經由在醋酸異丙烯酯與TFA中攪拌,使粗製 物質(1.04克)轉變成標題化合物。獲得淡黃色固體(〇8克)。 MS (EI) 229 (M+);熔點 i38°C (分解)。 實例N5 2,2-二甲基-6-(3-三氟甲基-苯基)+,3]二氧陸圜烯斗酮 3-酮基〇-(3-二說甲基_苯基)_丙酸,係根據一般程序μ (方 -94- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ----Ρ---------裝--- (請先閱讀背面之注意事項本頁) 訂: :線- 1255266General procedure for the preparation of N 6-aryl-2,2-dimethyl-[1,3]dioxanthene-4-one a) 6-aryl-2,2-dimethyl-[1 , 3] Dioxordecene-4-one, according to Chem. Pharm. Bull. 1983, 31, 1896, at 23 ° C in isopropyl acetate, from 3-aryl-3- The keto-propionic acid is in a concentrated amount of h2S04 or trifluoroacetic acid (TFA). Apply the most -92 - paper size to the Chinese National Standard (CNS) A4 specification (210 X 297 mm). I--1 II (please read the back note first on this page) -ir-ά. --Line · Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed A7 V. Inventive Note (9Q) The product was purified by column chromatography using hexane / Et〇Ac. Method b) 6-aryl-2,2-dimethyl-[1,3]dioxanthene ketone, according to Lett. 1998, 39, 2253, at 23 C, a mixture of tfa and acetone The third-butyl ester of 3-aryl keto-propionic acid was prepared by treatment with difluoroacetic anhydride (TFAA). If necessary, the final product was purified by column chromatography using hexane / EtOAc. Example N1 2,2-Dimethyl-6-thiophen-2-yl-[1,3]dioxanthene ketone 3·keto-3-thiophen-2-yl-propionic acid, according to the general procedure M (method c2), using n-BuLi (1.6 M in hexane, 62. 5 ml) in ether, said. c to 〇. The oxime was prepared from thiophene-2-carbonyl chloride (5.3 ml, 50 mmol) with bis(trimethyldecyl) oxalate (25.6 ml, 1 mM millimolar). According to the general procedure 方 (method a), the crude material (78 g) was transferred to the oxime compound by stirring in isopropenyl acetate and TFA. Obtained a yellow solid (4 09 g). MS (EI) 210 (M+); mp 42 (dec.). Example N2 6-(3-Chloro-pyrimidin-2-yl)-2,2-dimethyl-[U]dioxolene oxime 3-(3-chloro-pyrimen-2-yl) G-iso-propionic acid, according to the general procedure M (method cl) 'Use Ey N (12.65 ml, 90.7 mmol) and LiBr (3 53 g, 47·5 mmol) in CH3 CN, in 〇 . (: Manufactured from 3-gas-cetobutanyl carbonyl (7.82 g, 43. 2 mmol) and bis(trimethyldecyl) oxalate (ι 6 ml, 45 4 mmol). According to the general procedure 方法 (Method a), the crude material (5.69 g) was converted to the title compound by stirring in isopropyl acetate and concentrated. ____-93- This paper scale applies to the _ home standard (CNS) A4 specification ( 21Q χχ公发) ----^----------装--- (Please read the back note on this page first) _ Line · 1255266 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing A7 B7__ V. Inventive Note (91) Obtained an orange solid (2.3 g) MS (EI) 244 (M+) and 246 [(M+2)+]; mp 88-89 ° C (decomposition). Example N3 6 -(3-cyano-soul-2-yl)-2,2·dimethyl-[1,3]dioxanthrone-ketone 3-(3-cyano-p-cephen-2-yl) )-3-keto-propionic acid, according to the general procedure μ (method cl) 'Use Et3N (413⁄4: liter, 295.4 millimoles) with LiBr (13.5 grams, 154.7 millimoles) in CH3 CN 'at 0 Made from 3-cyano-farophene-2-carbonyl chloride (24.33 g, 140.6 mmol) and bis(trimethyldecane) malonate at °C ) g (38 ml, 147.7 mol). According to the general procedure n (method a), the crude material (24·8 g) was changed to the title by stirring in the wrong acid isopropenyl ester and concentrated H^SO4. Compound: Obtained as an orange solid (5.6 g). MS ( s) 235 ( Μ+); melting point 116-12 CTC (decomposition). Example N4 3-(2,2-dimethyl-6-keto-6H-[ 1,3]dioxantemene-4·«yl)-benzonitrile 3-(3-cyano-phenyl)-3-keto-propionic acid, according to the general procedure M (method c2) n-BuLi (1.6M in hexane, 6.25 ml) in ether, _6 (rc to below) self-gasification 3-cyanobenzoic (828 mg, 5 mmol) with malonic acid Bis(trimethyldecyl) vinegar (2.56 ml, 10 mmol). The crude material (1.04 g) was converted to the title compound by stirring in EtOAc (EtOAc) Obtained as a pale-yellow solid (m.p. 8g). MS (ESI) 229 (M+); mp. )+,3]dioxanthene ketone 3-keto oxime-(3-di-methyl-phenyl)-propionic acid, according to general Order μ (square-94- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) ----Ρ---------装--- (Please read the back Note this page) Order: :Line - 1255266

五、發明說明(92) 法cl),使用Et3N(20毫升,142毫莫耳)與LiBr(646克,744亳 莫耳)在CHsCN中,於〇°C下製自氣化弘三氟甲基苯甲醯(ω 笔升,67.6笔莫耳)與丙二酸雙(三甲基矽燒基)酉旨(丨8·2毫升, 71毫莫耳)。根據一般程序Ν(方法a),經由在醋酸異丙烯 酯與濃i^sc»4攪拌,使粗製物質(所獲得154克中之7〇克)轉 變成標題化合物。獲得淡黃色固體(5 3克)。 MS (EI) 272 (M+);熔點 77-78°C (分解)。 實例N6 6-(3-氣苯基)-2,2-二甲基-[1,3]二氧陸圜烯_4_酮 3-(3-氣苯基)-3-酮基-丙酸,係根據一般程序μ(方法ci),使 用EtsN (25毫升,180毫莫耳)與LiBr (8.19克,94·3毫莫耳)在 C^CN中,於〇°C下製自氣化3_氣基苯甲醯(11毫升,85·7毫 莫耳)與丙二酸雙(三甲基矽烷基)g旨(23.〇毫升,9〇 〇毫莫耳) 。根據一般程序N (方法a),經由在醋酸異丙烯酯與濃 H2 SO4中攪拌,使粗製物質(17.1克)轉變成標題化合物。獲 得黃褐色固體(8.0克)。 MS (EI) 238 (M+)與 240 [(M+2)+ ];熔點 87-88°C (分解)。 實例N7 6-(3-碘苯基)-2,2-二甲基-[1,3]二氧陸圜烯-4-酮 3-(3-碘苯基)各酮基-丙酸,係根據一般程序Μ(方法cl),使 用Et3N(23毫升,165.5毫莫耳)與LiBr(7.54克,86.7毫莫耳)在 CH3 CN中,於〇°C下製自氣化3-碘基苯甲醯(21.0克,78.8毫 莫耳)與丙二酸雙(三甲基矽烷基)酯(21.0毫升,82.8毫莫耳) 。根據一般程序N (方法a).,經由在醋酸異丙烯酯與濃 -95- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) I---.---------裝--- (請先閱讀背面之注意事項再本頁) . 經濟部智慧財產局員工消費合作社印製 1255266V. Description of the invention (92) Method cl), using Et3N (20 ml, 142 mmol) and LiBr (646 g, 744 亳 Mo) in CHsCN, at 〇 ° C, self-gasification Benzobenzidine (ω pen liter, 67.6 moles) and bis(trimethylsulfonyl) malonate (丨8·2 ml, 71 mmol). The crude material (7 g of the obtained 154 g) was converted to the title compound by stirring in EtOAc (EtOAc). Obtained as a pale yellow solid (5 3 g). MS (EI) 272 (M+); mp. 77-78 (dec.). Example N6 6-(3-Phenylphenyl)-2,2-dimethyl-[1,3]dioxolene-4-ylketone 3-(3-phenylphenyl)-3-keto-propanyl Acid, according to the general procedure μ (method ci), using EtsN (25 ml, 180 mmol) and LiBr (8.19 g, 94·3 mmol) in C^CN, at 〇 ° C 3_ gas-based benzamidine (11 ml, 85·7 mmol) and bis(trimethyldecyl) malonate (23. 〇 ml, 9 〇〇 millimolar). The crude material (17.1 g) was converted to the title compound by stirring in EtOAc EtOAc (EtOAc). A tan solid (8.0 g) was obtained. MS (EI) 238 (M+) and 240 [(M+2)+]; mp. 87-88 ° C (dec.). Example N7 6-(3-iodophenyl)-2,2-dimethyl-[1,3]dioxolene-4-one 3-(3-iodophenyl) keto-propionic acid, According to the general procedure 方法 (method cl), using Et3N (23 ml, 165.5 mmol) and LiBr (7.54 g, 86.7 mmol) in CH3 CN, self-gasification 3-iodo group at 〇 ° C Benzoquinone (21.0 g, 78.8 mmol) with bis(trimethyldecyl)malonate (21.0 mL, 82.8 mmol). According to the general procedure N (method a)., apply the Chinese National Standard (CNS) A4 specification (210 X 297 mm) via the isopropenyl acetate and concentrated-95- paper scales I-------- ----装--- (Please read the notes on the back and then this page). Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 1255266

五、發明說明(93) ΗΘ〇4中攪拌,使粗製物質(2i.9克)轉變成標題化合物。獲 得黃色固體(9.6克)。 ----:----------裝— (請先閱讀背面之注意事項本頁) MS (EI) 330 (M+);熔點 79-80°C (分解)。 實例N8 2,2-二甲基各(3-三氟甲氧基-苯基)^]二氧陸圜蹄冰酉同 3-酮基-3-(3-二氟甲氧基-苯基)-丙酸,係根據一般程序 方法cl),使用與LiBr,在〇^(^中,於此下製自氯化 3-二氟甲氧苯甲醯與丙二酸雙(三甲基矽烷基庙。根據一般 程序N(方法a),經由在醋酸異丙烯酯與濃As%中攪拌, 使粗製物質轉變成標題化合物。獲得橘色固體(2.27克)。 MS (EI) 288 (M+);熔點 49-54°C (分解)。 實例N9 2,2·—甲基各p比淀-4-基-[1,3]二氧陸圜晞酮 -線· 根據一般程序N (方法b),經由以丙酮、TFA及TFAA處理 ,製自3-酮基-3-吡啶-4-基-丙酸[根據抗生素期刊1978, 31,1245 ’在DMF中,於120 C下製自4-乙酿咐淀、碳酸甲g旨鎂及 C02]。獲得白色固體(1.3克)。 MS(EI) 205 (M+)。 經濟部智慧財產局員工消費合作社印製 實例N10 6-(3-咪哇-1-基-苯基)-2,2-二甲基-[1,3]二氧陸圜烯-4-酮 3-(3-咪唑-1-基-苯基)-3-酮基-丙酸,係根據一般程序Μ (方法 cl),使用Et3N與LiBr,在CH3 CN中,於〇°C下製自氣化Η1Η-咪唑-1-基)苯甲醯鹽酸鹽[經由以SOCl·^處理3-(1Η-咪唑小基)苯 甲酸(J· Med· Chem· 1987, 30, 1342 ; CAS·編號[108035-47-8]而製成] -96 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 'V. INSTRUCTION INSTRUCTION (93) Stir in ΗΘ〇4 to convert the crude material (2i.9 g) to the title compound. A yellow solid (9.6 g) was obtained. ----:----------Installation—(Please read the note on the back page first) MS (EI) 330 (M+); Melting point 79-80°C (decomposition). Example N8 2,2-Dimethyl(3-trifluoromethoxy-phenyl)^]dioxanthine scorpion with 3-keto-3-(3-difluoromethoxy-phenyl - propionic acid, according to the general procedure method cl), using with LiBr, in 〇 ^ (^, here from chlorinated 3-difluoromethoxybenzopyrene and malonic acid bis (trimethyl decane) The base was converted to the title compound by stirring in EtOAc EtOAc (EtOAc) EtOAc (EtOAc) Melting point 49-54 ° C (decomposition). Example N9 2,2·-methyl each p than phospho-4-yl-[1,3]dioxanthone-line · according to the general procedure N (method b ), prepared by treatment with acetone, TFA and TFAA, from 3-keto-3-pyridin-4-yl-propionic acid [according to antibiotic journal 1978, 31, 1245 'in DMF, at 120 C from 4-C) B. 咐 、 , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , . -1-yl-phenyl)-2,2-dimethyl-[1,3]dioxolene-4-one 3-(3-imidazol-1-yl-phenyl)-3-one -propionic acid, according to the general procedure 方法 (method cl), using Et3N and LiBr, in CH3 CN, at 〇 ° C, self-vaporizing Η 1Η-imidazol-1-yl) benzamidine hydrochloride [via SOCl·^ treatment of 3-(1Η-imidazole small group) benzoic acid (J· Med·Chem· 1987, 30, 1342; CAS·No. [108035-47-8]] -96 - This paper size is applicable to China National Standard (CNS) A4 specification (210 X 297 mm) '

1255266 五、發明說明(94) 與丙二酸雙(三甲基矽烷基)醋。根據一般程序!^(方法a), 經由在醋酸異丙烯酯與濃H2S〇4中攪拌,使粗製物質轉變成 標題化合物。獲得橘色半固體(617毫克)。 MS(EI) 270 (M+)。 實例Nil 2.2- 二甲基-6-(3-甲氧基-苯基)-[ι,3]二氧陸圜烯_4•酮 3-(3-甲氧基-苯基)-3-酮基-丙酸,係根據一般程序%(方法cl) ,使用Et3N(17.7毫升,127毫莫耳)與UBr (5.77克,66·4毫莫 耳)在CHfN中,於〇°C下製自氣化3_甲氧苯甲醯(1〇·3克, 60.4愛莫耳)與丙二酸雙(三甲基矽烷基)g旨(16·2毫升,63.4毫 莫耳)。根據一般程序Ν (方法a),經由在醋酸異丙烯酯與 濃H^SO4中攪拌,使粗製物質(6.38克)轉變成標題化合物。 獲得黃色油(640毫克)。 MS (ISP) 235 [(M+H)+ ]與 252 [(M+NH4)+ ]。 實例N12 2.2- 二甲基-6·(3-硝基-苯基)-[ι,3]二氧陸圜烯_4-酮 3-(3-硝基-苯基)各酮基-丙酸第三-丁酯,係根據一般程序 Μ(方法a),使用Et3N(4.5毫升,32.2毫莫耳)與MgCl2(3.48克 ,36.52毫莫耳)在CH3 CN中製自氯化3-硝基苯甲醯(2.71克, 14.6毫莫耳).與丙二酸第三-丁酯鉀鹽(6 〇克,3〇 〇毫莫耳)。 根據一般程序N (方法b),經由在TFA /丙酮與TFAA中攪拌 ,使粗製物質(3.88克)轉變成標題化合物。獲得黃色固體 (2.76 克)。 MS(EI)249 (M+);熔點 ll〇-u7°c。 - -97- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公餐) ---J----------裝 i I (請先閱讀背面之注意事項再本頁) · 線- 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明(95) 實例N13 ----l·---------裝—— (請先閱讀背面之注意事項再本頁) 2.2- 二甲基-6-(3-[1,2,4]三峻-1-基-苯基)_[丨,3]二氧陸圜烯冰酮 3-酮基-3-(3-[1,2,4]三唑小基-苯基)_丙酸第三-丁醋[r〇_69_ 3506/000]係根據一般程序Μ (方法b),經由以第三_ 丁基醋酸 麵處理,製自3-[1,2,4]三唑-1-基-苯甲酸甲酯[CAS-編號167626_ 27_9]。根據一般程序N (方法b),經由在TFA /丙酮與TFAA 中攪拌,製自(實例M6)。獲得黃色固體(539毫克)。 MS(EI)271(M+) 〇 實例N14 6-(2-咪唆-1-基-ρ比淀-4-基)-2,2-二甲基_[1,3]二氧陸圜晞酮 根據一般程序N (方法b),經由在TFA /丙酮與丁FAA中攪 掉’製自3-(2-味。坐-1-基-p比淀-4-基)-3-嗣基-丙酸第三-丁 g旨(實 例M5)。獲得褐色固體(10.8克)。 MS (EI) 271 (M+);熔點 151°C (分解)。 ·_ 線- 實例N15 2.2- 二甲基-6-[3-(2-甲基-咪唑小基)-苯基]-[1,3]二氧陸圜烯-4-酮 根據一般程序N (方法b),經由在TFA /丙酮與TFAA中攪 經濟部智慧財產局員工消費合作社印製 掉’製自3-[3-(2·甲基-味。坐-1-基)-木基]-3-嗣基-丙酸第三-丁酉旨( 實例M8)。獲得米黃色固體(2.13克)。 MS (EI) 284 (M+);熔點 122°C。 實例N16 4-(2,2,二甲基各酮基-6H-[1,3]二氧陸圜烯-4-基)-吡啶-2-甲腈 根據一般程序N (方法b),經由在TFA /丙酮與TFAA中攪 拌,製自3-(2-氰基—比啶-4-基)-3-酮基-丙酸第三-丁酯(實例M10) -98- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266 A71255266 V. Description of the invention (94) with bis(trimethyldecyl) vinegar. According to the general procedure! ^(Method a), the crude material was converted to the title compound by stirring in isopropyl acetate and concentrated H.sub.2. Obtained an orange semi-solid (617 mg). MS (EI) 270 (M+). Example Nil 2.2-Dimethyl-6-(3-methoxy-phenyl)-[ι,3]dioxolene-4-butanone 3-(3-methoxy-phenyl)-3- Keto-propionic acid, according to the general procedure % (method cl), using Et3N (17.7 ml, 127 mmol) and UBr (5.77 g, 66·4 mmol) in CHfN at 〇 ° C Self-gasification of 3-methoxybenzothymidine (1 〇·3 g, 60.4 Amol) and bis(trimethyldecyl) malonate (16. 2 ml, 63.4 mmol). The crude material (6.38 g) was converted to the title compound by stirring in EtOAc EtOAc (EtOAc). Obtained yellow oil (640 mg). MS (ISP) 235 [(M+H)+] and 252 [(M+NH4)+]. Example N12 2.2-Dimethyl-6·(3-nitro-phenyl)-[ι,3]dioxolene-4-one 3-(3-nitro-phenyl) keto-propyl Acidic third-butyl ester, according to the general procedure 方法 (method a), using Et3N (4.5 ml, 32.2 mmol) and MgCl2 (3.48 g, 36.52 mmol) in CH3 CN from chlorinated 3-nitrate Benzobenzamide (2.71 g, 14.6 mmol). Potassium tert-butylate malonate (6 g, 3 〇〇 millimolar). The crude material (3.88 g) was converted to the title compound by stirring in TFA /EtOAc and EtOAc. Obtained a yellow solid (2.76 g). MS (EI) 249 (M+); m.p. - -97- This paper size is applicable to China National Standard (CNS) A4 specification (210 X 297 public) ---J----------Install i I (please read the back note first) Page) · Line - Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 A7 B7 V. Invention Description (95) Example N13 ----l·---------Installation - (Please read the back first Precautions on this page) 2.2-Dimethyl-6-(3-[1,2,4]tris-l-yl-phenyl)_[丨,3]dioxene decyl ketone 3- Ketopropyl-3-(3-[1,2,4]triazole small-phenyl)-propionic acid tert-butyl vinegar [r〇_69_ 3506/000] according to the general procedure 方法 (method b), It was prepared from 3-[1,2,4]triazol-1-yl-benzoic acid methyl ester [CAS-No. 167626_27_9] by treatment with a third butyl acetate. According to the general procedure N (Method b), it was prepared by stirring in TFA / acetone and TFAA (Example M6). Obtained a yellow solid (539 mg). MS (EI) 271 (M+) 〇 Example N14 6-(2-Min-1-yl-p-preo-4-yl)-2,2-dimethyl-[1,3]dioxane The ketone was prepared according to the general procedure N (Method b) by stirring in TFA/acetone and butyl FAA from 3-(2-flavor.spin-1-yl-p-pred-4-yl)-3-indenyl - Propionic acid third - butyl g (example M5). A brown solid (10.8 g) was obtained. MS (EI) 271 (M+); m.p. · _ line - Example N15 2.2-Dimethyl-6-[3-(2-methyl-imidazolyl)-phenyl]-[1,3]dioxolene-4-one according to the general procedure N (Method b), printed in TFA / Acetone and TFAA, Ministry of Economic Affairs, Intellectual Property Office, Staff Cooperatives, printed, produced from 3-[3-(2.methyl-flavor. sit-1-yl)-wood base ]-3-mercapto-propionic acid third-butyr (example M8). Obtained as a beige solid (2.13 g). MS (EI) 284 (M+); mp. Example N16 4-(2,2,Dimethylhexanyl-6H-[1,3]dioxolyn-4-yl)-pyridine-2-carbonitrile according to General Procedure N (Method b) Stirring in TFA / acetone and TFAA from 3-(2-cyano-pyridin-4-yl)-3-keto-propionic acid tert-butyl ester (Example M10) -98- This paper size applies China National Standard (CNS) A4 Specification (210 X 297 mm) 1255266 A7

五、發明說明(96) 。獲得褐色固體(3.30克)。 MS (EI) 230 (M+);熔點 132°C (分解)。 下述實例係關於以區域異構物上純之方式製備4,心二芳基-1,3-二氫苯幷[bHM]二吖庚因-2-酮,個別爲4_芳基各芳基乙炔 基-1,3-二氫苯幷[b][1,4]二吖庚因冬酮與8•芳醯基斗芳基少二 氫苯幷[b][l,4]二吖庚因-2-酮(合成圖示: 一般程序Ο 經由(2·胺基'^芳基-苯基)-胺曱基酸第三-丁酯與3-芳基-3-酮基 -丙酸乙酯或6-芳基-2,2-二甲基_[1,3]二氧陸圜烯斗酮之反應, 製備{2-[3-芳基-3-酮基、丙醯基胺基]+芳基-苯基卜胺甲基酸第 三-丁酯; 亦經由2-硝基斗芳基-苯基胺與卜芳基_2,2_二甲基_[丨,3]二氧陸 圜烯I酮之反應,製備芳基-Ν-(2-硝基_4_芳基-苯基)-3-酮基-丙醯胺 使(2-胺基-4-芳基-苯基)_胺甲基酸第三_丁酯或2_硝基冰芳基 -苯胺(1_0 t莫耳)與過量(1·2-15毫莫耳)孓芳基各酮基_丙酸乙 經濟部智慧財產局員工消費合作社印製 ----:---------裝--- (請先閱讀背面之注意事項再@本頁) :線 酯[根據合成期刊1993, 290,使用Et3 Ν與MgCl2,在CH3 CN中 ,於23 C下製自氣化芳醯與丙二酸乙酯鉀鹽]或6-芳基-2,2-二 甲基-[1,3]二氧陸圜烯斗酮之混合物,在甲苯(8毫升)中回流 ’直到tlc顯示胺完全消耗爲止。使溶液冷卻至23Ό,於是 產物大致上已結晶(在結晶化作用未顯現之情況中,藉由添 加己坑引致 &lt;)。將固體過濾,以醚或醚/己烷混合物洗滌 ’並在眞空中乾燥,而得{2-[3-芳基各酮基-丙醯基胺基]-4-芳 基-苯基胺甲基酸第三_丁酯或芳基具(2-硝基冬芳基·苯基 ___ -99- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公复) &quot; !255266V. Description of invention (96). A brown solid (3.30 g) was obtained. MS (EI) 230 (M+); mp. The following examples relate to the preparation of 4, bistriaryl-1,3-dihydrophenylhydrazone [bHM]dioxepin-2-one in a pure manner on a regioisomer, individually 4 aryl aryl Ethyl ethynyl-1,3-dihydrophenylhydrazine [b][1,4]dioxanone and 8•arylindoleyl aryldihydrophenylhydrazine[b][l,4]dioxin Gyne-2-one (Synthesis Scheme: General Procedure 经由 via (2. Amino '^aryl-phenyl)-Amino-Mercaptoic Acid Tri-Butyl Ester with 3-Aryl-3-keto-Pro Preparation of {2-[3-aryl-3-keto, propyl ketone) by the reaction of ethyl acetate or 6-aryl-2,2-dimethyl-[1,3]dioxanthene Amino]+aryl-phenyl-b-aminomethyl-tert-butyl ester; also via 2-nitropanearyl-phenylamine and aryl-2,2-dimethyl-[[,3] Preparation of aryl-indole-(2-nitro-4-yl-phenyl)-3-keto-propanamide to give 2-amino-4-aryl- Phenyl)-amine methyl acid third-butyl ester or 2-nitrohaaryl-aniline (1_0 t-mole) with excess (1·2-15 mmol) aryl aryl ketone-propionic acid B Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing -----:--------- loaded--- (please read the back of the note first) @@)): Line ester [According to Synthetic Journal 1993, 290, using Et3 Ν and MgCl2, in CH3 CN, at 23 C, self-gasification of lanthanum and ethyl malonate potassium salt] or 6-fang a mixture of benzyl-2,2-dimethyl-[1,3]dioxanthene ketone, refluxed in toluene (8 ml) until tlc showed complete consumption of the amine. The solution was cooled to 23 Torr, then the product It is substantially crystallized (in the case where crystallization does not appear, by adding pits to cause &lt;). The solid is filtered, washed with ether or ether/hexane mixture 'and dried in the air, and {2- [3-aryl keto-propionylamino]-4-aryl-phenylamine methyl acid tert-butyl ester or aryl (2-nitro-t-arylphenyl) ___ 99- This paper size applies to China National Standard (CNS) A4 specification (210 X 297 public) &quot; !255266

^ 女,宁其直接使用於下一步驟,或若必要,則 將其藉再結晶或藉矽膠管柱層析純化。 /、 tjH 01 {2仰·氰基-苯基&gt;3,基福基胺基Μ•破基_5_硫代嗎福琳_ 4-基-苯基}-胺甲基酸第三-丁醋 根據一般程序〇,u(2m琪基_5_疏代嗎福&lt;_4_基 苯基胺甲基酸第三-丁醋(實例L1)(653毫克,15毫莫耳)^3· (2,2^甲基_6_酮基-叫1,3]:氧陸圜缔斗基)-苯甲腈(實例N4) (690笔克,2.25毫莫耳)。獲得黃色固體(629毫克)。 MS (ISP) 607 [(M+H)+] 〇 實例02 {2-[3·(3-氰基-苯基酮基_丙醯基胺基]冰碘基嗎福啉冰基_ 苯基}-胺甲基酸第三_丁酉旨 根據一般程序0,製自(2_胺基-4-碘基-5-嗎福啉冰基-苯基)-胺甲基酸第三-丁酯(實例L2)(690毫克,165毫莫耳)與孓(2,2_ 一甲基-6-酮基-6H-[1,3]二氧陸圜烯-4-基)-苯甲腈(實例N4)(566 毫克,2.47毫莫耳)。獲得橘色固體(523毫克)。 MS (ISP) 591 [(M+H)+ ]與 613 [(M+Na)+ ]。 實例〇3 {2-氣基-5-[3-(3-氰基-苯基)-3-酮基-丙酿基胺基]_聯苯基-4-基}-胺甲基酸第三-丁酯 根據一般程序〇,製自(5-胺基-2-氣-聯苯基-4-基)-胺甲基酸 第三-丁酯(實例L6)(652毫克,2.05毫莫耳)與3-(2,2-二甲基各 酮基-6H-[1,3]二氧陸圜烯斗基)-苯甲腈(實例N4)(564毫克,2.46 100- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -----I I------裝 i I (請先閱讀背面之注意事項再本頁) -Jr-a· :線· 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明(98 ) 毫莫耳)。獲得灰白色固體(725毫克)。 -----1---------裝--- (請先閱讀背面之注意事項再本頁) MS (ISN) 488 [(M-Η)· ] 〇 實例〇4 [2-[3-(3-氰基-苯基&gt;3-酮基-丙醯基胺基]-5-(2-二甲胺基-乙硫基)_ 4-苯基乙決基-苯基]-胺甲基酸第三-丁酯 根據一般程序0,製自[2-胺基-5-(2-二甲胺基-乙硫基)-4-苯 基乙炔基-苯基]-胺甲基酸第三-丁酯(實例L8)(206毫克,0.5 毫莫耳)與3-(2,2-二甲基-6-酮基-6H-[1,3]二氧陸圜烯-4-基)-苯甲 月膏(實例N4)(138毫克,0.6毫莫耳)。獲得黃色固體(210毫克)。 MS (ISP) 583 [(M+H)+ ];熔點 88°C。 實例05 {5-第三-丁氧羰基胺基-4-[3-(3-氰基-苯基)-3-酮基-丙醯基胺基]_ 2-苯基乙块基-苯硫基]-醋酸甲酯 :線- 根據一般程序Ο,製自(4-胺基-5-第三-丁氧羰基胺基-2-苯 基乙炔基-苯硫基)·醋酸甲酯(實例L9)(534毫克,1.3毫莫耳) 與3-(2,2-二甲基-6·酮基-6H-[1,3]二氧陸圜烯-4-基)-苯甲腈(實例 N4)(358毫克,1.56毫莫耳)。獲得黃色泡沫物(457毫克)。 經濟部智慧財產局員工消費合作社印製 MS (ISP) 584 [(M+H)+ ],601[(M+NH4)+ ]及 605 [(M+Na)+ ];熔點 69-73 °C ° 實例06 {5-第三-丁氧羰基胺基-4-[3-(3-氰基-苯基)-3-酮基-丙醯基胺基]-2-苯基乙炔基-苯基}-醋酸甲酯 根據一般程序Ο,製自(4-胺基-5-第三-丁氧羰基胺基-2-苯 基乙炔基·苯基)-醋酸甲酯(實例L10)(721毫克,2.0毫莫耳)與 -101 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) J255266 A7 五、 經濟部智慧財產局員工消費合作社印製 發明說明(99 ) 3-(2,2-二甲基-6-酮基-6H-[1,3]二氧陸圜烯-4-基)-苯甲腈(實例 N4)(550毫克,2.4毫莫耳)。獲得淡黃色固體(886毫克)。 MS (ISP) 552 [(M+H)+ ]與 569 [(M+NH4)十];熔點 138°C。 實例07 [2-[3-(3-氰基-苯基)各酮基-丙醯基胺基]-5-(2-甲氧基-乙氧基)冬 苯基乙炔基-苯基]-胺甲基酸第三-丁酯 根據一般程序0,製自〇胺基-5-(2-甲氧基-乙氧基)-4-苯基 乙块基-苯基]-胺甲基酸第三-丁酯(實例Lll)(415毫克,1.09毫 莫耳)與3·(2,2-二甲基-6-酮基-6H-[1,3]二氧陸圜晞-4-基)-苯甲腈 (實例N4)(373毫克,1.63毫莫耳)。獲得淡黃色固體(137毫克)。 MS (ISP) 554 [(M+H)+],571 [(M+NH4)+]及 576 [(M+Na)+];熔點 175-176〇C 〇 實例08 {2-[3-(3-氰基-苯基)-3-g同基-丙醯基胺基]·5_甲氧基-4-苯基乙炔 基·苯基}-胺甲基酸第三-丁酯 根據一般程序0,製自(2-胺基-5-曱氧基斗苯基乙炔基-苯 基)-胺甲基酸第三-丁酯(實例L12)(338毫克,1·〇毫莫耳)與3_ (2,2-二甲基-6-酮基-6Η-[1,3]二氧陸圜晞-4-基)-苯甲腈(實例 Ν4)(252毫克,U毫莫耳)。獲得黃色固體(388毫克)。 MS (ISP) 510 [(Μ+Η)+ ],527 [(Μ+ΝΗ4)+ ]與 532 [(M+Na)+ ];熔點 169。(:。 實例〇9 5-第三-丁氧羰基胺基-4-[3-(3-氰基-苯基)冬酮基-丙醯基胺基]_ 2-苯基乙炔基-苯甲酸甲酯 根據一般程序Ο ’製自4-胺基-5-第三-丁氧羰基胺基苯基 102- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ----l·---------裝 i — (請先閱讀背面之注意事項本頁) 訂: 1255266 A7 B7 五、發明說明(100) -----:----------裝--- (請先閱讀背面之注意事項再本頁) 乙炔基-苯甲酸甲酯(實例L14X396毫克,1.08毫莫耳)與3-(2,2-一甲基-6-酮基-6H-[1,3]二氧陸圜晞冰基)_苯甲腈(實例N4)(273 毫克,1.19毫莫耳)。獲得灰白色固體(54〇毫克)。^ Female, it is used directly in the next step, or if necessary, it is recrystallized or purified by column chromatography. /, tjH 01 {2 ano-cyano-phenyl>3, kefosylamine 破•cracking _5_thiofenofin _ 4-yl-phenyl}-amine methyl acid third- Ding vinegar according to the general procedure 〇, u (2m Qiji _5_ 代代福福 &lt;_4_ phenyl phenylamine methyl acid third-butyl vinegar (example L1) (653 mg, 15 millimoles) ^ 3 · (2,2^methyl_6-keto-- 1,3): oxoquinone-benzonitrile (example N4) (690 g, 2.25 mmol). Obtained a yellow solid ( 629 mg) MS (ISP) 607 [(M+H)+] 〇 Example 02 {2-[3·(3-Cyano-phenyl keto-propionylamino) ice iodophorronate ice The base _ phenyl}-amine methyl acid third _ 酉 酉 according to the general procedure 0, from (2_amino-4-iodo-5-morpholine ice-phenyl)-amine methyl acid Tri-butyl ester (Example L2) (690 mg, 165 mmol) and hydrazine (2,2-monomethyl-6-keto-6H-[1,3]dioxol-4-yl)- Benzoonitrile (Example N4) (566 mg, 2.47 mmol) afforded an orange solid (523 mg). MS (ESI) 591 [(M+H)+] and 613 [(M+Na)+]. Example 〇3 {2-Alkyl-5-[3-(3-cyano-phenyl)-3-keto-propyl-arylamino]-biphenyl-4-yl}-amine methyl acid three- Butyl ester was prepared according to the general procedure from (3-amino-2-methyl-biphenyl-4-yl)-amine methyl acid tert-butyl ester (Example L6) (652 mg, 2.05 mmol) With 3-(2,2-dimethylglycosyl-6H-[1,3]dioxanthene)-benzonitrile (Example N4) (564 mg, 2.46 100- this paper size applies to China National Standard (CNS) A4 Specification (210 X 297 mm) -----I I------ Install i I (Please read the back note before this page) -Jr-a· :Line· Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 A7 B7 V. Invention Description (98) Miller) Obtained off-white solid (725 mg). -----1--------- -- (Please read the notes on the back and then on this page) MS (ISN) 488 [(M-Η)· ] 〇Example〇4 [2-[3-(3-Cyano-phenyl)-3 Base-propionylamino]-5-(2-dimethylamino-ethylthio)-4-phenylethyl-phenyl]-aminomethyl acid tert-butyl ester according to the general procedure 0, Made from [2-amino-5-(2-dimethylamino-ethylthio)-4-phenylethynyl-phenyl]-amine methyl acid tert-butyl ester (Example L8) (206 mg , 0.5 mM) and 3-(2,2-dimethyl-6-keto-6H-[1,3] Lu won oxygen-4-yl) - benzoic months cream (Example N4) (138 mg, 0.6 mmol). Obtained a yellow solid (210 mg). MS (ISP) 583 [(M+H)+]; mp. Example 05 {5-Terti-butoxycarbonylamino-4-[3-(3-cyano-phenyl)-3-keto-propionylamino]- 2-phenylethylidene-benzene Thio]-methyl acetate: line - according to the general procedure, from (4-amino-5-tris-butoxycarbonylamino-2-phenylethynyl-phenylthio)-methyl acetate ( Example L9) (534 mg, 1.3 mmol) with 3-(2,2-dimethyl-6-keto-6H-[1,3]dioxol-4-yl)-benzonitrile (Example N4) (358 mg, 1.56 mmol). Yellow foam (457 mg) was obtained. MS (ISP) 584 [(M+H)+ ], 601[(M+NH4)+ ] and 605 [(M+Na)+ ]; Melting Point 69-73 °C ° Example 06 {5-Terti-butoxycarbonylamino-4-[3-(3-cyano-phenyl)-3-keto-propenylamino]-2-phenylethynyl-benzene Methyl acetate - methyl acetate (4-amino-5-tris-butoxycarbonylamino-2-phenylethynylphenyl)-methyl acetate (Example L10) (721) Mg, 2.0 millimoles) and -101 - This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) J255266 A7 V. Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed Description (99) 3 -(2,2-Dimethyl-6-keto-6H-[1,3]dioxol-4-yl)-benzonitrile (Example N4) (550 mg, 2.4 mmol). Obtained as a pale yellow solid (886 mg). MS (ISP) 552 [(M+H)+] and 569 [(M+NH4) dec. Example 07 [2-[3-(3-Cyano-phenyl) keto-propionylamino]-5-(2-methoxy-ethoxy)tolylethynyl-phenyl] -Aminomethyl 3-butyrate is prepared according to the general procedure 0, from guanamido-5-(2-methoxy-ethoxy)-4-phenylethylidene-phenyl]-aminomethyl Acid tri-butyl ester (Example L11) (415 mg, 1.09 mmol) and 3·(2,2-dimethyl-6-keto-6H-[1,3]dioxane-4 -yl)-benzonitrile (Example N4) (373 mg, 1.63 mmol). Obtained as a pale yellow solid (137 mg). MS (ISP) 554 [(M+H)+], 571 [(M+NH4)+] and 576 [(M+Na)+]; mp 175-176 〇C 〇 Example 08 {2-[3-( 3-cyano-phenyl)-3-g-iso-propionylamino]5-methoxy-4-phenylethynylphenyl}-aminomethyl-tert-butyl ester Procedure 0, made from (2-amino-5-nonoxyphenylphenylethynyl-phenyl)-amine methyl acid tert-butyl ester (Example L12) (338 mg, 1·〇 mmol) With 3_(2,2-dimethyl-6-keto-6Η-[1,3]dioxanthene-4-yl)-benzonitrile (Example Ν4) (252 mg, U mmol) . Obtained as a yellow solid (388 mg). MS (ISP) 510 [(Μ+Η)+ ], 527 [(Μ+ΝΗ4)+ ] and 532 [(M+Na)+]; melting point 169. (:. Example 〇9 5-Terve-butoxycarbonylamino-4-[3-(3-cyano-phenyl)oxanyl-propionylamino]_ 2-phenylethynyl-benzene Methyl formate is prepared according to the general procedure 4- 'from 4-amino-5-t-butoxycarbonylaminophenyl 102- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) -- --l·---------Install i — (Please read the back note on this page first) Order: 1255266 A7 B7 V. Invention description (100) -----:----- -----装--- (Please read the back of the note before this page) ethynyl-benzoic acid methyl ester (example L14X396 mg, 1.08 millimolar) and 3-(2,2-monomethyl- 6-keto-6H-[1,3]dioxanthyl)-benzonitrile (Example N4) (273 mg, 1.19 mmol).

MS (ISP) 538 [(M+H)+ ],555 [(M+NH4)+ ]及 560 [(M+Na)+ ];熔點 158°C (分解)。 實例010 {2-[3-(3-氰基-苯基)各酮基-丙醯基胺基]-5-嗎福啉_4_基冰苯基 乙炔基-苯基卜胺甲基酸第三-丁酯 根據一般程序Ο,製自(2-胺基-5-嗎福啉-4-基斗苯基乙块基 -苯基)-胺甲基酸第三-丁酯(實例L12)(483毫克,1.23毫莫耳) 與3-(2,2_二甲基各酮基-6H-[1,3]二氧陸圜烯冰基)-苯甲腈(實例 N4)(422毫克.,1.84毫莫耳)。獲得非晶質橘色物質(375毫克)。 MS (ISP) 565 [(M+H)+ ]與 587 [(M+Na)+]。 實例Oil [2-[3-(3-氰基-苯基)-3-酮基-丙醯基胺基]-5-(2-{2-〇(2-甲氧基-乙 ;線. 氧基)-乙氧基]-乙氧基}••乙氧基)-4-苯基乙块基-苯基]-胺甲基 酸第三-丁酯 經濟部智慧財產局員工消費合作社印製 根據一般程序Ο,製自[2-胺基-5-(2-{2-[2-(2-甲氧基-乙氧基)· 乙乳基]-乙乳基}-乙氧基)-4-苯基乙块基-苯基]-胺甲基酸第三-丁酯(實例L15)(514毫克,1.〇毫莫耳)與3_(2,2-二甲基冬酮基-6H-[1,3]二氧陸圜晞-4-基)-苯甲腈(實例N4)(344毫克,1.5毫莫 耳)。獲得淡黃色固體(353毫克)。 MS (ISP) 686 [(M+H)+ ]與 703 [(M+NH4)+ ];熔點 135-136X。 實例012 -103- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266 A7 __B7 五、發明說明(101) {5-第二-丁氧窥基胺基-4-[3-(3-氰基-苯基)-3-酮基-丙醯基胺基]_ 2-苯基乙炔基-苯氧基}-醋酸第三-丁酯 根據一般程序Ο,製自(4-胺基-5-第三-丁氧羰基胺基1苯 基乙決基-苯氧基)-醋酸第三-丁酯(實例L16)(877毫克,2.0毫 莫耳)與3-(2,2-二甲基-6-酮基-6H-[1,3]二氧陸圜烯-4_基)_苯甲腈 (實例N4)(504毫克,2.2毫莫耳)。獲得黃色固體(723毫克)。 MS (ISP) 610 [(M+H)+ ],627 [(M+NH4)+ ]及 632 [(M+Na)+ ];熔點95°C。 實例013 {5-氰基甲基-2-[3-(3•氰基-苯基)·3-酮基-丙醯基胺基;μ-苯基乙 炔基-苯基}-胺甲基酸第三-丁酯 根據一般程序Ο,製自(2-胺基-5-氰基甲基-4-苯基乙炔基_ 苯基)-胺甲基酸第三-丁 g旨(實例L17)(298毫克,〇·86毫莫耳) 與3-(2,2-二甲基-6-酮基-6Η-[1,3]二氧陸圜烯-4-基)-苯甲腈(實例 Ν4)(218毫克,0·95毫莫耳)。獲得黃色固體(299毫克)。 MS (ISP) 519 [(Μ+Η)+ ],536 [(Μ+ΝΗ4)+ ]及 541 [(M+Na)+ ] ·,熔點 98°C。 實例014 [2-0(3-氰基-苯基&gt;3-酮基-丙醯基胺基]-5-(1,4-二氧各氮-螺[4.5] 癸各基)-4-苯基乙炔基-苯基]-胺甲基酸第三-丁酯 根據一般程序0 ’製自[2-胺基-5-(1,4-二氧-8-氮-螺[4.5]癸各 基)-4-苯基乙.块基-苯基]-胺甲基酸第三-丁酯(實例L18)(393毫 克,0.87毫莫耳)與3-(2,2-二甲基-6-酮基-6H-[1,3]二氧陸圜烯斗 基)-苯甲腈(實例N4)(301毫克,1·31毫莫耳)。獲得非晶質橘 色物質(268毫克)。 MS(ISP)621[(M+H)+]。 -104 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -----Γ----------- (請先閱讀背面之注音?事項再本頁) 訂· 經濟部智慧財產局員工消費合作社印製 !255266 五、 經濟部智慧財產局員工消費合作社印製 發明說明(102) t例 015 (請先閱讀背面之注音?事項再本頁) [2-[3-(3-破木基)-3-酮基-丙酿基胺基]-5-(2-甲氧基-乙氧基M-苯 基乙炔基-苯基]-胺甲基酸第三_丁酯 根據一般程序0,製自[2-胺基-5-(2-甲氧基-乙氧基&gt;4-苯基 乙炔基-苯基]-胺甲基酸第三_丁酯(實例ul)(84〇毫克,2.2亳 莫耳)與6-(3-碘苯基)_2,2-二甲基-[1,3]二氧陸圜烯-4·酮(實例 N7)(780毫克,2·36亳莫耳)。獲得白色固體(1·3克)。 MS (ISP) 655 [(Μ+Η)+ ],672 [(Μ+ΝΗ4)+ ],677 [(M+Na)+ ]及 693 [(Μ+Κ)+ ] ;熔點 172°C。 實例016 [2-[3-(3-氰基-苯基)-3-酮基-丙醯基胺基]-5-(2,2-二曱基-[1,3]二氧 伍圜-4-基甲氧基)-4-苯基乙炔基-苯基]-胺甲基酸第三-丁酯 根據一般程序0,製自[2-胺基-5-(2,2-二甲基-[1,3]二氧伍圜- 4- 基甲氧基)-4-苯基乙炔基-苯基]-胺甲基酸第三-丁酯(實例 L20)(439毫克,1·0毫莫耳)與3-(2,2-二甲基-6-S同基-6仏[1,3]二氧 陸圜烯-4-基)-苯甲腈(實例Ν4)(345毫克,1.5毫莫耳)。獲得黃 色固體(275毫克)。 MS (ISP) 610 [(Μ+Η)+ ],627 [(Μ+ΝΗ4)+ ]及 632 [(M+Na)+ ];熔點 132- 134〇C 〇 實例017 5- 第三-丁氧羰基胺基-4-[3-(3-氰基-苯基)-3删基-丙醯基胺基]_ 2-碘-苯甲酸甲酯 根據一般程序0,製自4-胺基-5-第三-丁氧羰基胺基1碘-苯甲酸甲酯(實例L21)(395毫克,1·〇毫莫耳)與M2,2_二甲基各 105- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266 A7 B7 五、發明說明(103 ) 酮基-6H-[1,3]二氧陸圜烯-4-基)_苯甲腈(實例N4)(254毫克,1.1 毫莫耳)。獲得杏色固體(435毫克)。 MS (ISP) 564 [(M+H)+],581 [(M+NH4)+]及 586 [(M+Na)+];熔點 162-166〇C 〇 實例018 [[2-[3-(3-咪唑-1-基-苯基)-3-酮基-丙醯基胺基]-5-(2-甲氧基-乙氧 基)-4-苯基乙炔基-苯基]-胺甲基酸第三-丁酯 根據一般程序Ο,製自[2-胺基-5-(2-曱氧基-乙氧基)-4-苯基 乙块基-苯基]-胺甲基酸第三-丁酯(實例Lll)(191毫克,0.5毫 莫耳)與6-(3-咪唑-1-基·苯基)-2,2-二曱基-[1,3]二氧陸圜烯-4-酮( 實例N10)(135毫克,0.5毫莫耳)。獲得淡褐色蠟狀固體(206 毫克)。 MS (ISN) 593 [(Μ-ΗΠ ;熔點 122-129X:。 實例019 [Ι18]-[2-[3-(3-氰基-苯基&gt;3-酮基-丙醯基胺基]-5-(2-酮基-[1,3]二氧 伍圜-4-基甲氧基)-4-苯基乙炔基-苯基]-胺甲基酸第三-丁酯 根據一般程序K,製自[RS]-[2-胺基-5-(2-酮基-[1,3]二氧伍圜-4-基甲氧基)-4-苯基乙块基-苯基]-胺甲基酸第三-丁酯(實例 L22)(346 毫克,0.82 毫莫耳)與 3-(2,2-二甲基-6-酮基-6H-[1,3]二氧 陸圜烯-4-基)-苯甲腈(實例N4)(206毫克,0.9毫莫耳)。獲得淡 黃色固體(433 毫克)。MS (ISP) 594 [(M-H)+ ];熔點 181°C。 實例020 {2-[3·(3-氣基-苯基)-3-酮基-丙醢基胺基]-5-乙氧基甲基-4-苯基 乙炔基-苯基}-胺甲基酸第三-丁酉旨 -106- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ----^---------裝 i — (請先閱讀背面之注意事項本頁) 訂·- 經濟部智慧財產局員工消費合作社印製 1255266 A7 __B7 _ 五、發明說明(104) -----.---------裝--- (請先閱讀背面之注意事項再頁) 根據一般程序K,製自(2-胺基-5-乙氧基甲基-4-苯基乙炔基 -苯基 &gt;胺甲基酸第三-丁酯(實例L23)(130毫克,0.35毫莫耳) 與3-(2,2-二甲基-6-酮基-6H-[1,3]二氧陸圜晞-4-基)-苯甲腈(實例 N4)(80毫克,0.35毫莫耳)。獲得非晶質黃色物質(148亳克)。 MS(ISP) 538 [(M-H)+]。 實例021 2,2-二甲基-丙酸5-第三-丁氧羰基胺基-4-[3-(3-氰基-苯基)-3-酉同 基-丙醯基胺基]-2-苯基乙炔基·;酯 根據一般程序K,製自2,2-二曱基-丙酸4-胺基-5-第三-丁氧 羰基胺基-2-苯基乙块基-爷g旨(實例L24)(l55毫克,0.37毫莫耳) 與3-(2,2-二甲基-6-酮基-6H-[1,3]二氧陸圜烯-4-基)-苯甲腈(實例 N4)(94毫克,0.41毫莫耳)。獲得非晶質淡橘色物質(184毫克)。 MS(ISP)611[(M+NH4)+]。 實例022 線_ (RS)-[2-[3-(3-咪嗤-1-基-苯基)-3-酮基-丙酸基胺基]-4-苯基乙炔基 -5-(四氫-峰喃-2-基氧基甲基)-苯基]-胺甲基酸第三-丁酯 經濟部智慧財產局員工消費合作社印製 根據一般程序Ο,製自(RS)-[2-胺基-4-苯基乙炔基-5-(四氫-哌喃-2-基氧基甲基)-苯基]-胺甲基酸第三-丁酯(實例L25)與6-(3-咪唑小基-苯基&gt;2,2-二甲基-[1,3]二氧陸圜晞-4-酮(實例N10) 。獲得非晶.質黃色物質(267毫克)。 MS(ISP) 635 [(M+H)+]。 實例023 [2-[3-(3-咪唑-1-基-苯基)-3-酮基-丙醯基胺基]-5-(4-甲氧基-六氫 p比淀-1-基)-4-苯基乙決基-苯基]-胺甲基酸第三-丁酉旨 -107- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公餐) &quot; 1255266 Α7 Β7 五、發明說明(105) 根據一般程序0,製自[2_胺基士(4-甲氧基_六氫吡啶+基&gt; 4-苯基乙炔基-苯基]-胺甲基酸第三-丁酯(實例L26)(236毫克, 0.56笔莫耳)與6-(3-咪吐-i-基_苯基)_2,2_二甲基_[ι,3]二氧陸圜烯 -4-酮(實例N10)(151毫克,0.56毫莫耳)。獲得非晶質黃色物 質(253毫克)。 MS(ISP) 634 [(M+H)+] 〇 實例024 [2-[3-(3-氰基-苯基)-3-酮基-丙醯基胺基]_5-(4-甲氧基_六氫吡啶-1-基)-4-苯基乙炔基-苯基]-胺甲基酸第三_丁酯 根據一般程序Ο,製自[2-胺基甲氧基-六氫吡啶-1-基)-4-苯基乙块基-苯基]-胺甲基酸第三-丁酯(實例L26)(224毫克, 0.53毫莫耳)與3-(2,2-二甲基各酮基-6H-[1,3]二氧陸圜烯-4·基 苯甲腈(實例N4)(125毫克,〇·53毫莫耳)。獲得黃色泡沫物 (274毫克)。 MS (ISN) 591 [(M-H)·];熔點 97_100χ:。 實例025 {5-氧基甲氧基-2-[3-(3•咪吐-1-基-苯基)各酮基-丙醯基胺基]-4-苯基乙決基-苯基}-胺曱基酸第三_丁 @旨 根據一般程序0,製自(2-胺基氰基甲氧基I苯基乙炔基 -苯基)-胺甲基酸第三-丁酯(實例L27)與6-(3-咪唑小基-苯基)-2,2-一甲基-[1,j]一氧陸圜晞-4-S同(實例N10)。獲得非晶質黃色 物質(169毫克)。 MS(ISP) 576 [(M+H)+]。 實例〇26 -108- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 請 先 閱 讀 背 面 之 注 意 事 項 再 • έ 本衣 頁 訂 線 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明(106) {5-氣基甲乳基-2-[3-(3-乱基**冬基)-3-§同基-丙酿基胺基]-4-苯基 乙炔基-苯基}-胺曱基酸第三-丁酯 根據一般程序〇,製自(2-胺基;氰基甲氧基斗苯基乙炔基 -苯基)-胺甲基酸第三-丁酯(實例L27)(80毫克,0.22毫莫耳)與 3-(2,2·二甲基-6-酮基-6H-[1,3]二氧陸圜烯-4-基)_苯甲腈(實例 N4)(55毫克,0.24毫莫耳)。獲得非晶質黃色物質(96毫克)。 MS (ISN) 533 [(Μ-ΗΠ。 實例027 (RS)-[4-(4-氟苯基乙块基)-2-[3-(3-咪。坐-1-基-苯基)-3.基-丙醯基 胺基]-5-(四氫-喊喃-2-基氧基甲基)-苯基]-胺甲基酸第三_丁酉旨 根據一般程序Ο,製自(RS)-[2-胺基-4-(4-氟苯基乙炔基)-5-( 四氫碌喃-2-基氧基甲基)-苯基]-胺曱基酸第三-丁酯(實例L28) 與6-(3-咪唑-1-基-苯基)-2,2-二甲基-[1,3]二氧陸圜烯-4-酮(實例 N10)。獲得非晶質黃色物質(990毫克)。 MS(ISN)651 [(M-Η)-]。 實例028 (RS)-(4-4-氟苯基乙炔基)-2-[3-(3-咪唑-1-基-苯基)-3_酮基丙醯基 胺基]-5-{甲基-[2-(四氫-喊喃-2-基氧基)-乙基]-胺基}·苯基)_胺甲 基酸第三-丁酯 根據一般程序Ο,製自(RS)-(2-胺基-4-(4-氟苯基乙块基)-5-{ 甲基-[2-(四氫-喊喃-2-基氧基)-乙基]-胺基}-苯基)-胺甲基酸第 三-丁酯(實例L29)(242毫克,0.5毫莫耳)與6-(3-咪唑小基-苯基) -2,2-二甲基-[1,3]二氧陸圜烯斗酮(實例N10)(135毫克,〇·5毫莫 耳)。獲得非晶質黃色物質(198毫克)。 -109- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) --------------裝--- (請先閱讀背面之注意事項本頁) . 線. 經濟部智慧財產局員工消費合作社印製 1255266 經濟部智慧財產局員工消費合作社印製 A7 B7 發明說明(107 ) MS(ISN) 694 [(M-H)—]。 實例〇29 {5-(4,4-二乙氧基-六氫吡啶-1-基)-2-[3-(3-咪唑小基-苯基&gt;3-酮基-丙醯基胺基]-4-苯基乙炔基-苯基}-胺甲基酸第三-丁酯 根據一般程序Ο,製自[2-胺基-5-(4,4-二乙氧基-六氫吡啶-1-基)-4-苯基乙块基-苯基]-胺甲基酸第三-丁酯(實例L18)(321毫 克,0.67毫莫耳)與6·(3-咪唑-1-基-苯基)-2,2-二甲基-[1,3]二氧陸 圜烯-4-酮(實例Ν10)(240毫克,0.89毫莫耳)。獲得橘色泡沫 物(295毫克)。 MS(ISP) 692 [(M+H)+]。 實例030 (RS)-{2-[3-(3-味嗤-1-基-苯基)-3-嗣基-丙酿基胺基]-4-苯基乙块基 -5-[2-(四氫-哌喃_2_基氧基)-乙氧基]-苯基}-胺甲基酸第三-丁酯 根據一般程序Ο,製自(RS)-{2-胺基-4-苯基乙炔基-5-[2-(四氫 -哌喃-2-基氧基)-乙氧基]-苯基}-胺甲基酸第三-丁酯(實例 L30)(346毫克,0.76毫莫耳)與6-(3-咪唑-1-基-苯基)-2,2-二甲基-[1,3]二氧陸圜烯-4-酮(實例N10)(300毫克,1.11毫莫耳)。獲得 黃色泡沫物(196毫克)。 MS (ISP) 665 [(M+H)+ ]。 實例031 (RS)-{4·-氟基-5-[3-(3-咪唾-1-基-苯基)-3-酮基-丙醯基胺基]-2-[4-( 四氫-哌喃-2-基氧基)-六氫吡啶小基]-聯苯基-4-基卜胺甲基酸 第三-丁酯 根據一般程序0,製自(RS&gt;[2-胺基-4-(4-氟苯基乙炔基)-5-( -110- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ---:----------裝--- (請先閱讀背面之注意事項本頁) - 1255266 經濟部智慧財產局員工消費合作社印製 A7 B7 五、發明說明(108 ) 四氫-哌喃-2-基氧基甲基)-苯基]-胺甲基酸第三-丁酯(實例L28) 與6-(3-咪唑-1-基-苯基)-2,2-二甲基-[1,3]二氧陸圜烯-4-酮(實例 N10)。獲得黃色固體(282毫克)。 MS (ISP) 698 [(M+H)+ ];熔點 129-132X:。 實例032 {5-(2-第三-丁氧基-乙氧基)-4-(4-氟苯基乙炔基)-2-[3-(3-咪唑小 基-苯基)-3-酮基-丙醯基胺基]-苯基}_胺甲基酸第三-丁酯 根據般私序〇 ’製自[2-胺基-5-(2-第三-丁氧基·乙氧基)-4_ (4-氟苯基乙炔基)-苯基]-胺甲基酸第三-丁酯(實例L32)(560毫 克,1.27毫莫耳)與6-(3-咪唑-1-基-苯基)-2,2-二甲基-[1,3]二氧陸 圜烯-4-酮(實例N10)(413毫克,1.53毫莫耳)。獲得黃色固體 (507毫克)。 MS (ISP) 655 [(M+H)+ ];熔點 62-65°C。 實例033 (RS)-(4'_氟基-5-[3-(3-咪嗤-1-基-苯基)-3-§同基-丙醯基胺基]-2-{4-[2_ (四氫-峰喃-2-基氧基)-乙氧基]-六氫吡啶小基卜聯苯基冰基)_ 胺甲基酸第三-丁酯 根據一般程序0,製自(RS)-(5-胺基-4,-氟基-2-{4-[2-(四氫·哌 喃-2-基氧基)-乙氧基]-六氫吡啶-1-基丨_聯苯基|基 &gt;胺曱基酸 第三-丁酯(實例L33)與6-(3-咪唑小基-苯基)_2,2_二曱基-[1,3]二 氧陸圜晞斗酮(實例N10)。獲得黃色固體(473毫克)。 MS (ISP) 742 [(M+H)+ ];熔點 57-58°C。 實例034 (RS)-[4’_氟基-5-[3-(3Hl-基-苯基基_丙醯基胺基降(四 -111 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) • 11111 ----— 1--. I I (請先閱讀背面之注意事項再ϋβ►本頁)MS (ISP) 538 [(M+H)+], 555 [(M+NH4)+] and 560 [(M+Na)+]; melting 158 ° C (decomposition). Example 010 {2-[3-(3-Cyano-phenyl) keto-propionylamino]-5-morpholine _4-yl phenyl phenylethynyl-phenyl-p-aminomethyl acid The third-butyl ester was prepared according to the general procedure from (2-amino-5-morpholine-4-ylphenylphenylethyl-phenyl)-amine methyl acid tert-butyl ester (example L12) (483 mg, 1.23 mmol) with 3-(2,2-dimethyl keto ketone-6H-[1,3]dioxolysinyl)-benzonitrile (Example N4) (422 Mg., 1.84 millimoles). Obtained an amorphous orange material (375 mg). MS (ISP) 565 [(M+H)+ ] and 587 [(M+Na)+]. Example Oil [2-[3-(3-Cyano-phenyl)-3-keto-propenylamino]-5-(2-{2-〇(2-methoxy-B; Oxy)-ethoxy]-ethoxy}••ethoxy)-4-phenylethylidene-phenyl]-amine methyl acid third-butyl ester Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative According to the general procedure, prepared from [2-amino-5-(2-{2-[2-(2-methoxy-ethoxy)·ethyllacto]-ethylidyl}-ethoxyl -4-phenylethylidene-phenyl]-amine methyl acid tert-butyl ester (example L15) (514 mg, 1. 〇 millimol) and 3_(2,2-dimethylbutanone Base-6H-[1,3]dioxanthene-4-yl)-benzonitrile (Example N4) (344 mg, 1.5 mmol). Obtained as a pale yellow solid (353 mg). MS (ISP) 686 [(M+H)+] and 703 [(M+NH4)+]; mp 135-136. Example 012 -103- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1255266 A7 __B7 V. Description of invention (101) {5-Second-butoxyprokiol-4-[ 3-(3-Cyano-phenyl)-3-keto-propionylamino]-2-phenylethynyl-phenoxy}-acetic acid tert-butyl ester according to the general procedure, 4-Amino-5-tertiary-butoxycarbonylamino 1phenylethyl-phenoxy)-acetic acid tert-butyl ester (Example L16) (877 mg, 2.0 mmol) and 3-( 2,2-Dimethyl-6-keto-6H-[1,3]dioxolene-4-yl)benzonitrile (Example N4) (504 mg, 2.2 mmol). Obtained as a yellow solid (723 mg). MS (ISP) 610 [(M+H)+], 627 [(M+NH4)+] and 632 [(M+Na)+]; Example 013 {5-Cyanomethyl-2-[3-(3)cyano-phenyl)-3-keto-propionylamino; μ-phenylethynyl-phenyl}-aminomethyl The acid tert-butyl ester was prepared according to the general procedure from (2-amino-5-cyanomethyl-4-phenylethynyl-phenyl)-amine methyl acid to the third-butyr (example L17) ) (298 mg, 〇·86 mmol) with 3-(2,2-dimethyl-6-keto-6Η-[1,3]dioxol-4-yl)-benzonitrile (Example Ν 4) (218 mg, 0.95 mmol). Obtained as a yellow solid (299 mg). MS (ISP) 519 [(Μ+Η)+ ], 536 [(Μ+ΝΗ4)+ ] and 541 [(M+Na)+ ] ·, mp 98 °C. Example 014 [2-0 (3-cyano-phenyl&gt; 3-keto-propionylamino]-5-(1,4-dioxonitro-spiro[4.5]decyl)-4 -Phenylethynyl-phenyl]-amine methyl acid tert-butyl ester according to the general procedure 0 'from [2-amino-5-(1,4-dioxo-8-nitro-spiro[4.5]癸))-4-phenylethyl. Block-phenyl]-amine methyl acid third-butyl ester (Example L18) (393 mg, 0.87 mmol) and 3-(2,2-dimethyl Benzyl-6-keto-6H-[1,3]dioxolysine)-benzonitrile (Example N4) (301 mg, 1.31 mmol). Obtained amorphous orange material ( 268 mg). MS (ISP) 621 [(M+H)+]. -104 This paper size applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) -----Γ----- ------ (Please read the phonetic transcription on the back? This page is the first page) Order · Printed by the Ministry of Economic Affairs, Intellectual Property Bureau, Staff Consumer Cooperatives! 255266 V. Ministry of Economic Affairs, Intellectual Property Bureau, Staff Consumer Cooperatives, Printing Instructions (102) tExample 015 (Please read the phonetic transcription on the back side and then on this page) [2-[3-(3-Butyl)-3-keto-propyl arylamino]-5-(2-methoxy -ethoxymethyl-phenylethynyl-phenyl]-amine methyl acid tert-butyl ester According to the general procedure 0, from [2-amino-5-(2-methoxy-ethoxy] 4-phenylethynyl-phenyl]-amine methyl acid tert-butyl ester (example ul ) (84 〇 mg, 2.2 亳 Mo) and 6-(3-iodophenyl) 2,2-dimethyl-[1,3]dioxolene-4·one (Example N7) (780 mg) , 2·36亳莫耳). Obtained a white solid (1.3 g) MS (ISP) 655 [(Μ+Η)+ ],672 [(Μ+ΝΗ4)+ ],677 [(M+Na) + ] and 693 [(Μ+Κ)+ ] ; melting point 172 ° C. Example 016 [2-[3-(3-Cyano-phenyl)-3-keto-propenylamino]-5- (2,2-Dimercapto-[1,3]dioxoindol-4-ylmethoxy)-4-phenylethynyl-phenyl]-aminemethyl acid tert-butyl ester according to the general procedure 0, produced from [2-amino-5-(2,2-dimethyl-[1,3]dioxoin-4-ylmethoxy)-4-phenylethynyl-phenyl]- Aminomethyl 3-butyrate (Example L20) (439 mg, 1.00 mmol) and 3-(2,2-dimethyl-6-S-iso-6-[1,3] Oxylyzin-4-yl)-benzonitrile (Example Ν 4) (345 mg, 1.5 mmol) afforded a yellow solid (275 mg). MS (ISP) 610 [(Μ+Η)+], 627 [(Μ+ΝΗ4)+ ] and 632 [(M+Na)+ ]; melting point 132- 134 C 〇 Example 017 5- Third-butoxycarbonylamino-4-[3-(3-cyano-phenyl)-3pyridyl-propionylamino]_ 2-iodo-benzoic acid methyl ester according to General procedure 0, prepared from 4-amino-5-tertiary-butoxycarbonylamino 1 iodine-benzoic acid methyl ester (Example L21) (395 mg, 1·〇 mmol) and M2,2-dimethyl Based on the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1255266 A7 B7 5. Inventive Note (103) Keto-6H-[1,3] Dioxetene-4 -yl)-benzonitrile (example N4) (254 mg, 1.1 mmol). Obtained an amber solid (435 mg). MS (ISP) 564 [(M+H)+], 581 [(M+NH4)+] and 586 [(M+Na)+]; mp 162-166 〇C 〇 Example 018 [[2-[3- (3-imidazol-1-yl-phenyl)-3-keto-propionylamino]-5-(2-methoxy-ethoxy)-4-phenylethynyl-phenyl]- Aminomethyl acid tert-butyl ester according to the general procedure, prepared from [2-amino-5-(2-decyloxy-ethoxy)-4-phenylethylidene-phenyl]-amine A Tri-butyl ester (example L11) (191 mg, 0.5 mmol) and 6-(3-imidazol-1-yl-phenyl)-2,2-diindolyl-[1,3] Oxadecene-4-one (Example N10) (135 mg, 0.5 mmol). Obtained as a pale brown waxy solid (206 mg). MS (ISN) 593 [(Μ-ΗΠ; m.p. 122-129X: </RTI> </ RTI> </ RTI> </ RTI> </ RTI> </ RTI> </ RTI> [2-[3-(3-cyano-phenyl) 3- keto-propenylamino] -5-(2-keto-[1,3]dioxoindol-4-ylmethoxy)-4-phenylethynyl-phenyl]-amine methyl acid tert-butyl ester according to the general procedure K, made from [RS]-[2-amino-5-(2-keto-[1,3]dioxoin-4-ylmethoxy)-4-phenylethylidene-phenyl ]-Aminomethyl 3-butyrate (Example L22) (346 mg, 0.82 mmol) and 3-(2,2-dimethyl-6-keto-6H-[1,3]dioxo Tert-en-4-yl)-benzonitrile (Example N4) (206 mg, 0.9 mmol) afforded a pale yellow solid ( 433 mg). MS (ISP) 594 [(MH)+]; C. Example 020 {2-[3·(3-Alkyl-phenyl)-3-keto-propionylamino]-5-ethoxymethyl-4-phenylethynyl-phenyl} -Aminomethyl acid third- butyl---- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) ----^---------Install i — ( Please read the note on the back of this page.) ······· -------装--- (Please read the notes on the back page again) According to the general procedure K, from (2-amino-5-ethoxymethyl-4-phenylethynyl- Phenyl&gt; Amino acid tert-butyl ester (Example L23) (130 mg, 0.35 mmol) with 3-(2,2-dimethyl-6-keto-6H-[1,3] Dioxol-4-yl)-benzonitrile (Example N4) (80 mg, 0.35 mmol). Obtained amorphous yellow material (148 g) MS (ISP) 538 [(MH)+ Example 021 2,2-Dimethyl-propionic acid 5-tris-butoxycarbonylamino-4-[3-(3-cyano-phenyl)-3-indenyl-propenylamine Ethyl-2-phenylethynyl; ester according to the general procedure K, from 2,2-dimercapto-propionic acid 4-amino-5-tris-butoxycarbonylamino-2-phenyl Block base-Ye g (Example L24) (l55 mg, 0.37 mmol) with 3-(2,2-dimethyl-6-keto-6H-[1,3]dioxene terpene-4 -benzonitrile-benzonitrile (Example N4) (94 mg, 0.41 mmol). Obs. (yield: 184 mg). (MS) 611 [(M+NH4)+].线_(RS)-[2-[3-(3-Min-1-yl-phenyl)-3-keto-propionylamino]-4-phenylethynyl-5-(tetrahydro) -峰喃-2- Oxymethyl)-phenyl]-amine methyl acid third-butyl ester Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed according to the general procedure 制, from (RS)-[2-amino-4-phenyl Ethynyl-5-(tetrahydro-pyran-2-yloxymethyl)-phenyl]-amine methyl acid tert-butyl ester (example L25) and 6-(3-imidazolyl-phenyl &gt; 2,2-Dimethyl-[1,3]dioxanthene-4-one (Example N10). An amorphous yellow substance (267 mg) was obtained. MS (ISP) 635 [(M+H)+]. Example 023 [2-[3-(3-Imidazol-1-yl-phenyl)-3-keto-propenylamino]-5-(4-methoxy-hexahydrop-precipitate-1- Base)-4-phenylethyl-phenyl]-amine methyl acid third-butyr-107- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 public) &quot; 1255266 Α7 Β7 V. Description of the invention (105) According to the general procedure 0, from [2_Aminos (4-methoxy-hexahydropyridine + yl) 4-phenylethynyl-phenyl]-amine methyl acid Third-butyl ester (Example L26) (236 mg, 0.56 moles) and 6-(3-imipo-i-yl-phenyl)_2,2-dimethyl-[ι,3] dioxane Terpene-4-one (Example N10) (151 mg, 0.56 mmol). Obtained amorphous yellow material (253 mg). MS (ISP) 634 [(M+H)+] 〇 Example 024 [2- [3-(3-Cyano-phenyl)-3-keto-propionylamino]_5-(4-methoxy-hexahydropyridin-1-yl)-4-phenylethynyl-benzene ]--aminomethyl acid tert-butyl ester according to the general procedure, prepared from [2-aminomethoxy-hexahydropyridin-1-yl)-4-phenylethylidene-phenyl]-amine Tri-butyl methacrylate (Example L26) (224 mg, 0.53 mmol) and 3-(2,2-dimethyl ketone-6H-[1 , 3] Dioxetene-4-ylbenzonitrile (Example N4) (125 mg, 〇·53 mmol). Obtained yellow foam (274 mg). MS (ISN) 591 [(MH)· Melting point: 97_100 χ:. Example 025 {5-oxymethoxy-2-[3-(3)m-but-1-yl-phenyl) keto-propionylamino]-4-phenyl乙基基-phenyl}-amine hydrazinoic acid _ _ @ @ According to the general procedure 0, from (2-aminocyanomethoxy Iphenylethynyl-phenyl)-amine methyl acid Tri-butyl ester (Example L27) is the same as 6-(3-imidazolyl-phenyl)-2,2-monomethyl-[1,j]oxoxaindole-4-S (Example N10). Obtained amorphous yellow material (169 mg) MS (ISP) 576 [(M+H)+]. Example 〇26 -108- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) Please read the notes on the back first. έ έ 衣 订 订 经济 经济 经济 经济 经济 经济 经济 1 1 1 1 255 255 255 255 255 255 255 255 255 255 255 255 255 255 255 255 255 255 255 255 255 255 255 255 255 255 255 255 255 255 255 255 3-乱基**冬基)-3-§同基-propylaminoamino]-4-phenylethynyl-phenyl}-amine mercapto acid tert-butyl ester according to the general procedure〇 From (2-amino; cyanomethoxy phenyl ethynyl-phenyl)-amine methyl acid tert-butyl ester (example L27) (80 mg, 0.22 mmol) and 3-(2 2,Dimethyl-6-keto-6H-[1,3]dioxolyn-4-yl)benzonitrile (Example N4) (55 mg, 0.24 mmol). Obtained an amorphous yellow material (96 mg). MS (ISN) 533 [(Μ-ΗΠ. Example 027 (RS)-[4-(4-Fluorophenylethylidene)-2-[3-(3-M..-1-yl-phenyl)) -3. propyl-propyl decylamino]-5-(tetrahydro-pyran-2-yloxymethyl)-phenyl]-amine methyl acid third _ 酉 酉 according to the general procedure 制, from (RS)-[2-Amino-4-(4-fluorophenylethynyl)-5-(tetrahydrofuran-2-yloxymethyl)-phenyl]-amine hydrazinoic acid - Butyl ester (Example L28) with 6-(3-imidazol-1-yl-phenyl)-2,2-dimethyl-[1,3]dioxolene-4-one (Example N10). Amorphous yellow material (990 mg) MS (ISN) 651 [(M-Η)-]. Example 028 (RS)-(4-4-fluorophenylethynyl)-2-[3-(3- Imidazol-1-yl-phenyl)-3-ketopropionylamino]-5-{methyl-[2-(tetrahydro-pyran-2-yloxy)-ethyl]-amino }·Phenyl)-Aminomethyl 3-butyrate was prepared according to the general procedure from (RS)-(2-amino-4-(4-fluorophenylethylidene)-5-{methyl -[2-(tetrahydro-pyran-2-yloxy)-ethyl]-amino}-phenyl)-amine methyl acid tert-butyl ester (Example L29) (242 mg, 0.5 mmol) Ear) with 6-(3-imidazolyl-phenyl)-2,2-dimethyl-[1,3]dioxanthene (Example N10) (135 mg, 〇·5 mmol). An amorphous yellow material (198 mg) was obtained. -109- This paper size is applicable to China National Standard (CNS) A4 specification (210 X 297 mm) -------------- Pack--- (Please read the back note on this page first) Line. Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed A7 B7 Invention Description (107) MS(ISN) 694 [(MH)—]. Example 〇29 {5-(4,4-Diethoxy-hexahydropyridin-1-yl)-2-[3-(3-imidazolyl-phenyl)-3-keto-propionylamine Tert-butyl 4-phenylethynyl-phenyl}-amine methyl acid, according to the general procedure, from [2-amino-5-(4,4-diethoxy-hexahydro) Pyridin-1-yl)-4-phenylethylidene-phenyl]-amine methyl acid tert-butyl ester (Example L18) (321 mg, 0.67 mmol) and 6·(3-imidazole-1 -yl-phenyl)-2,2-dimethyl-[1,3]dioxolene-4-one (Example Ν10) (240 mg, 0.89 mmol). Obtained orange foam (295 Mg) MS (ISP) 692 [(M+H)+]. Example 030 (RS)-{2-[3-(3-Miso-1-yl-phenyl)-3-indolyl-propyl Triamino--4-phenylethylidene-5-[2-(tetrahydro-piperidin-2-yloxy)-ethoxy]-phenyl}-amine methyl acid tert-butyl ester According to the general procedure, from (RS)-{2-amino-4-phenylethynyl-5-[2-(tetrahydro-pyran-2-yloxy)-ethoxy]-phenyl }-Aminomethyl 3-butyrate (Example L30) (346 mg, 0.76 mmol) and 6-(3-imidazol-1-yl-phenyl)-2,2-dimethyl-[1 , 3] Dioxolene-4-one (Example N10) (300 mg, 1.11 mmol). Obtained as a yellow foam (196 mg). MS (ESI) 665 [(M+H)+]. Example 031 (RS)-{4·-fluoro-5-[3-(3-imsin-1-yl) -phenyl)-3-keto-propionylamino]-2-[4-(tetrahydro-pyran-2-yloxy)-hexahydropyridine small group]-biphenyl-4-yl Tert-butyl methacrylate is prepared according to the general procedure 0, from (RS>[2-amino-4-(4-fluorophenylethynyl)-5-(-110-) Standard (CNS) A4 specification (210 X 297 mm) ---:----------Installation--- (Please read the back note on this page first) - 1255266 Ministry of Economic Affairs Intellectual Property Office staff Consumer Cooperatives Printing A7 B7 V. INSTRUCTIONS (108) Tetra-Butyl-Chan-2-yloxymethyl)-phenyl]-Aminomethyl Acid Tri-Butyl Ester (Example L28) and 6-(3) -Imidazolyl-1-yl-phenyl)-2,2-dimethyl-[1,3]dioxolene-4-one (Example N10) afforded a yellow solid (282 mg). MS (ISP) 698 [(M+H)+]; mp 129-132X: </RTI> </RTI> 032 {5-(2-tri-butoxy-ethoxy)-4-(4-fluorophenylethynyl)-2- [3-(3-Imidazolyl-phenyl)-3-keto-propionylamino]-phenyl}-amine methyl acid, third-butyl ester Private sequence 〇 'made from [2-amino-5-(2-tris-butoxyethoxy)-4_(4-fluorophenylethynyl)-phenyl]-amine methyl acid -Butyl ester (Example L32) (560 mg, 1.27 mmol) and 6-(3-imidazol-1-yl-phenyl)-2,2-dimethyl-[1,3]dioxene terpene 4- Ketone (Example N10) (413 mg, 1.53 mmol). Obtained a yellow solid (507 mg). MS (ISP) 655 [(M+H)+]; mp. 62-65. Example 033 (RS)-(4'-Fluoro-5-[3-(3-amido-1-yl-phenyl)-3-§-iso-propionylamino]-2-{4- [2_(tetrahydro-peak-n-yl-2-yloxy)-ethoxy]-hexahydropyridine small-base diphenyl phenyl)-aminomethyl acid tert-butyl ester according to the general procedure 0, (RS)-(5-Amino-4,-fluoro-2-{4-[2-(tetrahydro-piperidin-2-yloxy)-ethoxy]-hexahydropyridin-1-yl丨_biphenyl|yl group&gt; Amino-mercaptoic acid third-butyl ester (Example L33) and 6-(3-imidazolyl-phenyl)_2,2-diindolyl-[1,3]dioxo圜晞 酮 ketone (Example N10). Obtained as a yellow solid (473 mg). MS (ESI) 742 [(M+H)+]; mp. 57-58 ° C. Example 034 (RS)-[4 Base-5-[3-(3Hl-yl-phenylyl-propenylamine group (four-111 - this paper scale applies to Chinese National Standard (CNS) A4 specification (210 X 297 mm) • 11111 -- --- 1--. II (Please read the notes on the back and then ϋβ► this page)

Jrd- 線· 1255266 A7 B7 五、發明說明(109) 氫-系喃-2-基氧基甲基)-聯苯基斗基]_胺甲基酸第三-丁酯 根據一般程序〇,製自(RS)-[5-胺基旱氟基-2-(四氫-喊喃冬 基氧基甲基)-聯苯基-4-基]-胺甲基酸第三-丁酯(實例L34)與6-(3-咪唑-1-基-苯基)-2,2-二甲基_[1,3]二氧陸圜烯-4-酮(實例N10) 。獲得淡黃色固體(330毫克)。 實例〇35 {2-氰基甲氧基氟基-5-[3-(3-咪唑-1-基-苯基)-3-酮基-丙醯基胺 基]-聯苯基-4-基}-胺甲基酸第三-丁酯 根據一般程序0,製自(5-胺基-2-氰基甲氧基氟-聯苯基-4-基)-胺甲基酸第三-丁酯(實例L35)(190毫克,0.53毫莫耳)與 6-(3-咪唑-1-基-苯基)-2,2-二甲基_[1,3]二氧陸圜烯-4-酮(實例 N10)(164毫克,0.61毫莫耳)。獲得黃色膠質(90毫克)。 MS(ISP) 570 [(M+H)+]。 實例036 {2-二甲胺基甲基|氟基-5-[3-(3-咪唑-1-基-苯基)-3-酮基-丙醯基 月基]-聯苯基-4-基胺甲基酸第三-丁酉旨 根據一般程序0,製自5-胺基-2-二甲胺基甲基I氟-聯苯 基-4-基)-胺甲基酸第三-丁酯(實例L36)與6-(3-咪唑-1-基-苯基)· 2,2-二甲基_[1,3]二氧陸圜烯斗酮(實例N10)。獲得淡黃色固體 (329毫克)。 實例〇37 {2-(2,2-二甲基-四氫-[1,3]二氧伍圜幷[4,5-c]吡咯-5-基氟基-5-[3-(3·•咪唑小基-苯基)各酮基-丙醯基胺基]-聯苯基-4-基卜胺甲 基酸第三-丁酯 -112· 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -------------裝--- (請先閱讀背面之注意事項本頁) . --線· 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明( 110 ) 根據一般程序Ο,製自[5-胺基-2-(2,2-二甲基-四氫41,3]二氧 伍圜幷[4,5-cH咯-5-基)_4,_氟-聯苯基+基 &gt;胺甲基酸第三·丁醋 (實例L37)(465毫克,1.05毫莫耳)與6-(3·咪唑+基_苯基&gt;2,2-二 甲基-[1,3]一氧陸圜晞-4-酮(實例N10)(314毫克,ι·ΐ6毫莫耳) 。獲得非晶質黃色物質(540毫克)。 MS(ISN) 654 [(M-H)_]。 實例038 K-氟基-5-[3-(3-咪。坐-1-基-苯基)各銅基-丙醯基胺基甲氧基_ 聯苯基-4-基}-胺甲基酸第三-丁 g旨 根據一般程序Ο,製自(5-胺基-4,-氟基-2-甲氧基-聯苯基-4-基)-胺甲基酸第三-丁酯(實例L38)(332毫克,1.0毫莫耳)與6-(3-咪吐-1-基-苯基)_2,2_二甲基-[1,3]二氧陸圜晞-4-酮(實例N10) (270毫克,1.0毫莫耳)。獲得非晶質褐色物質(328毫克)。 MS (ISN) 543 [(M-Η)-]。 實例039 {2-(1,4-二氧-8-氮-螺[4.5]癸-8-基)-4,-氟基-5-[3-(3-咪唑-1·基-苯基)-3-酮基-丙醯基胺基]-聯苯基冰基}-胺甲基酸第三-丁酯 根據一般程序Ο,製自[5-胺基-2-(l,4-二氧各氮-螺[4.5]癸各 基);-氟-聯苯基-4-基]-胺甲基酸第三-丁酯(實例L39)(444毫克 ,1·〇毫莫耳·)與6-(3-咪唑-1-基-苯基)-2,2-二甲基_[1,3]二氧陸圜 烯冰酮(實例N10)(321毫克,1.19毫莫耳)。獲得褐色固體(457 毫克)。 MS (ISN) 654 [(M-H)-];熔點 1 ίο] 15°C (分解)。 實例040 -113- 本紙張尺度適用中國國家標準(CNS)A4規格(21〇 X 297公爱) -----.---------裝--- (請先閱讀背面之注意事項再本頁) -Jr-d· 線· 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明(111 ) {4,-氟基-5-[3-(3·咪唑小基-笨基)-3_酮基_丙醯基胺基]甲基_聯 苯基-4-基}-胺甲基酸第三-丁酯 根據一般程序0,製自(5-胺基_4,-氟基-2-甲基-聯苯基-4-基)-胺甲基酸第三-丁酯(實例L40)(316毫克,1.0毫莫耳)與6-(3_咪 咬-1-基-苯基)-2,2-二甲基[1,3]二氧陸圜烯冰酮(實例Ν1〇χ297毫 克’ 1.1愛:莫耳)。獲得非晶質黃色物質(361毫克)。 MS(ISP) 529 [(M+H)+]。 實例041 {4-第三-丁氧羰基胺基-4f-氟基-5-[3-(3-咪唑-1-基-苯基)-3.基-丙醯基胺基]-聯苯基-2-基氧基}-醋酸第三_丁酉旨 根據一般程序Ο,製自(5-胺基斗第三-丁氧羰基胺基-4,-氟-聯苯基-2-基氧基)-醋酸第三-丁酯(實例L41)(14克,3.24毫莫 耳)與6-(3-咪唑小基-苯基&gt;2,2-二甲基-[1,3]二氧陸圜晞-4-酮(實 例N10)(885毫克,3.27毫莫耳)。獲得淡褐色固體(759毫克)。 MS (ISP) 645 [(M+H)+ ];熔點 82-85°C。 實例042 {2-氯基-4f-氟基-5-[3-(3-咪嗤-1-基-苯基)-3-酮基-丙醯基胺基]-聯 苯基-4-基}-胺甲基酸第三-丁酯 根據一般程序0,製自(5-胺基-2-氣基I氟-聯苯基斗基)_胺 甲基酸第三-丁酯(實例L42)(168毫克,0.5毫莫耳)與6-(3_咪唑-1-基-苯基)·2,2-二甲基-[1,3]二氧陸圜烯-4-酮(實例N10)(252毫克 ,0.93毫莫耳)。獲得淡黃色固體(156毫克)。 MS (ISN) 547 [(M-Η)」。 實例043 -114- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ----r— --------裝 i I (請先閱讀背面之注意事項再13||^4頁) 訂: ί線· 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明( 112 ) [4’-氟基-5-[3-(3-咪唑-1-基-苯基)-3-酮基-丙醯基胺基]-2-(2-甲氧 基-乙氧基)-聯苯基-4-基]-胺甲基酸第三·丁酯 根據一般程序〇,製自[5-胺基-4,-氟基-2-(2-甲氧基-乙氧基)-聯苯基冰基]-胺甲基酸第三-丁酯(實例L43)(188毫克,0.5毫 莫耳)與6-(3-咪唑小基-苯基)-2,2-二甲基-[1,3]二氧陸圜烯-4-酮( 實例N10)(260毫克,0.96毫莫耳)。獲得橘色固體(218毫克)。 MS (ISP) 589 [(M+H)+ ];熔點 61-63T:。 實例044 {2-(2-第三-丁氧基-乙氧基)·4,_氟基-5-[3-(3-咪唑小基·苯基)各酮 基-丙酿基胺基]-聯苯基-4-基1-胺甲基酸第三-丁酯 根據一般程序Ο,製自[5-胺基-2-(2-第三-丁氧基-乙氧基)-4,-氟-聯苯基-4-基]-胺甲基酸第三-丁酯(實例L44)(209毫克,0.5 毫莫耳)與6-(3-咪唑-1-基-苯基)-2,2-二甲基-[1,3]二氧陸圜烯冰 酮(實例N10)(135毫克,0.5毫莫耳)。獲得米黃色固體(194毫 克)。 MS(ISP)631[(M+H)+];熔點 l〇l°C。 實例045 [心氟基-5-[3-(3-咪唑-1-基-苯基)各酮基-丙醯基胺基]-2-(2-酮基-呤唑啶-3-基)_聯苯基-4-基]-胺甲基酸第三-丁酯 根據一般程序〇,製自[5-胺基-4,-氟基-2-(2-酮基-崎唑啶-3-基)-聯苯基-4-基]-胺甲基酸第三-丁酯(實例L45)(130毫克, 0.34毫莫耳)與6-(3-咪唑小基-苯基)-2,2-二甲基-[1,3]二氧陸圜烯 -4-酮(實例N10)(92毫克,0.34毫莫耳)。獲得非晶質黃色物質 (86毫克)。 -115- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) illl·---------裝—— (請先閱讀背面之注意事項本頁) .- •丨線· 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明(113) MS(ISP) 600 [(M+H)+]。 實例046 -----,---------裝--- (請先閱讀背面之注音?事項再頁) {4·-說基-5-[3-(3-咪峻小基-苯基)-3-酮基-丙酿基胺基]-2-甲氧美 2^甲基-聯幕基-4-基1-胺甲基酸第三-丁 @旨 根據一般程序0,製自(5-胺基-4f-氟基-2-甲氧基-2,-甲基-聯 苯基-4-基)-胺甲基酸第三-丁 g旨(實例L46)(173毫克,〇·5毫莫 耳)與6-(3-咪唑小基-苯基)_2,2-二甲基-[1,3]二氧陸圜晞|酮(實 例N10)(199毫克,1.47毫莫耳)。獲得橘色固體(182亳克)。 MS (ISP) 559 [(M+H)+ ] ·,熔點 99-102°C。 實例047 {2-第三-丁氧基-4,-氟基-5-[3-(3-咪唑-1-基-苯基)-3-g同基-丙酸基 胺基]-聯苯基-4-基]-胺甲基酸第三-丁酯 '丨線 根據一般程序0,製自(5-胺基-2-第三-丁氧基-4,-氟-聯苯基. 4-基)-胺甲基酸第三-丁酯(實例L47)(187毫克,〇·5毫莫耳)與卜 (3-咪唑-1-基-苯基)-2,2-二甲基-[1,3]二氧陸圜烯斗酮(實例Nl〇) (135毫克,0.5毫莫耳)。獲得非晶質黃色物質(237毫克)。 MS(ISN) 585 [(M-H)_]。 實例048 經濟部智慧財產局員工消費合作社印製 {2-弟二-丁氣基-2’-氟基-5-[3-(3-味。坐-1-基-苯基)-3-明基-丙酿基 胺基]-聯苯基斗基}-胺曱基酸第三-丁酯 根據一般程序0,製自(5-胺基-2-第三-丁氧基-2’-氟-聯苯基· 4-基)-胺甲基酸第三-丁酯(實例L48)(187毫克,0.5毫莫耳)與卜 (3-咪唑小基苯基)-2,2-二甲基[1,3]二氧陸圜烯斗酮(實例Nl〇) (135毫克,0.5毫莫耳)。獲得非晶質黃色物質(234毫克)。 -116- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266Jrd-line · 1255266 A7 B7 V. INSTRUCTION DESCRIPTION (109) Hydrogen-systemane-2-yloxymethyl)-biphenyl phenyl]-amino acid tert-butyl ester according to the general procedure From (RS)-[5-Amino-hydrofluoro-2-(tetrahydro-pyranyloxymethyl)-biphenyl-4-yl]-amine methyl acid tert-butyl ester (example) L34) with 6-(3-imidazol-1-yl-phenyl)-2,2-dimethyl-[1,3]dioxolene-4-one (Example N10). Obtained as a pale yellow solid (330 mg). Example 〇35 {2-Cyanomethoxyfluoro-5-[3-(3-imidazol-1-yl-phenyl)-3-keto-propenylamino]-biphenyl-4- }--aminomethyl acid tert-butyl ester according to the general procedure 0, from (5-amino-2-cyanomethoxyfluoro-biphenyl-4-yl)-amine methyl acid third - Butyl ester (Example L35) (190 mg, 0.53 mmol) and 6-(3-imidazol-1-yl-phenyl)-2,2-dimethyl-[1,3]dioxene terpene- 4-ketone (Example N10) (164 mg, 0.61 mmol). Obtained yellow gum (90 mg). MS (ISP) 570 [(M+H)+]. Example 036 {2-Dimethylaminomethyl|Fluoro-5-[3-(3-imidazol-1-yl-phenyl)-3-keto-propenyl)-biphenyl-4 - Aminomethyl acid, third-butyl hydrazine, according to the general procedure 0, prepared from 5-amino-2-dimethylaminomethyl Ifluoro-biphenyl-4-yl)-amine methyl acid - Butyl ester (Example L36) and 6-(3-imidazol-1-yl-phenyl). 2,2-dimethyl-[1,3]dioxanthene ketone (Example N10). Obtained as a pale yellow solid (329 mg). Example 〇37 {2-(2,2-Dimethyl-tetrahydro-[1,3]dioxos(4,5-c]pyrrole-5-ylfluoro-5-[3-(3) ··Imidazole small group-phenyl) keto-propionylamino]-biphenyl-4-yl-b-methylamino acid tert-butyl ester-112· This paper scale applies to China National Standard (CNS) A4 size (210 X 297 mm) ------------- Pack--- (Please read the note on the back page first. ) -- Line · Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 A7 B7 V. Description of the invention (110) According to the general procedure, it is prepared from [5-amino-2-(2,2-dimethyl-tetrahydro 41,3]dioxosole [4, 5-cH-rho-5-yl)_4,-fluoro-biphenyl+yl&gt;amine methyl acid third·butyl vinegar (example L37) (465 mg, 1.05 mmol) and 6-(3·imidazole +yl-phenyl&gt;2,2-dimethyl-[1,3]oxoxaindole-4-one (Example N10) (314 mg, ι·ΐ6 mmol). Obtained amorphous yellow Substance (540 mg) MS (ISN) 654 [(MH)-]. Example 038 K-Fluoro-5-[3-(3-M. Aminoamino-biphenyl-4-yl}-amine methyl acid third-butyr is based on the general procedure, from (5- Base-4,-fluoro-2-methoxy-biphenyl-4-yl)-amine methyl acid tert-butyl ester (Example L38) (332 mg, 1.0 mmol) and 6-(3 -methanol-1-yl-phenyl)_2,2-dimethyl-[1,3]dioxanthene-4-one (Example N10) (270 mg, 1.0 mmol). Obtained amorphous Brown substance (328 mg) MS (ISN) 543 [(M-Η)-]. Example 039 {2-(1,4-dioxo-8-nitro-spiro[4.5]癸-8-yl)- 4,-Fluoro-5-[3-(3-imidazolyl-1-yl-phenyl)-3-keto-propionylamino]-biphenylyl yl}-amine methyl acid third- Butyl ester is prepared according to the general procedure from [5-amino-2-(l,4-dioxo-nitro-spiro[4.5]indole);-fluoro-biphenyl-4-yl]-amine A Tri-butyl ester (example L39) (444 mg, 1·〇 mmol) and 6-(3-imidazol-1-yl-phenyl)-2,2-dimethyl-[1, 3] Dioxonone ketone (Example N10) (321 mg, 1.19 mmol). Obtained brown solid (457 mg). MS (ISN) 654 [(MH)-]; melting point 1 ίο] 15 ° C (Decomposition) Example 040 -113- This paper scale applies to China National Standard (CNS) A4 specification (21〇X 297 public) -----.---------装--- (Please Read the back first Precautions on this page) -Jr-d· Line· Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 A7 B7 V. Invention Description (111) {4,-Fluoro-5-[3-(3·imidazole small Base-styl)-3-keto-propionylamino]methyl-biphenyl-4-yl}-amine methyl acid tert-butyl ester according to the general procedure 0, from (5-amino group _4,-Fluoro-2-methyl-biphenyl-4-yl)-amine methyl acid, third-butyl ester (example L40) (316 mg, 1.0 mmol) and 6-(3_m) Biting 1-yl-phenyl)-2,2-dimethyl[1,3]dioxolone ketone (example Ν1〇χ297 mg '1.1 Love: Moer). An amorphous yellow material (361 mg) was obtained. MS (ISP) 529 [(M+H)+]. Example 041 {4-Terti-butoxycarbonylamino-4f-fluoro-5-[3-(3-imidazol-1-yl-phenyl)-3.yl-propenylamino]-biphenyl Benzyl-2-yloxy}-acetic acid _ 酉 酉 酉 酉 酉 酉 酉 酉 酉 酉 酉 ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( Base)-acetic acid third-butyl ester (Example L41) (14 g, 3.24 mmol) and 6-(3-imidazolyl-phenyl) 2,2-dimethyl-[1,3] Oxalindole-4-one (Example N10) (885 mg, 3.27 mmol) afforded a pale brown solid ( s s s s s s s s s s s s s s s s s s C. Example 042 {2-Chloro-4f-fluoro-5-[3-(3-amido-1-yl-phenyl)-3-keto-propenylamino]-biphenyl- 4-Butyl-aminomethyl acid tert-butyl ester according to the general procedure 0, prepared from (5-amino-2-yl-l-fluoro-biphenylyl)-amine methyl acid tert-butyl ester (Example L42) (168 mg, 0.5 mmol) with 6-(3-imidazol-1-yl-phenyl)-2,2-dimethyl-[1,3]dioxolene-4- Ketone (Example N10) (252 mg, 0.93 mmol) afforded a pale-yellow solid (156 mg). MS (ISN) 547 [(M-Η). Example 043 -114- Use Chinese National Standard (CNS) A4 specification (210 X 297 mm) ----r- -------- Install i I (please read the precautions on the back and then 13||^4 pages) : ί线· Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 A7 B7 V. Description of Invention ( 112 ) [4'-Fluoro-5-[3-(3-imidazol-1-yl-phenyl)-3 -keto-propionylamino]-2-(2-methoxy-ethoxy)-biphenyl-4-yl]-amine methyl acid, third butyl ester, according to the general procedure, [5-Amino-4,-fluoro-2-(2-methoxy-ethoxy)-biphenylylidyl]-amine methyl acid tert-butyl ester (Example L43) (188 mg, 0.5 mM) with 6-(3-imidazolyl-phenyl)-2,2-dimethyl-[1,3]dioxolene-4-one (Example N10) (260 mg, 0.96) Obtained an orange solid (218 mg). MS (ESI) 589 [(M+H)+]; mp 61-63T: Oxy)·4,_fluoro-5-[3-(3-imidazolyl-phenyl) keto-propyl arylamino]-biphenyl-4-yl 1-amine methyl acid Tri-butyl ester is prepared according to the general procedure from [5-amino-2-(2-tris-butoxy-ethoxy)-4,-fluoro-biphenyl- Tetra-butyl 4-amino]-aminomethyl acid (Example L44) (209 mg, 0.5 mmol) and 6-(3-imidazol-1-yl-phenyl)-2,2-dimethyl -[1,3] Dioxanedecene ketone (Example N10) (135 mg, 0.5 mmol). Obtained a beige solid (194 mg). MS (ISP) 631 [(M+H)+]; m.p. Example 045 [Heartylfluoro-5-[3-(3-imidazol-1-yl-phenyl) keto-propionylamino]-2-(2-keto-oxazolidine-3-yl) )-biphenyl-4-yl]-aminomethyl acid tert-butyl ester according to the general procedure, prepared from [5-amino-4,-fluoro-2-(2-keto-sodium oxazide) -3-yl)-biphenyl-4-yl]-amine methyl acid tert-butyl ester (Example L45) (130 mg, 0.34 mmol) and 6-(3-imidazolyl-phenyl) -2,2-Dimethyl-[1,3]dioxolene-4-one (Example N10) (92 mg, 0.34 mmol). Obtained an amorphous yellow material (86 mg). -115- This paper size is applicable to China National Standard (CNS) A4 specification (210 X 297 mm) illl·---------Installation - (Please read the back note on this page first) .- •丨线· Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 1255266 A7 B7 V. Invention description (113) MS (ISP) 600 [(M+H)+]. Example 046 -----,---------Install--- (Please read the phonetic on the back? Matters again page) {4·-说基-5-[3-(3-咪峻Small base-phenyl)-3-keto-propyl arylamino]-2-methoxy-2-phenyl-co-brenyl-4-yl 1-amine methyl acid third-butyl@ Procedure 0, prepared from (5-amino-4f-fluoro-2-methoxy-2,-methyl-biphenyl-4-yl)-amine methyl acid, third-butyr (example L46) (173 mg, 〇·5 mmol) and 6-(3-imidazolyl-phenyl)_2,2-dimethyl-[1,3]dioxanthone|ketone (Example N10) 199 mg, 1.47 mmol.) Obtained an orange solid (182 g). MS (ISP) 559 [(M+H)+], mp. 99-102. Example 047 {2-Terti-butoxy-4,-fluoro-5-[3-(3-imidazol-1-yl-phenyl)-3-g-iso-propionylamino]-linked Phenyl-4-yl]-amine methyl acid tert-butyl ester' fluorene line according to the general procedure 0, from (5-amino-2-tri-butoxy-4,-fluoro-biphenyl 4-Base)-Aminomethyl 3-butyrate (Example L47) (187 mg, 〇·5 mmol) and Bu (3-Imidazol-1-yl-phenyl)-2,2-di Methyl-[1,3]dioxanthene ketone (Example Nl〇) (135 mg, 0.5 mmol). An amorphous yellow material (237 mg) was obtained. MS (ISN) 585 [(M-H)_]. Example 048 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed {2-di-di-butanyl-2'-fluoro-5-[3-(3-flavor. sit-1-yl-phenyl)-3- Benzo-propyl arylamino]-biphenyl phenyl}-amino phthalic acid tert-butyl ester according to the general procedure 0, from (5-amino-2-tri-butoxy-2'- Fluorine-biphenyl-4-yl)-amine methyl acid tert-butyl ester (Example L48) (187 mg, 0.5 mmol) and Bu (3-imidazolylphenyl)-2,2-di Methyl [1,3]dioxanthene ketone (example Nl) (135 mg, 0.5 mmol). An amorphous yellow material (234 mg) was obtained. -116- This paper size is applicable to China National Standard (CNS) A4 specification (210 X 297 mm) 1255266

五、發明說明( 114 ) MS(ISN) 585 [(M«H)-]。 實例049 裝i I (請先閱讀背面之注意事項再本頁) (RS)-K-氟基-5-[3-(3-咪唑-i-基-苯基&gt;3姻基-丙醯基胺基]_2·[⑻_ 3- (四氫-旅喃-2-基氧基)·四氫吡咯小基]-聯苯基冰基卜胺甲基 酸第三-丁酯 根據一般私序0,製自(RS&gt;{5-胺基I氟基[⑻各(四氫4 喃-2-基氧基)-四氫吡咯+基]_聯苯基|基卜胺甲基酸第三-丁 酯(實例L49)(236毫克,〇·5毫莫耳)與6〇米唑小基_苯基)_2,2_ 一甲基-[1,3]一氧陸圜晞酮(實例Ν10)(200毫克,0.74毫莫耳) 。獲得橘色固體(188毫克)。 MS(ISP) 684 [(M+H)+];溶點 99-l〇3°C。 實例050 {2-氟基-5-[3-(3-咪唑-1-基-苯基)各酮基-丙醯基胺基]1甲氧基_ 聯苯基-4-基}-胺甲基酸第三_丁酉旨 線· 根據一般程序0,製自(5-胺基-2’-氟基-2-甲氧基-聯苯基-4-基)-胺甲基酸第三-丁酯(實例L50)(159毫克,0.5毫莫耳)與6-(3-咪峻-1-基-苯基)-2,2-二甲基_[1,3]二氧陸圜烯-4-酮(實例N10) (135毫克,0.5毫莫耳)。獲得非晶質黃色物質(199毫克)。 經濟部智慧財產局員工消費合作社印製 MS (ISN) 543 [(M-H)-]。 實例051 {2-弟二-丁乳基-5-[3-(3-夜基-冬基)-3-S同基-丙酿基胺基]-4’-^ ••聯 苯基冰基}-胺甲基酸第三-丁酯 根據一般程序0,製自(5-胺基-2·第三-丁氧基-4’-氟-聯苯基- 4- 基)-胺甲基酸第三-丁基酯(實例L47)(187毫克,0.5毫莫耳) -117- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266 A7 B7 五、發明說明(115) 與3-(2,2-二甲基各酮基-6H-[1,3]二氧陸圜烯-4-基)-苯甲腈(實例 N4)(126毫克,0.55毫莫耳)。獲得非晶質淡粉紅色物質(196 毫克)。 MS(ISP) 546 [(M+H)+]。 實例052 {2-第三-丁氧基-5-[3-(3-氰基-苯基)-3-酮基-丙醯基胺基]-2,·氟·聯 苯基-4-基}-胺甲基酸第三-丁酯 根據一般程序Ο,製自(5-胺基—2-第三-丁氧基-2f-氟-聯苯基-4·基)-胺甲基酸第三-丁酯(實例L48)(187毫克,0.5毫莫耳)與3-(2,2-二甲基-6-酮基-6H-[1,3]二氧陸圜烯-4-基)-苯甲腈(實例N4) (126毫克,0.55毫莫耳)。獲得非晶質淡粉紅色物質(丨97毫克)。 MS(ISP) 546 [(M+H)+]。 實例053 {5-[3-(3-氰基-苯基)-3-酮基•丙醯基胺基]-2^·氟基-2-甲氧基-聯苯 基冰基}-胺甲基酸第三-丁酯 根據一般程序Ο,製自(5-胺基-氟基-2-甲氧基-聯苯基斗 基)-胺甲基酸第三-丁酯(實例L50)(112毫克,〇·35毫莫耳)與3_ (2,2-二甲基-6-酮基-6H-[1,3]二氧陸圜烯-4-基)-苯甲腈(實例 N4)(80毫克,0.35毫莫耳)。獲得黃色泡沫物(131毫克)。 MS (ISN) 502 [(Μ-Η:Γ ]。 實例054 (2^·氟基-2-甲氧基-5-{3-[3-(2-曱基-咪唑小基)-苯基]-3-酮基-丙酿 基胺基}-聯苯基-4-基)-胺甲基酸第二-丁酉旨 根據一般程序Ο,製自(5-胺基氟基-2-甲氧基-聯苯基冰 -118- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ----^---------裝--- (請先閱讀背面之注意事項再1?^4頁) . :線· 經濟部智慧財產局員工消費合作社印製 1255266V. INSTRUCTIONS (114) MS(ISN) 585 [(M«H)-]. Example 049 Install i I (please read the back note on this page first) (RS)-K-Fluoro-5-[3-(3-imidazo-i-yl-phenyl)3-marine-propionate Aminoamino]_2·[(8)-3-(tetrahydro-methane-2-yloxy)·tetrahydropyrrole small group]-biphenylyl yl-p-aminomethyl acid tert-butyl ester according to general private order 0, made from (RS&gt;{5-aminolfluoro group [(8) each (tetrahydrotetram-2-yloxy)-tetrahydropyrrole+yl]-biphenyl] carbamide methyl acid third -Butyl ester (Example L49) (236 mg, 〇·5 mmol) and 6-carbazole small group _phenyl)_2,2-monomethyl-[1,3]monooxanthone (Example Ν10 (200 mg, 0.74 mmol). Obtained an orange solid (188 mg). MS (ISP) 684 [(M+H)+]; melting point 99-l 〇 3 ° C. Example 050 {2-Fluor 5-[3-(3-imidazol-1-yl-phenyl) keto-propionylamino]1 methoxy-biphenyl-4-yl}-amine methyl acid _ Ding Yu Line · According to the general procedure 0, from (5-amino-2'-fluoro-2-methoxy-biphenyl-4-yl)-amine methyl acid third-butyl ester (example L50 ) (159 mg, 0.5 mmol) and 6-(3-imiran-1-yl-phenyl)-2,2-dimethyl-[1,3]dioxolene-4-one ( Instance N10) (135 mg, 0.5 mmol). Obtained amorphous yellow material (199 mg). Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed MS (ISN) 543 [(MH)-]. Example 051 {2- Di-butyl-butyryl-5-[3-(3-indolyl-winteryl)-3-S-yl-propyl-arylamino]-4'-^ ••biphenylyl yl}-amine A The third acid - butyl ester was prepared according to the general procedure 0 from (5-amino-2,t-butoxy-4'-fluoro-biphenyl-4-yl)-amine methyl acid - Butyl ester (Example L47) (187 mg, 0.5 mmol) -117- This paper size applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1255266 A7 B7 V. Invention description (115) and 3 -(2,2-Dimethyl ketone-6H-[1,3]dioxol-4-yl)-benzonitrile (Example N4) (126 mg, 0.55 mmol). Crystal light pink material (196 mg) MS (ISP) 546 [(M+H)+]. Example 052 {2-T-butoxy-5-[3-(3-cyano-phenyl) )-3-keto-propionylamino]-2,-fluoro-biphenyl-4-yl}-amine methyl acid tert-butyl ester according to the general procedure, from (5-amino group - 2-tert-butoxy-2f-fluoro-biphenyl-4-yl)- Tri-butyl methacrylate (Example L48) (187 mg, 0.5 mmol) and 3-(2,2-dimethyl-6-keto-6H-[1,3]dioxene terpene 4-yl)-benzonitrile (Example N4) (126 mg, 0.55 mmol). An amorphous pale pink material (丨97 mg) was obtained. MS (ISP) 546 [(M+H)+]. Example 053 {5-[3-(3-Cyano-phenyl)-3-keto•propanylamino]-2^·fluoro-2-methoxy-biphenylylidyl}-amine Third-butyl methacrylate was prepared according to the general procedure from (5-amino-fluoro-2-methoxy-biphenyl phenyl)-amine methyl acid tert-butyl ester (Example L50) (112 mg, 〇35 mmol) and 3_(2,2-dimethyl-6-keto-6H-[1,3]dioxol-4-yl)-benzonitrile (example) N4) (80 mg, 0.35 mmol). Yellow foam (131 mg) was obtained. MS (ISN) 502 [(Μ-Η:Γ]. Example 054 (2^·Fluoro-2-methoxy-5-{3-[3-(2-indolyl-imidazolyl)-phenyl) ]-3-keto-propyl arylamino}-biphenyl-4-yl)-amine methyl acid second-butyl hydrazine is prepared according to the general procedure, from 5-aminofluoro-2-yl Oxy-biphenyl ice-118- This paper size is applicable to China National Standard (CNS) A4 specification (210 X 297 mm) ----^---------装--- (please first Read the notes on the back and then 1?^4 pages. . : Line· Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266

五、發明說明(116) 基)-胺甲基酸第三-丁酯(實例L50)(249毫克,0.75毫莫耳)與3-[3-(2-甲基-咪吐小基)-苯基]-3-酮基-丙酸第三_ 丁酯(實例M8) (275毫克,0.92毫莫耳)。獲得黃色固體(312毫克)。 MS (ISP) 559 [(M+H)+ ];熔點 83-86°C。 實例055 {5-[3-(5-氰基-嘍吩-2-基)-3-酮基-丙醯基胺基]-2,-氟基-2-甲氧基_ 聯苯基-4-基}-胺甲基酸第三-丁酯 根據一般程序0,製自(5-胺基-2f-氟基-2-甲氧基-聯苯基冰 基)-胺甲基酸第三-丁酯(實例L50)(166毫克,0.5毫莫耳)3-(5-氰 基-魂吩-2-基)-3-酮基-丙酸第三-丁酯(實例M17)(138毫克,0.55 毫莫耳)。獲得淡黃色固體(244毫克)。 MS (ISP) 510 [(M+H)+ ] ·,熔點 200°C (分解)。 實例056 {2,-氟基-2-甲氧基-5-[3-酮基-3-(3-[1,2,4]三唑-4-基-苯基)_丙醯基 胺基]-聯苯基-4-基}-胺甲基酸第三-丁酯 根據一般程序Ο,製自(5-胺基-2,-氟基-2-甲氧基-聯苯基冰 基)·胺甲基酸第三-丁酯(實例L50)(166毫克,0.5毫莫耳)與3-酮基-3-(3-[1,2,4]三唑-4-基-苯基)-丙酸乙酯(實例M1)(260毫克, 1.0¾莫耳)。獲得黃色膠質(70毫克)。 MS(ISP) 546 [(M+H)+]。 實例057 {5-[3-(2-氰基-吡啶-4-基)-3-酮基-丙醯基胺基]-2,-氟基-2-甲氧基- 聯木基-4-基}-胺曱基酸第三_丁酉旨 根據一般程序〇,製自(5-胺基-2,-氟基-2-甲氧基-聯苯基冰 119- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ----1---------裝--- (請先閱讀背面之注意事項本頁) 訂: -線- 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明(117) 基)-胺甲基酸第三-丁酯(實例L50)與3-(2-氰基4啶-4-基)-3-酮 基-丙酸第三-丁酯(實例M10)。獲得淡黃色固體(189亳克)。 MS(ISP) 522 [(M+NH4)+]。 實例058 (2-第二-丁氧基-4^-氟基-5-{3-[3-(2-甲基-咪嗤-1-基)-苯基]-3-酮基_ 丙醯基胺基}-聯苯基-4-基)-胺甲基酸第三-丁酯 根據一般程序0,製自(5-胺基-2-第三-丁氧基-4,-氟-聯苯基_ 4-基)-胺甲基酸第三-丁酯(實例L47)(140毫克,〇.37亳莫耳)與 3- [3-(2·甲基-咪唑-1-基)-苯基]-3-酮基-丙酸第三-丁酯(實例M8) (111毫克,0.37毫莫耳)。獲得非晶質黃色物質(139毫克)。 MS(ISP)601 [(M+H)+]。 實例059 {5-[3-(5-氰基-2-氟苯基)-3-酮基-丙醯基胺基]-2’-氟基-2-甲氧基_ 聯苯基-4-基}•胺甲基酸第三-丁酯 根據一般程序0,製自(5-胺基氟基-2-甲氧基-聯苯基斗 基)-胺甲基酸第三-丁酯(實例L50)(166毫克,0.5毫莫耳)與3-(5-氰基-2-氟苯基)-3-S同基-丙酸乙g旨(實例M18)(141毫克,0.6毫 莫耳)。獲得非晶質黃色物質(165毫克)。 MS (ISP) 522 [(M+H)+ ] 〇 實例060 {2-弟二-丁乳基-5-[3-(2-乱基-p比淀-4-基)-3-嗣基-丙酿基胺基]4-氟-聯苯基-4-基}-胺甲基酸第三-丁酯 根據一般程序Ο,製自(5-胺基-2-第三-丁氧基-4,-氟-聯苯基- 4- 基)-胺甲基酸第三-丁酯(實例L47)(140毫克,〇_37毫莫耳)與 -120- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) --------------裝--- (請先閱讀背面之注意事項再本頁) · 經濟部智慧財產局員工消費合作社印製 1255266 經濟部智慧財產局員工消費合作社印製 A7 B7___ 五、發明說明(118) 3- (2-氰基^比呢-4-基)-3-酮基-丙酸第三-丁酯(實例M10)(91毫克 ,0.37毫莫耳)。獲得非晶質黃色物質(164毫克)。 MS(ISP) 547[(M+H)+] 〇 實例061 {2-第三-丁氧基-2’-氟基-5-[3-酮基-3-(3-[1,2,3]三唑-1-基-苯基)-丙 醒基胺基]-聯苯基-4-基}-胺甲基酸第三_丁酉旨 根據一般程序Ο,製自(5-胺基-2-第三-丁氧基-2’-氟-聯苯基- 4- 基)-胺甲基酸第三-丁酯(實例L48)(187毫克,〇·5毫莫耳)與3-酮基-3-(3-[1,2,3]三唑-1-基-苯基)丙酸乙酯(實例M2)(i8〇毫克, 0.69毫莫耳)。獲得淡黃色固體(257毫克)。 MS (ISP) 588 [(M+H)+];熔點 47-50°C。 實例062 [5-[3-(3-氰基-苯基)-3-酮基-丙醯基胺基]_2-(l.,4-二氧-8-氮-螺[4.5] 癸各基)-2f-氟-聯苯基-4-基]-胺甲基酸第三-丁酯 根據一般程序Ο,製自[5-胺基-2-(l,4-二氧-8-氮-螺[4.5]癸各 基)-2’-氟-聯苯基-4-基]胺甲基酸第三-丁酯(實例L51)(222毫克 ,0.5毫莫耳)與3-(3-氰基-苯基)-3-酮基-丙酸第三-丁酯(實例 M3)(182毫克,0.8毫莫耳)。獲得非晶質黃色物質(258毫克)。 MS(ISP)615[(M+H)+]。 實例063 {2-(1,4-一 氧-8-氛-螺[4.5]癸-8-基)-2’-氣-5-[3-(3-味也-1-基-苯基)-3_ 酮基-丙醯基胺基]-聯苯基-4-基}-胺甲基酸第三-丁酯 根據一般程序Ο,製自[5-胺基-2-(l,4-二氧-8-氮-螺[4.5]癸-8-基)-2^氟-聯苯基-4-基]-胺甲基酸第三-丁酯(實例L51)(222毫克 -121 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) --------------裝--- (請先閱讀背面之注意事項再頁) . 線· 1255266 A7 B7 五、發明說明(119) ,0.5愛莫耳)與6-(3·&quot;咪。坐-1-基-苯基)-2,2-二甲基_[ι,3]二氧陸圜 烯4-銅(實例N10)(135亳克,0.5毫莫耳)。獲得非晶質黃色物 質(294毫克)。 MS(ISP) 656 [(M+H)+]。 實例064 (2-第二-丁氧基-2’·氟基-5-{3-[3-(2-甲基-咪峻—1-基)_苯基]_3-|同基_ 丙酿基胺基}-聯苯基-4-基)-胺甲基酸第三-丁酯 根據一般程序0,製自(5-胺基-2-第三·丁氧基-2l氟-聯苯基_ 4-基)-胺甲基酸第三-丁酯(實例L48)(187毫克,〇·5毫莫耳)與 2,2-二甲基-6-[3-(2-甲基-咪吐-1-基)-苯基]-[ι,3]二氧陸圜晞4-酮( 實例N15)(142毫克,0.5毫莫耳)。獲得非晶質黃色物質(234 毫克)。 MS(ISP)601[(M+H)+]。 實例065 {2-第三-丁氧基-5-[3-(2-氰基比啶-4-基)-3-酮基-丙醯基胺基]-2f-氟-聯苯基-4-基}-胺甲基酸第三-丁酯 根據一般程序0,製自(5-胺基-2-第三-丁氧基-2,-氟-聯苯基-4-基)_胺甲基酸第三-丁酯(實例L48)(187毫克,0.5毫莫耳)與4-(2,2-二甲基-6-酮基-6H-[1,3]二氧陸圜烯斗基)-吡啶-2-甲腈(實例 N16)(115毫克.,0.5毫莫耳)。獲得非晶質黃色物質(216毫克)。 MS(ISP) 547 [(M+H)+]。 實例066 (2-第三-丁氧基-2’-氟基-5-{3-[3-(2-甲硫基-咪唑-1-基)-苯基]-3-酮 基-丙醯基胺基}-聯苯基-4-基)-胺甲基酸第三-丁酯 -122- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) •-------------裝 i I (請先閱讀背面之注意事項再本頁) . 線· 經濟部智慧財產局員工消費合作社印製 1255266 A7 ..............B7_____ 五、發明說明(120) 根據一般程序0,製自(5_胺基i第三-丁氧基-2,_氟_聯苯基_ 4-基)-胺甲基酸第三-丁酯(實例L48)(187毫克,〇 5毫莫耳)與3_ [3-(2-甲硫基《咪吐小基 &gt;苯基]各酮基-丙酸第三-丁酯(實例 M13)(211毫克,0.63毫莫耳)。獲得淡黃色固體(26〇毫克)。 MS (ISN) 631 [(M-H)_ ];熔點 59-62°C。 實例067 {5-[3-(3-氰基-苯基)-3-酮基-丙醯基胺基]-2’,5’-二氟-2-曱氧基-聯 苯基_4-基}-胺甲基酸第三-丁酯 根據一般程序Ο,製自(5-胺基-2’,5’-二氟-2-甲氧基-聯苯基斗 基)-胺甲基酸第三-丁酯(實例L52)(175毫克,〇·5毫莫耳)與3-(2,2-二甲基各酮基-6H-[1,3]二氧陸圜烯-4-基)-苯甲腈(實例N4) (115毫克’ 0.5毫莫耳)。獲得非晶質黃色物質(丨36毫克)。 MS(ISP) 522 [(M+H)+] 〇 實例068 {2’,5’_二氟-2-甲氧基-5-[3-酮基-3-(3-[1,2,3]三唑小基-苯基)-丙醯基 胺基]-聯苯基-4-基}-胺甲基酸第三-丁酉旨 根據一般程序Ο,製自(5-胺基-2’,5’-二氟-2-甲氧基-聯苯基斗 基)-胺甲基酸第三-丁酯(實例L52)(175毫克,0.5毫莫耳)與3-酮基-3-(3-[1,2,3]三唑-1-基-苯基)-丙酸乙酯(實例M2)(130毫克, 0.5毫莫耳)。獲得非晶質淡黃色物質(185毫克)。 MS(ISN) 562 [(M-H)·]。 實例〇69 {2-第三-丁氧基-5-[3-(3-氰基-噻吩-2-基)-3-酮基-丙醯基胺基]-2^ 氟-聯苯基-4-基]-胺甲基酸第三-丁酯 -123- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) --------------裝 i I (請先閱讀背面之注意事項再本頁) 訂: 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明(121) 根據一般程序0,製自(5-胺基冬第三-丁氧基_2,_氟_聯苯基_ 4-基)-胺甲基酸第三-丁酯(實例l48)(187毫克,0.5毫莫耳)與6_ (3-氰基-魂吩-2-基)-2,2·二甲基#,3]二氧陸圜烯-4-酮(實例 N3)(130毫克,0.55毫莫耳)。獲得黃色油(278毫克)。 MS(ISN) 550 [(M-H)-] 〇 實例070 {2-第三-丁氧基-5-[3-(5-氰基-噻吩-2-基)-3-酮基-丙醯'基胺基]-2,- 氟-聯苯基-4-基}-胺甲基酸第三·丁酯 根據一般程序Ο,製自(5_胺基1第三-丁氧基-21-氟-聯苯基_ 4-基)-胺甲基酸第三-丁酯(實例L48)(187毫克,0.5毫莫耳)與3-(5-氰基4吩-2-基)-3-酮基-丙酸第三-丁酯(實例M17)(138毫克 ’ 0.55愛莫耳)。獲得非晶質黃色物質(268毫克)。 MS(ISN) 550 [(M-Hy]。 實例071 《2-弟一* -丁氧基-4 -氣基-5-[3-嗣基-3-(3-[1,2,3]二哇-1-基·冬基)-丙 醯基胺基]-聯苯基-4-基}-胺甲基酸第三-丁酯 經濟部智慧財產局員工消費合作社印製 ----r---------裝--- (請先閱讀背面之注意事項再本頁) ί線· 根據一般程序Ο,製自(5-胺基-2-第三-丁氧基-4’-氟-聯苯基· 4-基)-胺甲基酸第三-丁酯(實例L47)(187毫克,0.5毫莫耳)與3_ 酮基-3-(3-[1,2,3]三唑小基-苯基)-丙酸乙酯(實例M2)(156毫克, 〇·6毫莫耳)。獲得黃色膠質(198毫克)。 MS(ISP) 588 [(M+H)+]。 實例072 [5-[3-(3-氰基-苯基)-3-酮基-丙醯基胺基]-2'-氟基-2-(2-甲氧基-乙 氧基)-聯苯基-4-基]-胺甲基酸第三-丁酯 -124- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) A7 1255266 ________B7_ 五、發明說明(122 ) 根據一般程序〇 ’製自15-胺基-2’-氟基-2-(2-甲氧基-乙氧基)_ 聯苯基-4-基)-胺甲基酸第三-丁酯(實例L53)與3·(2,2-二甲基各 酮基-6Η-[1,3]二氧陸圜晞-4-基)-苯甲腈(實例Ν4)。獲得黃色固 體(188毫克)。 MS(ISP) 548 [(M+H)+]。 實例〇73 (RS)-[5-[3-(3-氰基-苯基)-3-酮基-丙酿基胺基]-21-氟基-2-(四氫-喊 喃-2-基氧基甲基)-聯苯基-4-基]-胺甲基酸第三-丁酯 根據一般程序0,製自(RS)-[5-胺基-2,-氟基-2-(四氫-哌喃—2-基氧基甲基)-聯苯基-4-基]-胺甲基酸第三-丁醋(實例L54)與3-(2,2_二甲基-6-酮基-6H-[1,3]二氧陸圜晞-4-基)-苯曱腈(實例N4) 。獲得黃色固體(155毫克)。 MS(ISP) 548 [(M+NH4)+]。 實例074 (2·-氟基-2-(4-甲氧基-苄氧基)-5-{3-[3-(3-甲基-異吟唑-5-基)-苯基]-3-酮基-丙醯基胺基}-聯苯基基)-胺甲基酸第三-丁酯 根據一般程序0,製自[5-胺基-2,-氟基-2-(4-甲氧基-爷氧基)_ 聯苯基斗基]-胺甲基酸第三-丁酯(實例L55)(438毫克,1.〇毫 莫耳)與3-[3-(3-甲基-異呤唑-5-基)-苯基]-3-酮基-丙酸第三-丁酯 (實例M14)(301毫克,1.0毫莫耳)。獲得非晶質淡黃色物質 (561毫克)。 MS(ISP) 666 [(M+H)+]。 實例075 {2-第三-丁氧基-5-[3-(3-氰基-苯基)-3-酮基-丙醯基胺基]-2,,5,-二 _ -125- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公爱) -------------裝 i I (請先閱讀背面之注意事項再本頁) .- 經濟部智慧財產局員工消費合作社印製 1255266 A7V. INSTRUCTIONS (116) s-aminomethyl acid tert-butyl ester (example L50) (249 mg, 0.75 mmol) and 3-[3-(2-methyl-mipropionyl)- Phenyl]-3-keto-propionic acid tert-butyl ester (Example M8) (275 mg, 0.92 mmol). A yellow solid (312 mg) was obtained. MS (ISP) 559 [(M+H)+]; mp. Example 055 {5-[3-(5-Cyano-indol-2-yl)-3-one-propenylamino]-2,-fluoro-2-methoxy-biphenyl- 3-Benzyl-aminomethyl acid tert-butyl ester according to the general procedure 0, from (5-amino-2f-fluoro-2-methoxy-biphenylyl)-amino acid Tri-butyl ester (Example L50) (166 mg, 0.5 mmol) 3-(5-cyano-soul-phen-2-yl)-3-keto-propionic acid tert-butyl ester (Example M17) 138 mg, 0.55 mmol. Obtained as a pale yellow solid (244 mg). MS (ISP) 510 [(M+H)+], mp. 200 ° C (dec.). Example 056 {2,-Fluoro-2-methoxy-5-[3-keto-3-(3-[1,2,4]triazol-4-yl-phenyl)-propionylamine Benzyl-terphenyl-4-yl}-amine methyl acid tert-butyl ester according to the general procedure, prepared from (5-amino-2,-fluoro-2-methoxy-biphenyl ice Amino acid tert-butyl ester (Example L50) (166 mg, 0.5 mmol) and 3-keto-3-(3-[1,2,4]triazol-4-yl- Phenyl)-propionic acid ethyl ester (Example M1) (260 mg, 1.03⁄4 mol). Obtained yellow gum (70 mg). MS (ISP) 546 [(M+H)+]. Example 057 {5-[3-(2-Cyano-pyridin-4-yl)-3-one-propenylamino]-2,-fluoro-2-methoxy-Limyl-4 -基}-Amino-based acid third _ 酉 酉 according to the general procedure 制, made from (5-amino-2,-fluoro-2-methoxy-biphenyl ice 119- this paper scale applies to China Standard (CNS) A4 specification (210 X 297 mm) ----1---------Installation--- (Please read the back note on this page first) Order: -Line - Ministry of Economics Property Bureau Staff Consumer Cooperative Printed 1255266 A7 B7 V. Description of Invention (117) Base)-Aminomethyl 3-butyrate (Example L50) and 3-(2-Cyano-4-pyridin-4-yl)-3 - Keto-propionic acid tert-butyl ester (Example M10). A pale yellow solid (189 g) was obtained. MS (ISP) 522 [(M+NH4)+]. Example 058 (2-second-butoxy-4^-fluoro-5-{3-[3-(2-methyl-amido-1-yl)-phenyl]-3-oneyl-propane Tert-butylamino}-biphenyl-4-yl)-amine methyl acid tert-butyl ester according to the general procedure 0, from (5-amino-2-tris-butoxy-4,-fluoro -biphenyl-4-yl)-aminomethyl acid tert-butyl ester (example L47) (140 mg, 〇.37 亳mol) and 3-[3-(2.methyl-imidazole-1- Tris-phenyl]-3-keto-propionic acid tert-butyl ester (Example M8) (111 mg, 0.37 mmol). An amorphous yellow material (139 mg) was obtained. MS (ISP) 601 [(M+H)+]. Example 059 {5-[3-(5-Cyano-2-fluorophenyl)-3-one-propenylamino]-2'-fluoro-2-methoxy-biphenyl-4 -Based on the basis of the general procedure 0, from (5-aminofluoro-2-methoxy-biphenylyl)-amine methyl acid tert-butyl ester (Example L50) (166 mg, 0.5 mmol) and 3-(5-cyano-2-fluorophenyl)-3-S synthyl-propionic acid B g (Example M18) (141 mg, 0.6 m Moore). An amorphous yellow material (165 mg) was obtained. MS (ISP) 522 [(M+H)+ ] 〇 Example 060 {2-di-butyl-butyryl-5-[3-(2-ranyl-p-pred-4-yl)-3-indenyl - propylamino] 4-fluoro-biphenyl-4-yl}-amine methyl acid tert-butyl ester according to the general procedure, from (5-amino-2-tri-butoxy -4,-fluoro-biphenyl-4-yl)-amine methyl acid tert-butyl ester (example L47) (140 mg, 〇_37 mmol) and -120- This paper scale applies to Chinese national standards (CNS) A4 size (210 X 297 mm) -------------- Pack --- (Please read the back note before this page) · Ministry of Economic Affairs Intellectual Property Bureau staff consumption Cooperatives printed 1255266 Ministry of Economic Affairs Intellectual Property Bureau employees consumption cooperatives printed A7 B7___ V. Description of invention (118) 3- (2-cyano-pyridyl-4-yl)-3-keto-propionic acid third-butyl Ester (Example M10) (91 mg, 0.37 mmol). Obtained an amorphous yellow material (164 mg). MS (ISP) 547 [(M+H)+] 〇 Example 061 {2-T-butoxy-2'-fluoro-5-[3-keto-3-(3-[1,2, 3] Triazol-1-yl-phenyl)-propanylamino]-biphenyl-4-yl}-amine methyl acid _ 酉 酉 酉 酉 酉 酉 酉 酉 酉 酉 酉 酉 酉2-tert-butoxy-2'-fluoro-biphenyl-4-yl)-amine methyl acid tert-butyl ester (example L48) (187 mg, 〇·5 mmol) and 3 Ethyl keto-3-(3-[1,2,3]triazol-1-yl-phenyl)propanoate (Example M2) (i.sup.8 mg, 0.69 mmol). Obtained as a pale yellow solid (257 mg). MS (ISP) 588 [(M+H)+]; mp. 47-50. Example 062 [5-[3-(3-Cyano-phenyl)-3-keto-propenylamino]_2-(l.,4-dioxo-8-nitro-spiro[4.5] The base -2f-fluoro-biphenyl-4-yl]-amine methyl acid tert-butyl ester was prepared according to the general procedure from [5-amino-2-(l,4-dioxo-8-). Nitrogen-spiro[4.5]decyl)-2'-fluoro-biphenyl-4-yl]aminemethyl acid tert-butyl ester (example L51) (222 mg, 0.5 mmol) and 3-( 3-Cyano-phenyl)-3-keto-propionic acid tert-butyl ester (Example M3) (182 mg, 0.8 mmol). An amorphous yellow material (258 mg) was obtained. MS (ISP) 615 [(M+H)+]. Example 063 {2-(1,4-Oxo-8-Aromatic-spiro[4.5]dec-8-yl)-2'-gas-5-[3-(3-flamo-1-yl-phenyl) -3-keto-propionylamino]-biphenyl-4-yl}-amine methyl acid tert-butyl ester according to the general procedure, from [5-amino-2-(l, 4 -Dioxo-8-nitro-spiro[4.5]dec-8-yl)-2^fluoro-biphenyl-4-yl]-amine methyl acid tert-butyl ester (Example L51) (222 mg-121 - The paper size applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) --------------Installation --- (Please read the notes on the back page again). Line · 1255266 A7 B7 V. Description of invention (119), 0.5 Amor) and 6-(3·&quot;M..-1-yl-phenyl)-2,2-dimethyl-[ι,3 Dioxetene 4-copper (example N10) (135 g, 0.5 mmol). Obtained an amorphous yellow material (294 mg). MS (ISP) 656 [(M+H)+]. Example 064 (2-second-butoxy-2'-fluoroyl-5-{3-[3-(2-methyl-miquid-1-yl)-phenyl]_3-|isolated _ propyl Tert-butyl ester of arylamino}-biphenyl-4-yl)-amine methyl acid according to the general procedure 0, prepared from (5-amino-2-tris-butoxy-2l fluoro-linked Phenyl-4-yl)-amine methyl acid tert-butyl ester (Example L48) (187 mg, 〇·5 mmol) and 2,2-dimethyl-6-[3-(2-A) Methyl-i-but-1-yl)-phenyl]-[ι,3]dioxanthene 4-one (Example N15) (142 mg, 0.5 mmol). Obtained an amorphous yellow material (234 mg). MS (ISP) 601 [(M+H)+]. Example 065 {2-Terti-butoxy-5-[3-(2-cyanopyridin-4-yl)-3-keto-propionylamino]-2f-fluoro-biphenyl- Tetra-butyl 4-amino}-aminomethyl acid was prepared according to the general procedure 0 from (5-amino-2-tri-butoxy-2,-fluoro-biphenyl-4-yl)_ Aminomethyl 3-butyrate (Example L48) (187 mg, 0.5 mmol) and 4-(2,2-dimethyl-6-keto-6H-[1,3]dioxane Benzene)-pyridine-2-carbonitrile (Example N16) (115 mg., 0.5 mmol). Obtained an amorphous yellow material (216 mg). MS (ISP) 547 [(M+H)+]. Example 066 (2-Terti-butoxy-2'-fluoro-5-{3-[3-(2-methylthio-imidazol-1-yl)-phenyl]-3-one-propyl Mercaptoamine}-biphenyl-4-yl)-amine methyl acid tert-butyl ester-122- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) •--- ---------- Install i I (please read the notes on the back and then this page). Line · Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed 1255266 A7 .......... ....B7_____ V. INSTRUCTIONS (120) According to the general procedure 0, from (5-amino i-t-butoxy-2,-fluoro-biphenyl-4-yl)-amine methyl acid Third-butyl ester (Example L48) (187 mg, 〇 5 mmol) and 3_ [3-(2-methylthio) imidol] phenyl] keto-propionic acid third-butyl Ester (Example M13) (211 mg, 0.63 mmol) afforded a pale-yellow solid (26 mg). MS (ISN) 631 [(MH)_]; mp. 59-62 ° C. Example 067 {5-[ 3-(3-Cyano-phenyl)-3-keto-propionylamino]-2',5'-difluoro-2-indolyl-biphenyl-4-yl}-amine A The third-butyl acrylate is prepared according to the general procedure from (5-amino-2',5'-difluoro-2-methoxy- Phenyl phenyl)-aminomethyl acid tert-butyl ester (example L52) (175 mg, 〇·5 mmol) and 3-(2,2-dimethyl ketone-6H-[1, 3] Dioxolene-4-yl)-benzonitrile (Example N4) (115 mg '0.5 mmol). Obtained amorphous yellow material (丨 36 mg). MS (ISP) 522 [(M +H)+] 〇Example 068 {2',5'-Difluoro-2-methoxy-5-[3-keto-3-(3-[1,2,3]triazole-based-benzene ))-propionylamino]-biphenyl-4-yl}-amine methyl acid, the third-butyr, according to the general procedure, is prepared from (5-amino-2',5'-difluoro- 2-methoxy-biphenylyl)-amine methyl acid tert-butyl ester (Example L52) (175 mg, 0.5 mmol) and 3-keto-3-(3-[1,2 , 3] triazol-1-yl-phenyl)-propionic acid ethyl ester (Example M2) (130 mg, 0.5 mmol). Obtained as a pale yellowish material (185 mg). MS (ISN) 562 [ (MH)·]. Example {69 {2-Terti-butoxy-5-[3-(3-cyano-thiophen-2-yl)-3-one-propenylamino]-2 ^ Fluorine-biphenyl-4-yl]-amine methyl acid tert-butyl ester-123- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) ------- - ------Install i I (please read the note on the back and then this page) Order: Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 1255266 A7 B7 V. Invention description (121) According to the general procedure 0, (5-Amino-Tungsten-tert-butoxy-2,-fluoro-biphenyl-4-yl)-aminomethyl acid tert-butyl ester (Example l48) (187 mg, 0.5 mmol) and 6_(3-Cyano-soul-phen-2-yl)-2,2·dimethyl-#,3]dioxolene-4-one (Example N3) (130 mg, 0.55 mmol). Obtained yellow oil (278 mg). MS (ISN) 550 [(MH)-] 〇 Example 070 {2-T-butoxy-5-[3-(5-cyano-thiophen-2-yl)-3-one-propionyl-' Aminoamino-2,-fluoro-biphenyl-4-yl}-amine methyl acid, third butyl ester, according to the general procedure, prepared from (5-amino-1 tert-butoxy-21- Fluorine-biphenyl-4-yl)-amine methyl acid tert-butyl ester (Example L48) (187 mg, 0.5 mmol) and 3-(5-cyano-4 phen-2-yl)-3 - Keto-propionic acid tert-butyl ester (Example M17) (138 mg '0.55 Amor). Obtained an amorphous yellow material (268 mg). MS (ISN) 550 [(M-Hy]. Example 071 "2-di-*-butoxy-4-carbyl-5-[3-indolyl-3-(3-[1,2,3]] Diwax-1-yl-winteryl)-propionylamino]-biphenyl-4-yl}-amine methyl acid third-butyl ester Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing ----- r---------装--- (Please read the notes on the back and then on this page) ί线· According to the general procedure, from 5-amino-2-tri-butoxy -4'-Fluoro-biphenyl-4-yl)-amine methyl acid tert-butyl ester (Example L47) (187 mg, 0.5 mmol) and 3-keto-3-(3-[1, 2,3]triazole-p-phenyl)-propionic acid ethyl ester (Example M2) (156 mg, 〇·6 mmol). Obtained yellow gum (198 mg). MS (ISP) 588 [(M+ H) +]. Example 072 [5-[3-(3-Cyano-phenyl)-3-keto-propenylamino]-2'-fluoro-2-(2-methoxy- Ethoxy)-biphenyl-4-yl]-amine methyl acid tert-butyl ester-124- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) A7 1255266 ________B7_ V. Description of the invention (122) According to the general procedure 制'from 15-amino-2'-fluoro-2-(2-methoxy-ethoxy)-biphenyl-4- Amino acid-tert-butyl ester (Example L53) and 3·(2,2-dimethylglycosyl-6Η-[1,3]dioxolan-4-yl)-benzene Formonitrile (example Ν 4). A yellow solid (188 mg) was obtained. MS (ISP) 548 [(M+H)+]. Example 〇73 (RS)-[5-[3-(3-Cyano-phenyl)-3-keto-propyl-arylamino]-21-fluoro-2-(tetrahydro-pyro-2 - methoxymethyl)-biphenyl-4-yl]-amine methyl acid tert-butyl ester according to the general procedure 0, from (RS)-[5-amino-2,-fluoro-2 -(tetrahydro-pyran-2-yloxymethyl)-biphenyl-4-yl]-amine methyl acid, third-butyl vinegar (example L54) and 3-(2,2-dimethyl -6-keto-6H-[1,3]dioxolyl-4-yl)-benzonitrile (Example N4). A yellow solid (155 mg) was obtained. MS (ISP) 548 [(M+NH4)+]. Example 074 (2·-Fluoro-2-(4-methoxy-benzyloxy)-5-{3-[3-(3-methyl-isoxazol-5-yl)-phenyl]- 3-keto-propionylamino}-biphenylyl)-amine methyl acid tert-butyl ester according to the general procedure 0, from [5-amino-2,-fluoro-2-(4) -Methoxy-yloxy)-biphenylindolyl--aminomethyl acid tert-butyl ester (example L55) (438 mg, 1. 〇 millimol) and 3-[3-(3- Methyl-isoxazol-5-yl)-phenyl]-3-keto-propionic acid tert-butyl ester (Example M14) (301 mg, 1.0 mmol). Obtained an amorphous light yellow material (561 mg). MS (ISP) 666 [(M+H)+]. Example 075 {2-Terti-butoxy-5-[3-(3-cyano-phenyl)-3-one-propenylamino]-2,5,-di-125- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 public) ------------- Install i I (please read the back note before this page) .- Economy Ministry of Intellectual Property Bureau employee consumption cooperative printed 1255266 A7

五、發明說明(123) 氣-聯苯基-4-基]-胺甲基酸第三-丁酉旨 根據一般私序0,製自(5_胺基1第三_丁氧基_2,,5,_二氟-聯 苯基-4-基)-胺甲基酸第三-丁酯(實例ί56χ1%毫克,〇 5毫莫 耳)與3-(2,2-二甲基-6-酮基-6Η-[1,3]二氧陸圜烯-4-基)_苯甲腈( 實例Ν4)(115毫克,0.5毫莫耳)。獲得非晶質米黃色物質(155 亳克)。 MS(ISP) 564 [(M+H)+]。 1 m 076 {5-第三-丁氧基-4-(4-氟苯基乙炔基&gt;2-[3-(3-咪唑-1-基-苯基)-3-酮基-丙醯基胺基]-苯基}-胺甲基酸第三_丁酯 根據一般程序Ο,製自[2-胺基-5-第三-丁氧基-4-(4-氟苯基 乙炔基)-苯基]-胺甲基酸第三-丁酯(實例L57)(160毫克,0·4毫 莫耳)與3-(3-咪唑-1-基-苯基)-3-酮基-丙酸第三-丁酯(實例Μ4) (115毫克,0.4毫莫耳)。獲得非晶質黃色物質(140毫克)。 MS(ISP)611[(M+H)+] 〇 實例077 {5-第三-丁氧基-4-(4-氟苯基乙炔基)-2-[3-酮基各(3-[1,2,3]三唑-1-基-苯基)-丙酿基胺基]-苯基卜胺甲基酸第三-丁 §旨 根據一般程序Ο,製自[2-胺基-5-第三-丁氧基冰(4-氟苯基 乙炔基)-苯基]-胺甲基酸第三-丁酯(實例L57)(160毫克,0.4毫 莫耳)與3-酮基-3-(3-[1,2,3]三唑-1-基-苯基)_丙酸乙酯(實例 M2)(104毫克,0.4毫莫耳)。獲得黃色膠質(150毫克)。 MS(ISP)612[(M+H)+]。 一般程序P : -126- _ 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) --------------裝— (請先閱讀背面之注意事項再本頁) 訂: -丨線· 經濟部智慧財產局員工消費合作社印製 [255266 經濟部智慧財產局員工消費合作社印製 A7 B7 五、發明說明(124 ) 4,8-二方基-1,3-二氫苯幷问[1,4]二吖庚因:酮,4_芳基各芳醯 基-1,3-二氫苯幷[b][l,4]二吖庚因_2_酮或4_芳基j芳基乙炔基_ 1,3-二氫苯幷[b][l,4]二吖庚因-2-酮之製備 將{2-[3-芳基各酮基-丙醯基胺基]冰芳基·苯基卜胺〒基酸第 二-丁酯或{2-[3-芳基-3-酮基-丙醯基胺基芳基乙炔基-苯基 卜胺甲基酸第二-丁酯(1.0毫莫耳)在CH2 Cl2 (5毫升)[若必要可 添加甲苯醚或1,3-二甲氧基苯(5_15毫莫耳)]中之懸浮液,以 TFA (0.5-5.0毫升)在〇°C下處理,且於2yC下持續攪拌,直到 tic頰π起始物質芫全消耗爲止。在眞空中移除溶劑,將殘 留物以極少量醚處理,於是使其結晶。將固體與飽和 NaHC〇3溶液一起攪掉,過濾,以%〇及醚或醚/己烷之混 合物洗絡,並乾燥,而得標題化合物,若必要可使其自丁 / 0¾¾ /醚/己烷,藉結晶化作用純化。 一般程序0 : 藉由4-(3-碘苯基)-8-苯基乙炔基_i,3_二氫苯幷[b][1,4]二吖庚因_ 2項同之Pd-催化羰基胺化作用,製備4_[3_(胺基斗羰基)_苯基]_8_ 苯基乙炔基-1,3-二氫苯幷[b][i,4]二吖庚因1酮 將4-(3-碘苯基)-8-苯基乙炔基_丨,3-二氫苯幷[b][1,4]二吖庚因_ 2-酮(1.0毫莫耳)、二級胺(5·〇毫莫耳)、ppM6莫耳。么)或 dPPp(3 莫耳 % )、Pd(〇Ac)2(3 莫耳 % )及 Et3N(2〇 毫莫耳)在 DMF (4愛升)中之溶液,於2yC及c〇大氣下攪拌,直到❿顯 示碘化物完全消耗爲止。以Et0Ac稀釋後,以飽和NaHc〇3溶 液及鹽水洗滌,有機相以NkSO4脱水乾燥。移除溶劑,留 下褐色油,將其藉矽膠管柱層析純化,使用己烷/段〇怂, ---il,---------^--- (請先閱讀背面之注意事項再本頁) . :線. -127- I255266 A7 --—-— B7____ 五、發明說明(125) 而得標題化合物。 二呈序R : 藉由(5-烯丙氧基-2-硝基-苯基)-胺甲基酸第三_丁酯之催化 脱烯丙基化作用,製備(5-羥基-2-硝基·苯基)_胺甲基酸第三_ 丁酯 根據J·〇rg. Chem· 1973, 38, 3224,使(5-晞丙氧基冬硝基·苯基&gt; 胺甲基酸第二-丁酯、(PPh3 )3 RhCl (5莫耳% )及DABCO (20莫耳 % )在EtOH中之混合物,回流2·5小時。添加5%擰檬酸,於 23 C下撥掉15分鐘,以EtOAc萃取,以鹽水洗條,以MgS〇4 乾燥。移除溶劑,留下橘色固體,將其藉矽膠管柱層析純 化,使用己烷/ EtOAc,而得標題化合物。 宜例R1 (5-羥基冰碘基-2-硝基··苯基)-胺甲基酸第三-丁酯 根據一般程序R,製自(5-烯丙氧基_4·碘基冬硝基·苯基)_胺 甲基酸第三-丁酯(實例B4)、(PPh h RhCl (5莫耳% )及DABC〇 (20莫耳。/。)在EtOH中。獲得黃色固體。 MS (ISN) 379 [(M-H)·];熔點 140°C。 一般程序S : 自(5-¾基-4-碘基-2-硝基-苯基)-胺曱基酸第三-丁酯,製備5_〇_ 取代-(4-破基_2_硝基-苯基)_胺甲基酸第三-丁酯 將(5-羥基-4-碘基-2-硝基-苯基)_胺甲基酸第三-丁酯(實例R1) 、KHC〇3及適當烷基化試劑之混合物,在DMF中,於23至6〇 C下攪掉’直到tic顯示旯全轉化爲止。以Et〇Ac稀釋,接著 以5。/。檸檬酸、飽和NaHC〇3溶液、鹽水進行水溶液處理,及 -128- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公爱) ----:---------裝--- 請先閱讀背面之注意事項再本頁) 線· 經濟部智慧財產局員工消費合作社印製 A7 1255266 B7_____ 五、發明說明(126 ) 以MgS04脱水乾燥。移除溶劑,留下粗製物質,將其藉矽 膠管柱層析純化,使用己烷/ Et〇Ac,而得標題化合物。 實例S1 (5-第三-丁氧羰基胺基-2-碘基-4-硝基-苯氧基)-醋酸第三-丁酯 根據一般程序S,製自(5-羥基斗碘基-2-硝基-苯基)-胺甲基 酸第三-丁酯(實例ρπχΐ.23克,3.24毫莫耳)、KHC03 (0.39克, 3.89毫莫耳)及溴醋酸第三-丁酯(〇·59毫升,3.89毫莫耳)。獲 得黃色固體(1.5克,94% )。 MS (ISP) 495 [(M+H)+],512 [(M+NH4)+]及 517 [(M+Na)+];熔點 103°C。 實例S2 (5-氰基甲氧基-4-破基-2-硝基-苯基)-胺甲基酸第三-丁酯 根據一般程序S,製自(5-羥基-4-碘基-2-硝基·苯基)-胺甲基 酸第三-丁酯(實例R1)(614毫克,1.62毫莫耳)、KHC03 (208毫 克,2·08毫莫耳)及溴基乙腈(〇·21毫升,3.16毫莫耳)。獲得 黃色固體(574毫克,85% )。 MS (ISN) 418 [(Μ-ΗΠ ;熔點 125°C。 實例S3 (RS)-{4-破基-2-硝基-5-[2-(四氫-峰喃-2-基氧基)-乙氧基]-苯基卜 胺甲基酸第三-丁酯 根據一般程序S,製自(5·羥基-4-碘基—2-硝基-苯基)-胺甲基 酸第三-丁酯(實例Rl)(760毫克,2毫莫耳)、khcc^mo毫克 ’ 4愛莫耳)及2-(2-&gt;臭基乙氧基)四氫喃(0.6毫升,2.6毫 莫耳)。獲得橘色油(804毫克,79% )。 MS(EI) 508 (M+)。 -129- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -----:---------裝 i — (請先閱讀背面之注意事項再本頁) 訂· ί線· 經濟部智慧財產局員工消費合作社印製 1255266V. Description of the invention (123) Gaso-biphenyl-4-yl]-amine methyl acid The third-butyr is based on the general private order 0, from (5-amino 1 3 -butoxy 2, ,5,-Difluoro-biphenyl-4-yl)-amine methyl acid, third-butyl ester (example ί 56 χ 1% mg, 〇 5 mmol) and 3-(2,2-dimethyl-6 -Ketyl-6Η-[1,3]dioxolyn-4-yl)benzonitrile (Example Ν4) (115 mg, 0.5 mmol). Obtained amorphous beige material (155 grams). MS (ISP) 564 [(M+H)+]. 1 m 076 {5-Terti-butoxy-4-(4-fluorophenylethynyl)&gt;2-[3-(3-imidazol-1-yl-phenyl)-3-keto-propionate The amino-amino]-phenyl}-amine methyl acid tert-butyl ester is prepared according to the general procedure from [2-amino-5-tris-butoxy-4-(4-fluorophenylethynyl). -Phenyl]-aminomethyl acid tert-butyl ester (Example L57) (160 mg, 0.4 mmol) and 3-(3-imidazol-1-yl-phenyl)-3-one - Tert-propionic acid tert-butyl ester (Example Μ 4) (115 mg, 0.4 mmol). Obtained amorphous yellow material (140 mg). MS (ISP) 611 [(M+H)+] 〇 Example 077 { 5-Terti-butoxy-4-(4-fluorophenylethynyl)-2-[3-keto(3-[1,2,3]triazol-1-yl-phenyl)- Propylamino]-phenyl-p-aminomethyl acid third-butyr is prepared according to the general procedure from [2-amino-5-tris-butoxy ice (4-fluorophenylethynyl) -Phenyl]-aminomethyl acid tert-butyl ester (Example L57) (160 mg, 0.4 mmol) and 3-keto-3-(3-[1,2,3]triazole-1 Ethyl-phenyl)-propionic acid ethyl ester (Example M2) (104 mg, 0.4 mmol) afforded yellow gum (150 mg) MS (ISP) 612 [(M+H)+]. : -126- _ this paper Applicable to China National Standard (CNS) A4 specification (210 X 297 mm) -------------- Installation — (Please read the back note before this page) Order: -丨· Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing [255266 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing A7 B7 V. Invention description (124) 4,8-diaryl-1,3-dihydrobenzoquinone [ 1,4] Dioxane: ketone, 4_aryl, aryl fluorenyl-1,3-dihydrophenylhydrazine [b][l,4]dioxine-2-one or 4-aryl Preparation of arylethynyl-1,3-dihydrophenylhydrazone [b][l,4]dioxepin-2-one {2-[3-aryl keto-propionylamino] Ice aryl phenyl amidinoic acid second-butyl ester or {2-[3-aryl-3-keto-propionylamino arylethynyl-phenyl-p-aminomethyl acid second -butyl ester (1.0 mmol) in CH2Cl2 (5 mL) [If necessary, add xylene or 1,3-dimethoxybenzene (5-15 mmol)] to TFA (0.5- 5.0 ml) was treated at 〇 ° C and stirring was continued at 2 yC until the tic cheek π starting material was completely consumed. The solvent was removed in the sputum and the residue was treated with a very small amount of ether. Then, it is crystallized. The solid is stirred up with a saturated NaHC〇3 solution, filtered, washed with a mixture of % hydrazine and ether or ether/hexane, and dried to give the title compound. / 03⁄43⁄4 /ether / hexane, purified by crystallization. General procedure 0: by 4-(3-iodophenyl)-8-phenylethynyl_i,3-dihydrophenylhydrazone [b][1,4]dioxine _ 2 as well as Pd- Catalyzing carbonyl amination to prepare 4_[3_(amino phenylcarbonyl)-phenyl]_8_phenylethynyl-1,3-dihydrophenylhydrazone [b][i,4]dioxine 1 ketone 4 -(3-iodophenyl)-8-phenylethynyl-indole, 3-dihydrophenylhydrazine [b][1,4]dioxine-2-one (1.0 mmol), secondary amine (5·〇毫莫耳), ppM6 Mo Er. 】) or dPPp (3 mole %), Pd (〇Ac) 2 (3 mole %) and Et3N (2 〇 millimolar) solution in DMF (4 liters), under 2yC and c〇 atmosphere Stir until ❿ shows complete consumption of iodide. After diluting with Et0Ac, it was washed with a saturated NaHc? Remove the solvent, leave a brown oil, and purify it by column chromatography, using hexane / hexane, ---il,---------^--- (please read the back first) Precautions on this page) . : Line. -127- I255266 A7 ----- B7____ V. Inventive Note (125) The title compound was obtained. Preparation of (5-hydroxy-2-) by catalytic allysylation of (5-allyloxy-2-nitro-phenyl)-amine methyl acid tert-butyl ester Nitro-phenyl)-amine methyl acid third-butyl ester according to J. 〇rg. Chem. 1973, 38, 3224, (5-fluorenyloxy-nitro-phenyl)-amino acid Mixture of second-butyl ester, (PPh3)3 RhCl (5 mol%) and DABCO (20 mol%) in EtOH, reflux for 2.5 hours. Add 5% citric acid and dial off at 23 C The mixture was extracted with EtOAc EtOAc (EtOAc m. Example R1 (5-hydroxy ice iodo-2-nitro·phenyl)-amine methyl acid tert-butyl ester according to the general procedure R, from (5-allyloxy_4·iodyl winter nitrate Base phenyl)-amino acid tert-butyl ester (Example B4), (PPh h RhCl (5 mol %) and DABC 〇 (20 mol %) in EtOH. Obtained a yellow solid. (ISN) 379 [(MH)·]; melting point 140 ° C. General procedure S: from (5-3⁄4yl-4-iodo-2-nitro-phenyl)-amine fluorenyl Acidic third-butyl ester, preparation of 5_〇_substituted-(4-diyl-2-nitro-phenyl)-amine methyl acid tert-butyl ester (5-hydroxy-4-iodo-2 a mixture of -nitro-phenyl)-amine methyl acid third-butyl ester (Example R1), KHC〇3 and a suitable alkylating agent, in DMF, stirred at 23 to 6 ° C until tic Show full conversion of 旯. Diluted with Et〇Ac, followed by aqueous solution with 5% citric acid, saturated NaHC〇3 solution, brine, and -128- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 public) ----:---------Installation--- Please read the notes on the back of this page again) Line· Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Print A7 1255266 B7_____ Five , Inventive Note (126) Dehydrated with MgS04, the solvent was removed, and the crude material was purified, which was purified by column chromatography eluting with hexane / Et EtOAc to give the title compound. -butoxycarbonylamino-2-iodo-4-nitro-phenoxy)-acetic acid tert-butyl ester according to the general procedure S, from (5-hydroxy phenyl iodo-2-nitro-phenyl )-Aminomethyl acid third-butyl ester (example ρπχΐ .23 g, 3.24 mmol, KHC03 (0.39 g, 3.89 mmol) and tri-butyl bromoacetate (〇·59 ml, 3.89 mmol). Obtained a yellow solid (1.5 g, 94%) . MS (ISP) 495 [(M+H)+], 512 [(M+NH4)+] and 517 [(M+Na)+]; mp. Example S2 (5-Cyanomethoxy-4-bromo-2-nitro-phenyl)-amine methyl acid tert-butyl ester according to the general procedure S, from (5-hydroxy-4-iodo) 2-Nitro-phenyl)-aminomethyl acid tert-butyl ester (Example R1) (614 mg, 1.62 mmol), KHC03 (208 mg, 2.08 mmol) and bromoacetonitrile ( 〇·21 ml, 3.16 mmol.) Obtained as a yellow solid (574 mg, 85%). MS (ISN) 418 [(Μ-ΗΠ; melting point 125 ° C. Example S3 (RS)-{4-Bus-2-nitro-5-[2-(tetrahydro-peak-2-yloxy) --ethoxy]-phenyl-b-aminomethyl acid tert-butyl ester according to the general procedure S, prepared from (5. hydroxy-4-iodo-2-nitro-phenyl)-amine methyl acid Tri-butyl ester (Example Rl) (760 mg, 2 mmol), khcc^mo mg' 4 Amol) and 2-(2-&gt; odoryl ethoxy) tetrahydrofuran (0.6 mL, 2.6 Millions of ears). Obtained orange oil (804 mg, 79%). MS (EI) 508 (M+). -129- This paper size is applicable to China National Standard (CNS) A4 specification (210 X 297 mm) -----:---------Install i — (Please read the back note before you Page) Book · ί Line · Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266

五、發明說明(127) JL^1_S4 (5-第三-丁氧基-4-碘基_2-硝基-苯基)-胺甲基酸第三-丁酯 將N,N-二甲基甲醯胺二-第三·丁基縮醛(19.2毫升,8〇亳莫 耳)’在15分鐘内,逐滴添加至(5-¾基-4·•琪基-2-硝基-苯基)· 胺甲基酸第三-丁酯(實例Rl)(7.60克,20毫莫耳)在甲苯中, 於80°C下之溶液内,並在80。(:下持續攪拌3小時(參閱,合 成期刊1983, 135)。獲得黃色固體(5.97克,68% )。 MS (ISN) 435 [(Μ-ΗΠ ;熔點 94°C。 實例1 3-(7-碘基斗酮基各硫代嗎福啉斗基-4,5-二氫-3H-苯幷[b][i,4]二 吖庚因-2-基)-苯曱腈 根據一般程序P,經由以TFA在CH2 Cl2中處理,製自 氰基-苯基)-3-酮基-丙醯基胺基]-4-碘基-5-硫代嗎福啉-4-基_苯 基}•胺甲基酸第三-丁酯(實例01)(629毫克,1·〇4亳莫耳)。獲 得橄欖色固體(437毫克)。 熔點227-228°C (分解)。 實例2 3-(7-碘基-8-嗎福啉-4-基-4-酮基-4,5-二氫-3H-苯幷[b][i,4]二,丫庚 因-2-基)-苯曱腈 根據一般程序P,經由以TFA在(:¾%中處理,製自{2-[3_ (:&gt;-氧基-冬基)-3-嗣基-丙酿基胺基]-4-破基-5-嗎福ί/林芙苯某 }-胺甲基酸第三-丁酯(實例02)(518毫克,〇·877毫莫耳)。獲 得米黃色固體(309毫克)。 MS (ΕΙ) 472 (Μ+);熔點 224Ό (分解)。 -130- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -------------裝— (請先閱讀背面之注意事項本頁) 訂 •線· 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 經濟部智慧財產局員工消費合作社印製 五、發明說明(128) 實例3 3-(8-氯基-4-酮基-7-苯基乙炔基_4,5-二氫-3H-苯幷[b][i,4]二叮庚 因-2-基)-苯甲猜 根據一般程序0 ,製自(2-胺基_5_氯基+苯基乙炔基-苯基)· 胺甲基第二-丁酯(貫例L3)(171毫克,〇·5毫莫耳)與弘(2 2· 一 甲基-6-酮基-6Η-[1,3]一氧陸圜# -4-基)-苯甲腈(實例爾)(183亳 克,〇·6毫莫耳)。獲得淡黃色固體(284毫克)。根據一般程 序Ρ,經由以TFA在0¾¾中處理,使此物質去除保護及環 化。獲得橘色固體(483毫克)。 MS (ISP) 343 [(Μ+ΗΠ 與 345 [(M+2+Na)+ 熔點 248-25ιχ:(分解)。 實例4 3-(8-甲基-4-自同基-7-苯基乙炔基-4,5-二氫-3Η-苯幷[b][l,4]二吖庚 因-2-基)苯甲腈 根據一般程序0,製自(2-胺基-5-甲基斗苯基乙炔基-苯基)_ 胺甲基酸第三-丁酯(實例L4)(161毫克,〇.5毫莫耳)與3_(2,2•二 甲基-6-酮基-6H-[1,3]二氧陸圜烯-4-基)苯甲腈(實例N4)(23〇毫克 ,〇·75笔莫耳,75%純)。獲得淡黃色固體(227毫克)。根據 一般程序P,經由以丁FA在0¾¾中處理,使此物質去除保 護及環化。獲得淡黃色固體(83毫克)。 MS (ISP) 375 (M+);熔點 237-239°C (分解)。 實例5 3-[8-(4-甲基-六氫吡畊小基)冰酮基_7-苯基乙炔基二氫-3H-苯幷[b][l,4]二吖庚因-2-基]-苯甲腈 根據一般程序0,製自[2-胺基冬(4-甲基_六氫吡畊+基)冰 -131 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) (靖先閱讀背面之注音?事項再本頁} 裝 訂 線· 1255266 A7 B7 五、發明說明(129 經濟部智慧財產局員工消費合作社印製 苯基乙块基-苯基]-胺甲基酸第三-丁酯(實例L5x203毫克, 0.5笔莫耳)與3-(2,2-二甲基各酮基二氧陸圜烯冰基)_苯 甲腈(實例N4)(230毫克,〇.75毫莫耳,75%純)。藉層析獲得 橘色油(181耄克)。根據一般程序p,經由以TFA在ch2 ci2中 處理’使此物質去除保護及環化。獲得橘色固體(82毫克)。 MS (ISP) 46〇_5 [(M+H)+ ];熔點 mMc (分解)。 實例6 3- [8-(1,1_二酮基-硫代嗎福啉斗基)冰酮基冬苯基乙炔基-4,5-二 氫-3H-苯幷[b][l,4]二吖庚因-2-基]-苯甲腈 根據一般程序Ο,製自[2_胺基冬(丨山二酮基·6•硫代嗎福啉- 4- 基)冰苯基乙炔基-苯基]_胺甲基酸第三_ 丁酯(實例l19)(22〇 毫克,〇·5毫莫耳)與3-(2,2_二甲基_6_酮基-6Η-[1,3]二氧陸圜晞-4-基)-苯曱腈(貫例Ν4)(172毫克,0.75毫莫耳)。根據一般程 序Ρ,經由以TFA在CH2C12中處理,使所獲得之物質去除保 護及環化。獲得黃色固體(47毫克)。 MS (ISP) 495 [(M+H)+ ];熔點 &gt;250°C (分解)。 實例7 3-(8-氯基-4-酮基-7-苯基-4,5-二氫-3H-苯幷[b][l,4]二吖庚因-2-基)- 苯甲腈 根據一般程序P,經由以TFA在CH2C12中處理,製自{2-氣 基-5-[3-(3-氰基-苯基)-3-酮基-丙酿基胺基]-聯苯基4-基}-胺甲 基酸第三-丁酯(實例03)(720毫克,1.47亳莫耳)。獲得灰白 色固體(457毫克)。 MS (EI) 371 (M+)與 373 [(M+2)+ ];熔點 242-244°C (分解)。 132 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 請 先 閱 讀 背 δ 之 注 意 事 項 再 本 頁 裝 訂 線 1255266 經濟部智慧財產局員工消費合作社印製 Α7 Β7 五、發明說明(130) 實例8 3-(8-甲基-4-酮基-7-苯基-4,5-二氫-3H-苯幷[b][l,4]二吖庚因:基)- 苯甲腈 根據一般程序Ο,製自(5-胺基-2-甲基-聯苯基-4-基)-胺甲基 酸第三-丁酯(實例L7)(298毫克,1.0毫莫耳)與3-(2,2-二甲基-6-酮基-6H-[1,3]二氧陸圜烯冬基)-苯甲腈(實例N4)(460毫克,1.5 t莫耳)。根據一般程序p,經由以TFA在CH2 Cl2中處理, 使所獲得之物質(351毫克)去除保護及環化。獲得淡黃色固 體(206毫克)。 MS (EI) 351 (M+);熔點 236-239Ό (分解)。 實例9 3-[8-(1,4-二氧冬氮-螺[4.5]癸各基&gt;4-酮基-7-苯基乙炔基-4,5-二氫 -3H-苯幷[b][l,4]二吖庚因-2-基]-苯甲腈 根據一般程序P,經由以TFA在CH2C12中處理,製自[2-〇 (3-氰基-苯基)-3-酮基-丙醯基胺基]_5-(l,4-二氧各氮-螺[4.5]癸-8- 基)-4-苯基乙块基-苯基]_胺甲基酸第三-丁酯(實例〇14)(265毫 克,0.43毫莫耳)。獲得褐色固體(121毫克)。 MS (ISP) 503 [(M+H)+ ];熔點 239-243。(:(分解)。 實例10 3-(8-嗎福琳-4-基-4-酮基-7-苯基乙块基-4,5-二氫-3H-苯幷[b][l,4] 二吖庚因-2-基)-苯甲腈 根據一般程序P,經由以TFA在CH2Cl2中處理,製自{2-[3_ (3-氰基-苯基&gt;3-酮基-丙醯基胺基]嗎福啉冰基·4•苯基乙炔 基-苯基}-胺甲基酸第三-丁酯010(370毫克,〇·66毫莫耳)。獲 -133- 本紙張尺度適用中國國家標準(CNS)A4規格(210 x 297公釐) -----»---------裝—— (請先閱讀背面之注意事項再本頁) 訂: -•線- 1255266 經濟部智慧財產局員工消費合作社印製 A7 ____ B7___ 五、發明說明(131 ) 得淡褐色固體(216毫克)。 MS (El) 446(M+);熔點 239-243°C (分解)。 實例11 3-[8-(2-二甲胺基-乙硫基)-4·酮基-7-苯基乙炔基-4,5-二氫-3H-苯 幷[b][l,4]二吖庚因-2-基]-苯甲腈 根據一般程序P,經由以TFA及甲苯醚,在CH2 Cl2中處理 ,製自[2-[3-(3-氰基-苯基)-3-酮基-丙醯基胺基]-5-(2-二甲胺基_ 乙硫基)-4-苯基乙块基-苯基]_胺甲基酸第三-丁酯(實例〇4) (166毫克,0.28毫莫耳)。獲得淡黃色固體(1〇3毫克)。 MS (ISP) 465 [(M+H)+ ];熔點 197°C (分解)。 實例12 [4-(3-氰基-苯基&gt;2-酮基-8-苯基乙炔基-2,3-二氫-1H-苯幷[b][i,4] -一叶庚因-7-硫基]-酷酸甲酉旨 根據一般程序P,經由以TFA及甲苯醚,在CH2 Cl2中處理 ’製自{5-弟二-丁氧談基胺基_4-[3-(3-棄基-苯基)-3-嗣基丙酿 基胺基]-2-苯基乙炔基-苯硫基卜醋酸甲酯(實例〇5)(421毫克, 0.72毫莫耳)。獲得淡黃色固體(3〇9毫克)。 MS (ISP) 465 [(M+H)+ ];熔點 201。(:(分解)。 實例13 [4-(3-氰基-苯基)-2-酮基-8-苯基乙炔基-2,3-二氫-1H-苯幷[b][l,4] 一叶庚因-7-基硫基]-醋酸 將[4-(3-氰基-苯基&gt;2-酮基-8-苯基乙炔基-2,3-二氫-1H-苯幷 [b][l,4]二吖庚因-7-基硫基]-醋酸甲酯(實例12)(265毫克,0.57 毫莫耳)與Li〇H · Η2 Ο (26毫克,0.63毫莫耳)在THF (5毫升)、 -134- 本紙張尺度適用中國國家標準(CNS)A4規格(21〇 X 297公釐) ----l·---------裝—— (請先閱讀背面之注意事項再本頁) · 線· 1255266V. INSTRUCTIONS (127) JL^1_S4 (5-Terti-butoxy-4-iodo-2-nitro-phenyl)-amine methyl acid, third-butyl ester, N,N-dimethyl Carbamide-di-tert-butyl acetal (19.2 ml, 8 Torr) was added dropwise to (5-3⁄4 bp-4····· Phenyl)· Aminomethyl 3-butyrate (Example R1) (7.60 g, 20 mmol) in toluene at 80 ° C and at 80. (: stirring was continued for 3 hours (see, Synthetic Journal 1983, 135). Obtained a yellow solid (5.97 g, 68%). MS (ISN) 435 [(Μ-ΗΠ; melting point 94 ° C. Example 1 3-(7 - Iodo- ketone-based thio-of-of-fosfosin-4,5-dihydro-3H-benzoquinone [b][i,4]dioxane-2-yl)-benzonitrile according to the general procedure P, prepared by treatment with TFA in CH2Cl2, from cyano-phenyl)-3-keto-propionylamino]-4-iodo-5-thioxofolin-4-yl-benzene Amino acid mono-butyl ester (Example 01) (629 mg, 1·4 亳 4 亳). Obtained an olive solid (437 mg). mp 227-228 ° C (decomposition). 3-(7-iodo-8-morpholine-4-yl-4-keto-4,5-dihydro-3H-benzoquinone [b][i,4]di,azepine-2- Benzo-benzonitrile was prepared according to the general procedure P by treatment with TFA in (:3⁄4% from {2-[3_(:&gt;-oxy-mungyl)-3-indolyl-propyl aryl amine Alkyl-4-pyrene-5-? 309 mg) MS (ΕΙ) 472 (Μ+); melting point 224Ό (decomposed). -130- paper ruler Applicable to China National Standard (CNS) A4 specification (210 X 297 mm) ------------- Installation - (Please read the back note on this page first) Order • Line · Ministry of Economics Property Bureau Staff Consumer Cooperative Printed 1255266 A7 B7 Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 5, Invention Description (128) Example 3 3-(8-Chloro-4-keto-7-phenylethynyl) ,5-dihydro-3H-benzoquinone [b][i,4]dioxane-2-yl)-benzidine according to the general procedure 0, from (2-amino-5-chloro+benzene) Ethyl ethynyl-phenyl)·amine methyl second-butyl ester (conventional L3) (171 mg, 〇·5 mmol) and hiro (2 2·monomethyl-6-keto-6Η-[ 1,3]-oxoindole # -4-yl)-benzonitrile (example) (183 g, 〇·6 mmol). Obtained as a pale yellow solid (284 mg). Treatment with TFA in 03⁄43⁄4, this material was deprotected and cyclized. Obtained an orange solid (483 mg) MS (ISP) 343 [(Μ+ΗΠ and 345 [(M+2+Na)+ melting point 248-25ιχ : (decomposition). Example 4 3-(8-Methyl-4-carbazyl-7-phenylethynyl-4,5-dihydro-3Η-benzoquinone [b][l,4]dioxane Because-2 -yl)benzonitrile according to the general procedure 0, from (2-amino-5-methyl-phenylphenylethynyl-phenyl)-amine methyl acid, third-butyl ester (example L4) (161 mg, 5.5 millimolar) with 3_(2,2•dimethyl-6-keto-6H-[1,3]dioxolyn-4-yl)benzonitrile (Example N4) (23〇 Mg, 〇·75 pens, 75% pure). Obtained as a pale yellow solid (227 mg). This material is removed for protection and cyclization according to the general procedure P by treatment with butyl FA in 03⁄4⁄4. Obtained as a pale yellow solid (83 mg). MS (ISP) 375 (M+); mp 237-239 (dec.). Example 5 3-[8-(4-Methyl-hexahydropyrazine)-free ketone-based 7-phenylethynyldihydro-3H-benzoquinone [b][l,4]dioxine- 2-Based]-benzonitrile is prepared according to the general procedure 0, from [2-amino-based (4-methyl-hexahydropyrazine + base) ice-131 - This paper scale applies to China National Standard (CNS) A4 specifications. (210 X 297 mm) (Jing Xian read the phonetic transcription on the back? Matters again page) Gutter 1255266 A7 B7 V. Invention Description (129 Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed Phenyl Ethyl-Phenyl ]-Aminomethyl 3-butyrate (example L5x203 mg, 0.5 moles) and 3-(2,2-dimethyl ketodioxanthene)-benzonitrile (Example N4) (230 mg, 〇.75 mmol, 75% pure). Obtained orange oil (181 g) by chromatography. According to the general procedure p, the material was removed by treatment with TFA in ch2 ci2. Cyclization. Obtained an orange solid (82 mg). MS (ESI) 46 〇 _5 [(M+H)+]; melting point mMc (decomposition). Example 6 3- [8-(1,1-dione) -thio-fosfosin)-iceketo-t-phenylphenylethynyl-4,5-dihydro-3H-benzoquinone [b][l,4]dioxepin-2-yl]- The carbonitrile is prepared according to the general procedure from [2_Amino-based (Adenyl diketo-6·thionorfosolin-4-yl) ice phenylethynyl-phenyl]-amine methyl acid _ Butyl ester (Example l19) (22 〇 mg, 〇·5 mmol) and 3-(2,2-dimethyl-6-keto-6Η-[1,3]dioxane-4 -yl)-benzonitrile (Example Ν4) (172 mg, 0.75 mmol). The obtained material was deprotected and cyclized by treatment with TFA in CH2C12 according to the general procedure. 47 mg) MS (ISP) 495 [(M+H)+]; melting point &gt; 250 ° C (decomposition). Example 7 3-(8-chloro-4-keto-7-phenyl-4, 5-Dihydro-3H-benzoquinone [b][l,4]dioxan-2-yl)-benzonitrile was prepared according to the general procedure P by treatment with TFA in CH2C12 from {2- gas. -5-[3-(3-Cyano-phenyl)-3- keto-propyl arylamino]-biphenyl 4-yl}-aminomethyl acid tert-butyl ester (Example 03) 720 mg, 1.47 mol.) Obtained as an off-white solid (457 mg) MS (EI) 371 (M+) and 373 [(M+2)+]; mp 242-244 ° C (decomposition). Applicable to China National Standard (CNS) A4 specification (210 X 297厘) Please read the precautions of the back δ and then the binding line of this page 1255266 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed Α7 Β7 V. Invention description (130) Example 8 3-(8-methyl-4-keto- 7-Phenyl-4,5-dihydro-3H-benzoquinone [b][l,4]dioxine:yl)-benzonitrile according to the general procedure, from (5-Amino-2- Methyl-biphenyl-4-yl)-amine methyl acid tert-butyl ester (Example L7) (298 mg, 1.0 mmol) and 3-(2,2-dimethyl-6-keto) -6H-[1,3]dioxanthene,ylyl)-benzonitrile (Example N4) (460 mg, 1.5 t mole). The obtained material (351 mg) was deprotected and cyclized by treatment with TFA in CH2Cl2 according to the general procedure. A pale yellow solid (206 mg) was obtained. MS (EI) 351 (M+); mp 236-239 (m.). Example 9 3-[8-(1,4-Dioxoxane-spiro[4.5]fluorene>&gt; 4-keto-7-phenylethynyl-4,5-dihydro-3H-benzoquinone [ b][l,4]dioxan-2-yl]-benzonitrile was prepared from [2-indole-3-cyano-phenyl)-3 by treatment with TFA in CH2C12 according to the general procedure P -keto-propionylamino]_5-(l,4-dioxa nitrogen-spiro[4.5]dec-8-yl)-4-phenylethylidene-phenyl]-amine methyl acid Tri-butyl ester (Example 〇 14) (265 mg, 0.43 mmol) afforded brown solid (121 mg). MS (ESI) 503 [(M+H)+]; mp 239-243. Example 10 3-(8-moffin-4-yl-4-keto-7-phenylethylidene-4,5-dihydro-3H-benzoquinone [b][l,4] Indole-2-yl)-benzonitrile was prepared from {2-[3_(3-cyano-phenyl)3-keto-propenyl) by treatment with TFA in CH2Cl2 according to the general procedure P Amino] morphine sulphate · 4 · phenylethynyl-phenyl}-amine methyl acid tert-butyl ester 010 (370 mg, 〇 · 66 mmol). Obtained -133- This paper size applies China National Standard (CNS) A4 Specification (210 x 297 mm) -----»---------Installation - (Please read the notes on the back and then on this page) -•线- 1255266 Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative Printed A7 ____ B7___ V. Inventive Note (131) Obtained as a light brown solid (216 mg) MS (El) 446 (M+); mp 239-243 ° C ( Decomposition) Example 11 3-[8-(2-Dimethylamino-ethylthio)-4.keto-7-phenylethynyl-4,5-dihydro-3H-benzoquinone [b][ l,4]Dioxein-2-yl]-benzonitrile was prepared from [2-[3-(3-cyano-benzene) by treatment with TFA and toluene in CH2Cl2 according to the general procedure P. ))-3-keto-propionylamino]-5-(2-dimethylamino-ethylthio)-4-phenylethylidene-phenyl]-amine methyl acid third-butyl Ester (Example 〇 4) (166 mg, 0.28 mmol) afforded a pale-yellow solid (1 </ </ RTI> </ RTI> </ RTI> </ RTI> </ RTI> MS (ISP) 465 [(M+H)+]; 12 [4-(3-Cyano-phenyl)-2-keto-8-phenylethynyl-2,3-dihydro-1H-benzoquinone[b][i,4]-one-leaf -7-thio]-succinic acid is prepared according to the general procedure P, by treatment with TFA and toluene in CH 2 Cl 2 'from {5-di-di-butoxyamino} 4-[3- (3-apo-phenyl)-3-mercaptopropylamino]-2-phenylethynyl-phenylthiob Methyl acetate (Example 〇 5) (421 mg, 0.72 mmol). A pale yellow solid (3 〇 9 mg) was obtained. MS (ISP) 465 [(M+H)+]; mp. (: (decomposition). Example 13 [4-(3-Cyano-phenyl)-2-keto-8-phenylethynyl-2,3-dihydro-1H-benzoquinone [b][l, 4] Azepin--7-ylthio]-acetic acid [4-(3-cyano-phenyl)-2-keto-8-phenylethynyl-2,3-dihydro-1H- Benzoquinone [b][l,4]dioxine-7-ylthio]-acetic acid methyl ester (Example 12) (265 mg, 0.57 mmol) with Li〇H · Η2 Ο (26 mg, 0.63) Millimeter) in THF (5 ml), -134- This paper scale applies Chinese National Standard (CNS) A4 specification (21〇X 297 mm) ----l·--------- —— (Please read the notes on the back and then the page) · Line · 1255266

五、發明說明(132)V. Description of the invention (132)

MeOH (1毫升)及Η2 Ο (1毫升)中之溶液,於23°C下攪拌24小時 。獲得淡黃色固體(257毫克)。 MS (ISP) 452 [(M+H)+ ] ;容點 202°C (分解)。 實例14 [4-(3-氰基-苯基)-2-g同基冬苯基乙炔基_2,3_二氫-1H_苯幷[吨以] 二吖庚因-7-基]-醋酸甲酯 根據一般程序P,經由以TFA在CH2C12中處理,製自{5_第 三-丁氧羰基胺基-4-[3-(3-氰基-苯基)-3-酮基-丙醯基胺基&gt;2_苯 基乙块基·苯基卜醋酸甲酯(實例06)(846毫克,153亳莫耳)。 獲得淡黃色固體(557毫克)。 MS (EI) 433 (M+);熔點 236°C (分解)。 實例15 [4-(3-氰基-表基)-2-|同基各苯基乙炔基-2,3-二氫-1H-苯并[b][l,4] 二吖庚因-7-基]-醋酸 將LiOH· H2〇(54亳克,1·28毫莫耳)在h2〇(2毫升)與Me〇H (2毫升)中之溶液,添加至THF (10毫升)中之[4-(3_氰基-苯基)_ 2-酮基-8-苯基乙炔基-2,3-二氫_1H-苯幷[b][1,4]二吖庚因孚基]_ 醋酸甲酯(實例14)(505毫克,U7毫莫耳)内,並將反應混合 物於23 C下擾拌48小時。獲得淡黃色固體(62毫克)。 MS (ISP) 452 [(M+H)+ ];熔點 248°C (分解)。 實例16 4-(3-氰基,苯基)各碘基:酮基-2,3-二氫-1Η_苯幷[吨⑷二吖庚因 -7-複故甲@旨 根據一般程序P,經由以TFA在CH2C12中處理,製自5_第 -135- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -----:---------裝—— (請先閱讀背面之注意事項再本頁) 訂: 1.·線· 經濟部智慧財產局員工消費合作社印製 1255266 A7 ____B7__ 五、發明說明(133) 三-丁氧羰基胺基-4-[3-(3-氰基-苯基&gt;3-酮基_丙醯基胺基]_2_碘_ 苯甲酸甲酯(實例〇17)(430毫克,0.763亳莫耳)。獲得鮭肉色 固體(199毫克)。 MS (El) 445(M+);熔點 247-248°C (分解)。 實例17 2- [4-(3-氰基-苯基)-2-酮基-8-苯基乙炔基_2,3-二氫-1H-苯幷[b][l,4] 一叶庚因-7-基]-乙酿胺 將[4-(3-氰基-苯基)-2-酮基-8-苯基乙炔基-2,3_二氫-苯并 [b][l,4]二吖庚因-7-基]-醋酸(實例15)(48亳克,(U14毫莫耳), 以BcK2〇(37毫克)、顺4此〇3(13毫克)及吡啶(6微升)在dmf (0.6愛升)中’於23 C下處理24小時[參閲Tetrahedron Letters 1995, 36, 7115]。獲得淡黃色固體(14毫克)。 MS (ISN) 417 [(M-Η)·];熔點 250°C (分解)。 實例18 3- [8-(2-甲氧基-乙氧基)-4_酮基_7_苯基乙块基_4,5_二氫-3H-苯幷 [b][l,4]二吖庚因-2-基]-苯甲腈 根據一般程序P,經由以TFA在CH2 Cl2中處理,製自[2-[3-(3-氰基-苯基)-3-酮基-丙醯基胺基]-5·(2-甲氧基-乙氧基)_4_苯基 乙炔基·苯基]-胺甲基酸第三-丁酯(實例07)(135毫克,0.251毫 莫耳)。獲得淺綠色固.體(82毫克)。 MS (EI) 435 (M+);熔點 174-176°C。 實例19 4- (3-氰基-苯基)-2-酮基-8-笨基乙炔基-2,3-二氫·1Η-苯幷[b][l,4]二 吖庚因-7邊酸甲酯 -136- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ----.---------裝--- 請先閱讀背面之注意事項再@本頁) . •線· 經濟部智慧財產局員工消費合作社印製 1255266 A7 五、發明說明(134) 裝i I C請先閱讀背面之注音?事項再本頁) 根據一般程序P,經由以TFA在CH2%中處理,製自5_第 三-丁氧羰基胺基-4-[3-(3-氰基-苯基&gt;3-酮基-丙醯基胺基]_2_苯 基乙块基-苯甲酸甲酯(實例09)(511毫克,〇·95毫莫耳)。獲 得灰白色固體(321毫克)。 MS (ΕΙ) 419 (Μ+);熔點 &gt;250°C。 實例20 3-(8_甲氧基-4-酮基-7-苯基乙炔基4,5-二氫-3H-苯幷[b][l,4]二口丫 庚因-2-基)-苯甲腈 根據一般程序P,經由以TFA在CH2 Cl2中處理,製自{2-[3-(3-氰基-苯基)-3.基-丙醯基胺基]甲氧基-4-苯基乙块基-苯 基]-胺甲基酸第三-丁酯(實例08)(359毫克,〇·7毫莫耳)。獲 得黃褐色固體(87毫克)。 MS (EI) 391 (M+);熔點 &gt;250°C。 實例21 3-[8-(2-{2-[2-(2-甲氧基-乙氧基)-乙氧基]-乙氧基}_乙氧基)冰明 基-7-苯基乙炔基-4,5-二氫-3H-苯幷[b][l,4]二吖庚因-2-基]-苯甲 腈 經濟部智慧財產局員工消費合作社印製 根據一般程序P,經由以TFA在CH2 Cl2中處理,製自[2-[3-(3-氰基-苯基)-3-酮基-丙醯基胺基]-5-(2-{2-[2-(2-甲氧基-乙氧基)-乙氧基]-乙氧基}-乙氧基)-4-苯基乙炔基-苯基]-胺甲基酸第三_ 丁酯(實例011)(300毫克,0.437毫莫耳)。獲得淡黃色固體 (211毫克)。 MS (EI) 435 (M+);熔點 140-141°C (分解)。 實例22 -137- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266A solution of MeOH (1 mL) and EtOAc (1 mL) was stirred at 23 °C for 24 hr. Obtained as a pale yellow solid (257 mg). MS (ISP) 452 [(M+H)+ ] ; capacitance 202 ° C (decomposition). Example 14 [4-(3-Cyano-phenyl)-2-g-iso-phenylphenylethynyl-2,3-dihydro-1H-benzoquinone [Tonne to] Dioxepin-7-yl] - Methyl acetate is prepared according to the general procedure P by treatment with TFA in CH2C12 from {5_tris-butoxycarbonylamino-4-[3-(3-cyano-phenyl)-3-one -propenylamino group &gt; 2-phenylphenyl phenyl phenylacetate (Example 06) (846 mg, 153 Torr). Obtained as a pale yellow solid (557 mg). MS (EI) 433 (M+); mp 236 (dec.). Example 15 [4-(3-Cyano-epiyl)-2-|isopicophenylphenylethynyl-2,3-dihydro-1H-benzo[b][l,4] Dioxeine- 7-yl]-acetic acid A solution of LiOH·H2 (54 g, 1.28 mmol) in EtOAc (2 mL) [4-(3-Cyano-phenyl)-2-keto-8-phenylethynyl-2,3-dihydro-1H-benzoquinone[b][1,4]dioxine Methyl acetate (Example 14) (505 mg, U7 mmol), and the mixture was stirred at 23 C for 48 hours. Obtained as a pale yellow solid (62 mg). MS (ISP) 452 [(M+H)+]; mp 248 (dec.). Example 16 4-(3-Cyano, phenyl) each iodo group: keto-2,3-dihydro-1Η-phenylhydrazine [T (4) dioxetane-7-recovery A] According to the general procedure P , processed by TFA in CH2C12, manufactured from 5_第-135- This paper scale applies Chinese National Standard (CNS) A4 specification (210 X 297 mm) -----:-------- - Packing - (Please read the notes on the back and then this page) Order: 1.·Line· Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 A7 ____B7__ V. Description of Invention (133) Tri-butoxycarbonylamino -4-[3-(3-Cyano-phenyl)-3-keto-propionylamino]_2-iodo-benzoic acid methyl ester (Example 〇17) (430 mg, 0.763 mmol). Obtained as a flesh-colored solid (199 mg). MS (El) 445 (M+); mp 247 - 248 C (dec.). Example 17 2-[4-(3-Cyano-phenyl)-2-one- 8-Phenylethynyl 2,3-dihydro-1H-benzoquinone [b][l,4] geninyl-7-yl]-ethinyl[4-(3-cyano-benzene) Yl)-2-keto-8-phenylethynyl-2,3-dihydro-benzo[b][l,4]dioxepin-7-yl]-acetic acid (Example 15) (48亳Gram, (U14 millimolar), with BcK2〇 (37 mg), cis 4 this 〇3 (13 mg) And pyridine (6 μL) was treated in dmf (0.6 liters) at 23 C for 24 hours [see Tetrahedron Letters 1995, 36, 7115] to obtain a pale yellow solid (14 mg). MS (ISN) 417 [ (M-Η)·]; melting point 250 ° C (decomposition). Example 18 3- [8-(2-methoxy-ethoxy)-4-keto-yl-7-phenylethylidene-4, 5_Dihydro-3H-benzoquinone [b][l,4]dioxan-2-yl]-benzonitrile was prepared according to the general procedure P by treatment with TFA in CH2Cl2 from [2-[ 3-(3-cyano-phenyl)-3-keto-propionylamino]-5-(2-methoxy-ethoxy)-4-phenylethynylphenyl]-amine A Third-butyl acrylate (Example 07) (135 mg, 0.251 mmol). mp. mp. mp. 4-(3-cyano-phenyl)-2-keto-8-phenylethynyl-2,3-dihydro·1Η-benzoquinone[b][l,4]dioxine-7 Methyl ester-136- This paper scale is applicable to China National Standard (CNS) A4 specification (210 X 297 mm) ----.---------Installation--- Please read the notes on the back first. @@)) • Line· Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 A7 V. Description of Invention (134) Install i I C Please read the phonetic transcription on the back first? Matters again on this page) According to the general procedure P, prepared by treatment with TFA in CH2% from 5-tris-butoxycarbonylamino-4-[3-(3-cyano-phenyl)-3-one Methyl-propenylamino] 2 -phenylethylidene-methyl benzoate (Example 09) (511 mg, EtOAc EtOAc) (m. Μ+); melting point &gt; 250 ° C. Example 20 3-(8-methoxy-4-keto-7-phenylethynyl 4,5-dihydro-3H-benzoquinone [b][l, 4] 2-oxoheptin-2-yl)-benzonitrile was prepared from {2-[3-(3-cyano-phenyl)-3 by treatment with TFA in CH2Cl2 according to the general procedure P. Base-propionylamino]methoxy-4-phenylethylidene-phenyl]-amine methyl acid tert-butyl ester (Example 08) (359 mg, 〇·7 mmol). Tawny solid (87 mg). MS (ESI) 391 (M+): mp. )-ethoxy]-ethoxy}-ethoxy)brydenyl-7-phenylethynyl-4,5-dihydro-3H-benzoquinone[b][l,4]dioxine- 2-Base]-benzonitrile Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed according to the general procedure P, via TFA in CH2 Cl2 Medium treatment, prepared from [2-[3-(3-cyano-phenyl)-3-keto-propenylamino]-5-(2-{2-[2-(2-methoxy) -ethoxy)-ethoxy]-ethoxy}-ethoxy)-4-phenylethynyl-phenyl]-amine methyl acid tert-butyl ester (example 011) (300 mg, 0.437 Obtained a pale yellow solid (211 mg). MS (EI) 435 (M+); mp 140-141 ° C (decomposition). Example 22 -137- This paper scale applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1255266

五、發明說明(135) 經濟部智慧財產局員工消費合作社印製 [4-(3-氰基-私基)-2-g同基-8-苯基乙決基-2,3-二氫1H-苯幷[b][l,4]二 吖庚因-7-基氧基]-醋酸 根據一般程序P,經由以TFA在CH2C12與甲苯醚中處理, 製自{5-第二-丁氧羰基胺基4-[3-(3-氰基-苯基)-3-酮基-丙酿基 胺基]-2-苯基乙炔基-苯氧基卜醋酸第三-丁酯(實例〇12)(698毫 克’ U4毫莫耳)。獲得黃色固體(265毫克)。 MS (ISN) 434 [(M-Η)-];熔點 257°C (分解)。 實例233-(8-氰基甲基-4-酮基-7-苯基乙炔基-4,5-二氫-3H-苯并[b][l,4]二 吖庚因-2-基)苯曱腈 根據一般程序P,經由以TFA在CH2 Cl2與曱苯醚中處理, I自{5-氣基甲基-2-[3-(3-來基-苯基)-3-酮基-丙酿基胺基]-4-苯 基乙決基-苯基}-胺甲基酸第三-丁酯(實例〇13)(266毫克, 0.51毫莫耳)。獲得黃色固體(145毫克)。MS (EI) 400 (M+);熔點 262°C (分解)。 實例24 3-[8-(2,3-二羥基-丙氧基)冰酮基-7-苯基乙炔基·4,5-二氫-3H-苯并 [b][l,4]二吖庚因-2-基]-苯甲腈 根據一般程序P,經由以TFA在CH2 Cl2與曱苯醚中處理, 製自[2-[3-(3-氰基-苯基)-3-酮基-丙醯基胺基]-5-(2,2-二曱基_[1,3] 二氧伍圜-4-基甲氧基)-4-苯基乙炔基-苯基]-胺甲基酸第三-丁酯 (實例016)(265毫克,0.435毫莫耳)。獲得黃色固體(62毫克)。 MS (ISP) 452 [(M+H)+ ]與 474 [(M+Na)+];熔點 230-234°C (分解)。 實例25 請 先 閱 讀 背 δ 之 注 意 事 項 再 # 本 頁 裝 訂 線 -138 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266 A7 B7 五、發明說明(136) 4-(3-碘苯基)-7-(2-甲氧基-乙氧基)各苯基乙炔基]}二氫苯幷 [b][ 1,4]二吖庚因-2-酮 請先閱讀背面之注意事項再本頁) 根據一般程序P,經由以TFA在CH2Cl2與甲苯醚中處理, 製自[2-[3-(3-碘苯基)-3-酮基-丙醯基胺基]-5-(2-甲氧基_乙氧基)_ 4-苯基乙炔基-苯基]_胺甲基酸第三-丁酯(實例〇15)(124克, 1·89毫莫耳)。獲得黃色固體(517毫克)。 MS (ΕΙ) 536 (Μ+);熔點 192°C (分解)。 實例26 2-[4-(3-氰基-豕基)·2_酮基各苯基乙炔基·2,3-二氫-1H-苯幷[b][l,4] 一叶庚因-7-基氧基]-乙酿胺 在〇 C下,將EDC (42毫克,0.22毫莫耳)添加至[4-(3-氰基-苯 基&gt;2-嗣基-8-表基乙块基-2,3-二氫-1H·苯幷[b][l,4]二。丫庚因-7-基氧基]-醋酸(實例22)(50毫克,0.11毫莫耳)、nh4C1 (18毫克 ,〇·33毫莫耳)及NMM (56毫克,0.55毫莫耳)在DMF (1.1毫升) 中’並將反應混合物於23°C下攪拌2小時。獲得黃色固體(5 毫克)。 MS (ISN) 417 [(M-Η)-];熔點 250°C (分解)。 實例27 經濟部智慧財產局員工消費合作社印製 4-(3-咪峻-1-基-苯基)-7-(2-甲氧基-乙氧基)_8_苯基乙炔基二 氫苯幷[b][l,4]二吖庚因-2-酮 根據一般程序P,經由以TFA在CH2C12與甲苯醚中處理, 製自[[[2-[3-(3-咪唑-1-基-苯基)-3-g同基-丙醯基胺基]_5_(2_甲氧基、 乙氧基)-4-冬基乙块基-冬基]-胺甲基酸第三_ 丁酉旨(實例 〇18)(200毫克,0.336毫莫耳)。獲得黃色固體(28毫克)。 -139 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266 A7 B7 五、發明說明(137) 經濟部智慧財產局員工消費合作社印製 MS (EI) 476 (M+);熔點 187-189°C。實例28 [RS]_3_[4_酮基_8—(2姻基4U]二氧伍圜冰基甲氧基)_7_苯基乙炔 基-4,5-二氫-3H-苯幷[b][l,4]二吖庚因_2_基]_苯甲腈 根據一般程序P,經由以TFA在CH2 Cl2中處理,製自[RS]-[2-[3-(3-來基-本基)-3-酮基-丙驢基胺基]-5-(2-酮基-[1,3]二氧伍圜 -4-基甲氧基)-4-苯基乙炔基-苯基]—胺甲基酸第三·丁酯(實例 019)(400毫克,〇·67毫莫耳)。獲得黃色固體(287毫克)。MS (ΕΙ) 477 (Μ+).;熔點 222°C (分解)。實例29 3-(8-乙氧基甲基-4-酮基-7-苯基乙块基-4,5-二氫-3H-苯幷[b][l,4] 二吖庚因-2-基)-苯甲腈 根據一般程序P,經由以TFA在CH2 Cl2中處理,製自{2-[3-(3-氰基-苯基)-3-酮基-丙醯基胺基]-5-乙氧基甲基-4-苯基乙炔 基-苯基}-胺甲基酸第三-丁酯(實例020)(140毫克,0.26毫莫 耳)。獲得黃色固體(93毫克)。MS (EI) 419 (M+);熔點 229°C。 實例30 2,2-一甲基-丙故4-(3-氰基-苯基)-2-酮基-8-苯基乙块基-2,3-二氫-1H-苯幷[b][lr4]二吖庚因-7-基甲酯 根據一般程序P,經由以TFA在CH2 Cl2中處理,製自2,2-二 甲基-丙酸5-第三-丁氧羰基胺基-4-[3-(3-氰基-苯基)-3-酮基-丙 醯基胺基]-2-苯基乙炔基-字酯(實例021)(156毫克,0.26毫莫 耳)。獲得淡黃色固體(75毫克)。 -140- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 請 先 閱 讀 背 © 之 注 意 事 項 再 # 本 頁 裝 訂 線 1255266V. Description of invention (135) Printed by the Ministry of Economic Affairs, Intellectual Property Office, Staff Consumer Cooperative, [4-(3-cyano-private)-2-g-iso-yl-8-phenylethylidene-2,3-dihydro 1H-benzoquinone [b][l,4]dioxine-7-yloxy]-acetic acid was prepared from {5-second-butyl via TFA in CH2C12 with toluene according to the general procedure P Oxycarbonylamino 4-[3-(3-cyano-phenyl)-3-keto-propylamino]-2-phenylethynyl-phenoxyacetic acid tert-butyl ester (example) 〇 12) (698 mg 'U4 millimoles). Obtained as a yellow solid (265 mg). MS (ISN) 434 [(M-Η)-]; mp 257 ° C (dec.). Example 233-(8-Cyanomethyl-4-keto-7-phenylethynyl-4,5-dihydro-3H-benzo[b][l,4]dioxan-2-yl Phenyl nitrile is treated according to the general procedure P via TFA in CH2Cl2 with decyl ether, I from {5-carbylmethyl-2-[3-(3-)-phenyl)-3-one Tert-butylamino-4-phenylethyl-phenyl}-amine methyl acid tert-butyl ester (Example 〇 13) (266 mg, 0.51 mmol). Obtained as a yellow solid (145 mg). MS (EI) 400 (M+); mp 262 (dec.). Example 24 3-[8-(2,3-Dihydroxy-propoxy)crallow-7-phenylethynyl-4,5-dihydro-3H-benzo[b][l,4]吖heptyl-2-yl]-benzonitrile is prepared from [2-[3-(3-cyano-phenyl)-3-) by treatment with TFA in CH2Cl2 and decyl ether according to the general procedure P Ketopropyl-propionylamino]-5-(2,2-dimercapto-[1,3]dioxoindol-4-ylmethoxy)-4-phenylethynyl-phenyl]- Aminomethyl 3-butyrate (Example 016) (265 mg, 0.435 mmol). Obtained as a yellow solid (62 mg). MS (ISP) 452 [(M+H)+] and 474 [(M+Na)+]; melting point 230-234 ° C (decomposition). Example 25 Please read the precautions of the back δ and then #PAGE binding line-138 This paper scale applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1255266 A7 B7 V. Invention Description (136) 4-( 3-iodophenyl)-7-(2-methoxy-ethoxy)phenylphenylethynyl]}dihydrophenylhydrazone [b][ 1,4]dioxane-2-one, please read first Precautions on the back side of this page) According to the general procedure P, by treatment with TFA in CH2Cl2 and toluene ether, [2-[3-(3-iodophenyl)-3-keto-propenylamino) ]-5-(2-methoxy-ethoxy)-4-phenylethynyl-phenyl]-amine methyl acid tert-butyl ester (Example 〇 15) (124 g, 1.89 mmol) ear). Obtained as a yellow solid (517 mg). MS (ΕΙ) 536 (Μ+); melting point 192 ° C (decomposition). Example 26 2-[4-(3-Cyano-indenyl)-2-yl-1-ylphenylethynyl-2,3-dihydro-1H-benzoquinone[b][l,4] -7-yloxy]-ethonamine EDC (42 mg, 0.22 mmol) was added to [4-(3-cyano-phenyl)2-indolyl-8-form under 〇C Ethyl bromide-2,3-dihydro-1H·benzoquinone [b][l,4]di.azepine-7-yloxy]-acetic acid (Example 22) (50 mg, 0.11 mmol) , nh4C1 (18 mg, 〇·33 mmol) and NMM (56 mg, 0.55 mmol) in DMF (1.1 mL) and the mixture was stirred at 23 ° C for 2 hours to obtain a yellow solid ( 5 mg) MS (ISN) 417 [(M-Η)-]; melting point 250 ° C (decomposition). Example 27 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed 4-(3-Mijun-1-yl- Phenyl)-7-(2-methoxy-ethoxy)-8-phenylethynyldihydrophenylhydrazone [b][l,4]dioxepin-2-one according to the general procedure P, TFA is treated with CH2C12 in toluene ether from [[[2-[3-(3-imidazol-1-yl-phenyl)-3-g]-yl-propenylamino]_5_(2-methoxy , ethoxy)-4-methylene-yl-branched-mungyl--amino acid, third _ 酉 酉 (example 〇 18) (200 Gram, 0.336 millimolar). Obtained a yellow solid (28 mg). -139 - This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1255266 A7 B7 V. Description of invention (137) Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative Printed MS (EI) 476 (M+); Melting Point 187-189 ° C. Example 28 [RS]_3_[4_keto-8-(2 Martyo 4U) Dioxetan Ice Base Methoxy)_7_phenylethynyl-4,5-dihydro-3H-benzoquinone [b][l,4]dioxine-2-yl]benzonitrile is passed according to the general procedure P TFA was treated in CH2Cl2 from [RS]-[2-[3-(3-)-yl-yl)-3-keto-propenylamino]-5-(2-keto-[ 1,3] Dioxin-4-ylmethoxy)-4-phenylethynyl-phenyl]-amine methyl acid, third butyl ester (Example 019) (400 mg, 〇·67 mmol) Obtained as a yellow solid (287 mg). MS ( s) 477 ( Μ+).; mp 222 ° C (decomposition). Example 29 3-(8-ethoxymethyl-4-keto-7- Phenylethylidene-4,5-dihydro-3H-benzoquinone [b][l,4] Dioxepin-2-yl)-benzonitrile according to the general procedure P, via TFA in CH2Cl2 Treatment, made from {2-[3-(3-cyano-phenyl)-3-keto- Propionylamino]-5-ethoxymethyl-4-phenylethynyl-phenyl}-amine methyl acid tert-butyl ester (Example 020) (140 mg, 0.26 mmol). Obtained as a yellow solid (93 mg). MS (EI) 419 (M+); mp. Example 30 2,2-Methyl-propyl 4-(3-cyano-phenyl)-2-keto-8-phenylethylidene-2,3-dihydro-1H-benzoquinone [b ] [lr4] Dioxepin-7-ylmethyl ester was prepared according to the general procedure P by treatment with TFA in CH2Cl2 from 2,2-dimethyl-propionic acid 5-tris-butoxycarbonylamino 4-[3-(3-Cyano-phenyl)-3-keto-propionylamino]-2-phenylethynyl-word ester (Example 021) (156 mg, 0.26 mmol) . Obtained as a pale yellow solid (75 mg). -140- This paper size is applicable to China National Standard (CNS) A4 specification (210 X 297 mm). Please read the back © Note Note Item #再页 装线 1255266

五、發明說明(138) MS(EI) 475 (M+);熔點 218°C。 實例31 請先閱讀背面之注意事項再本頁) 3- (8-¾甲基-4-酮基-7-苯基乙炔基-4,5-二氫-3H-苯幷[b][l,4]二吖 庚因-2-基)-苯甲腊 製自2,2-一甲基-丙酸‘(3-氰基-苯基)_2_酮基j苯基乙炔基_ 2,3-二氫-1H-苯幷[b][l,4]二吖庚因-7-基甲酯(實例3〇)(3〇毫克, 〇·〇63 4莫耳)與LiOH · Η: 0 (8耄克,〇.289毫莫耳)在thf (2毫 升)、MeOH (0.4毫升)及h2〇 (0.4毫升)中,於23°C下歷經3天 。獲得黃色固體(17毫克)。 MS (EI) 391 (M+);熔點 &gt;255°C。 實例32 7-羥甲基-4-(3-咪唑小基-苯基)各苯基乙炔基'3-二氫苯幷问 [1,4]— 口f庚因-2-酉同 根據一般程序P,經由以TFA在CH2 Cl2中處理,製自(RS)_ [2-[3-(3-咪唆-1-基-苯基)冬酮基_丙醯基胺基]-4_苯基乙块基冬( 四氫^底喃-2-基氧基甲基)_苯基]_胺甲基酸第三_丁酯(實例〇22) 。獲得黃色固體(77毫克)。 MS (EI) 432 (M+);溶點 227°C。 經濟部智慧財產局員工消費合作社印製 實例33 4- (3-咪吐-1-基-苯基)-7_(4呷氧基_六氫吡啶+基)各苯基乙炔基_ 1,3-二氫苯幷[b][i,4]二吖庚因冬酮 根據一般程序P,經由以TFA在CH2 Cl2中處理,製自[2-[3-斤咪峻基-苯基)-3-酮基-丙醯基胺基]-5-(4-甲氧基-六氫吡啶-1-基)-4-苯基乙炔基·苯基]_胺甲基酸第三_丁酯(實例〇23)。獲 _ _ -141 - 本紙張尺度適用中國國家標準(CNS)A4規格(21〇 x 297公釐) 1255266 經濟部智慧財產局員工消費合作社印製 A7 B7__ 五、發明說明(139) 得黃色固體(159毫克)。 MS (ISP) 516 [(M+H).];溶點 222°C。 實例34 3- [8-(4-甲氧基-六氫吡啶小基&gt;4-酮基-7-苯基乙炔基-4,5-二氫-3H-苯幷[b][l,4]二吖庚因-2-基]-苯甲腈 根據一般程序P,經由以TFA在CH2 Cl2中處理,製自[2-[3-(3_氰基-苯基)-3-酮基-丙醯基胺基]甲氧基-六氫吡啶-1-基)_ 4- 苯基乙炔基-苯基]-胺曱基酸第三-丁酯(實例〇24)。獲得黃 色固體(128毫克)。 MS (ISP) 475 [(M+H)+ ];熔點 250-251Ό。 實例35 [4-(3-咪。坐-1-基-苯基)-2-酮基-8-苯基乙炔基-2,3-二氫-1H-苯幷[b] [1,4]二吖庚因-7-基氧基]-乙腈 根據一般程序P,經由以TFA在CH2 Cl2中處理,製自{5-氰 基甲氧基-2-〇(3-咪唑-1-基-苯基)_3_酮基-丙醯基胺基]-4_苯基 乙炔基-苯基卜胺曱基酸第三-丁酯(實例〇25)。獲得黃色固體 (43毫克)。 MS (EI) 457 (M+);熔點 214°C。 實例36 3-(8-氰基甲氧基I酮基_7_苯基乙炔基_4,5_二氫-3沁苯幷[邱⑷ 二吖庚因-2-基)-苯甲腈 根據一般程序P,經由以TFA在CH2 Cl2中處理,製自氰 基甲氧基-2-〇(3-氰基-苯基)-3-酮基-丙醯基胺基]苯基乙炔 基-苯基}-胺甲基酸第三-丁酯(實例〇26)。獲得黃色固體(7][ -142- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公爱) -----r---------裝—— (請先閱讀背面之注意事項再#本頁) tj· —·線- 1255266 A7 B7 經濟部智慧財產局員工消費合作社印製 五、發明說明(140) 毫克)。 MS (EI) 416 (M+);熔點 212°C。 實例37 8-(4-氟苯基乙炔基)_7·羥甲基-4-(3-咪唑小基-苯基)-1,3-二氫苯 幷[b][l,4]二吖庚因-2-酮 根據一般程序P,經由以TFA在CH2C12中處理,製自(RS)-[4-(4-氟苯基乙炔基)_2-[3-(3-咪唑-1-基-苯基)-3-酮基-丙醯基胺基] -5-(四氫-旅喃-2-基氧基甲基)-苯基卜胺甲基酸第三-丁酯(實例 027)。獲得黃色固體(462毫克)。 MS (EI) 450 (M+);熔點 234°C (分解)。 實例38 8-(4-氟苯基乙決基)-7-[(2-羥基·乙基)_甲基-胺基]冬(3-咪唑小基-苯基:Μ,3-二氫苯幷[b][l,4]二吖庚因-2-酮 根據一般程序P,經由以TFA在CH2 Cl2中處理,製自(RS)-(4-(4-氟冬基乙炔基)-2-[3-(3-味峻-1-基-苯基)-3-酮基-丙醯基胺基] -5-{甲基-[2-(四氫-哌喃-2-基氧基)_乙基]-胺基}_苯基胺甲基酸 第三-丁酯(實例028)。獲得黃色固體(73毫克)。 MS (EI) 493 (M+);熔點 217X:(分解)。 實例39 4-(3-咪唑-1-基-苯基)-7-(4-酮基-六氫吡啶小基)-8-苯基乙块基-1,3-二氫苯幷[b][l,4]二吖庚因-2-酮 根據一般程序P,經由以TFA在CH2 Cl2中處理,製自{5-(4,4-一乙乳基鼠p比症-1-基)-2-[3-(3-味峻-1-基-苯基)-3-嗣基-丙 醯基胺基]-4-苯基乙炔基-苯基卜胺甲基酸第三-丁酯(實例〇29) -143- (請先閱讀背面之注意事項再本頁) -裝 • I I eaia ·βι·β ---訂---------線' 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公》) 1255266 經濟部智慧財產局員工消費合作社印製 A7 五、發明說明(141) 。獲得黃色固體(180毫克)。 MS (EI) 499 (M+);熔點 231°C (分解)。 實例40 N-第三-丁基-2-[4-(3-氰基-苯基)_2_酮基各苯基乙炔基二氫_ 1H-苯幷[b][l,4]二吖庚因-7_基氧基]_乙醯胺 經由以氯化草醯(26微升,〇·3毫莫耳)在DMp (〇·6毫升)中 ,於〇 C下處理1小時,然後以第三-丁胺(1〇6微升,ι 〇毫莫 耳),在0 C下再處理30分鐘,製自[4-(3-氰基·苯基)_2_酮基各 苯基乙炔基-2,3-二氫-1Η-苯并[b][l,4]二吖庚因_7-基氧基]_醋酸( 貫例22)(87耄克,〇·2毫莫耳),獲得黃色固體(21毫克)。 MS (EI) 490 (M+);熔點 &gt;250°C。 實例41 2-[4-(3-氰基-苯基)-2-酮基-8-苯基乙炔基_2,3-二氫-1H-苯并[b][l,4] 二叶庚因-7-基氧基]·Ν-甲氧基-乙醯胺 經由以EDC (38亳克,〇.2毫莫耳)、Me0NH2 HC1 (9毫克, 0.11笔莫耳)、NMM(0.021毫升,〇·3毫莫耳)及h〇BT(15毫克 ’ 0.11¾莫耳)在DMF(1毫升)中,於〇至23°C下處理20小時 ’製自[4-(3-氰基-苯基)-2-酮基-8-苯基乙炔基-2,3-二氫-1H-苯幷 [b][l,4]一 &lt;庚因-7-基氧基]-醋酸(實例22)(44毫克,〇.1毫莫耳) 。獲得黃色.固體(36毫克)。 MS (ISP) 465 [(M+H)+ ];熔點 &gt;250°C。 實例42 1(2-輕基-乙氧基)-4-(3-咪唑小基-苯基)-8-苯基乙炔基二氫 苯幷[b][l,4]二吖庚因-2-酮 I · I I (請先閱讀背面之注意事項再本頁) . -144 - 12552665. Description of the invention (138) MS (EI) 475 (M+); m.p. 218. Example 31 Please read the notes on the back side of this page again) 3- (8-3⁄4 methyl-4-keto-7-phenylethynyl-4,5-dihydro-3H-benzoquinone [b][l , 4] dioxin-2-yl)-benzazole from 2,2-monomethyl-propionic acid '(3-cyano-phenyl)-2-keto-l-phenylethynyl _ 2, 3-Dihydro-1H-benzoquinone [b][l,4]dioxine-7-ylmethyl ester (Example 3〇) (3〇mg, 〇·〇63 4mol) and LiOH · Η: 0 (8 gram, 〇. 289 mmol) in thf (2 mL), MeOH (0.4 mL) and H.sub.2 (0.4 mL). Obtained as a yellow solid (17 mg). MS (EI) 391 (M+); m.p. &gt; 255. Example 32 7-Hydroxymethyl-4-(3-imidazolyl-phenyl)phenylphenylethynyl '3-dihydrobenzoquinone [1,4]-portal f-gyne-2-pyrene Procedure P, prepared by treatment with TFA in CH2Cl2 from (RS)_[2-[3-(3-imifluor-1-yl-phenyl)butanyl-propionylamino]-4_ Phenylethylidene hexyl (tetrahydro^endan-2-yloxymethyl)-phenyl]-amine methyl acid tert-butyl ester (Example 〇 22). Obtained as a yellow solid (77 mg). MS (EI) 432 (M+); melting point 227 °C. Ministry of Economic Affairs, Intellectual Property Office, Staff Consumer Cooperatives, Printing Example 33 4- (3-Methoxy-1-yl-phenyl)-7-(4-decyloxy-hexahydropyridinium + yl) phenylethynyl _ 1,3 -Dihydrophenylhydrazine [b][i,4] Dioxanthone is prepared according to the general procedure P, by treatment with TFA in CH2Cl2, from [2-[3-] 3-keto-propionylamino]-5-(4-methoxy-hexahydropyridin-1-yl)-4-phenylethynyl-phenyl]-amine methyl acid tert-butyl ester (Example 〇 23). _ _ -141 - This paper size applies to China National Standard (CNS) A4 specification (21〇x 297 mm) 1255266 Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative Printed A7 B7__ V. Invention Description (139) Yellow solid ( 159 mg). MS (ISP) 516 [(M+H).]; melting point 222 °C. Example 34 3-[8-(4-Methoxy-hexahydropyridine small group &gt; 4-keto-7-phenylethynyl-4,5-dihydro-3H-benzoquinone [b][l, 4] Dioxepyn-2-yl]-benzonitrile was prepared from [2-[3-(3-cyano-phenyl)-3-one by treatment with TFA in CH2Cl2 according to the general procedure P Base-propionylamino]methoxy-hexahydropyridin-1-yl)-4-phenylethynyl-phenyl]-aminocarbamic acid tert-butyl ester (Example 〇 24). Obtained a yellow solid (128 mg). MS (ISP) 475 [(M+H)+]; mp. 250-251. Example 35 [4-(3-Miso.Spin-1-yl-phenyl)-2-keto-8-phenylethynyl-2,3-dihydro-1H-benzoquinone [b] [1,4 Dioxepin-7-yloxy]-acetonitrile was prepared from {5-cyanomethoxy-2-indole (3-imidazol-1-yl) by treatment with TFA in CH.sub.2 Cl. -Phenyl)_3_keto-propionylamino]-4-phenylethynyl-phenyl-benzamidinoic acid tert-butyl ester (Example 〇 25). Obtained as a yellow solid (43 mg). MS (EI) 457 (M+); mp. Example 36 3-(8-Cyanomethoxylketo)-7-phenylethynyl-4,5-dihydro-3-indole benzoquinone [Qiu (4) Dioxe-2-yl)-benzonitrile Prepared from the cyanomethoxy-2-indole (3-cyano-phenyl)-3-keto-propenylamino]phenylethynyl group by treatment with TFA in CH2Cl2 according to the general procedure -Phenyl}-aminomethyl acid tert-butyl ester (Example 〇 26). Obtained a yellow solid (7][ -142- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 public) -----r---------Installation - (please first Read the precautions on the back ##页) tj·—·线- 1255266 A7 B7 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 5, invention description (140) mg). MS (EI) 416 (M+); mp. Example 37 8-(4-Fluorophenylethynyl)-7-hydroxymethyl-4-(3-imidazolyl-phenyl)-1,3-dihydrophenylhydrazone [b][l,4]dioxin Glycan-2-one is prepared according to the general procedure P by treatment with TFA in CH2C12 from (RS)-[4-(4-fluorophenylethynyl)_2-[3-(3-imidazol-1-yl) -Phenyl)-3-keto-propionylamino]-5-(tetrahydro-methane-2-yloxymethyl)-phenyl-p-methylamino acid tert-butyl ester (Example 027 ). Obtained as a yellow solid (462 mg). MS (EI) 450 (M+); mp. Example 38 8-(4-Fluorophenylethyl)-7-[(2-hydroxyethyl)-methyl-amino] Winter (3-imidazolyl-phenyl: fluorene, 3-dihydro Phenylhydrazone [b][l,4]dioxan-2-one was prepared from (RS)-(4-(4-fluorobutylidene) by treatment with TFA in CH2Cl2 according to the general procedure P. -2-[3-(3-benzophen-1-yl-phenyl)-3-keto-propionylamino]-5-{methyl-[2-(tetrahydro-pyran-2- (Ethyloxy)-ethyl]-amino}-phenylamine methyl acid, tert-butyl ester (Example 028), obtained as a yellow solid (yield: 73 mg). MS (EI) 493 (M+); Decomposition) Example 39 4-(3-Imidazol-1-yl-phenyl)-7-(4-keto-hexahydropyridine small)-8-phenylethylidene-1,3-dihydrobenzene幷[b][l,4] Dioxepin-2-one is prepared according to the general procedure P, by treatment with TFA in CH2Cl2, from {5-(4,4-E-emulsion-based mouse p-sense - 1-yl)-2-[3-(3-isophen-1-yl-phenyl)-3-indolyl-propenylamino]-4-phenylethynyl-phenyl-p-aminomethyl acid Third-Butyl Ester (Example 〇29) -143- (Please read the note on the back and then on this page) -Installation • II eaia ·βι·β ---订----线线Paper scale applies to Chinese national standards (CNS ) A4 specification (210 X 297 public)) 1255266 Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative Printed A7 V. Inventive Note (141) Obtained a yellow solid (180 mg) MS (EI) 499 (M+); melting point 231° C (decomposition). Example 40 N-Terti-butyl-2-[4-(3-cyano-phenyl)-2-keto-phenylphenylethynyldihydro-1H-benzoquinone [b][l , 4] Dioxepin-7-yloxy]-acetamide via chlorinated grass mash (26 μl, 〇·3 mmol) in DMp (〇·6 ml), under 〇C After treatment for 1 hour, it was further treated with tri-butylamine (1 〇 6 μl, ι 〇 millimolar) at 0 C for 30 minutes from [4-(3-cyano·phenyl)_2_ Ketosylphenyl phenylethynyl-2,3-dihydro-1 fluorene-benzo[b][l,4]dioxine-7-yloxy]-acetic acid (Example 22) (87 g, 〇·································· -keto-8-phenylethynyl 2,3-dihydro-1H-benzo[b][l,4] diheptan-7-yloxy]·Ν-methoxy-acetamidine The amine is via EDC (38 g, 〇. 2 mmol), Me0NH2 HC1 (9 mg, 0.11 pen) Mole), NMM (0.021 ml, 〇·3 mmol) and h〇BT (15 mg '0.113⁄4 mol) in DMF (1 ml), treated at 〇 to 23 ° C for 20 hours. [4-(3-Cyano-phenyl)-2-keto-8-phenylethynyl-2,3-dihydro-1H-benzoquinone [b][l,4]-&lt;gine- 7-Alkyloxy]-acetic acid (Example 22) (44 mg, 〇. 1 mmol). Obtained as a yellow solid (36 mg). MS (ISP) 465 [(M+H)+]; mp. Example 42 1 (2-Light-ethoxy)-4-(3-imidazolyl-phenyl)-8-phenylethynyldihydrophenylhydrazone [b][l,4]dioxine- 2-ketone I · II (please read the precautions on the back page again) . -144 - 1255266

經濟部智慧財產局員工消費合作社印製 五、發明說明(142) 根據一般程序P,經由以TFA在CH2C12中處理,製自(RS&gt; {2-[3-(3-咪唑-1-基-苯基)-3_酮基-丙醯基胺基]冰苯基乙炔基_5_ [2-(四氫-峰喃-2-基氧基)_乙氧基]_苯基胺甲基酸第三-丁酯( 實例029)。獲得淡黃色固體(48毫克)。 MS (EI) 462 (M+);熔點 224-227°C。 實例43 8-(4-氟本基)-7-(4-¾基-六氫吨m )_4_(3-咪嗤小基_苯基),3-二氫苯幷[b][l,4]二吖庚因-2-g同 根據一般程序P,經由以TFA在CH2C12中處理,製自(RS&gt;{4L 氟基-5-[3-(3-咪唑-1-基-苯基&gt;3-酮基-丙醯基胺基]ι[4_(四氫-哌 喃-2-基氧基)-κ氫p比淀-1-基]-聯苯基冬·基卜胺甲基酸第三_丁 酯(實例031)。獲得淡黃色固體(1〇9毫克)。 MS (ISP) 496 [(Μ+Η)+ ];熔點 238-240°C。 實例44 8-(4-氟苯基乙炔基)-7-(2-羥基-乙氧基)-4-(3-咪唑小基-苯基,)_1,3_ 二氫苯幷[b][l,4]二吖庚因-2-酮 根據一般程序P,經由以TFA在CH2 Cl2中處理,製自{5-(2-第三-丁氧基-乙氧基)-4-(4-氟苯基乙炔基)-2-0(3-咪唾-1-基-苯 基)-3-酮基-丙酿基胺基]-苯基}_胺甲基酸第三-丁酯(實例〇32) 。獲得淡黃·色固體(83毫克)。 MS (EI) 480 (M+);熔點 220-222°C。 實例45 8-(4-氟苯基)-7-[4-(2-羥基-乙氧基)-六氫吡啶-1-基]-4-(3-咪唑-1-基 -苯基H,3-二氫苯幷[b][l,4]二吖庚因-2-酮 -145- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ----1---------裝---1 (請先閱讀背面之注意事項本頁) 訂----------線· 1255266 A7 B7 五、發明說明(143) 根據一般程序P,經由以TFA在CH2C12中處理,製自(RS)- (4f-氟基-5-[3-(3-咪。坐-1-基-苯基)-3-酮基-丙醯基胺基]_2-{4-[2-(四 氫碌喃-2-基氧基)-乙氧基]-六氫吡啶小基卜聯苯基冬基)_胺甲 基第二-丁醋(貫例033)。獲得淡黃色固體(97毫克)。 MS (ISP) 540 [(M+H)+ ];熔點 225-227°C。 實例46 8-(4-氟苯基)-7-羥甲基-4-(3-咪唑小基-苯基η,3^氫苯幷问以,4] 二吖庚因-2-酮 根據一般程序P,經由以TFA在0¾¾中處理,製自(RS&gt; [4f-氟基-5-[3-(3-咪峻-1-基-苯基)-3-酮基-丙醯基胺基]-2-(四氫碌 喃-2-基氧基甲基)-聯苯基-4-基]-胺甲基酸第三_丁酯(實例〇34) 。獲得淡黃色固體(162毫克)。 MS (EI) 426 [(M)+ ];熔點 180-195°C。 實例47 [8-(4-氟苯基)-4-(3-咪唆-1-基-苯基)-2-酮基·2,3-二氣苯幷[b] [1,4]一 17 f庚因-7-基乳基]-乙月青 根據一般程序P,經由以TFA在CH'l2中處理,製自{2_氨 基甲氧基基-5-[3-(3-咪吐小基-苯基)_3_酮基-丙醯基胺基]_ 經濟部智慧財產局員工消費合作社印製 -----:---------裳 i I (請先閱讀背面之注意事項#本頁) •線- 聯苯基-4-基}-胺甲基酸第三-丁醋(實例035)。獲得黃色固體 (11 毫克)。 ' ^ MS(EI)451(M+);熔點 164°C。 實例48 7-二甲胺基甲基-8-(4-氟苯基)-4-(3-咪唑ι基-笨基H 3_二 并[b][l,4]二吖庚因-2_酮 工 -146 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公嫠) 1255266 A7 B7 五、發明說明(144) 根據一般程序P,經由以TFA在CH2 Cl2中處理,製自{2-二 甲胺基甲基·4^氟基-5-[3-(3-咪吐小基-苯基)-3-酮基-丙醯基胺基] -聯苯基-4-基}-胺甲基酸第三-丁 g旨(實例〇36)。獲得褐色固體 (180毫克)。 MS (ISP) 454 (M+H)+ ;熔點 115-140°C (分解)。 實例49 7-(2,2-二甲基-四氫-[1,3]二氧伍圜幷[4,5-c]p比洛-5-基)各(4-氟苯基) -4-(3-咪吐-1-基-苯基)-1,3-二氫苯幷[1^][1,4]二σ丫庚因-2-酮 根據一般程序Ρ,經由以TFA在CH2 Cl2中處理,製自{2_ (2,2-二曱基-四氫-[1,3]二氧伍圜幷[4,5-c]p比洛-5-基)-4,-氟基-5-[3-(3-咪嗤-1-基-苯基)-3-酮基-丙酿基胺基]-聯苯基_4-基}-胺甲基 酸第三-丁酯(實例037)。獲得黃色固體(358毫克)。 MS (EI) 537 (M+);熔點 240°C (分解)。 實例50 7- (順式-3,4-«一經基-四氮p比洛-1-基)-8-(4-氣苯基)-4-(3-咪口坐-1-基_ 苯基)-1,3-二氫苯并[b][l,4]二吖庚因-2-酮 經由以13% HC1 (15毫升)在THF (50毫升)中,於23°C下處理 16小時,製自7-(2,2-二甲基-四氫-[1,3]-二氧伍圜幷[4,5-c]吡咯-5-基)-8-(4-氟-苯基)-4-(3_咪峻小基-苯基)-1,3-二氫苯幷[b][l,4]二 口丫庚因-2-酮(實例49)(304毫克,0.57毫莫耳)。獲得黃色固體 (209毫克)。 MS (ISP) 498 [(M+H)+ ];熔點 244°C。 實例51 8- (4-氟苯基)-4-(3-咪唑-1-基-苯基)-7-甲氧基-1,3-二氫苯幷[b][l,4] -147- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) (請先閱讀背面之注意事項本頁) 裝---·-----訂--------:線· 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明(145) 二吖庚因-2-酮 根據一般程序P ’經由以TFA在CH2 C12中處理,製自{心氣 基-5-[3-(3-咪吐-1-基-苯基)-3-酮基-丙酿基胺基]-2-甲氧基_聯苯 基-4-基卜胺甲基酸第三-丁酯(實例038)。獲得黃色固體(182 毫克)。 MS (EI) 426 (M+);熔點 221°C (分解)。 實例52 8-(4-氟苯基)-4-(3-咪唑-1-基-苯基)-7-(4-酮基-六氫吡啶小基h,3-二氫苯幷[b][l,4]二吖庚因-2-酮 根據一般程序P,經由以TFA在0¾ %中處理,製自 (1,4-一氧-8-氮-螺[4.5]癸-8-基)-4’-氟基-5-[3-(3-咪峻-1-基-苯基)各 酮基-丙酿基胺基]-聯苯基_4-基}-胺甲基酸第三-丁酯(實例〇39) 。獲Y于橘褐色固體(150毫克)。 MS (ISP) 494 [(M+H)+ ];熔點 204°C。 實例53 8-(4-氟苯基)-4-(3-咪唑-1-基-苯基)-7-甲基-1,3-二氫苯幷二 口丫庚因-2-酮 經濟部智慧財產局員工消費合作社印製 ----:---------裝—— (請先閱讀背面之注意事項本頁) -丨線_ 根據一般程序Ρ,經由以TFA在CH2 Cl2中處理,製自{4,-氟 基-5-[3-(3-咪唑-1-基-苯基)-3-酮基-丙醯基胺基]_2·甲基-聯苯基_ 4-基}-胺甲基酸第三-丁酯(實例〇4〇)。獲得淡黃色固體(216 毫克)。 MS(EI)410(M+);熔點 196°C。 實例54 [8-(4-氟苯基)冰(3-咪唑-1-基-苯基)_2-酮基-2,3-二氫-1H-苯幷[b] -148 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公爱) 1255266 A7 經濟部智慧財產局員工消費合作社印製 五、發明說明(146) [1,4]一叶庚因-7-基氧基]-醋酸 根據一般程序P,經由以丁从在⑶2%中處理,製自⑷第 三-丁氧談基胺基术氣基-5-[3-(3_咪吐+基-苯基);酮基_丙醯 基胺基]-聯苯基-2-基氧基卜醋酸第三-丁酯(實例〇41)。獲得 米黃色固體(570毫克)。 又 MS (ISP) 471 [(M+H)+ ];熔點 209°C (分解)。 實例55 2-[8-(4-氟苯基)-4-(3-咪唑小基-苯基&gt;2_酮基^二氫·m_苯幷问 [1,4]一叶庚因-7-基氧基]-N-經基·乙酿胺 經由與〇-三苯甲基羥胺(61毫克,〇·22亳莫耳)、h〇b丁⑼ 毫克,0.22毫莫耳)、队甲基嗎福啉(66微升,〇·6毫莫耳)及 EDC (77笔克,0.4 φ莫耳)在j)MF (2毫升)中,從〇至23。〇反應 18小時,製自[8-(4-氟苯基)-4-(3-咪唑小基·苯基酮基_2&gt;二 氫-1H-苯幷[b][l,4]二吖庚因-7_基氧基醋酸(實例54)(94毫克, 〇·2耄莫耳)。根據一般程序P,於萃取與層析後,將所形成 之橘色固fa與TFA在CH2 Cl2中攪拌。獲得淡黃色固體(7丨毫 克)。 MS (ISP) 486 [(M+H)+];熔點 i47-157°C (分解)。 實例56 7-氣基-8-(4-氟苯基)-4-(3-咪基-苯基)-1,3_二氫苯幷[^[m]二 吖庚因-2-酮 根據一般程序P,經由以TFA在CH2Cl2中處理,製自{2-氯 基I氟基-5-[3-(3-咪唆-1_基_苯基)冬酮基_丙醯基胺基 &gt;聯苯基-4-基卜胺甲基酸第三-丁酯(實例〇42)。獲得淡黃色固體⑺毫 請 先 閱 讀 背 面 之 注 意 事 項 i 裝 訂 -149- 一紙張尺度適用中國國家標準(CNS)A4規格(21〇 X 297公釐 1255266 Α7 Β7 經濟部智慧財產局員工消費合作社印製 五、發明說明( 147 ) 克)。 MS (EI) 430 (M+);熔點 209-21 rC。 實例57 H4-氟苯基)-4-(3-咪唑小基-苯基)_7_(2-甲氧基_乙氧基&gt;:1,3二氫 苯幷[b][l,4]二吖庚因-2-酮 根據一般程序P,經由以TFA在0¾ %中處理,製自[4匕氟 基-5-[3_(3-咪唑-1-基-苯基)_3_酮基-丙醯基胺基甲氧基-乙 氧基)-聯苯基-4-基]-胺甲基酸第三-丁酯(實例〇43)。獲得黃 色固體(96毫克)。 MS (El) 470(M+);熔點 196-197°C。 實例58 8-(4-氟苯基&gt;7-(2-羥基-乙氧基)-4-(3-咪唑-1-基-苯基h,3-二氫苯 幷[b][l,4]二吖庚因-2-酉同 根據一般程序P,經由以TFA在CH2%中處理,製自{2-(2· 第一-丁氧基-乙氧基)-4f-氟基-5-[3-(3-咪嗤-1-基-苯基)_3_g同基·丙 ‘基胺基]-聯冬基-4-基}-胺甲基酸第二-丁 g旨(實例044)。獲 得淺綠色固體(95毫克)。 MS (EI) 456 (M+);熔點 225°C。 實例 8_(4-氟苯基)-4-(3-咪唑小基-苯基)-7-(2-酮基-噚唑啶_3_基H,3-二 氫苯幷[b][l,4]二吖庚因-2-酮 根據一般程序P,經由以TFA在CH2 C!2中處理,製自[4^氣 基-5-[3-(3-咪唑小基-苯基酮基-丙醯基胺基酮基号嗤 咬-3-基)_聯苯基_4_基]_胺甲基酸第三-丁酯(實例〇45)。獲得黃 __ -150- 本紙張尺度適用中國國家標準(CNS)A4規格(21〇 χ 297公^&quot;) ^ -----Γ 1 I--- I I (請先閱讀背面之注意事項再本頁) 訂_ 1· _線·Ministry of Economic Affairs, Intellectual Property Bureau, Staff Consumer Cooperatives, Printing, V. Inventions (142) According to the general procedure P, by TFA in CH2C12, from (RS&gt; {2-[3-(3-imidazol-1-yl-) Phenyl)-3-keto-propionylamino] bromophenylethynyl_5_ [2-(tetrahydro-peak-2-yloxy)-ethoxy]-phenylamine methyl acid The third-butyl ester (Example 029) gave a pale-yellow solid (48 mg). MS (ESI) 462 (M+); 4-3⁄4 yl-hexahydro ton m ) _4_(3-imidinyl phenyl), 3-dihydrophenylhydrazine [b][l,4]dioxine-2-g is according to the general procedure P By treatment with TFA in CH2C12, (RS&gt;{4L fluoro-5-[3-(3-imidazol-1-yl-phenyl)-3-keto-propionylamino]ι[ 4_(tetrahydro-pyran-2-yloxy)-κhydropp-pred-1-yl]-biphenylwhenylamine methyl acid tert-butyl ester (Example 031). Solid (1 〇 9 mg) MS (ISP) 496 [(Μ+Η)+]; mp 238-240 ° C. Example 44 8-(4-fluorophenylethynyl)-7-(2-hydroxy- Ethoxy)-4-(3-imidazolyl-phenyl,)_1,3-dihydrophenylhydrazone [b][l,4]dioxepin-2-one Prepared from {5-(2-tris-butoxy-ethoxy)-4-(4-fluorophenylethynyl)-2-0 by treatment with TFA in CH2Cl2 according to the general procedure 3-Myryl-1-yl-phenyl)-3-keto-propyl-arylamino]-phenyl}-aminomethyl acid tert-butyl ester (Example 〇 32). Obtained pale yellow solid (83 mg) MS (EI) 480 (M+); mp. 220-222 ° C. Example 45 8-(4-fluorophenyl)-7-[4-(2-hydroxy-ethoxy)-hexahydro Pyridin-1-yl]-4-(3-imidazol-1-yl-phenyl H,3-dihydrophenylhydrazone [b][l,4]dioxepin-2-one-145- paper scale Applicable to China National Standard (CNS) A4 specification (210 X 297 mm) ----1---------Installation---1 (Please read the back note on this page first) Order--- ------- Line 1255266 A7 B7 V. INSTRUCTIONS (143) According to the general procedure P, by TFA in CH2C12, from (RS)-(4f-fluoro-5-[3-( 3-Miso.Spin-1-yl-phenyl)-3-keto-propionylamino]_2-{4-[2-(tetrahydrofuran-2-yloxy)-ethoxy] - Hexahydropyridine small base diphenyl phenylmethylene) - amine methyl second - butyl vinegar (Case 033). Obtained as a pale yellow solid (97 mg). MS (ISP) 540 [(M+H)+]; mp. Example 46 8-(4-Fluorophenyl)-7-hydroxymethyl-4-(3-imidazolyl-phenyl η,3^hydrobenzoquinone, 4] Dioxepin-2-one according to General Procedure P, prepared by treatment with TFA in 03⁄4⁄4, from [RS&gt;[4f-fluoro-5-[3-(3-imis-l-yl-phenyl)-3-keto-propenyl) Amino]-2-(tetrahydrofuran-2-yloxymethyl)-biphenyl-4-yl]-amine methyl acid tert-butyl ester (Example 〇 34). Obtained as a pale yellow solid ( 162 mg) MS (EI) 426 [(M)+]; mp. 180-195 ° C. Example 47 [8-(4-Fluorophenyl)-4-(3-Minyl-1-yl-phenyl) )-2-keto- 2,3-dioxaquinone [b] [1,4]-17 f-glycol-7-yl-lactyl]-ethyl acetoin according to the general procedure P, via TFA in CH' Processed in l2, made from {2_aminomethoxy-5-[3-(3-imipo-yl-phenyl)_3-keto-propenylamino]] Ministry of Economic Affairs Intellectual Property Office staff consumption Co-operative printing -----:---------Shang Yi I (please read the notes on the back #this page) • Line - biphenyl-4-yl}-amine methyl acid Tri-butyl vinegar (Example 035). Obtained as a yellow solid (11 mg). &lt;RTI ID=0.0&gt;&gt;&&&&&&&&&&&& Phenyl -4-(3-imidazolium-stupyl H 3_bis[b][l,4]dioxine-2-ketone-146 This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 嫠) 1255266 A7 B7 V. INSTRUCTIONS (144) According to the general procedure P, by treatment with TFA in CH2Cl2, from {2-dimethylaminomethyl.4^fluoro-5-[3 -(3-Imidazo-phenyl)-3-keto-propionylamino]-biphenyl-4-yl}-amine methyl acid #3 - butyl g (Example 〇 36). Obtained as a brown solid (180 mg). MS (ESI) 454 (M+H)+; mp s:::::::::::::: Dioxosulfon [4,5-c]ppirin-5-yl)(4-fluorophenyl)-4-(3-imtop-1-yl-phenyl)-1,3- Dihydrophenylhydrazine [1^][1,4]di-sigma-heptan-2-one is prepared according to the general procedure, by treatment with TFA in CH2Cl2, from {2_(2,2-didecyl-tetra Hydrogen-[1,3]dioxosin [4,5-c]ppylo-5-yl)-4,-fluoro-5-[3-(3-imifluor-1-yl-benzene) Benzyl-3-keto-propylaminoamino]-biphenyl-4-yl}-aminomethyl acid tert-butyl ester (Example 037). Obtained as a yellow solid (358 mg). MS (EI) 537 (M+); mp. 240 (dec.). Example 50 7-(cis-3,4-«-mono-yl-tetrazine p-l-l-yl)-8-(4-phenylphenyl)-4-(3- propyl-l-yl) Phenyl)-1,3-dihydrobenzo[b][l,4]dioxan-2-one via 13% HCl (15 ml) in THF (50 mL) at 23 ° C Treatment for 16 hours, from 7-(2,2-dimethyl-tetrahydro-[1,3]-dioxacillin [4,5-c]pyrrole-5-yl)-8-(4- Fluoro-phenyl)-4-(3_imistenyl-phenyl)-1,3-dihydrophenylhydrazone [b][l,4]dioxalyl-2-one (Example 49) 304 mg, 0.57 mmol. Obtained a yellow solid (209 mg). MS (ISP) 498 [(M+H)+]; mp. Example 51 8-(4-Fluorophenyl)-4-(3-imidazol-1-yl-phenyl)-7-methoxy-1,3-dihydrophenylhydrazone [b][l,4] - 147- This paper size applies to China National Standard (CNS) A4 specification (210 X 297 mm) (please read the back note on this page first) Pack------------ -: Line · Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 A7 B7 V. Description of Invention (145) Dioxane-2-one is processed according to the general procedure P' via TFA in CH2 C12, from {心气5-[3-(3-imith-1-yl-phenyl)-3-keto-propyl-arylamino]-2-methoxy-biphenyl-4-yl-b-aminomethyl Acidic third-butyl ester (Example 038). Obtained a yellow solid (182 mg). MS (EI) 426 (M+); mp 221 (dec.). Example 52 8-(4-Fluorophenyl)-4-(3-imidazol-1-yl-phenyl)-7-(4-keto-hexahydropyridine small group h,3-dihydrophenylhydrazine [b ][l,4] Dioxepin-2-one was prepared according to the general procedure P by treatment with TFA in 03⁄4 % from (1,4-oxo-8-nitro-spiro[4.5]癸-8- -4'-Fluoro-5-[3-(3-imiran-1-yl-phenyl) keto-yl-arylamino]-biphenyl-4-yl}-aminomethyl Acidic third-butyl ester (Example 〇 39) obtained Y in orange-brown solid (150 mg) MS (ESI) 494 [(M+H)+]; mp. 204 ° C. Example 53 8-(4-fluoro Phenyl)-4-(3-imidazol-1-yl-phenyl)-7-methyl-1,3-dihydrophenyl hydrazine dioxetane-2-one Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative System----:---------Installation - (Please read the note on the back of this page first) - 丨 line _ according to the general procedure Ρ, by TFA in CH2 Cl2, from { 4,-Fluoro-5-[3-(3-imidazol-1-yl-phenyl)-3-keto-propionylamino]_2-methyl-biphenyl-4-yl}-amine Tri-butyl methacrylate (Example 〇 4 〇) gave a pale-yellow solid (216 mg). MS (EI) 410 (M+); mp 196 ° C. Example 54 [8-(4-fluorophenyl) Ice (3-imidazole-1- -Phenyl)_2-keto-2,3-dihydro-1H-benzoquinone [b] -148 - This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 public) 1255266 A7 Ministry of Economics Property Bureau employee consumption cooperative printing 5, invention description (146) [1,4] a leaf gem-7-yloxy]-acetic acid according to the general procedure P, by Ding from (3) 2%, from (4) Third-butoxysylamine-based oxy-5-[3-(3-m- ox+yl-phenyl); keto-propionylamino]-biphenyl-2-yloxy Tri-butyl acetate (Example 〇 41) gave a beige solid (570 mg). MS (ESI) 471 [(M+H)+]; mp 209 ° C (decomposition). Example 55 2-[8 -(4-fluorophenyl)-4-(3-imidazolyl-phenyl)-2-ylenyldihydromethane benzophenanyl[1,4]azepin-7-yloxy ]-N-radio-yl-bromoamine via hydrazine-tritylhydroxylamine (61 mg, 〇·22 亳 molar), h〇b butyl (9) mg, 0.22 mmol, (66 μl, 〇·6 mmol) and EDC (77 gram, 0.4 φ mol) in j)MF (2 ml), from 〇 to 23. The hydrazine reaction was carried out for 18 hours from [8-(4-fluorophenyl)-4-(3-imidazolyl·phenyl ketone-2-&gt;dihydro-1H-benzoquinone[b][l,4]吖gyne -7-yloxyacetic acid (Example 54) (94 mg, 〇·2 耄 Mo). According to the general procedure P, after extraction and chromatography, the formed orange solid fa and TFA in CH2 Stir in Cl2 to give a pale-yellow solid (7 mg). MS (ESI) 486 [(M+H)+]; melting point i47-157 ° C (decomposition). Example 56 7-Gas-8-(4- Fluorophenyl)-4-(3-micyl-phenyl)-1,3-dihydrophenylhydrazine [^[m]dioxan-2-one is treated according to the general procedure P via TFA in CH2Cl2 , from {2-chloro-1 fluoro-5-[3-(3-amido-1-yl-phenyl)-butanyl-propionylamino>&gt;biphenyl-4-ylpamine Third-butyl methacrylate (Example 〇 42). Obtained a pale yellow solid (7). Please read the notes on the back first. Binding-149- A paper scale applies to the Chinese National Standard (CNS) A4 specification (21〇X 297 PCT 1255266 Α7 Β7 Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed V. Inventions ( 147 ) g ) MS (EI) 430 (M+); melting point 209-21 rC. Example 57 H4- Fluorophenyl)-4-(3-imidazolyl-phenyl)-7-(2-methoxy-ethoxy)&gt;: 1,3 dihydrophenylhydrazone [b][l,4]dioxine 2-ketone was prepared according to the general procedure P by treatment with TFA in 03⁄4 % from [4匕fluoro-5-[3_(3-imidazol-1-yl-phenyl)-3-yl-propyl) Aminomethoxy-ethoxy)-biphenyl-4-yl]-amine methyl acid tert-butyl ester (Example 〇 43). Obtained as a yellow solid (96 mg). MS (El) 470 (M+); mp 196-197. Example 58 8-(4-Fluorophenyl&gt;7-(2-hydroxy-ethoxy)-4-(3-imidazol-1-yl-phenylh,3-dihydrophenylhydrazine [b][l , 4] Dioxin-2-yl is prepared according to the general procedure P, by treatment with TFA in CH2%, from {2-(2·first-butoxy-ethoxy)-4f-fluoro -5-[3-(3-imifluoren-1-yl-phenyl)_3_g synthyl-propyl-ylamino]-binyl-4-yl}-amine methyl acid second-butyr Example 044). Obtained as a pale green solid (95 mg). MS (EI) 456 (M+); mp 225 C. Example 8 (4-fluorophenyl)-4-(3-imidazolyl-phenyl)- 7-(2-keto-oxazolidinyl-3-yl H,3-dihydrophenylhydrazone [b][l,4]dioxepin-2-one according to the general procedure P, via TFA in CH2 C Processed in !2, prepared from [4^ gas-based-5-[3-(3-imidazolyl-phenyl keto-propionylaminoketone ketone-3-yl)-3-biphenyl _ 4_基]_Amino acid tert-butyl ester (Example 〇 45). Obtained yellow __ -150- This paper scale applies to China National Standard (CNS) A4 specification (21〇χ 297 公^&quot;) ^ -----Γ 1 I--- II (Please read the notes on the back and then on this page) Order _ 1· _ Line·

1255266 五、發明說明(148 ) 色固體(35毫克)。 MS(EI)481(M+);熔點 23(rc。 實例60 8-(4-氟基-2-甲基-苯基)冰(3』米唑」_基-苯基)·7_甲氧基—I,)·二氡 苯幷[b][l,4]二吖庚因冬酮 i ’ 一 &amp; 根據一般程序P,經由以TFA在CH2%中處理,製自氣 基-5-[3-(3-咪唆-1-基-苯基)各酉同基_丙醯基胺基]_2_甲氧基甲 基-聯苯基-4-基}-胺甲基酸第三_丁酯(實例〇46)。獲得米黃色 固體(101毫克)。 ^ MS (EI) 440 (M+);溶點 225°C。 實例61 8-(4-氟苯基)-7-羥基-4-(3-咪唑小基-苯基)-ΐ,3·二氫苯幷[b][1,4]二 吖庚因-2-酮 根據一般程序P,經由以TFA在CH2C12中處理,製自p第 二-丁氧基-4’-氟基-5-[3-(3-咪唑-1-基-苯基)-3-酮基-丙醯基胺基]_ 聯苯基斗基胺甲基酸第三-丁酯(實例047)。獲得黃色固體 (109毫克)。 MS (EI) 412 (M+);熔點 250°C。 實例62 8-(2-氟苯基)-7-羥基-4-(3-咪唑-1-基-苯基)-1,3-二氫苯幷[b][l,4]二 吖庚因-2-酮 根據一般程序P,經由以TFA在CH2C12中處理,製自{2-第 一 丁氧基·氣基-5-[3-(3-味峻-1-基-冬基)-3-嗣基-丙酿基胺基]_ 聯苯基-4-基}-胺甲基酸第三-丁酯(實例〇48)。獲得黃色固體 -151 - 本紙張尺度適用中國國家標準(CNS)A4規格(21〇 x 297公釐) ^--- (請先閱讀背面之注意事項再本頁) '•線- 經濟部智慧財產局員工消費合作社印製 12552661255266 V. INSTRUCTIONS (148) Colour solid (35 mg). MS (EI) 481 (M+); m.p. 23 ( s. s. s. s s s s s s s s s s s s s s.基—I,···································································· [3-(3-Min-1-yl-phenyl)- each fluorenyl-propionylamino]_2-methoxymethyl-biphenyl-4-yl}-amine methyl acid _ Butyl ester (Example 〇 46). Obtained a beige solid (101 mg). ^ MS (EI) 440 (M+); melting point 225 ° C. Example 61 8-(4-Fluorophenyl)-7-hydroxy-4-(3-imidazolyl-phenyl)-indole, 3·dihydrophenylhydrazine [b][1,4]dioxine- 2-ketone was prepared according to the general procedure P from p- 2,4-butoxy-4'-fluoro-5-[3-(3-imidazol-1-yl-phenyl)- via TFA in CH2C12 3-keto-propionylamino]-biphenyl phenylaminomethyl acid tert-butyl ester (Example 047). Obtained a yellow solid (109 mg). MS (EI) 412 (M+); mp. Example 62 8-(2-Fluorophenyl)-7-hydroxy-4-(3-imidazol-1-yl-phenyl)-1,3-dihydrophenylhydrazone [b][l,4]dioxane In-2-ketone is prepared according to the general procedure P, by treatment with TFA in CH2C12, from {2-first butoxy-oxyl-5-[3-(3-flavor-1-yl-winter) -3-indolyl-propylaminomethyl]-biphenyl-4-yl}-amine methyl acid tert-butyl ester (Example 〇 48). Obtained a yellow solid -151 - This paper scale applies to the Chinese National Standard (CNS) A4 specification (21〇x 297 mm) ^--- (Please read the back note before this page) '•Line - Ministry of Economics Intellectual Property Bureau employee consumption cooperative printing 1255266

五、發明說明(149) (132毫克)。 MS (EI) 412 (M+);熔點 220°C。 -------------裝--- (請先閱讀背面之注意事項再0本頁) 實例63 8-(4-氟苯基)-7-((R&gt;3-羥基-四氫吡咯+基&gt;4-(3_咪唑小基-苯基)· 1,3-二氫苯幷[b][l,4]二吖庚因-2-酮 根據一般程序p,經由以TFA在CH2Cl2中處理,製自(rs)_ K-氟基-5-[3-(3-咪唑-1-基-苯基)各酮基_丙醯基胺基]_2_[(ιι)各(四 氫-喊喃-2-基氧基)-四氫吡咯+基 &gt;聯苯基·4•基卜胺甲基酸第 三-丁酯(實例049)。獲得黃色固體(74毫克)。 MS (ΕΙ) 481 (Μ+);熔點 155-158°C。 實例64 8-(2-氟苯基)-4-(3-咪唑-1-基-苯基)-7-甲氧基―丨}二氫苯幷[b][i,4] 二吖庚因-2-酮 根據一般程序P,經由以TFA在CH2Cl2中處理,製自{2,-氟 基-5-[3-(3-咪唑-1-基-苯基)-3-酮基-丙醯基胺基设甲氧基·聯苯 基斗基}-胺甲基酸第三-丁酯(實例〇5〇)。獲得黃色固體⑽毫 克)。 MS (EI) 426 (M+);熔點 216°C (分解)。 經濟部智慧財產局員工消費合作社印製 實例65 3-[7-(4-氟苯基)-8-羥基-4-酮基-4,5-二氫-3H-苯幷[b][l,4]二吖庚因- 2-基]-苯甲腈 根據一般程序P,經由以TFA在CH2 Cl2中處理,製自{2-第三 -丁氧基-5-〇(3-氰基-苯基)-3.基-丙醯基胺基]_4,_氟-聯苯基 基}-胺甲基酸第三-丁酯(實例〇51)。獲得黃色固體(66毫克)。 -152 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公爱) 1255266 A7 五、發明說明(150) MS (EI) 371 (M+);熔點 &gt;250°C。 實例66 3-[7-(2-氟苯基)-8-羥基-4-酮基4,5-二氫-3H-苯幷[b][1,4p ,丫庚因 2- 基]-苯甲腈 ' 根據一般程序P,經由以TFA在(:¾¾中處理,製自{2_第三 -丁氧基-5-[3-(3-氰基-苯基)-3-酮基-丙酿基胺基]_2,_氟__聯苯基4 基}-胺甲基酸第三-丁酯(實例〇52)。獲得黃色固體(8〇毫克)。 MS (EI) 371 (M+);熔點 &gt;250°C。 實例67 3- [7-(2-氟苯基)-8-曱氧基-4-酮基-4,5-二氫-3H-苯幷[b][l,4]二σ丫庚 因-2-基]-苯甲腈 根據一般程序P,經由以TFA在CH2C12處理,製自{5-[3-(3-氰基-苯基)-3-嗣基-丙醯基胺基]-2,-氟基-2-甲氧基-聯苯基|基} -胺甲基酸第三-丁酯(實例〇53)。獲得淡黃色固體(51毫克)。 MS (EI) 385 (M+);熔點 245-247Ό。 實例68 8-(2-氟苯基)-7-甲氧基-4-[3-(2-甲基-咪唑-1-基)-苯基]-1,3-二氫苯 幷0][1,4]二吖庚因-2-酮 根據一般程序P,經由以TFA在CH2 Cl2中處理,製自(2,_氟 基_2-甲氧基-5-{3-[3-(2-甲基-味哇-1-基)-苯基]-3-§同基-丙酿基胺 基}-聯苯基-4-基)-胺甲基酸第三-丁酯(實例〇54)。獲得黃色 固體(207毫克)。 MS (EI) 440 (M+);熔點 220-222°C。 實例69 -153 本紙張尺度適用中國國家標準(CNS)A4規格(21〇 X 297公釐) -----r---------裝--- c請先閱讀背面之注意事項再本頁) 訂· 線· 經濟部智慧財產局員工消費合作社印製 1255266V. Description of the invention (149) (132 mg). MS (EI) 412 (M+); mp. 220. -------------Installation--- (Please read the notes on the back and then 0) Example 63 8-(4-Fluorophenyl)-7-((R&gt;3- Hydroxy-tetrahydropyrrole+yl&gt;4-(3-imidazolyl-phenyl)·1,3-dihydrophenylhydrazone [b][l,4]dioxepin-2-one according to the general procedure p , by treatment with TFA in CH2Cl2, from (rs)-K-fluoro-5-[3-(3-imidazol-1-yl-phenyl) keto)-propionylamino]_2_[( Ιι) (tetrahydro-pyran-2-yloxy)-tetrahydropyrrole+yl]diphenyl- 4 benzylamine methyl acid tert-butyl ester (Example 049). Obtained a yellow solid ( 74 mg) MS (ΕΙ) 481 (Μ+); mp 155-158 ° C. Example 64 8-(2-fluorophenyl)-4-(3-imidazol-1-yl-phenyl)-7- Methoxy-oxime]dihydrophenylhydrazine [b][i,4] Dioxepin-2-one is prepared from {2,-fluoro-5-- via TFA in CH2Cl2 according to the general procedure P. [3-(3-imidazol-1-yl-phenyl)-3-keto-propionylamino group methoxy-biphenyl phenyl]-amine methyl acid tert-butyl ester (example 〇 5〇). Obtained a yellow solid (10) mg) MS (EI) 426 (M+); melting point 216 ° C (decomposition). Printed by the Ministry of Economic Affairs, Intellectual Property Bureau, Staff Consumer Cooperative Example 65 3-[7-(4-Fluorophenyl)-8-hydroxy-4-keto-4,5-dihydro-3H-benzoquinone [b][l,4]dioxine- 2- Benzyl-benzonitrile was prepared from {2-tri-butoxy-5-indole (3-cyano-phenyl)-3.-propanyl via TFA in CH2Cl2 according to General Procedure Tert-Amino]_4,-fluoro-biphenylyl}-aminomethyl acid tert-butyl ester (Example 〇 51). Obtained a yellow solid (66 mg). -152 - The paper scale applies to the Chinese national standard ( CNS) A4 Specification (210 X 297 public) 1255266 A7 V. Description of the Invention (150) MS (EI) 371 (M+); Melting Point &gt; 250 ° C. Example 66 3-[7-(2-Fluorophenyl) -8-hydroxy-4-keto 4,5-dihydro-3H-benzoquinone [b][1,4p, azepine-2-yl]-benzonitrile' according to the general procedure P, via TFA ( :3⁄43⁄4 in the preparation, from {2_T-butoxy-5-[3-(3-cyano-phenyl)-3- keto-propyl arylamino]_2, _ fluoro__ Phenyl 4-yl}-aminomethyl acid tert-butyl ester (Example 〇 52). Obtained as a yellow solid (8 mg). MS (EI) 371 (M+); melting point &gt; 250 ° C. Example 67 3- [7-(2-Fluorophenyl)-8-indolyl-4-keto-4,5-dihydro-3H-benzoquinone [b][l,4]di-sigma-heptan-2-yl ]-benzene The nitrile was prepared according to the general procedure P from [5-[3-(3-cyano-phenyl)-3-indolyl-propenylamino]-2,-fluoro-2 via TFA in CH2C12. -Methoxy-biphenyl]-yl}-aminomethyl acid tert-butyl ester (Example 〇 53). Obtained as a pale yellow solid (51 mg). MS (EI) 385 (M+); mp 245-247. Example 68 8-(2-Fluorophenyl)-7-methoxy-4-[3-(2-methyl-imidazol-1-yl)-phenyl]-1,3-dihydrophenylhydrazine 0] [1,4] Dioxepin-2-one is prepared according to the general procedure P by treatment with TFA in CH2Cl2 from (2,-fluoro-2-bromo-5-{3-[3- (2-methyl-myroxy-1-yl)-phenyl]-3-§-yl-propyl-arylamino}-biphenyl-4-yl)-amine methyl acid tert-butyl ester ( Example 〇 54). Obtained a yellow solid (207 mg). MS (EI) 440 (M+); mp. 220-222. Example 69 -153 This paper scale applies to China National Standard (CNS) A4 specification (21〇X 297 mm) -----r---------Install--- c Please read the back of the note first Matters again page) Order · Line · Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 1255266

五、發明說明(151) 5-[7-(2-氟苯基)各甲氧基I酮基_4,5_二氫·3Η•苯并[b][i,4]二吖庚 因-2-基]-p塞吩-2-甲腈 根據一般程序P,經由以TFA在⑶2%中處理,製自G屮_ (5-氰基-噻吩-2-基)-3-酮基-丙醯基胺基]_2L氟基j甲氧基_聯苯 基斗基}-胺甲基酸第三-丁酯(實例〇55)。獲得黃色固體(1〇3 毫克)。 MS (EI) 391 (M+);熔點 &gt;25〇°C。 實例70 8-(2_氟苯基&gt;7-甲氧基斗(3-[1,2,4]三唑-4-基-苯基沁头二氫苯并 [b][l,4]二吖庚因-2-酮 根據一般程序P,經由以TFA在CH^Cl2中處理,製自{2L氟 基-2-甲氧基-5-[3-酮基各(3-[1,2,4]三唑_4_基-苯基)·丙醯基胺基]_ 聯苯基-4·基卜胺甲基酸第三-丁酯(實例〇56)。獲得黃色固體 (22毫克)。 &quot; MS (EI) 427 (M+);熔點 188°C (分解)。 實例71 4-[7-(2-氟苯基)-8-甲氧基-4-酮基-4,5-二氫-3H-苯并[b][i,4]二p丫庚 因-2-基]π比咬-2-曱猜 根據一般程序P,經由以TFA在¢:¾¾中處理,製自{5-(&gt; (2-氰基4啶-4-基)-3·酮基-丙醯基胺基]-2f-氟基么甲氧基_聯苯 基-4-基}-胺甲基酸第三-丁酯(實例〇57)。獲得黃色固體⑽毫 克)。 MS (EI) 386 (M+);熔點 240-242°C。 實例72 -154- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ———-----裝i— (請先閱讀背面之注意事項再本頁) 言 :線. 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明(152) 經濟部智慧財產局員工消費合作社印製 8-(4-氟苯基&gt;7-羥基_4-[3-(2-甲基-咪唑小基)-苯基H,3-二氫苯幷 [b][l,4]二吖庚因-2-酉同 根據一般程序P,經由以TFA在Cj^d2中處理,製自仏第 三-丁氧基I氟基-5-{3-[3-(2-甲基-咪唑小基)-苯基]_3-酮基丙醯 基胺基}-聯苯基-4-基)-胺甲基酸第三-丁酯(實例〇58)。獲得 黃色固體(49亳克)。 &amp; MS (ISP) 427 [(Μ+Η)+ ];熔點 260°C。 實例73 4-氟基-3-[7-(2-氟笨基)-8-甲氧基-4-酮基_4,5_二氫-3H-苯并[b][l 4] 二吖庚因-2-基]-苯曱腈 根據一般程序P,經由以丁FA在CH2%中處理,製自 (5-氣基-2-氟冬基)-3-酮基-丙醯基胺基]_2’_氟基_2_甲氧基_聯苯 基-4-基卜胺甲基酸第三-丁酯(實例〇59)。獲得黃色固體(52毫 克)。 MS (ISP) 404 [(M+H)+ ];熔點 &gt;25〇Ό。 實例74 4-[7-(4-氟苯基)各輕基-4-酮基-4,5-二氫-3Η-苯幷[b][i,4]二ρ丫庚因· 2-基]比淀-2-甲月青 根據一般程序P,經由以TFA在CH2 (¾中處理,製自{2_第 三-丁氧基-5-[3-(2-氰基-p比啶-4-基)-3-酮基-丙醯基胺基]-4,_氣_聯 苯基-4-基}-胺甲基酸第三-丁酯(實例〇60)。獲得黃色固體(24 毫克)。 MS(EI) 372 (M+);熔點 164°C。 實例75 -155- (請先閱讀背面之注意事項本頁) 裝 訂-_ -線· 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266V. INSTRUCTIONS INSTRUCTION (151) 5-[7-(2-Fluorophenyl)-methoxyl-keto- 4,5-dihydro·3Η•benzo[b][i,4]dioxine 2-yl]-p-cephen-2-ylcarbonitrile was prepared from G屮_(5-cyano-thiophen-2-yl)-3-one by treatment with TFA in (3) 2% according to the general procedure P -propenylamino] 2 L fluorojjmethoxy-biphenyl phenyl}-aminomethyl acid tert-butyl ester (Example 〇 55). Obtained a yellow solid (1 〇 3 mg). MS (EI) 391 (M+); mp. &lt; Example 70 8-(2-Fluorophenyl)-7-methoxy ketone (3-[1,2,4]triazol-4-yl-phenylindene dihydrobenzo[b][l,4 Dioxepin-2-one is prepared according to the general procedure P by treatment with TFA in CH^Cl2 from {2L-fluoro-2-methoxy-5-[3-keto-(3-[1 , 2,4]triazole_4_yl-phenyl)·propanylamino]_biphenyl-4·ylbuminic acid tri-butyl ester (Example 〇 56). Obtained a yellow solid ( &lt;2&gt; MS (EI) 427 (M+); mp 188 ° C (decomposition). Example 71 4-[7-(2-fluorophenyl)-8-methoxy-4-keto-4 ,5-dihydro-3H-benzo[b][i,4]dip丫heptin-2-yl]π ratio bite-2-曱 guess according to the general procedure P, by treatment with TFA in ¢:3⁄43⁄4 , from {5-(&gt;(2-cyano-4-pyridin-4-yl)-3.keto-propionylamino]-2f-fluoromethylmethoxy-biphenyl-4-yl }-Aminomethyl 3-butyrate (Example 〇 57). Obtained a yellow solid (10 mg). MS (EI) 386 (M+); mp. 240-242 ° C. Example 72 - 154 - National Standard (CNS) A4 Specification (210 X 297 mm) ———-----Install i— (Please read the note on the back and then on this page) Word: Line. Property Bureau employee consumption cooperative printed 1255266 A7 B7 V. Invention description (152) Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed 8-(4-fluorophenyl)7-hydroxy_4-[3-(2-A Base-imidazole small group)-phenyl H,3-dihydrophenylhydrazine [b][l,4]dioxeine-2-indole according to the general procedure P, by treatment with TFA in Cj^d2 Self-仏3 -butoxylfluoro-5-{3-[3-(2-methyl-imidazolyl)-phenyl]-3-ketopropenylamino}-biphenyl-4 -Based --Aminomethyl-tert-butyl ester (Example 〇 58). Obtained a yellow solid (49 g). & MS (ISP) 427 [(Μ+Η)+]; melting point 260 ° C. 73 4-fluoro-3-[7-(2-fluorophenyl)-8-methoxy-4-keto-4,5-dihydro-3H-benzo[b][l 4] diterpene Glycon-2-yl]-benzonitrile was prepared according to the general procedure P by treatment with butyl FA in CH2% from (5-methyl-2-fluoroundyl)-3-keto-propionylamine Base] 2'-Fluoro- 2 -methoxy-biphenyl-4-yl-b-methylamino acid, tert-butyl ester (Example 〇 59). Obtained a yellow solid (52 mg). MS (ISP) 404 [(M+H)+]; Melting Point &gt; 25〇Ό. Example 74 4-[7-(4-Fluorophenyl)fosyl-4-keto-4,5-dihydro-3Η-benzoquinone [b][i,4]di-p-heptane·2- ]] 淀-2-甲月青 according to the general procedure P, via TFA in CH2 (3⁄4, from {2_T-butoxy-5-[3-(2-cyano-p ratio) Pyridin-4-yl)-3-keto-propionylamino]-4,_qi_biphenyl-4-yl}-amine methyl acid tert-butyl ester (Example 〇 60). Obtained yellow Solid (24 mg) MS (EI) 372 (M+); mp 164 ° C. Example 75 - 155 - (Please read the back note on this page) Binding - _ - Line · This paper size applies to Chinese national standards ( CNS) A4 size (210 X 297 mm) 1255266

五、發明說明(153) 經濟部智慧財產局員工消費合作社印製 8-(2-氟苯基)-7-羥基-4-(3-[l,2,3]三唑-1-基-苯基&gt;u-二氫苯并问 [M]二吖庚因-2-酮 根據一般程序P,經由以TFA在0¾¾中處理,製自{2_第 三-丁氧基-2,-氟基-5-[3-酮基各(3-[1,2,3]三唑-1-基-苯基)·丙酿基 胺基]-聯苯基-4-基}-胺甲基酸第三-丁酯(實例〇61)。黃色固體⑹毫克)。 &quot;MS (ISP) 414 [(M+H)+ ];熔點〉250°C。 實例76 3-[8-(1,4-二氧-8-氮·-螺[4.5]癸各基)-7-(2-氟苯基)-4-酮基-4,5-二氯 _ 3H-苯幷[b][l,4]二吖庚因-2-基]-苯甲腈 根據一般程序P,經由以TFA在CH2 Cl2中處理,製自[5-[3· (3-氰基-苯基)各酮基-丙醯基胺基]_2-(l,4-二氧冬氮-螺[4.5]癸-8-基)-2f-氟-聯苯基-4-基]-胺甲基酸第三-丁酯(實例062)。獲得 黃色固體(132毫克)。MS (ISP) 497 [(M+H)+ ];熔點 253°C。 實例77 7-(1,4-二氧-8·氮-螺[4.5]癸各基)-8-(2-氟苯基)-4-(3-咪唑-1-基苯基)_ 1,3-二氫苯幷[b][l,4]二吖庚因-2-酮 根據一般程序P,經由以TFA在CH2 Cl2中處理,製自{2· (1,4-二氧-8-氮-螺[4.5]癸各基)-2,-氟基-5-[3-(3-咪唑-1-基-苯基)冬 酮基-丙醯基胺基]-聯苯基冰基}_胺甲基酸第三-丁酯(實例063) 。獲得黃色固體(133毫克)。 MS (ISP) 538 [(M+H).];溶點 225°C。 實例78 -156- 本紙張尺度適用中國國豕標準(CNS)A4規格(21〇 X 297公爱) 請先閱讀背面之注意事項再本頁) 裝 訂* · 線·V. Description of the invention (153) 8-(2-fluorophenyl)-7-hydroxy-4-(3-[l,2,3]triazol-1-yl-printed by the Consumers' Cooperative of the Intellectual Property Office of the Ministry of Economic Affairs Phenyl&gt;u-dihydrobenzo[M]dioxepin-2-one was prepared from {2_tris-butoxy-2, by treatment with TFA in 03⁄43 according to the general procedure P. Fluoro-5-[3-keto-(3-[1,2,3]triazol-1-yl-phenyl)-propylaminoamino]-biphenyl-4-yl}-amine A Third acid butyl acrylate (Example 〇 61). Yellow solid (6) mg). &quot;MS (ISP) 414 [(M+H)+]; melting point > 250 °C. Example 76 3-[8-(1,4-Dioxo-8-nitro--spiro[4.5]fluorenyl)-7-(2-fluorophenyl)-4-keto-4,5-dichloro _ 3H-benzoquinone [b][l,4]dioxan-2-yl]-benzonitrile was prepared from [5-[3· (3) by treatment with TFA in CH2Cl2 according to the general procedure P. -cyano-phenyl) keto-propionylamino]_2-(l,4-dioxil-spiro[4.5]dec-8-yl)-2f-fluoro-biphenyl-4- Alkyl--aminomethyl acid tert-butyl ester (Example 062). Obtained a yellow solid (132 mg). MS (ISP) 497 [(M+H)+]; mp. Example 77 7-(1,4-Dioxo-8·nitro-spiro[4.5]fluorenyl)-8-(2-fluorophenyl)-4-(3-imidazol-1-ylphenyl)_ 1 , 3-dihydrophenylhydrazine [b][l,4]dioxine-2-one is prepared according to the general procedure P by treatment with TFA in CH2Cl2 from {2·(1,4-dioxo- 8-Nitro-spiro[4.5]fluorenyl)-2,-fluoro-5-[3-(3-imidazol-1-yl-phenyl)oxanyl-propionylamino]-biphenyl Ice-based amino acid-tert-butyl ester (Example 063). Obtained as a yellow solid (133 mg). MS (ISP) 538 [(M+H).]; melting point 225 °C. Example 78 -156- This paper size applies to China National Standard (CNS) A4 specification (21〇 X 297 public) Please read the note on the back before this page) Binding* · Line·

1255266 五、發明說明(1&amp;4 ) 8_(2-氟苯基)_4-(3_咪唑+基_苯基酮基_六氫吡啶小基p,3_ 二氫苯幷[b][l,4]二口丫庚因-2-酉同 絰由在IN HC1 (1耄升)與丙酮(1毫升)中,於23。〇下攪拌44 小時,製自7-(1,4-二氧-8-氮-螺[4.5]癸j基)-8-(2-氟苯基)-4-(3-咪 坐1基苯基)-1,3-一氫苯幷[b][i,4]二吖庚因酮(實例77)(54毫 克,〇_1毫莫耳)。獲得黃色固體(39毫克)。 MS (EI) 493 (M+);溶點 230。(3。 實例79 8-(2-氟苯基)-7-羥基-4-l&gt;(2-甲基-咪唑-丨-基}-苯基二氫苯幷 [b][l,4]二吖庚因-2-酮 根據一般程序P,經由以丁从在⑶2%中處理,製自(2-第 二-丁氧基-2’-氟基-5-{3-[3-(2-甲基-咪唑+基)_苯基]各酮基-丙醯 基胺基}-聯苯基-4-基 &gt;胺甲基酸第三_丁酯(實例〇64)。獲得 黃色固體(111毫克)。 MS (ISN) 425 [(M-Η)·];熔點 &gt;250°C。 實例80 4-[7-(2-氟苯基)-8-羥基-4-酮基-4,5-二氫-3H-苯幷师叫二,丫庚因_ 2-基]比淀-2-甲猜 根據一般程序P,經由以TFA在0¾¾中處理,製自{2·第 二-丁氧基-5-[3-(2-氰基-吡啶-4·基)-3-酮基-丙醯基胺基]-2,·氟-聯 苯基-4-基]_胺曱基酸第三-丁酯(實例〇65)。獲得黃色固體(47 毫克)。 MS (ISN) 371 [(M-Η)·];熔點 &gt;250°C。 實例81 -157- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -----J---------裝—— (請先閱讀背面之注意事項本頁) · 經濟部智慧財產局員工消費合作社印製 1255266 A71255266 V. INSTRUCTIONS (1&amp;4) 8_(2-Fluorophenyl)_4-(3-imidazole+yl-phenylketo-hexahydropyridine small group p,3_dihydrophenylhydrazine[b][l, 4] Two 丫 因 酉 酉 酉 酉 酉 酉 酉 酉 绖 IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN IN -8-nitro-spiro[4.5]癸j-yl)-8-(2-fluorophenyl)-4-(3-miso-1 phenyl)-1,3-monohydrophenylhydrazine [b][i , 4] Dioxenone (Example 77) (54 mg, 〇 1 mmol). Obsed a yellow solid (39 mg). MS (EI) 493 (M+); melting point 230. (3. 8-(2-Fluorophenyl)-7-hydroxy-4-l&gt;(2-methyl-imidazo-indenyl)-phenyldihydrophenylhydrazone [b][l,4]dioxine- The 2-ketone was prepared according to the general procedure P from (2) 2% by weighting from (2-second-butoxy-2'-fluoro-5-{3-[3-(2-methyl-) Imidazole + yl) phenyl] keto-propionylamino}-biphenyl-4-yl&gt; Amino acid tert-butyl ester (Example 〇 64). Obtained a yellow solid (111 mg) MS (ISN) 425 [(M-Η)·]; melting point &gt; 250 ° C. Example 80 4-[7-(2-fluorophenyl)-8-hydroxy-4-keto-4,5- Dihydro-3H-benzoquinone , 丫 因 _ 2- base 比 -2- -2- 猜 根据 according to the general procedure P, by TFA in 03⁄43⁄4, from {2 · second-butoxy-5-[3-(2-cyanide Base-pyridin-4-yl)-3-keto-propionylamino]-2,-fluoro-biphenyl-4-yl]-aminocarbamic acid tert-butyl ester (Example 〇 65). Obtained as a yellow solid (47 mg). MS (ISN) 371 [(M-Η)·]; melting point &gt; 250 ° C. Example 81 - 157 - This paper scale applies to the Chinese National Standard (CNS) A4 specification (210 X 297 ----)J---------Installation - (Please read the note on the back of this page first) · Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed 1255266 A7

五、發明說明(155) 8-(2-氟苯基)-7-羥基冬[3-(2-甲硫基-咪吐小基)_苯基]」,3_二氫苯 幷[b][l,4]二吖庚因酮 請先閱讀背面之注意事項本頁) 根據一般程序P,經由以TFA在CH2^中處理,製自(2 一第 三-丁氧基-2,-氟基-5-{3-[3-(2-甲硫基』米唑小基)_苯基]_3•酮基_丙 醯基胺基卜聯苯基-4-基)-胺甲基酸第三-丁酯(實例〇66)。獲 得淡黃色固體(148毫克)。 MS (ISN) 457 [(M-H)-];熔點 &gt;250°C。 實例82 3- [7-(2,5·一氟-苯基)冬甲氧基_4-酮基-4,5-二氫-3H-苯幷[b][l,4]二 吖庚因-2-基]-苯甲腈 根據一般程序P,經由以TFA在CH2Cl2中處理,製自{5_[3_ (3-氰基-苯基)各酮基-丙醯基胺基]_2,,5,_二氟-2-甲氧基-聯苯基- 4- 基}-胺甲基酸第三-丁酯(實例〇67)。獲得黃色固體(49毫克)。 MS(EI) 403 (M+);熔點 251Ό。 實例83 8-(2,5-二氟-苯基)-7-甲氧基-4-(3-[1,2,3]三唑-1-基-苯基)-l,3-二氫 苯并[b][l,4]二吖庚因同 根據一般程序P,經由以TFA在CH2 Cl2中處理,製自{2,,5匕 經濟部智慧財產局員工消費合作社印製 二氟-2-甲氧基-5-[3-酮基各(3-[1,2,3]三唑-1-基-苯基)-丙醯基胺基] 聯苯基-4-基卜胺甲基酸第三-丁酯(實例〇68)。獲得黃色固體 (78毫克)。 MS (EI) 445 (M+);熔點 241°C。 實例84 2-[7-(2-氟苯基)各羥基-4·酮基-4,5-二氫-1H-苯并[b][l,4]二吖庚因· ____ -158- 本紙張尺度適用中國國家標準(CNS)A4規格⑽χ 297公餐) 1255266V. INSTRUCTIONS (155) 8-(2-Fluorophenyl)-7-hydroxy-t-[3-(2-methylthio-mipropionyl)-phenyl]",3-dihydrophenylhydrazine [b ][l,4] Dioxephenone Please read the following notes on the back of this page. According to the general procedure P, by treatment with TFA in CH2^, (2 - 3 -butoxy-2,- Fluoro-5-{3-[3-(2-methylthio)mazole small group)-phenyl]_3•keto-propionylaminodiphenyl-4-yl)-aminomethyl Acidic third-butyl ester (Example 〇 66). A pale yellow solid (148 mg) was obtained. MS (ISN) 457 [(M-H)-]; mp. &lt;250. Example 82 3-[7-(2,5·F-Phenyl-phenyl)-t-methoxy-4-butanyl-4,5-dihydro-3H-benzoquinone[b][l,4]dioxine In-2-yl]-benzonitrile is prepared from {5_[3_(3-cyano-phenyl) keto-propionylamino]_2 by treatment with TFA in CH2Cl2 according to the general procedure P. , 5,-Difluoro-2-methoxy-biphenyl-4-yl}-aminomethyl acid tert-butyl ester (Example 〇 67). Obtained as a yellow solid (49 mg). MS (EI) 403 (M+); mp. Example 83 8-(2,5-Difluoro-phenyl)-7-methoxy-4-(3-[1,2,3]triazol-1-yl-phenyl)-l,3-di Hydrogen benzo[b][l,4] dioxin is produced according to the general procedure P, by TFA in CH2 Cl2, from {2,,5匕 Ministry of Economic Affairs, Intellectual Property Bureau, Staff Consumption Cooperative, printing of difluoride 2-methoxy-5-[3-keto(3-[1,2,3]triazol-1-yl-phenyl)-propenylamino]biphenyl-4-yl Aminomethyl 3-butyrate (Example 〇 68). Obtained a yellow solid (78 mg). MS (EI) 445 (M+); mp. Example 84 2-[7-(2-Fluorophenyl)hydroxy-4-ketone-4,5-dihydro-1H-benzo[b][l,4]dioxine·____-158- This paper scale applies to China National Standard (CNS) A4 specifications (10) 297 297 public meals) 1255266

2-基]-噻吩-3-甲腈 根據一般程序P,經由以丁从在⑶2%中處理,製自(2·第 三-丁氧基-5-[3-(3-氰基塞吩:基&gt;3-酮基-丙醯基胺基]·2,·氟-聯 苯基斗基卜胺甲基酸第三叮酯(實例〇69)。獲得橘色固體(= 毫克)。 MS (ISN) 376 [(Μ-Η)_ ];熔點 242°C。 實例85 5-[7-(2-氟苯基)冬羥基酮基4,5_二氫苯幷[b][1,4]二吖庚因· 2- 基]-噻吩-2-甲腈 根據一般程序P,經由以TFA在CH2Cl2中處理,製自{2_第 二- 丁氧基-5-[3-(5-氰基-遠吩-2-基)-3姻基-丙醯基胺基]_2,_氟_聯 苯基冰基}-胺甲基酸第三-丁酯(實例〇7〇)。獲得黃色固體 (126 毫克)。 &amp; MS(EI)377 (M+);熔點 實例86 8-(4_氟苯基&gt;7-羥基-4-(3-[1,2,3]三唑小基-苯基从^二氫苯幷[b] [1,4]二吖庚因-2-酮 根據一般程序P,經由以TFA在CH2C12中處理,製自{2•第 三- 丁氧基-4’-氟基-5-[3-酮基-3-(3-[1,2,3]三唑+基·苯基)_丙醯基 胺基]-聯苯基-4-基}-胺甲基酸第三-丁酯(實例〇71)。獲得黃 色固體(78毫克)。 MS(ISP)414[(M+H)+];熔點 &gt;250°C。 實例87 3- [7-(2-氟苯基)-8-(2-甲氧基-乙氧基)-4-酮基_4,5-二氫-3H-苯幷[b] -159- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -------------裝— C請先閱讀背面之注意事項再本頁) J^T· 線· 經濟部智慧財產局員工消費合作社印製2-yl]-thiophene-3-carbonitrile was prepared according to the general procedure P from (3) 2%, from (2·3 -butoxy-5-[3-(3-cyano-septene) :&gt; 3-keto-propionylamino group]·2,·Fluoro-biphenylindolylmethylamine tert-ester (Example 〇69). An orange solid (=mg) was obtained. MS (ISN) 376 [(Μ-Η)_]; m.p. 242 ° C. Example 85 5-[7-(2-fluorophenyl)-hydroxyl ketone 4,5-dihydrophenylhydrazine [b][1 , 4] Dioxepin-2-yl]-thiophene-2-carbonitrile was prepared from {2_second-butoxy-5-[3-( according to the general procedure P, by treatment with TFA in CH2Cl2. 5-cyano-farophen-2-yl)-3 marriage-propionylamino]_2,_fluoro-biphenylyl yl}-amine methyl acid tert-butyl ester (example 〇7〇) Obtained a yellow solid (126 mg) &amp; MS (EI) 377 (M+); mp. 86. 8- (4-fluorophenyl) 7-hydroxy-4-(3-[1,2,3] Oxazolyl-phenyl from [dihydrophenylhydrazine [b] [1,4] dioxepin-2-one according to the general procedure P, by treatment with TFA in CH2C12, from {2•third-butyl Oxy-4'-fluoro-5-[3-keto-3-(3-[1,2,3]triazole+ylphenyl)-propionylamino]-biphenyl-4 -yl}-amine Third-butyl acrylate (Example 〇 71). Obtained as a yellow solid (78 mg). MS (ESI) 414 [(M+H)+]; melting point &gt; 250 ° C. Example 87 3- [7-( 2-fluorophenyl)-8-(2-methoxy-ethoxy)-4-keto_4,5-dihydro-3H-benzoquinone [b] -159- This paper scale applies to Chinese national standards (CNS) A4 specification (210 X 297 mm) ------------- Installation - C Please read the notes on the back first page) J^T· Line · Ministry of Economic Affairs Intellectual Property Bureau Printed by employee consumption cooperatives

五、 !255266 發明說明(157 [1,4]二吖庚因-2-基]-苯甲腈 根據一般程序P,經由以TFA在CH2Cl2中處理,製自[5_[3_ (3-氰基-苯基)-3-酮基-丙醯基胺基]_2L氟基4(2_甲氧基_乙氧基 )-聯苯基斗基]-胺甲基酸第三·丁酯(實例〇72)。獲得淡黃色 固體(141毫克)。 MS(EI)429 (M+);溶點 2ii-213°C。 實例88 3-[7-(2-氟苯基)-8-羥曱基冰酮基-4,5-二氫-3H-苯并[b][l,4]二吖庚 因-2-基]-苯甲腈 根據一般程序P,經由以TFA在CH2C12中處理,製自(RS)-[5-[3-(3-氰基-苯基)-3-酮基-丙醯基胺基]_2l氟基四氫_哌喃 基氧基甲基)-聯苯基-4-基]-胺甲基酸第三-丁酯(實例〇73)。 獲得淡黃色固體(69毫克)。 MS (EI) 385 (M+);熔點 9〇-9ΐΧ:。 實例89 8-(2-氟苯基)-7-羥基-4-[3-(3-甲基-異哼唑-5-基)-苯基]-丨}二氫苯 并[b][l,4]二吖庚因-2-酮 根據一般程序P,經由以TFA在CH2 Cl2中處理,製自(2,-氟 基-2_(4·甲氧基4氧基)-5-{3-[3-(3-甲基-異呤唑-5-基)-苯基]各酉同 基-丙酷基胺基}-聯苯基·4_基)_胺甲基酸第三-丁酯(實例〇74) 。獲得黃色固體(278毫克)。 MS(ISP)428 (M+H)+ ;熔點 237°C。 實例90 3-[7-(2,5-二氟-苯基)-8-¾ 基-4-酮基-4,5-二氫-3H-笨幷[b][l,4]二口丫 -160- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ----:---------裝—— (請先閱讀背面之注意事項本頁) · -線· 經濟部智慧財產局員工消費合作社印製 1255266 A7V. 255266 DESCRIPTION OF THE INVENTION (157 [1,4] Dioxephin-2-yl]-benzonitrile is prepared from [5_[3_(3-cyano) according to the general procedure P by treatment with TFA in CH2Cl2 -Phenyl)-3-keto-propionylamino]_2L fluoro 4(2-methoxy-ethoxy)-biphenyl phenyl]-aminomethyl acid tert-butyl ester (example) 〇 72). Obtained as a pale yellow solid (141 mg). MS (EI) 429 (M+); melting point 2 ii - 213 ° C. Example 88 3-[7-(2-fluorophenyl)-8-hydroxyindole Ice keto-4,5-dihydro-3H-benzo[b][l,4]dioxan-2-yl]-benzonitrile was prepared according to the general procedure P by TFA in CH2C12 From (RS)-[5-[3-(3-cyano-phenyl)-3-keto-propenylamino]_2l fluorotetrahydro-hydropyridyloxymethyl)-biphenyl -4-yl]-aminomethyl acid tert-butyl ester (Example 〇73). Obtained as a pale yellow solid (69 mg). MS (EI) 385 (M+); m.p. 9-9. Example 89 8-(2-Fluorophenyl)-7-hydroxy-4-[3-(3-methyl-isoxazol-5-yl)-phenyl]-indole] dihydrobenzo[b][ 1,4] Dioxepin-2-one is prepared according to the general procedure P by treatment with TFA in CH2Cl2 from (2,-fluoro-2-(4.methoxymethoxy)-5-{ 3-[3-(3-Methyl-isoxazol-5-yl)-phenyl]-indenyl-propanylamino}-biphenyl-4-yl)-amino acid - Butyl ester (Example 〇 74). Obtained as a yellow solid (278 mg). MS (ISP) 428 (M+H)?; mp. Example 90 3-[7-(2,5-Difluoro-phenyl)-8-3⁄4yl-4-keto-4,5-dihydro-3H-alum[b][l,4]丫-160- This paper size applies to China National Standard (CNS) A4 specification (210 X 297 mm) ----:---------Installation - (Please read the back note on this page first) ) - Line · Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 A7

五、發明說明(158) 庚因-2-基]-苯甲猜 根據一般程序P,經由以TFA在CH2 %中處理,製自{2-第 二*丁氧基-5-[3-(3-氰基-苯基)-3-酮基-丙酿基胺基]_2,,5f-二氣耳# 苯基-4-基卜胺甲基酸第三-丁酯(實例075)。獲得黃色固體(56 毫克)。 MS (ISP) 390 (M+H)+ ;溶點 &gt;250°C。 實例91 8-(4-氟苯基乙块基)-7-¾基-4-(3-咪。坐-1-基-苯基)-1,3_二氫苯幷 [b][l,4]二吖庚因-2-酮 根據一般程序Ρ Λ經由以TFA在CH2 Cl2中處理,製自斤第 三·丁氧基-4-(4-氟苯基乙炔基)-2-[3_(3-咪唑-1-基-苯基)冬_基一 丙醯基胺基]-苯基}-胺曱基酸第三-丁酯(實例076)。獲得黃 色固體(55毫克)。 MS(EI)436 (M+);熔點 247°C。 實例92 8-(4-氟苯基乙炔基)-7-羥基-4-(3-[1,2,3]三唑小基-苯基)·ι,3-二氫 苯幷[b][l,4]二吖庚因-2-酮 根據一般程序P,經由以TFA在CH2 Cl2中處理,製自{5-第 二-丁乳基-4-(4-鼠冬基乙块基)-2-[3-嗣基-3-(3-[1,2,3]三嗤小基-苯 基)-丙醯基胺基]-苯基}_胺甲基酸第三_丁酯(實例〇77)。獲得 黃色固體(56毫克)。 MS(EI) 437 (M+);熔點 243°C。 下述實例係舉例説明4-芳基各碘基-1,3-二氫苯幷[b][l,4]二吖 庚因-2-酮亦可充作Sonogashira偶合之起始物質,如合成圖示 -161 - 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公髮) -------------裝--- 請先閱讀背面之注意事項異本頁) 0 I、線. 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明(159) G中所示。 實例93 3-(4-酮基-7-苯基乙块基-8-硫代嗎福啉斗基_4,5_二氫·3h_苯并 [b][l,4]二吖庚因-2-基)-苯甲腈 根據一般程序K,製自3-(7-碘基斗酮基各硫代嗎福啉斗基_ 4,5-一氫-3H-苯幷[b][l,4]二吖庚因j基 &gt;苯甲腈(實例1)(437亳克 ,0.895耄莫耳)與苯乙块(〇_15毫升,134毫莫耳)。獲得咖囉 色固體(334毫克)。 MS (EI) 391 (M+) ·’ 熔點 234-235°C (分解)。 實例94 (RS)-3-[4-酮基各(1-酮基-硫代嗎福啉冰基)尽苯基乙炔基_4,5-二 氫-3H-苯幷[b][l,4]二吖庚因-2-基]-苯甲腈 將3-(4-酮基-7-苯基乙炔基各硫代嗎福啉_4_基-4,5-二氫-3H-苯 幷1&gt;][1,4]二吖庚因-2-基)-苯甲腈(實例27χ5〇毫克,〇18〇毫莫 耳)與Davis試劑(116毫克,〇·432毫莫耳)在DCM (4.5毫升)中 之混合物,於23°C下攪拌1小時。濾出產物,並以〇〇^洗滌 。獲得淡黃色固體(16毫克)。 MS (ISP) 479 [(M+H)+ ]與 501 [(M+Na)+];熔點〉250°C (分解)。 4-(3-碘苯基)-8-苯基乙炔基·1,3-二氫苯幷[b][l,4]二吖庚因-2-酮,於二級胺存在下之鈀-催化羰基化作用,會直接導致相 應醯胺,如合成圖示I中所示。 實例95 3-[8-(2-甲氧基-乙氧基)-4·酮基-7-苯基乙決基-4,5-二氫-3H-苯幷 [b][l,4]二吖庚因-2-基]-苯甲醯胺 -162- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) &quot; --------------裝--- (請先閱讀背面之注意事項再^|?本頁) I - I-線· 經濟部智慧財產局員工消費合作社印製 1255266 A7 B7 五、發明說明(160) 根據*般程序Q ’製自4-(3-破冬基)-7-(2-甲乳基-乙乳基)-8_ 苯基乙炔基-1,3-二氫苯幷[b][l,4]二吖庚因-2-酮(實例25)(268毫 克,0.5毫莫耳)與六甲基二矽氮烷(0.52毫升,2.5毫莫耳)。 獲得黃色固體(102毫克)。 MS (EI) 453 (M+);熔點 227-230°C (分解)。 實例I 下列組成之片劑,係以習用方式製成: 毫克/片劑 活性成份 100 粉末狀乳糖 95 白玉米澱粉 35 聚乙烯基四氫吡咯酮 8 Na羧甲基澱粉 10 硬脂酸鎂 2 片劑重量250 實例II 下列組成之片劑,係以習用方式製成·· 毫克/片劑 (請先閱讀背面之注意事項本頁) 裝 訂- 1·丨線· 經濟部智慧財產局員工消費合作社印製 活性成份 200 粉末狀乳糖 100 白玉米澱粉 64 聚乙烯基四氫吡咯酮 12 Na叛甲基澱粉 20 硬脂酸鎂‘ 4 片劑重量400 Γ -163- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1255266 A7 B7 五、發明說明(161 膠囊 50 60 34 5V. INSTRUCTIONS (158) Gyne-2-yl]-benzidine is prepared according to the general procedure P, by treatment with TFA in CH2%, from {2-second*butoxy-5-[3-( 3-cyano-phenyl)-3-keto-propylaminomethyl]_2,,5f-dier ############################### Obtained a yellow solid (56 mg). MS (ISP) 390 (M+H)+; melting point &gt; 250 °C. Example 91 8-(4-Fluorophenylethyl)-7-3⁄4yl-4-(3-miso.spin-1-yl-phenyl)-1,3-dihydrophenylhydrazine [b][l , 4] Dioxepin-2-one according to the general procedure Λ Λ by treatment with TFA in CH 2 Cl 2 , from the third · butoxy-4-(4-fluorophenylethynyl)-2-[ 3-(3-Imidazol-1-yl-phenyl)-t-yl-propenylamino]-phenyl}-amine decyl acid tert-butyl ester (Example 076). Obtained a yellow solid (55 mg). MS (EI) 436 (M+); mp. Example 92 8-(4-Fluorophenylethynyl)-7-hydroxy-4-(3-[1,2,3]triazole small-phenyl)·ι,3-dihydrophenylhydrazine [b] [l,4] Dioxepin-2-one was prepared according to the general procedure P, by treatment with TFA in CH2Cl2 from {5-Second-butyl-butyr-4- )-2-[3-mercapto-3-(3-[1,2,3]triammonium-phenyl)-propionylamino]-phenyl}-amine methyl acid third-butyl Ester (Example 〇 77). Obtained a yellow solid (56 mg). MS (EI) 437 (M+); mp. The following examples illustrate that 4-aryl iodo-1,3-dihydrophenylhydrazone [b][l,4]dioxepin-2-one can also be used as a starting material for Sonogashira coupling, such as Synthetic illustration -161 - This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mil) ------------- Pack--- Please read the notes on the back first This page) 0 I. Line. Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1255266 A7 B7 V. Invention Description (159) G is shown. Example 93 3-(4-keto-7-phenylethylidene-8-thiofifoxaline bucket base_4,5-dihydro·3h_benzo[b][l,4]dioxin In-2-yl)-benzonitrile is prepared according to the general procedure K from 3-(7-iodopiperidinyl thio-ofofolinine _ 4,5-monohydro-3H-benzoquinone [b] [l,4] Dioxane j base &gt; benzonitrile (Example 1) (437 g, 0.895 mol) and phenyl bromide (〇 15 ml, 134 mmol). Solid (334 mg) MS (EI) 391 (M+) · mp 234-235 ° C (decomposition). Example 94 (RS)-3-[4-keto-(1-keto-thio- phen Phenyl ethyl) phenyl ethynyl _4,5-dihydro-3H-benzoquinone [b][l,4]dioxepin-2-yl]-benzonitrile 3-(4-keto -7-phenylethynyl thiomorpholine _4_yl-4,5-dihydro-3H-benzoquinone 1&gt;][1,4]dioxan-2-yl)-benzonitrile (Example 27 χ 5 〇 mg, 〇 18 〇 mmol) and a mixture of Davis reagent (116 mg, 432· 432 mmol) in DCM (4.5 mL), and stirred for 1 hour at 23 ° C. Wash with 〇〇^ to give a pale yellow solid (16 mg). MS (ESI) 479 [(M+H)+] and 501 [(M+Na)+]; °C (decomposition) 4-(3-iodophenyl)-8-phenylethynyl-1,3-dihydrophenylhydrazone [b][l,4]dioxepin-2-one, in the second The palladium-catalyzed carbonylation in the presence of a hydrazine directly leads to the corresponding guanamine as shown in the synthetic scheme I. Example 95 3-[8-(2-Methoxy-ethoxy)-4.one Benzyl-7-phenylethylidene-4,5-dihydro-3H-benzoquinone[b][l,4]dioxan-2-yl]-benzamide-162- This paper size applies China National Standard (CNS) A4 specification (210 X 297 mm) &quot; -------------- Pack--- (Please read the notes on the back and then ^|?) I - I-line · Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 1255266 A7 B7 V. Invention description (160) According to the general procedure Q 'from 4-(3-breaking winter base)-7-(2-A乳-乙乙基)-8_phenylethynyl-1,3-dihydrophenylhydrazone [b][l,4]dioxan-2-one (Example 25) (268 mg, 0.5 mmol) And hexamethyldioxane (0.52 ml, 2.5 mmol). Obtained as a yellow solid (102 mg). MS (EI) 453 (M+); mp 227-230 ° C (decomposition). The tablets are made in the usual way: mg /Tablet active ingredient 100 Powdered lactose 95 White corn starch 35 Polyvinyltetrahydropyrrolidone 8 Nacarboxymethyl starch 10 Magnesium stearate 2 Tablet weight 250 Example II Tablets of the following composition are prepared by conventional means成··mg/tablet (please read the note on the back page first) Binding - 1·丨线· Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed Active Ingredients 200 Powdered Lactose 100 White Corn Starch 64 Polyethylene Four Hydropyrrolidone 12 Na Methyl Starch 20 Magnesium Stearate ' 4 Tablets Weight 400 Γ -163- This paper size applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1255266 A7 B7 V. Invention Description (161 capsules 50 60 34 5

實例III 製造下列組成之膠囊: 毫克 活性成份 結晶性乳糖 微晶性纖維素 滑石 硬脂酸鎂 1 膠囊填充物重量150 將具有適當粒子大小之活性成份、結晶性乳糖及微晶性 纖維素,肖句地互相混合’筛遽,然後與滑石及硬脂酸幾 互混。將最後混合物填入適當大小、 ~ j &lt;硬明膠膠囊中。 -----------------Γ (請先閱讀背面之注意事項本頁) 二叮 經濟部智慧財產局員工消費合作社印製 164 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐)EXAMPLE III Capsules of the following composition: mg active ingredient crystalline lactose microcrystalline cellulose talc magnesium stearate 1 capsule filling weight 150 active ingredient with appropriate particle size, crystalline lactose and microcrystalline cellulose, xiao The sentences are mixed with each other's sieves, and then mixed with talc and stearic acid. The final mixture is filled into an appropriate size, ~ j &lt; hard gelatin capsule. -----------------Γ (Please read the note on the back page first) Ericsson Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative print 164 This paper scale applies to Chinese national standards ( CNS) A4 size (210 X 297 mm)

Claims (1)

I255· 9120913號專利申請案 中文申請專利範圍替換本(94年10) 六、申請專利範圍 A8 B8 C8 D8 94·ΐα _Patent application No. I255·9120913 Chinese patent application scope replacement (94 years 10) VI. Patent application scope A8 B8 C8 D8 94·ΐα _ 1· 一種通式(I)之苯并二吖庚因衍生物,A benzodioxine derivative of the formula (I), 其中 X為單键或乙块二基,其中 若X為單鍵,貝IJ 1^為_素或苯基’其係未經取代或經由素或C&quot;燒基取 代; 若X為乙块二基,則 R1為苯基,其未經取代或經!I素取代. R2為齒素;羥基;Cl-7燒基;Cl.7烷氧基;羥甲基;羥 乙氧基;C丨-7燒氧基_(乙氧基)η(η:=ι至4); c】-7燒氧基甲 基;氰基甲氧基;嗎福淋-4-基;硫代嗎福琳_4_基;卜嗣 基硫代嗎福啉斗基;u_二酮基硫代嗎福啉斗基;4_酮基_ 六氫P比咬小基;4-C&quot;燒氧基-六氫峨基;4-經基-六 氫吡咬-i-基;4-經乙氧基-六氫吡咬小基;4Χ]·7坑基.六 氫心井-基;Cm*充氧談基;2&lt;Ci-7燒胺基-乙疏基· ,N,N-雙c ! . 7烷基胺基c ! - 7燒基;胺甲醯基甲基;c ! · 7 烷氧基羰基-C&quot;烷基;Cl·”充基羧基_Ci 7烷基;羧 基-Cm烷基;C】·7烷氧羰基甲硫基;羧甲硫基;以二 氧I氮-螺[4.5]癸各基;羧基-Cy烷氧基;氰基_Ci.7烷 本紙張尺度適用中國國家標準(CNS) A4規格(210X297公釐) 1255266 、申請專利範圍 基;2,3-二羥基X】-7烷氧基;胺甲醯基甲氧基;2•酮基. [1,3]-二氧伍圜冰基Χι-7垸氧基;(2·羥基Xl·7烷基)χΐ7 燒胺基;羥基胺甲醯基-C】.7烷氧基;2,2-二甲基-四氯 [1,3]二氧伍圜并[4,5〇μ比咯士基;C】j烷氧基_胺甲酿^ _ C〗-7烷氧基;3R-羥基·四氫吡咯+基;3,4•二羥基-四氫吡 =小基;2-酮基-今咬啶-3_基;Cl_7烷基_胺甲醯基甲氧 R3為苯基、噻吩基或吡啶基,其未經取代或經_素、氰 基或胺甲醯基取代; ^ 或經咪唑基,H3-三唑基,〗,2,4_三唑基;異呤唑 基取代,該等取代基本身係未經取代或經C】·7燒基或 C 1 · 7烷基磺醯基取代; 1 及其藥學上可接受之加成鹽。 2··根據中請專利範圍第!項之衍生物,其中r3為在間位上 被取代 &lt; 苯基,取代基為氰基、_素或咪唑基(其係未 經取代或經C〗j烷基或甲硫基取代),三唑基、 =广三唑基或異呤唑基(其係未經取代或經c ^ 7烷^取 3·根據申請專利範圍第2項之衍生物,其係為 氯基-4-酮基-7-苯基乙炔基·4,5^Α.苯并_,4]二叮 庚因-2-基)-苯甲腈; 3-[8-(4-甲基-六氫吡畊]•基)斗酮基苯|乙炔基·4,5_二氫-3Η-苯并[b][l,4]二吖庚因_2_基]_苯甲腈; 氯基-4-酮基-7·苯基妙二氫视苯并[哪,4]二口丫庚因j -2 本紙張尺度適用中® @家料(CNS) A4規格(21〇 X 297公釐) 1255266 A BCD —----- 六、申請專利範圍 基)-苯甲腈; [4-(3-氰基-苯基&gt;2-酮基·8_苯基乙块基-y-二氫-苯并 [b][l,4]一 口「庚因-7-基硫基]-醋酸甲@旨; 2 [4-(3-氰基-苯基)_2_g同基各苯基乙块基_2,3_二氫苯并 [b][M]—叶庚因-7-基]-乙酸胺; 3-(心甲氧基-4-酮基-7-苯基乙炔基-4,5-二氫-3H-苯并[b][l,4]二 p丫庚因1基)-苯甲腈; 3- 屮氰基甲基冬酮基·7-苯基乙炔基_4,5_二氫_犯·苯并[吨^] 二吖庚因-2-基)-苯甲腈; 4 (3破苯基)-7-(2-甲氧基_乙氧基苯基乙炔基_丨,3_二氫苯 并[b][l,4]二吖庚因-2-酮; 4- (3-咪唑+基_苯基)-7-(2-甲氧基·乙氧基)各苯基乙炔基·^ 二氫苯并[b][l,4]二吖庚因-2-酮; [RS]-3-[4·酮基-8-(2-朗基-[1,3]二氧伍圜冰基甲氧基)_、苯基乙 炔基4,5-二氫-3H-苯并[b][l,4]二吖庚因-2-基]-苯甲腈; 7- 羥甲基冰(3-咪唑+基-苯基&gt;8•苯基乙炔基二氫苯并 [b][l,4]二吖庚因-2_酮; [4-(3-咪唆-1-基-苯基)-2_酮基各苯基乙炔基_2,3_二氫·iH_苯并 [b][l,4]二吖庚因π基氧基 &gt; 乙腈; 8- (4-敦苯基乙块基)_7_經曱基冰(3·»咪峻-1-基-苯基)-i,3-二氫 苯并[b][l,4]二吖庚因-2-酮; 7- (2-¾基-乙氧基)冰(3-咪唑-1-基-苯基)_8_苯基乙炔基·丨义二 氫苯并[b][l,4]二吖庚因-2-銅; 8- (4-氟苯基)-7-[4-(2-經基-乙氧基)_六氫吡啶基]冬〇咪唑_ -3- 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 1255266Wherein X is a single bond or an ethylenic diyl group, wherein if X is a single bond, the shell IJ 1^ is _ or phenyl' which is unsubstituted or substituted by a saccharin or a C&quot;alkyl group; if X is a block II Base, then R1 is phenyl, which is unsubstituted or passed! I substituted. R2 is dentate; hydroxyl; Cl-7 alkyl; Cl.7 alkoxy; hydroxymethyl; hydroxyethoxy; C丨-7 alkoxy _(ethoxy) η (η: =ι to 4); c]-7 alkoxymethyl; cyanomethoxy; whal-4-yl; thiofenoflavin _4_yl; dithiol thioporfosin; _diketothio-fosfosin bucket base; 4-keto group _ hexahydro-P ratio bite base; 4-C&quot;alkoxy-hexahydroindenyl; 4-thio-hexahydropyridyl-i- Base; 4-ethoxy-hexahydropyridyl small base; 4Χ]·7 pit base. Hexahydroxin well-base; Cm* oxygenated base; 2&lt;Ci-7 aromatine-ethylidene , N,N-double c ! . 7 alkylamino c - 7 alkyl; amine methyl hydrazino methyl; c ! · 7 alkoxycarbonyl-C &quot;alkyl; Cl · "charged carboxyl group _Ci 7 alkyl; carboxy-Cm alkyl; C]·7 alkoxycarbonylmethylthio; carboxymethylthio; dioxyl nitrogen-spiro[4.5]fluorenyl; carboxy-Cy alkoxy; cyano The Ci.7 alkane paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) 1255266, the scope of the patent application; 2,3-dihydroxyX]-7 alkoxy; amine mercaptomethoxy; 2•keto group. [1,3]-dioxoanthene ice-based Χι-7垸 oxygen (2. hydroxy Xl.7 alkyl) χΐ7 acrylamine; hydroxyamine-methane-C-.7 alkoxy; 2,2-dimethyl-tetrachloro[1,3]dioxo And [4,5〇μ 比罗士基; C]j alkoxy_amine 甲^^ _ C -7-7 alkoxy; 3R-hydroxy·tetrahydropyrrole+ group; 3,4•dihydroxy-four Hydropyridyl = small group; 2-keto-indanyl-3-yl; Cl_7 alkyl-amine-mercaptomethoxyl R3 is phenyl, thienyl or pyridyl, unsubstituted or via cyano Substituted by an amine or an aminomethyl group; ^ or via an imidazolyl group, H3-triazolyl, 〗 2, 4-triazolyl; isoxazolyl substituted, the substituents are unsubstituted or C] 7 alkyl or C 1 · 7 alkylsulfonyl substituted; 1 and its pharmaceutically acceptable addition salt. 2 · According to the patent scope of the scope of the derivative of the item, where r3 is in the meta position Substituted &lt; phenyl, the substituent is cyano, _ or imidazolyl (which is unsubstituted or substituted by C alkyl or methylthio), triazolyl, = wide triazolyl or isoxazole a group (which is unsubstituted or substituted by c ^ 7 alkane). 3. According to the derivative of claim 2, which is a chloro-4-keto-7- Phenylethynyl·4,5^Α.Benzo-,4]dioxaheptan-2-yl)-benzonitrile; 3-[8-(4-methyl-hexahydropyrazine)•yl) Benzenyl benzene|ethynyl·4,5-dihydro-3Η-benzo[b][l,4]dioxine-2-yl]benzonitrile; chloro-4-keto-7 · Phenyl dihydrogen benzo [, 4] two 丫 因 j j j j j j j j j j j j j j j j j j j j j j j j j j j j j j j b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b b --- Six, the scope of the patent application base) - benzonitrile; [4-(3-cyano-phenyl) 2-keto-8-phenylethylidene-y-dihydro-benzo[b ][l,4] A "gyne-7-ylthio"-acetic acid@@; 2 [4-(3-cyano-phenyl)_2_g homophenyl phenyl bromide_2,3_ Dihydrobenzo[b][M]-ephedos-7-yl]-acetic acid amine; 3-(cardiomethoxy-4-keto-7-phenylethynyl-4,5-dihydro- 3H-benzo[b][l,4]dipyridin-1-yl)-benzonitrile; 3-decanocyanomethylbutanyl-7-phenylethynyl-4,5-dihydro_ Benzene [ton^] dioxin-2-yl)-benzonitrile; 4 (3 phenyl)-7-(2-methoxy-ethoxyphenylethynyl 丨, 3 _Dihydrobenzo[b][l,4]dioxepin-2-one; 4-(3-imidazole+yl-benzene - 7-(2-methoxyethoxy) phenylethynyl·^ Dihydrobenzo[b][l,4]dioxepin-2-one; [RS]-3-[ 4-keto-8-(2-Langyl-[1,3]dioxoanthracene methoxy)-, phenylethynyl 4,5-dihydro-3H-benzo[b][l , 4] dioxin-2-yl]-benzonitrile; 7-hydroxymethyl ice (3-imidazole + phenyl-phenyl &gt; 8 phenyl ethynyl dihydro benzo[b][l, 4] Dioxepin-2-one; [4-(3-Min-1-yl-phenyl)-2-keto-phenylphenylethynyl-2,3-dihydro-iH_benzo[ b][l,4]dioxine π-yloxy&gt;acetonitrile; 8-(4-d-phenylphenyl)- 7-7-based thiol ice (3·»imiban-1-yl-phenyl )-i,3-dihydrobenzo[b][l,4]dioxepin-2-one; 7-(2-3⁄4-yl-ethoxy) ice (3-imidazol-1-yl-benzene _8_phenylethynyl-pyridyldihydrobenzo[b][l,4]dioxepin-2-copper; 8-(4-fluorophenyl)-7-[4-(2- Mercapto-ethoxy)-hexahydropyridyl]whenimidazole _ -3- This paper scale applies to Chinese National Standard (CNS) A4 specification (210X 297 mm) 1255266 A BCD 1-基-苯基H,3-二氫苯并[b][M]二吖庚因·2_酮; 苯基)-7遗基邻-咪也小基-苯基-二氫苯并_,4] —叶庚因-2-酉同; 8-(2_氟苯基π甲氧基邻♦甲基_味峻小基)_苯基⑷_二氫 表并[b][l,4]二 ρ丫庚因·2__ ; 8-(2_氟苯基&gt;7_羥基-4-(3-[1,2,3]三峻小基-苯基出二氫苯并 [b][l,4]二吖庚因 _2_酮; 8-(2-氟苯基&gt;7_羥基·4_[3_(2_甲基_咪唑·丨_基)_苯基Η}二氫苯 并[b][l,4]二吖庚因_2_酮; 8-(2-氟苯基)-7-羥基冰[3·(2·甲硫基_咪唑+基)·苯基3_二氫 苯并[b][l,4]二吖庚因冬酮; 心(2,5-二氟苯基甲氧基-4-(3-[152,3]三唑]•基_苯基二 氫苯并[b][l,4]二吖庚因·2_酮; 8-(2-氟苯基)-7-羥基-4-[3-(3-甲基_異吟唑_5_基)_苯基]二氫 苯并[b][l,4]二吖庚因-2_酮; 3-[7-(2,5-二氟苯基)-8-羥基冰酮基-4&gt;二氫_3Η_苯并[b][14]二 口 f庚因-2-基]-苯甲猜; 8-(4-氟苯基乙炔基);羥基冰(3-咪唑+基_苯基Η》二氫苯 并[b][l,4]二吖庚因冬酮;及 5 8-(4-氟苯基乙块基&gt;7·羥基-4_(3_[l52,3]三唑小基-苯基)^―二 氫苯并[b][l,4]二吖庚因-2·酮。 4.根據申請專利範圍第1項之衍生物,其中”為^塞吩基(其 係未經取代或經氰基或函素取代)或吡咬基(在2_位置上 係未經取代或經氰基或函素取代)。 -4- 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 1255266 A BCD 申請專利範圍 5·根據申請專利範圍第4項之衍生物,其係為 5-|&gt;(2-氟苯基)各甲氧基冰酮基二氫_阳-苯并[研丨⑷二吖 庚因-2-基ρ塞吩-2-甲腈; 2-[7-(2·氟苯基)-8-羥基冰酮基_4&gt;二氫苯并[b][14]二吖庚 因-2-基]-嘧吩各甲腈; 4 [7-(2-氟苯基)各甲氧基冰酮基_4,5-二氫-3H-苯并[b][l,4]二吖 庚因-2-基]-ρ比沒-2-甲腈; 4-[&gt;(4-說苯基)各經基冰酮基-4,5-二氫-3H-苯并[b][l,4]二吖庚 因-2-基]-吡啶-2-甲腈;及 4-[7-(2-氟苯基)-8-羥基冰酮基-4,5-二氫-3H-苯并[b][l,4]二吖庚 因-2-基]-p比咬-2-甲腈。 6· —種治療急性及/或慢性神經病症之醫藥組成物,其含 有一或多種根據申請專利範圍第1至5項中任一項之衍 生物’及藥學上可接受之賦形劑。 7.根據申請專利範圍第6項之醫藥組成物,其中該急性及 /或慢性神經病症包括精神病、精神分裂症、阿耳滋海 默氏疾病、認知病症及記憶不足。 8· —種製備根據申請專利範圍第丨項之苯并二吖庚因衍生 物之方法,此方法包括使式π化合物A BCD 1-yl-phenyl H,3-dihydrobenzo[b][M]dioxepin-2-one; phenyl)-7-redomyl-imidinyl-phenyl-dihydro Benzo-,4]-ylidene-2-anthracene; 8-(2-fluorophenylπmethoxy-o-methyl-methyl------------- [l,4]2ρ丫gine·2__ ; 8-(2-fluorophenyl)-7-hydroxy-4-(3-[1,2,3]tristiminyl-phenyl-dihydrobenzene And [b][l,4]dioxine-2-one; 8-(2-fluorophenyl&gt;7-hydroxy.4_[3_(2_methyl-imidazolium)-phenyl) Η}Dihydrobenzo[b][l,4]dioxine-2-one; 8-(2-fluorophenyl)-7-hydroxy ice [3·(2·methylthio-imidazole+yl) )·Phenyl 3_dihydrobenzo[b][l,4]dioxanone; heart (2,5-difluorophenylmethoxy-4-(3-[152,3]3 Azole]-yl-phenyldihydrobenzo[b][l,4]dioxepin-2-one; 8-(2-fluorophenyl)-7-hydroxy-4-[3-(3- Methyl-isoxazole_5_yl)-phenyl]dihydrobenzo[b][l,4]dioxepin-2-one; 3-[7-(2,5-difluorophenyl) )-8-hydroxycryl group-4&gt;dihydro-3-indole_benzo[b][14]di-f-h-hept-2-yl]-benzica; 8-(4-fluorophenylethynyl) Hydroxyl ice (3-imidazole + phenyl-phenyl) Η"Dihydrobenzo[b][l,4]dioxanone; and 5 8-(4-fluorophenylethyl)&gt;7-hydroxy-4_(3_[l52,3]triazole Small base-phenyl)^-dihydrobenzo[b][l,4]dioxan-2-one. 4. A derivative according to the first aspect of the patent application, wherein "is thiophene ( It is unsubstituted or substituted by cyano or genomic or pyridyl (unsubstituted at the 2 position or substituted with cyano or genomic). -4- This paper scale applies to Chinese national standards (CNS) A4 size (210X 297 mm) 1255266 A BCD Patent Application No. 5: A derivative according to item 4 of the patent application, which is 5-|&gt;(2-fluorophenyl) methoxy ketone base Dihydro-cation-benzo[Rigmentary (4) Dioxepyn-2-yl-p-phen-2-ylcarbonitrile; 2-[7-(2.fluorophenyl)-8-hydroxyecroleinyl_4&gt; Dihydrobenzo[b][14]dioxan-2-yl]-pyrimidine each carbonitrile; 4 [7-(2-fluorophenyl) methoxy ketone group _4,5-di Hydrogen-3H-benzo[b][l,4]dioxan-2-yl]-p is not-2-carbonitrile; 4-[&gt;(4-phenylene) thioglycolate 4--4,5-dihydro-3H-benzo[b][l,4]dioxan-2-yl]-pyridine-2-carbonitrile; 4-[7-(2-fluorophenyl)-8-hydroxyecrocarbyl-4,5-dihydro-3H-benzo[b][l,4]dioxan-2-yl]-p Than 2-acetonitrile. A pharmaceutical composition for treating an acute and/or chronic neurological condition, which comprises one or more derivatives according to any one of claims 1 to 5 and a pharmaceutically acceptable excipient. 7. A pharmaceutical composition according to claim 6 wherein the acute and/or chronic neurological condition comprises psychosis, schizophrenia, Alzheimer's disease, cognitive condition and memory deficiency. 8. A method of preparing a benzodiazepine derivative according to the scope of the patent application, the method comprising -5- 本紙張尺度it财Η ®家鱗(CNS) Μ規格(21G χ 297公潑) Ϊ255266 圍範 利 專請 中 A BCD 在8 〇 C至1 6 0 °C間之溫度下與式IV或IVa化合物反應 或 CO.R IV IVa 其中R為乙基或丁基,而成為式冚化合物-5- The paper size it is Η 家 家 家 家 家 家 家 家 家 家 家 Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ Ϊ B B B B B B Or IVa compound reaction or CO.R IV IVa wherein R is ethyl or butyl, and becomes a hydrazine compound 接耆進行胺基之去保護作用,及環化作用,而得根據申 請f利範圍第丨項之式!衍生物,其中去保護_環化步驟 係藉由式III化合物與布朗司特酸(Br〇nsted acid)在 〇 C與5 0 °C間之溫度下反應。 9. 根據巾請專利範圍第丨至5項中任—項之衍生物,其係 =於治療急性及/或慢性神經病症,包括精神病、精神 刀表症、阿耳滋海默氏疾病、認知病症及記憶不足。 10. 一種根據中請專利範圍第liL5項中任_项^衍生物用 於製造藥劑的用途,該藥劑係用於治療急性及/或慢性 神經病症,包括精神病、精神分裂症、阿耳滋海默^疾 病、認知病症及記憶不足。 -6- 本紙張尺度it 财酬家β^Ν8)Α4ϋ·(21〇χ2ϋ--------The deprotection of the amine group and the cyclization are carried out, and the formula of the scope of the application is obtained according to the scope of the application! The derivative, wherein the deprotection-cyclization step is carried out by reacting a compound of formula III with Brünnsted acid at a temperature between 〇 C and 50 °C. 9. According to the patents of the scope of the patents, from the fifth to the fifth, the derivatives are for the treatment of acute and / or chronic neurological disorders, including mental illness, mental knife disease, Alzheimer's disease, cognition Insufficient illness and memory. 10. Use of a derivative according to item liL5 of the scope of the patent application for the manufacture of a medicament for the treatment of acute and/or chronic neurological disorders, including psychosis, schizophrenia, Alzheimer Silent disease, cognitive illness and lack of memory. -6- The paper scale it financial rewards β^Ν8)Α4ϋ·(21〇χ2ϋ--------
TW89120913A 2000-10-06 2000-10-06 Benzodiazepine derivatives TWI255266B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW89120913A TWI255266B (en) 2000-10-06 2000-10-06 Benzodiazepine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW89120913A TWI255266B (en) 2000-10-06 2000-10-06 Benzodiazepine derivatives

Publications (1)

Publication Number Publication Date
TWI255266B true TWI255266B (en) 2006-05-21

Family

ID=37613196

Family Applications (1)

Application Number Title Priority Date Filing Date
TW89120913A TWI255266B (en) 2000-10-06 2000-10-06 Benzodiazepine derivatives

Country Status (1)

Country Link
TW (1) TWI255266B (en)

Similar Documents

Publication Publication Date Title
TWI280245B (en) Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
EP3331876B1 (en) Modulators of ror-gamma
TW577878B (en) A pharmaceutical composition having agonist-like activity selective at alpha 2B and 2B/2C adrenergic receptors
US6407094B1 (en) Glutamate receptor antagonists
JP6289485B2 (en) Heteroaryl inhibitors of PDE4
JP4018736B2 (en) Pyrazolo [1,5-A] [1,3,5] triazine derivatives as cannabinoid receptor ligands
TW316904B (en)
JP4041153B2 (en) Cannabinoid receptor ligands and uses thereof
KR100674560B1 (en) Purine Compounds and Uses Thereof as Cannabinoid Receptor Ligands
TWI333488B (en) Pyrazole derivatives, the pharmaceutical composition including such compounds, the compounds for use as a medicament, a reverse transcriptase inhibitor or modulator, for use in the treatment of an hiv infection or a resulting acquired immune deficiency s
NL1026029C2 (en) Cannabinoid receptor ligands and their applications.
NL1031473C2 (en) Cyclopentapyridine and tetrahydroquinoline derivatives.
JP2006514942A (en) Pyrazole and imidazole compounds and their use
RU2270197C2 (en) DERIVATIVES OF DIHYDROBENZO[b][1,4]DIAZEPINE-2-ONE AS I mGluR2 ANTAGONISTS
US20110166146A1 (en) IMIDAZO[1,2-a]PYRIDINE COMPOUNDS
WO2007055418A1 (en) Aza-substituted spiro derivative
JP2021530451A (en) Ligand for cereblon (CRBN)
MXPA05004115A (en) Cannabinoid receptor ligands and uses thereof.
JP2004533447A (en) Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
JP2010111624A (en) Indazole derivative having ttk inhibitory action
WO2007037534A1 (en) 2-heteroaryl-substituted indole derivative
JP2008531679A (en) 1,2,4-Triazole derivatives and their use as oxytocin antagonists
JP2012502979A (en) Pyrazolopyridine derivatives as NADPH oxidase inhibitors
AU2003235259B2 (en) Benzimidazole derivatives
TW200526625A (en) Pharmaceutically active compounds

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees